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ABSTRACT 
Medicines Reconciliation: Roles and Process 
Rachel Urban 
Keywords Medicines Reconciliation; Hospital Admission; Medication History 
Taking; Hospital Discharge; Health Care Professionals; Patient Involvement; 
Patient Safety; Human Factors; Medication Safety; Care Transitions 
 
Medication safety and improving communication at care transitions are an 
international priority.  There is vast evidence on the scale of error associated 
with medicines reconciliation and some evidence of successful interventions to 
improve reconciliation.  However, there is insufficient evidence on the factors 
that contribute towards medication error at transitions, or the roles of those 
involved.  This thesis examined current UK medicines reconciliation practice 
within primary and secondary care, and the role of HCPs and patients.  Using a 
mixed-method, multi-centre design, the type and severity of discrepancies at 
admission to hospital were established and staff undertaking medicines 
reconciliation across secondary and primary care were observed, using 
evidence-informed framework, based on a narrative literature review. 
The overall processes used to reconcile medicines were similar; however, there 
was considerable inter and intra-organisational variation within primary and 
secondary care practice.  Patients were not routinely involved in discussions 
about their medication, despite their capacity to do so.    Various human factors 
in reconciliation-related errors were apparent; predominantly inadequate 
communication, individual factors e.g. variation in approach by HCP, and 
patient factors e.g. lack of capacity.  Areas of good practice which could reduce 
medicines reconciliation-related errors/discrepancies were identified.  There is a 
need for increased consistency and standardisation of medicines reconciliation-
related policy, procedures and documentation, alongside communication 
optimisation.  This could be achieved through a standardised definition and 
taxonomy of error, the development of a medicines reconciliation quality 
assessment framework, increased undergraduate and post-graduate education, 
improved patient engagement, better utilisation of information technology and 
improved safety culture.  
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GLOSSARY OF TERMS 
 
Active Failure 
An active failure is an unsafe act (error or violation) committed by those with 
direct contact with the patient. 
 
Addition (also known as commission) 
The accidental prescription of a medication to the patient’s current treatment 
regimen following inaccurate medication history taking. 
 
Adverse Drug Event (ADE) 
An injury resulting from the use of a drug. 
 
Caldicott Guardian 
A senior person responsible for protecting the confidentiality of patient and 
service-user information and enabling appropriate information-sharing within an 
organisation.  
 
Care Home 
A home for people who need continuous medical treatment or who are unable 
to look after themselves. 
 
Care Setting 
A setting where people receive care.  It may include hospitals, nursing homes, 
residential homes, a patient’s own home or intermediate care. 
 
Care Transition 
The movement of patients between healthcare locations, providers or different 
levels of care within the same location, as their condition and care needs 
change. 
 
Clerking 
To take a full medical history, perform a physical examination, record the 
findings in the patient’s notes, then write a care plan for the patient. 
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Clinical Check 
A clinical review of the inpatient medication chart (IMC) to determine problems 
such as over and under dosing, interactions and missing or innappropriate 
information such as the form, strength or dosage of the medication.  The clinical 
check can be conducted to varying degrees.  A basic chart review would usually 
be conducted without the use of extra information such as the presence of the 
clinical notes, the patient or test results compared with a full chart review where 
these items would be present. 
 
Clinical Commissioning Groups (CCGs)  
NHS organisations set up by the Health and Social Care Act 2012 to organise 
the delivery of NHS services in England. They replace some of the functions of 
primary care trusts (PCTs), which ceased to exist in April 2013.   
 
Commissioning for Quality and Innovation (CQUIN) 
A framework to support improvements in the quality of services and the creation 
of new, improved patterns of care, within the NHS. 
 
Complementary and Alternative Medicines (CAMs) 
Non-conventional approaches to healing, beyond traditional medicine. 
Complementary medicine is any form of therapy used in combination with other 
alternative treatments or standard/conventional medicine. Alternative medicine 
is used alone without recommended standard treatment. 
 
Counsel  
To provide the patient with information and advice on how to take/use their 
medication. 
 
Core Training Year 1 (CT1) & Core Training Year 2 (CT2) 
Following two years of foundation year training, doctors who wish to specialise 
within hospital may progress on to a further two years of generic training before 
entering their specialty. 
 
Delphi Approach 
A process for merging opinion on a specific topic or issue.  
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Discharge Summary  
A clinical report prepared by a physician or other health professional at the end 
of a hospital stay. It outlines the patient's reason for admission, the diagnostic 
findings, the treatment received, and recommendations on discharge including 
medication. 
 
E-discharge Summary 
An electronically produced discharge summary.  In some instances this is 
transmitted electronically to the recipient. 
 
Electronic Health Record (EHR) 
An electronic version of a patient’s medical history, maintained by a provider or 
several providers over time.  It includes clinical data relevant to the persons 
healthcare, including demographics, progress notes, consultations, 
medications, immunisations and laboratory reports. 
 
Executive Walk Round 
Visits by hospital executives to patient care areas to discuss patient safety 
issues with providers. 
 
Foundation Year 1 (FY1) & Foundation Year 2 (FY2) 
The two-year, general postgraduate medical training programme, which bridges 
medical school and specialist/general practice training. It is compulsory for all 
newly qualified medical practitioners in the UK. 
 
Grandparenting 
The ‘grandparenting’ arrangements for pharmacy technicians were put in place 
to ease the transition to regulation for pharmacy technicians. Up until midnight 
on the 30th June 2011 an individual with the relevant work experience and 
qualifications could apply to register as a pharmacy technician without 
undertaking specific technician training. 
 
Guidelines 
A rule, principle or recommendation of good practice, which is often based on 
evidence obtained from research and/or from a broad body of experience from 
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multiple contributors, often a body of experts in a particular discipline e.g. a 
professional body. 
 
Handover 
The transfer of responsibility and accountability between one or more clinicians 
on a temporary or permanent basis. 
 
Healthcare Professional (HCP) 
A person who by education, training, or certification is qualified to and is 
engaged in providing healthcare, for example, a doctor, pharmacist, nurse. 
 
High Reliability Organisation (HRO) 
An organisation that has succeeded in avoiding catastrophes in an environment 
where normal accidents can be expected due to risk factors and complexity. 
 
Inpatient Medication Chart (IMC) 
An A4-sized document/ booklet which provides a running log of the medications 
ordered by a prescriber.  It is usually kept at the bedside of an inpatient or 
retained with the patient’s medical records at the nursing station. 
 
Intentional round 
To implement hourly nursing rounds, to check on patients and ensure their 
fundamental care needs are met. 
 
Interdisciplinary Rounding 
The planning and evaluation of patient care with health professionals from a 
variety of other health disciplines. 
 
Intermediate Care 
The term used for a range of services that deliver short term care, support or 
rehabilitation to patients. It bridges the gap between hospital and home, helping 
patients recover more quickly, so they can cope in their own home, preventing 
either unnecessary admission to hospital or allowing earlier discharge to 
patients who are medically fit but need some rehabilitation.  
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Latent Failure 
A latent failure is an organisational or managerial failure for example lack of 
policy and/or procedure. 
 
Lean Methodology 
Lean is an improvement approach to improve flow and eliminate waste 
 
Liverpool Care pathway (LCP) 
An integrated care pathway recommended as a best practice model by the UK 
Department of Health, used in the last hours and days of life. It is to be replaced 
this year with the ‘End of Life Care Plan’. 
 
Medication Error 
A failure in the treatment process that leads to, or has the potential to lead to, 
harm to the patient. 
 
Medication formulary 
A list of drugs which is evidence based and cost-effective that enables health 
practitioners to prescribe treatment that is medically appropriate.  
 
Medicines Use Review (MUR) 
An advanced service offered by pharmacies in the United Kingdom. It is part of 
the contract pharmacies hold with the National Health Service (NHS).  The 
patient is provided with an opportunity to discuss their medicines use with a 
qualified pharmacist. 
 
National Institute for Health and Care Excellence (NICE) 
Provides national guidance and advice to improve health and social care in the 
UK. 
 
National Patient Safety Agency (NPSA) 
An Arm’s Length Body of the Department of Health which improves safe 
patient care by informing, supporting and influencing organisations and people 
working in the health sector in the UK. 
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Outlier 
Hospital inpatients who are allocated a bed on a hospital ward which is not 
clinically appropriate for their illness due to a lack of inpatient beds.  Also 
commonly named ‘sleep-outs’ or ‘boarders’. 
 
Over the Counter (OTC) medication 
Medicines sold directly to a patient without a prescription, usually from a 
community pharmacy. 
 
Potential Adverse Drug Event (PADE) 
A ‘serious error or mishap that has the potential to cause an adverse event but 
fails to do so because of chance or because it is intercepted (also called ‘near 
miss’ or ‘close call’)’. 
 
Primary Care  
Primary care is the local healthcare received from GPs, NHS-walk-in centres, 
dentists, pharmacists and optometrists in the UK. They were provided and 
managed by PCTs up until April 2013.  They are now managed by NHS 
England.  
 
Primary Care Trust 
Primary care trusts (PCTs) were, up until April 2013, the statutory bodies in 
England responsible for ensuring NHS services were available in a defined 
geographical area and for improving the health of people living in that area. 
They have been superseded by NHS England. 
 
Process 
A sequence of interdependent and linked procedures which, at every stage, 
consume one or more resources (e.g. employee time, energy, machines, 
money) to convert inputs (data, material, parts, etc.) into outputs. These outputs 
then serve as inputs for the next stage until a known goal or end result is 
reached. 
 
Procedure 
A series of steps taken to accomplish an end.  
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Protocol 
The accepted or established code of procedure or behaviour in any group, 
organisation, or situation. 
 
Policy 
A statement of intent by an organisation to follow a particular course of action. 
 
Post-take ward round (PTWR) 
The first ward round where patients are seen by doctors following emergency 
admission. 
 
Read Codes  
A catalogue of codes which represent clinical terms for example diagnoses and 
investigations.  They are used to record patient findings and procedures in UK 
health and social care Information Technology (IT) systems across primary and 
secondary care e.g. General Practice and pathology reporting.  The codes 
enable efficient electronic communication and support activity reporting, 
payments, audit, and research. 
 
SBAR (Situation, Background, Assessment, Recommendation) 
A structured method for communicating critical information that requires 
immediate attention and action contributing to effective escalation and 
increased patient safety. 
 
Secondary Care  
Secondary (or 'acute') care is the healthcare received in hospital. It may be 
unplanned emergency care or surgery, or planned specialist medical care or 
surgery.  
 
Shared Care 
A model of integrated healthcare delivery where practitioners of different 
disciplines or with different skills and knowledge collaborate to allow the most 
appropriate healthcare practitioner to deliver patient care.  
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Six Sigma 
A service improvement technique which seeks to improve the quality of process 
outputs by identifying and removing the causes of errors and minimise 
variability in processes. 
 
Specialist Registrar (SpR) 
A doctor who has completed their foundation and core training and has begun 
to specialise 
 
Specials 
'Specials' are special-order unlicensed medicines made to meet the needs of an 
individual patient. 
 
System 
A set of principles or procedures according to which something is done; an 
organised scheme or method. 
 
SystmOne 
An electronic health record (EHR) predominantly used in primary care, mainly 
general medical practices.  Its unique feature is that it allows sharing of the 
patient’s EHR between HCPs and organisations. 
 
Workforce 
The people engaged in or available for work, either in a country or area or in a 
particular firm or industry. 
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ABBREVIATIONS 
A&E Accident and Emergency 
ACE Angiotensin Converting Enzyme 
ADE Adverse Drug Event 
ADR Adverse Drug Reaction 
AHRQ Agency for Healthcare Research and Quality 
APhA American Pharmacist Association 
APHID Automated Patient History Intake Device 
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BMJ  British Medical Journal 
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BP Blood Pressure 
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EHR   Electronic Health Record 
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CHAPTER 1 INTRODUCTION 
1.1  Background 
‘The single biggest problem in communication is the illusion that it has 
taken place.‘        
George Bernard Shaw  
‘If you can't describe what you are doing as a process, you don't know 
what you're doing.‘ 
       William Edwards Deming  
Within the current United Kingdom (UK) healthcare system many patients will 
repeatedly transition from one healthcare organisation to another.  The general 
lack of one unified patient healthcare record within the National Health Service 
(NHS) means that at each transition point information regarding a patient’s 
previous medical history must be ascertained, including information about their 
medication.  This is most apparent during transitions between hospital and 
primary care.  At admission, the hospital relies on information and 
communication from various sources to pull together a picture of previous 
health and treatment. Similarly, at discharge, primary care relies on the hospital 
providing relevant information on treatment and changes made to treatment 
during the patients stay, including any changes to medication.   Without 
relevant, comprehensive communication there is an increased risk of error and 
patient harm.  This can be due to inappropriate omission, addition or alteration 
of treatment.  Throughout the patient’s journey, as they transition between 
healthcare settings, different healthcare professionals (HCPs) undertake a 
series of tasks to try to ensure accurate ‘reconciliation’ of information regarding 
medication.  This thesis aims to examine, and critically appraise the medicines 
reconciliation processes at transition points in care in order to better understand 
the roles of HCPs, the potential reasons why medication error occurs at 
transitions and reveal good practices which have been implemented to prevent 
this type of error occurring.  The analysis and subsequent recommendations will 
take into account current thinking in patient safety, including a human factors 
and systems perspective.  
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1.2  Patient Safety 
Quality and patient safety are high on the international1-5 and UK agenda,6 with  
many agencies dedicated to co-ordinating improvement efforts (e.g. National 
Institute for Health and Care Excellence & National Patient Safety Agency 
[NICE & NPSA]),6 United States (US) Agency for Healthcare Research and 
Quality (AHRQ)7 and the Australian Commission for Safety and Quality in 
Healthcare).3 The drive for improvement started in the 1990s following a large 
scale epidemiological study (The Harvard Medical Practice Study [HMPS]), 
conducted by Brennan and Leape8,9 which found that adverse events occurred 
in 3.7% of hospitalisations; adverse drug events (ADEs) being the most 
common (19%).10  This signified the start of the identification of a substantial 
series of preventable events. The nature of the adverse events demonstrated 
key factors which might increase the likelihood of such an event, including 
inadequate communication.  These findings stimulated the first influential policy 
document which centred on medical error, published by the US Institute of 
Medicine; To Err is Human.11 This policy made two overarching 
recommendations.  The first around leadership and the second around the 
creation of safety systems in health through the implementation of known 
medication safety practices.  Since then, patient safety has gained considerable 
momentum, with many healthcare organisations placing greater emphasis on 
improvements for their patients. 
Meanwhile, in December 1997 in the UK, the Government published a White 
Paper The New NHS: Modern, Dependable,12 which set out a ten year 
modernisation strategy for the NHS. The main aim of this paper was to improve 
the quality of clinical care delivered to patients within the NHS.   Each 
organisation had a new statutory duty to improve quality through the 
implementation of clinical governance.  They were obliged to translate the 
principle of clinical governance into locally appropriate structures, processes, 
roles and responsibilities. From 1999, NHS Boards would assume a legal 
responsibility for quality of care within their organisation.  Soon after, An 
organisation with a memory (2000),13 the British equivalent to To Err is Human 
(1999) was released.  This highlighted the scale of the problem within the UK 
and recognised the human cost and organisational cost to the NHS. It was 
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decreed that the NHS must learn from its failures in a new culture of openness. 
This signified the start of prioritising patient safety within the UK.  
Like many terms a variety of definitions exist to describe patient safety.  The 
most widely used is that of Vincent et al (2006) who describes it as:  
‘The avoidance, prevention and amelioration of adverse outcomes or 
injuries stemming from the process of healthcare’.14   
To understand patient safety, it is necessary to understand the causes of error 
and the barriers to ensuring safe patient care.  The National Patient Safety 
Foundation,15 US, elaborates further describing safety as emerging from the 
components of a system.  Thus, improving safety depends on learning how 
safety emerges from the interaction of the components.  This is supported by 
the work of Reason who proposes that human error can be understood either 
by taking the person approach or the systems approach.16  It is the latter which 
squarely acknowledges the human factor perspective.  The system approach 
recognises that humans are fallible and errors must be expected, even within 
the most eminent organisations.  Reason claims that:  
‘We cannot change the human condition, but we can change the 
conditions under which humans work.’   
       (Reason, 2000, p76916) 
In 2006, the Department of Health (DOH) identified, through their publication of 
Safety First: a report for patients, clinicians and healthcare managers, that 
despite a high level of awareness, patient safety continued to be a challenge.17  
It recommended the implementation of a campaign, Patient Safety First.  Their 
aim was to focus on the safety culture in the NHS and to engage clinical staff as 
well as enable behavioural change leading to safer, better healthcare.18  The 
campaign ran from 2008 to 2010 and emphasised the role of human factors 
when reviewing patient safety.19   
  
4 
 
1.2.1  Human factors  
Human factors can be defined as: 
‘the scientific discipline concerned with the understanding of interactions 
among humans and other elements of a system, and the profession that 
applies theory, principles, data and methods to design in order to 
optimize human well-being and overall system performance.’   
     International Ergonomics Association20 
It takes into account psychology and engineering principles to support human 
performance and safety in an attempt to eliminate human error.21 It examines 
human interactions and their characteristics within the work environment to 
design systems which support the cognitive and physical abilities of humans.  
Work systems that are not designed with human factors in mind can create 
opportunity for error and compromise patient safety.  This is important given 
that many hospital systems were not designed or planned in the light of human 
factors.   
Multiple elements impinge on human factors and thus affect performance.  
Humans consistently interact with systems and vice versa, especially in 
complex organisation such as healthcare. Reason proposes that by recognising 
and accepting human variability, organisations can devote management 
resources in a more comprehensive approach to error which takes into account 
individuals, teams, local conditions and latent organisational failuresa.16 
Therefore, if we can understand how organisational systems work and their 
interrelations with other external systems and people we go some way to 
understanding and potentially resolving the issues associated with medicines 
reconciliation; a process that typically includes many different personnel and 
organisational systems.   
It was not until the publication of To err is human11 in 1999 that human factors 
was recognised as essential to understanding patient safety and why errors 
                                            
a Latent organisational failures can be described as ‘resident pathogens’ which arise from 
factors such as organisational culture, management decisions, the design of procedures, or 
deficiencies in training (Reason, 2000). 
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occur in the healthcare setting. Since then, the emphasis on understanding 
human factors and human error in healthcare has grown and is becoming more 
common place.  The NPSA believes understanding the role of human factors is 
vital to reducing human error and harm to patients.22   
Reason states that the human error problem can be viewed in two ways: the 
person approach and the system approach.16 The person approach views 
‘unsafe acts’ as arising primarily from atypical mental processes such as 
forgetfulness, inattention, poor motivation, carelessness, negligence, and 
recklessness.  The system approach concentrates on the conditions under 
which individuals work and tries to build defences to avert errors or mitigate 
their effects. Reason hypothesises that most accidents can be traced to one or 
more of four levels of failure, as described by the organisational accident model 
(see figure 1.1): organisational influences, unsafe supervision, preconditions for 
unsafe acts, and the unsafe acts themselves. In this model, an organisation's 
defences against failure are depicted as a series of barriers, with individual 
weaknesses in specific parts of the system, which are continually varying in size 
and position. The system as a whole produces failures when all individual 
barrier weaknesses align, permitting ‘a trajectory of accident opportunity’, so 
that a hazard passes through all of the holes in all of the defences, leading to a 
failure. Reason describes a ‘Swiss cheese’ model (see figure 1.2).  It 
demonstrates a succession of defensive layers (barriers and safeguards) each 
represented by a slice of cheese with holes which continuously open and shut. 
The presence of holes in any one ‘slice’ does not normally cause a harmful 
outcome. Only when the series of holes line up can an error pass through and 
cause harm.  In a similar way, not all medication errors lead to Adverse Drug 
Events (ADEs) (see section 1.4.1).23,24   The holes in the defences arise for 
three reasons: active failures, local (or error producing) conditions, and latent 
conditions. Nearly all adverse events involve a combination of these three sets 
of factors.  The active failures are unsafe practices of the people who are in 
direct contact with the patient or system, for example the prescriber failing to 
double check a prescription, or the pharmacist failing to identify an incorrect 
dose on a prescription. They take a variety of forms: slips, lapses, fumbles, 
mistakes, and procedural violations (see table 1.1).  Local conditions can give 
rise to increased workload and supervision; latent conditions reflect the 
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structure of the organisation, its resources, management and processes which, 
either alone or in combination with an active failure, can result in error.16  
Researchers have tried to identify these various factors in relation to patient 
safety events. 
 Figure 1.1  Stages in the development of an organisational accident25 
(reprinted with kind permission) 
 
 
Figure 1.2 The Swiss cheese model of how defences, barriers, and 
safeguards may be penetrated by an accident trajectory16 
(reprinted with kind permission) 
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Table 1.1  Errors of action and planning: summary definitions (originally 
from Reason 1990, modified by Armitage26 (reprinted with kind permission) 
Slip: a potentially observable error which results from failure in the execution 
and/or storage stage of an action, regardless of the original plan’s adequacy 
 
Lapse: predominantly related to memory failure, a less observable error 
which may only be apparent to the protagonist which also results from failure 
of the execution and/or storage stage of an action, regardless of the original 
plan’s adequacy 
 
Mistake: a deficiency or failure in the judgmental or inferential processes 
involved in selecting an objective or means of achieving it, regardless of the 
outcome of any actions 
1.3  Medication Safety 
Building a safer NHS for patients: implementing an organisation with a memory 
(2001)27 led to a supporting publication (Building a safer NHS for patients, 
improving medication safety 2004) which focused on improving medication 
safety.28  This aimed to reduce the number of medication safety incidents within 
the NHS.  Medication incidents have been defined by the NPSA as ‘any 
unintended or unexpected incident which could have or did lead to harm for one 
or more patients.’29  The majority of incidents do not result in patient harm, 
however, some go on to cause severe harm or even death.29  Medication safety 
incidents are known to lead to readmission, increased hospital stay, disability 
and mortality.28  It is estimated that this preventable harm from medicines could 
cost England up to 750 million pounds per year.30  Medication errors can occur 
at any stage in the process of prescribing, ordering, and administration;29 and 
with so many steps within each stage, there is considerable opportunity for 
error.  Boling suggests that although there are many individual factors which 
contribute to errors at transition and re-admissions, the complex relationship 
between medication, communication and care coordination continues to be a 
problem.31 
Several national documents and multiple papers have previously highlighted the 
need for improving safety and seamless care across interfaces.32-35  It is well 
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known that lack of effective communication poses a threat to both patient 
safety36,37 and medication safety.38  Communication is one of the main 
contributory factors discussed within the human factors approach.39  Research 
illustrating issues with communication about medication at transition points in 
care dates back over 25 years within the UK.40-42  In response, various 
interventions and initiatives have been suggested and implemented in some 
hospitals, such as patients bringing their own drugs into hospital, one stop 
dispensing, self-administration schemes and electronic prescribing.32-35 
1.4  Medicines Reconciliation 
In 1998, the Mayo Clinic, Minnesota (a not-for-profit medical and research 
group) sent a team to an Institute for Healthcare Improvement (IHI) sponsored 
collaborative that focused on patient safety related to the use of 
medication.  One member of the team (a nurse) highlighted transitions of care 
as one of the most dangerous times for patients.  This included transfers within 
the hospital, transfers to home or to other long term care facilities.  Although 
there was some previous published evidence that medication issues occurred at 
transition points, the doctors decided to undertake a retrospective review of 20 
charts revealing a high number of medication-related errors.  The errors were 
directly related to misinformation regarding medication at admission to 
secondary care.  The team designed a new process with a specific name; 
‘medication reconciliation’ (referred to in the UK as medicines reconciliation).  
The idea gathered momentum and in early 2000 the US Joint Commission on 
Accreditation of Healthcare Organizations (JCAHO) became interested. Finally, 
in 2005 the JCAHO issued a standard which required all hospitals in the US to 
have a process in place to accomplish accurate medicines reconciliation.43  The 
goal spanned the continuum of care, applicable to all settings including 
ambulatory, emergency, urgent, long-term and home care as well as in the in-
patient setting (Resar R, Senior IHI fellow, IHI US. Personal communication. 
29th November 2013).  
Over the last seven years, the profile of medicines reconciliation has been 
further raised internationally by the World Health Organisation (WHO),1 the 
JCAHO,43,44 and the IHI2 - all of whom have issued relevant guidance on 
reducing the number of medication errors attributed to medicines management 
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when patients move care settings.  Within the UK, there has been a national 
drive to improve communication regarding medication at transitions in care 
through the publication of various national guidelines.  These laid out core 
principles, standards and recommendations regarding the transfer of 
information at care interfaces and the reconciliation of medication at admission 
and discharge.  
More recently, the notion of medicines reconciliation has been encompassed 
into the UK medicines optimisation agenda to ensure patients get the right 
medicine at the right time.45  There is international agreement that organisations 
should implement appropriate protocols and policies to standardise medicines 
reconciliation processes and that any existing procedures should be 
reviewed.1,2,6,44  The difficulties in implementation of standards associated with 
medicines reconciliation were recognised through the review and refinement of 
the medicines reconciliation National Patient Safety Goals (NPSG) in the US in 
2009, however,  medicines reconciliation still remains a NPSG  in the US.46 
Between November 2003 and March 2007, 1,372,062 incidents were reported 
to the National Patient Safety Agency,47  117,332 (8.5%) of which were 
associated with medication and 7070 (0.05%) of those specifically related to 
medicines reconciliation (Khunpha S, NPSA. Personal communication by e-
mail. 3rd November, 2010).  A systematic review commissioned by NICE 
concluded that the scale of the current problems associated with medicines 
reconciliation, exacerbated by failures in existing systems, contributed to 
medication error.48  This review estimated that medication error associated with 
medicines reconciliation at admission varied between 30 to 70% medicines 
taken per patient.  It gained these figures and based its recommendations on an 
American49 and Canadian50 study making its applicability to the UK unclear.  
This led to the joint publication between NICE and NPSA which suggested 
hospitals focus their efforts on improving medicines reconciliation at admission.  
There has been considerable variation on the implementation of medicines 
reconciliation across NHS hospitals and a range of different systems have been 
employed to improve the process. 
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1.4.1  Measuring error associated with medicines reconciliation  
Terms used when describing error and outcome associated with medicines 
reconciliation include medication error, ADEs and medication discrepancy.  A 
medication error is defined as ‘a failure in the treatment process that leads to, or 
has the potential to lead to, harm to the patient’.51 This acknowledges that error 
may or may not lead to patient harm. When a medication error does lead to 
harm, it can be described as an ADE which is defined as ‘an injury due to 
medication’.24 The term ADE includes harm caused by the drug (adverse drug 
reactions (ADRs) and overdoses) and harm from the under-use of the drug 
(including dose reductions and inappropriate discontinuations of drug 
therapy)’.24  Aronsen and Morimoto both show the relationship between 
medication error, ADEs and potential adverse drug events (pADEs) (see figures 
1.3 and 1.4).23,24  Medication errors can be further classified to include various 
other types of error e.g. prescribing error, administration error etc.  There is a 
difference between a prescribing error and medicines reconciliation-related 
error.  A prescribing error is ‘a failure in the prescribing [decision-making] 
process that leads to, or has the potential to lead to, harm to the patient’.23  
Dean et al specify that  ‘a clinically meaningful prescribing error occurs when, 
as a result of a prescribing decision or prescription writing process, there is an 
unintentional significant (i) reduction in the probability of treatment being timely 
and effective; or (ii) increase in the risk of harm when compared with generally 
accepted practice’.52  In comparison, a prescription error is ‘a failure in the 
prescription writing process that results in a wrong instruction about one or 
more of the normal features of a prescription’.23  Medicines reconciliation error 
is not well defined although one could argue that medicines reconciliation error 
in part is ‘a failure in the medication history taking process’, although this does 
not encompass the errors in communication due to poor documentation when 
medication is altered.  
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Figure 1.3  Relationship between medication error and adverse drug 
events (ADEs) according to Aronsen et al23 (reprinted with kind 
permission) 
 
Figure 1.4  Relationship between medication error and Adverse Drug 
Events (ADEs) according to Morimoto et al 24 (reprinted with kind 
permission) 
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Bates et al highlights that medication errors are common, although relatively 
few result in ADEs.53 ADEs are most common in the first three weeks post 
discharge54 and are often preventable.55,56  Where medication errors are active 
failures, they can be classified according to whether they are mistakes, slips, or 
lapses.  During medicines reconciliation, there can be a mismatch between two 
sources of information or two medication lists e.g. the general medical practice 
electronic health record (EHR) and the inpatient medication chart (IMC).  At the 
point of comparison it is unclear whether the mismatch is an error (mistake, slip 
or lapse) or an intentional, conscious change to the patient’s medication 
regimen.  These mismatches in information are referred to as medication 
discrepancies.  The Collins dictionary defines ‘discrepancy’ as ‘a conflict or 
variation, as between facts, figures, or claims’.57  The term medication 
discrepancy, therefore implies a lack of agreement between different medication 
regimens, and provides a more precise term for capturing the potential 
medication errors that can occur at transition points in care, mainly admission 
and discharge.  The discovery of a medication discrepancy does not necessarily 
infer error nor does it imply potential harm.   
Medication discrepancies can be further classified into those which are 
intentional discrepancies (IDs) (e.g. stopping aspirin in a patient with a gastro-
intestinal bleed) and those which are unintentional discrepancies (UIDs) (e.g. 
accidental omission of medication at admission) (see figure 1.5). Where 
medication discrepancies are unintentional this has the potential to result in an 
ADE and patient harm although not all UIDs will lead to harm.  This is 
sometimes termed potential adverse drug event (pADE).  The WHO defines a 
pADE as a ‘serious error or mishap that has the potential to cause an adverse 
event but fails to do so because of chance or because it is intercepted (also 
called ‘near miss’ or ‘close call’)’.58  In the case of medicines reconciliation (at 
admission) it is often intercepted by the pharmacist during the verification of the 
medication history, thus does not result in an ADE.   
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Figure 1.5  Relationship between discrepancy and adverse drug event 
(ADE) 
 Intentional 
Discrepancy  No Harm (pADE) 
 Unintentional  
  Harm (ADE)  
1.5  Rationale for this Study 
The majority of published studies associated with medicines reconciliation have 
been conducted in the US making some aspects of generalisability to the UK 
difficult and creating a need for further studies in the UK. The systematic review 
which underpins the NICE & NPSA guidance,6,48 also highlighted the need for 
better designed studies, which include adequate methods to minimise bias. This 
is reinforced in further systematic reviews by Mueller et al and Chabbra et al 
who highlight the need for more rigorously designed studies to compare 
different medicines reconciliation practices and their effectiveness especially on 
clinical outcomes.59,60  The American Pharmacists Association and American 
Society of Health-Systems Pharmacists (APhA & ASHSP) have emphasised the 
need for more studies on effective medicines reconciliation processes which 
can identify best practice’,61 with Campbell et al requesting better controlled 
studies.48 Before relevant interventions can be designed and implemented it is 
important to understand where things go wrong and how errors associated with 
medicines reconciliation arise through exploration of the process. 
There has been much research published over the last 15 years highlighting the 
problems associated with different aspects of medicines reconciliation,40,48,62 
together with many recommendations for good practice some of which 
demonstrate a decrease in error.59,63-73  Despite these recommendations, there 
is little to suggest that practice has changed.  There is continued need for 
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process improvement to enable a smoother transition between care settingsb, a 
significant reduction in medication errors and discrepancies and the eradication 
of adverse events.  Within the UK, the most common source of error associated 
with medicines reconciliation is the omission of clinically relevant medication 
from in-patient charts.74-79  This often goes unnoticed, highlighting the 
importance of medicines reconciliation processes at transitions in care.78  
The National Prescribing Centre (NPC) stipulates that there needs to be enough 
competent people available to undertake medicines reconciliation at all times 
and that restricting the responsibility for medicines reconciliation to one 
professional group could make it difficult for some organisations to provide a 
reliable service, especially ‘out-of-hours’.80  The WHO goes further to suggest 
that healthcare organisations assign personal, professional and corporate levels 
of responsibility, and allocate clear roles and responsibilities to all HCPs for all 
steps in the medicines reconciliation process to ensure accountability.1  There 
are recommendations that the responsibility for carrying out medicines 
reconciliation should be included in job descriptions and personal development, 
endorsing it as a multidisciplinary effort.  However, there is no clear indication 
within these documents or other supporting evidence to suggest what these 
roles and responsibilities may be.  This is supported by an analysis of clinicians 
perceptions which revealed two questions: What does medicines reconciliation 
really mean and who is actually responsible for the process?81 
Many descriptive papers (predominantly international) emphasise the rates and 
severity of discrepancies with fewer looking at the solutions to the errors that 
arise and the barriers that may be encountered.  These descriptive papers often 
report on a specific specialty or department e.g. care of the elderly or accident & 
emergency (A&E) and isolated parts of the process rather than the process as a 
whole, across a healthcare economy. This was previously identified as an issue 
by Pickrell et al82 in 2001 with no signs of improvement since. Pharmacist-led 
interventions have been shown to have greatest benefit in comparison to those 
delivered by other HCPs.  However, the role of the HCP and indeed the patient 
within the process is not well defined.  Recent advances in technology provide 
                                            
b A care setting may include hospitals, nursing homes, residential homes, a patient’s own home or 
intermediate care. 
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opportunity to improve the medicines reconciliation process and add safeguards 
to the system, however, the extent to which they add benefit and the role of IT is 
not clearly determined. 
The timeliness of this research is significant as the UK starts to implement the 
medicines optimisation agenda; a holistic patient-focused approach to getting 
the best from medicines which requires an enhanced level of professionalism, 
and partnership between clinicians and the patient.45  Medicines optimisation 
looks at how patients use medicines over time. It may involve stopping some 
medicines as well as starting others both of which must be communicated 
accurately to other healthcare providers and indeed the patient. Medicines 
optimisation covers all aspects of medicines usage, including safe processes 
and systems, and effective communication between professionals. This 
research as well as exploring the role of the patient in medicines reconciliation 
might also inform the implementation of the ‘Professional Standards for Hospital 
Pharmacy’ which provides a framework through which to improve the quality of 
hospital pharmacy services and includes medication accuracy at admission and 
provision of information to patients.83 
Mindful that much of the work on the scale of reconciliation errors and 
discrepancies has been in North America, this research aims to determine 
whether the epidemiology of medicines reconciliation indicators within the study 
population mirror those of international studies.  This research will then identify 
through observation, both good practice and the reasons why medicines 
reconciliation errors occur, whereabouts in the process they occur and the role 
of both the patient and healthcare HCP. A human factors approach is employed 
to explore medicines reconciliation following the patient journey from primary to 
secondary care and back again, transitioning through the hospital setting.  
In summary, there is lack of effective medicines reconciliation process studies 
especially those which look at the process as a whole.  There is also need to 
define roles and responsibilities surrounding medicines reconciliation.  This 
study addresses these deficiencies and makes recommendations about 
standards of good practice which should be incorporated into the medicines 
reconciliation process together with the roles and responsibilities of HCPs. 
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1.6  Thesis Outline  
The purpose of this thesis is to examine current medicines reconciliation 
practice within primary and secondary care together with the role of different 
HCPs and patients within the process. The objectives are:  
a)  To determine a picture of medicines reconciliation within the West Yorkshire 
region and consider where this fits nationally and internationally, 
demonstrating the difference between desired practice, guidance and 
current practice. 
b)  To establish the role of different HCPs including pharmacists, doctors and 
nurses within the medicines reconciliation process.  
c)  To explore the role of patients and patient engagement in the reconciliation 
of medicines.  
d)  To examine the overall process by which hospital staff undertake medicines 
reconciliation.  
e)  To examine how general practitioner (GP) practices within primary care 
process information and/ or receive communication about medication from 
other care settings.  
f)  To determine the role of IT and, in particular, the EHR in improving 
communication around Medicines Reconciliation.  
The thesis has been divided into four stages which scope current practice and 
ways of working then recommend standards.  Using a mixed methods, 
exploratory design, data were collected through: (1) a literature review, (2) a 
descriptive prospective study which collected data on the type and severity of 
discrepancies related to medicines reconciliation; (3) a structured observation of 
the reconciliation process within primary and secondary care (including 
documentary analysis); qualitative and quantitative data were collected and 
analysed to illustrate current medicines reconciliation practice and highlight 
areas of quality and concern.  The analysis was informed by a human factors 
perspective and communication theory.  The reviewed literature and data 
collected was then used to (4) identify good practice recommendations for 
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medicines reconciliation.  Potential interventions and appropriate further work 
are also identified.  This thesis comprises seven Chapters outlined below: 
Chapter 2 explores the literature, first looking at definitions of medicines 
reconciliation and the scale of the problem, secondly reviewing the process of 
medicines reconciliation and the role of the HCP and lastly looking at the 
patient’s role within the medicines reconciliation process. 
Chapter 3 describes the methodologies used, justifies the use of a mixed 
methodology and offers the rationale behind each method and how the methods 
relate to underpinning theory. 
Chapter 4 applies a quantitative methodology to identify the type and severity 
of discrepancies observed in four acute UK hospitals.   
Chapter 5 uses an evidence-informed framework and qualitative methods to 
contextualise the findings from the prior quantitative study (Chapter 4).  Through 
the systematic observation of the reconciliation process and the role of various 
HCPs, the tasks relating to medicines reconciliation within secondary care are 
examined and considered in the light of human factors.  This includes nurse 
handover, medicines administration, ward rounds, pharmacy staff verification of 
the medication history, patient counsellingc, prescribing & transcribing and the 
writing of discharge advice notes. 
Chapter 6 uses a second evidence-informed framework and qualitative 
methods to observe the receipt and processing of discharge information within 
primary care. 
Chapter 7 discusses the research findings with reference to the existing 
literature to explain both concerns and good in the medicines reconciliation 
process. This chapter also discusses potential implications and 
recommendations for practice, strengths and limitations of the research and 
proposals for further work.  
                                            
c Counsel – To provide the patient with information and advice on how to take their medication 
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CHAPTER 2 LITERATURE REVIEW 
2.1  Background 
This chapter explores medicines reconciliation by presenting the findings from a 
narrative review to determine what is already known about medicines 
reconciliation, the processes associated with medicines reconciliation and the 
roles of those involved in the process.  It will outline significant findings and 
inconsistencies, highlighting any gaps in the current literature to support and 
demonstrate this study’s contribution.  The review will first set the context of 
medicines reconciliation including existing definitions and the scale of the 
current problems concerning reconciliation (Part 1); secondly review the 
process of medicines reconciliation and the role of different HCPs, establishing 
the evidence for specific interventions (Part 2); and lastly, look at the patient’s 
role within the medicines reconciliation process (Part 3).  The inclusive 
approach of a narrative review enables comprehensive coverage of both roles 
and process and includes a range of empirical studies with varied measures 
and methods, which is unlikely to be covered in a systematic review.  The 
complexity of medicines reconciliation, the sheer range of studies, and the 
variation in national guidance also makes the topic more suited to a narrative 
review.  Additionally, the narrative review provides detailed knowledge of the 
existing context, revealing problems, weaknesses and contradictions within the 
literature.  A traditional systematic review would diminish the number of studies 
included and not allow opportunity for full discussion and description of roles 
and process, ultimately limiting the full picture of current practice.  The literature 
review reports studies from 2000, up to and including October 2013.  Some 
studies from before this date are cited which provide background to the 
medicines reconciliation story. 
2.2  Methods 
A literature review was conducted using a systematic approach to determine the 
current UK picture of medicines reconciliation, within an international context. 
Studies included in the review were identified by keyword searches of Medline, 
Cumulative Index to Nursing and Allied Health (CINAHL), Cochrane, Pubmed 
and Embase databases. Keywords included medic* reconc*, medic* discrep*, 
patient discharge and community pharmacy, medication error and patient 
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history taking, seamless care, and interface. A search of publications by 
relevant government bodies and health organisations in the UK was also 
undertaken (including the DOH, NICE & NPSA).  Search terms were amended 
to match keywords used in specific databases.   
Results were merged using reference-management software (Endnote X7®), 
and duplicate references removed.  Articles were excluded if they were not 
published in English; published in peer-reviewed journals; empirical studies or 
primary studies. An information scientist assured the search strategy to ensure 
the capture of all relevant studies and ensure the validity of the literature review.  
All studies published before October 2013 were sought. Studies of all ages 
were initially included. The reference lists of all relevant articles identified were 
hand searched and relevant papers obtained.   
The electronic searches yielded 14,329 results from 1974 onwards.  Following 
elimination of irrelevant papers such as Dahlkvist et al84 and Zhang et al85 and 
duplicates, the inclusion and exclusion criteria were applied to 1128 papers. 
With the inclusion of 32 relevant papers found through hand searching the total 
number of empirical studies which were deemed relevant was 452.  Due to the 
high volume of studies and their age an exclusion criteria of papers published 
before 2000 was applied.  The current relevance of studies prior to 2000 is 
unclear due to the length of time since publication. This year also coincides with 
the introduction of clinical governance and the increased drive for patient safety 
(including medication safety) outlined within the NHS Plan86 and An 
Organisation with a Memory.13  The application of these criteria eliminated 67 
studies leaving 385 papers, 60 of which were from the UK and 325 
international.  The literature review focused on those studies from the UK, using 
the international studies to put them in context (see figure 2.1). 
The studies were reviewed to determine whether they were intervention or non-
intervention studies.  The intervention studies were then assessed for quality 
using a simple quality assessment tool adapted by Spinewhine et al, which 
reviewed the type of study design and whether the study was controlled, 
randomised or blinded.87  Also, whether a power calculation had been 
conducted, statistical tests used and confidence intervals 
reported.  Overall, from the 167 intervention studies, 60 were controlled of 
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which 23 were randomised and 7 blinded.  Inferential statistics, used to 
demonstrate significance, were reported in 98 studies, however, only 29 (1 
UK) reported power calculations and 46 confidence intervals.  Of the 22 UK 
intervention studies, nine were controlled of which two were randomised and 
none blinded. 
 
The remainder of studies consisted of a mixture of prospective descriptive 
comparative studies and non-controlled before and after studies, some of which 
were evaluated, for example, through opinion88-91, vignettes92 or competency 
assessment93-97 of the HCP rather than more quantitative outcome measures 
e.g. rates of discrepancy.  The way in which the authors described and 
explained the methods used within the study was not always clear. 
 
From this analysis it is clear that intervention studies published in relation to 
medicines reconciliation are heterogeneous in their design with a small number 
of randomised control trials (RCTs) and many which did not include a specific 
description of their design.  This supports the conclusion of the systematic 
review commissioned by NICE which concluded that  'better designed studies 
that include adequate methods to control for bias such as randomisation, 
allocation concealment, blinding at outcome assessment and intention to treat 
analysis' are needed.  Due to the nature of some of the interventions it would be 
difficult to blind the patient and in some cases the HCP providing the 
intervention, for example the provision of hand-held information or follow-up 
visits post discharge. The investigator or statistician could however be blinded 
when undertaking analysis.  This is more important for those studies which have 
subjective measures rather than objective measures.98 
Each study identified was also categorised into topic area within Endnote®, for 
example scale, severity, admission, discharge, counselling etc.  These topic 
areas form the sub-headings within the literature review.  Each paper was then 
reviewed methodically and relevant information extracted and tabulated where 
relevant.  The results presented are predominantly findings rather than the 
study author opinion. 
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Figure 2.1 Flow diagram of search and retrieval process 
 
 
Findings 
The results of the literature review will be presented in 3 parts: 
Part 1 – Describes the context of medicines reconciliation within the UK 
including definition, scale, severity and impact of discrepancies and/or error and 
places them in an international context. 
Part 2 – Looks at interventions introduced and tested at the different stages 
within the medicines reconciliation process and HCPs’ roles within the process.  
Part 3 – Describes the role of the patient within medicines reconciliation.  
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Number of empirical 
studies
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2.3  Part 1 - Definition, Scale and Severity of Discrepancies Found  
2.3.1 UK and international context 
There is an international drive to reduce the number of medication errors 
associated with medicines reconciliation at all transition points in care.   The UK 
is no exception, with relevant guidance and standards being published by 
several organisations.  Significant numbers of errors associated with medication 
and more specifically medicines reconciliation are cited in the literature and also 
reported to the NPSA (Khunpha S, NPSA. Personal communication.  3rd 
November, 2010).  A systematic review commissioned by NICE concluded that 
the scale of the current problems associated with medicines reconciliation and 
failures in existing systems is a major contribution to medication error.48  This 
first section of the literature review will describe and define medicines 
reconciliation, and provide a picture of the scale and severity of discrepancy 
rates at admission and discharge from secondary care.   
Studies reporting the rates of error in medication histories detected at admission 
and discharge have been published worldwide (see table 2.1), however, the 
majority of studies published which highlight the scale of error have been 
conducted within the US, making their applicability to the UK unclear due to the 
difference in healthcare systems.  There has also been a higher number of non-
intervention studies published compared with intervention studies both in the 
UK and internationally.  Several of the studies involve complex interventions i.e. 
interventions with several interacting components.  Complex interventions are 
widely used in the health service and present a number of problems for 
evaluation as it can be difficult to determine exactly which aspect has 
contributed to an observed outcome.99 This is particularly relevant as several of 
the UK intervention studies involve multiple interventions with multiple outcome 
measures.74,75,78,82,100-107 
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Table 2.1 Medicines reconciliation studies by country 
Country 
Intervention 
Studies 
Non-intervention 
studies 
Total 
number of 
studies 
UK 22 38 60 
Australia 17 17 34 
Austria 1 0 1 
Belgium 2 2 4 
Canada 12 17 29 
Denmark 3 6 9 
France 3 0 3 
Germany 1 2 3 
Ireland 1 5 6 
Israel 2 1 3 
Jordan 0 1 1 
Malaysia 0 1 1 
Netherlands 7 10 17 
New Zealand 0 1 1 
Nigeria 1 3 4 
Norway 0 1 1 
Pakistan 0 1 1 
Saudi Arabia 0 1 1 
Singapore 0 1 1 
Slovenia 0 1 1 
Spain 2 5 7 
Sweden 5 6 11 
Switzerland 1 1 2 
Taiwan 0 2 2 
USA 87 95 182 
Total Non-UK 145 180 325 
Overall Total 167 218 385 
 
Many studies focus on a specific clinical specialty, most commonly elderly 
care67,71,92,108-115 or general medicine,63,89,116-123 with fewer studying 
surgery,124,125 psychiatry126,127 or paediatrics.128-130  There are few studies which 
demonstrate   
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discrepancy rates within the UK.  Where they exist they have been published in 
abstracts rather than full studies.131-133  Nevertheless, it is clear that there is a 
problem internationally regarding the transfer of information about medication 
between care settings.  Different countries are at varying stages with the 
implementation of safe systems, processes and policies to ensure medicines 
reconciliation is conducted appropriately.  In more developed countries, such as 
the UK, US, Canada and Australia, aims at improvement have been 
implemented over the last 10 years,2-6,80,134,135 however, in more developing 
countries such as Malaysia the concept of medicines reconciliation is just 
beginning to emerge.136  However, within the developed countries there is a 
lack of uniformity around the implementation of improvement processes and 
outcome measures to support medicines reconciliation.137  
Internationally, a number of terms and acronyms are used to describe the 
complete list of medicines a patient was taking prior to hospital admission.  
These include ‘best possible medication history’ (BPMH),138,139 ‘pre-admission 
medication’ (PAM), ‘pre-admissions’ medication list’ (PAML),69,140-142 ‘gold 
standard medication history’,143 ‘gold standard medication list’ (GSML)140 and 
‘gold standard pre-admission medication list’ (GSPAML).144  There is no 
consensus as to which term should be used to best describe the most current 
and complete theoretical list of medication the patient is taking. The term used 
is perhaps not as important as the methods used to determine the list.  Although 
the literature describes the overarching stages within a medication history, there 
is lack of evidence around how to elicit a ‘gold standard’ to support systematic 
and consistent collection.  Pippins et al provide a protocol for collecting a ‘gold 
standard’ medication history, although it is not clear on what this is based.145  
There is consensus, however, that a medication history should contain 
prescription medications, over the counter (OTC) medications, Complementary 
and Alternative Medicines (CAMs), and allergies and ADRs/intolerances 
including the reaction suffered.146-150 
The studies which have investigated discrepancies associated with medicines 
reconciliation fall into two main categories; those which look at the recorded 
medication history in comparison with the best possible medication history 
available and those which look at the discrepancies between the different 
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sources of information available which contribute to the BPMH.  These will be 
discussed in the sections 2.1.5 Scale of the Problem and 2.1.8 Sources of 
Information respectively. 
2.3.2  Definition of medicines reconciliation  
(This section was informed by personal communication with Dr.David Alldred; 
Senior Lecturer in Pharmacy Practice, University of Bradford, 1st May 2013) 
Although the concept of medicines reconciliation was introduced in 1998 (Roger 
Resar. Senior IHI fellow. IHI, US. Personal communication. 29th November 
2013), it became more widespread within the literature around 2003,151-154 
especially in the US.  Whilst it is commonly used in practice in the UK, there are 
few UK studies which utilise the term, referring more often to terms such as 
medication history taking and discharge communication etc.  In practice, the 
term is often used interchangeably to mean different things, sometimes, 
specifically to refer to the verification step undertaken by a pharmacist to ensure 
that the medication history has been taken accurately and medicines prescribed 
appropriately on admission to hospital. Alternatively, the term can refer to the 
creation of an accurate account of a patient’s medicines at all transition points in 
care. 
There is no universally accepted definition used for medicines reconciliation, 
either internationally or within the UK.   The various definitions which do exist 
have been most commonly developed by either governments or professional 
bodies to try and improve standards of practice surrounding medicines 
reconciliation (see table 2.2). One commonly cited definition of medicines 
reconciliation was produced by the IHI.  It describes medicines reconciliation as: 
 ‘the process of creating the most accurate list possible of all medications 
a patient is taking — including drug name, dosage, frequency, and route 
— and comparing that list against the physician’s admission, transfer, 
and/or discharge orders, with the goal of providing correct medications to 
the patient at all transition points within the hospital’.2   
This restricts the idea of medicines reconciliation purely to a secondary care 
setting, disregarding the interface between primary and secondary care.  An 
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alternative description is provided by Cambridge et al2 who believe medicines 
reconciliation results in an ‘accurately communicated complete list of 
medications’.  Similarily, the WHO describe it as prevention of 
miscommunication; this leaves room for interpretation of finer detail.155  
Although the NICE & NPSA technical appraisal does not cite a definition, they 
specifically describe the aim of medicines reconciliation at hospital admission: 
‘to ensure that medicines prescribed on admission correspond to those 
that the patient was taking before admission, highlighting specifically the 
details to be recorded, i.e. the name of the medicine(s), dosage, 
frequency, and route of administration’.6  
Whilst the NPSA guidance specifically refers to admission, it also recognises 
that medicines reconciliation can occur when patients are transferred to other 
units within the hospital, to another hospital, or at discharge from hospital.  
Others have defined medicines reconciliation for the purpose of their research 
(see table 2.3). Without a common definition for medicines reconciliation, it is 
unsurprising that the term can be misinterpreted. 
Often medicines reconciliation is described as the process of matching one list 
of medicines to another and resolving any discrepancies that arise e.g. 
medication taken before admission compared with the IMC.  Cited definitions 
include several general components:  
1. Prevention of medication errors 
2. Identification of an accurate list of medication used prior to transfer  
3. Identification and clarification of  ‘discrepancies’ (between medicine lists)  
4. Verification/ Resolution of medication discrepancies  
5. Communication of changes to the patient and other HCPs 
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Table  2.2   Definitions of ‘medication reconciliation’ used by government 
and professional organisations 
Organisation Definition 
Australian 
Commission on 
Safety and 
Quality in 
Healthcare3 
‘Medication reconciliation is a formal process of obtaining and 
verifying a complete and accurate list of each patient’s current 
medicines. Matching the medicines the patient should be 
prescribed to those they are actually prescribed. Where there are 
discrepancies, these are discussed with the prescriber and 
reasons for changes to therapy are documented. When care is 
transferred (e.g. between wards, hospitals or home), a current 
and accurate list of medicines, including reasons for change is 
provided to the person taking over the patient’s care. Points of 
transition that require special attention are: 
• Admission to hospital 
• Transfer from the Emergency Department to other care 
areas (wards, Intensive Care, or home) 
• Transfer from the Intensive Care Unit to the ward 
• From the hospital to home, residential aged care facilities 
or to another hospital.’ 
National Patient 
Safety Agency 
(NPSA) (UK) 6 
‘The aim of medicines reconciliation on hospital admission is to 
ensure that medicines prescribed on admission correspond to 
those that the patient was taking before admission. Details to be 
recorded include the name of the medicine(s), dosage, frequency, 
and route of administration. Establishing these details may involve 
discussion with the patient and/or carers and the use of records 
from primary care. This does not include medicines review.’ 
Institute for 
Health 
Improvement 
(USA) 2 
‘The process of creating the most accurate list possible of all 
medications a patient is taking — including drug name, dosage, 
frequency, and route — and comparing that list against the 
physician’s admission, transfer, and/or discharge orders, with the 
goal of providing correct medications to the patient at all transition 
points within the hospital.’ 
The Joint 
Commission 
(USA)43 
‘Medication reconciliation is the process of comparing a patient's 
medication orders to all of the medications that the patient has 
been taking. This reconciliation is done to avoid medication errors 
such as omissions, duplications, dosing errors, or drug 
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Organisation Definition 
interactions. It should be done at every transition of care in which 
new medications are ordered or existing orders are rewritten.’ 
Institute for 
Safe Medication 
Practices (ISMP) 
(Canada)4 
‘Medication reconciliation is a formal process in which healthcare 
providers work together with patients, families and care providers 
to ensure accurate and comprehensive medication information is 
communicated consistently across transitions of care. Medication 
reconciliation requires a systematic and comprehensive review of 
all the medications a patient is taking (known as a BPMH) to 
ensure that medications being added, changed or discontinued 
are carefully evaluated. It is a component of medication 
management and will inform and enable prescribers to make the 
most appropriate prescribing decisions for the patient.’ 
High 5’s Project 
(WHO)155  
‘[Medication reconciliation] addresses the prevention of 
medication errors resulting from incomplete or mis-communicated 
information at points of transition in the patient care process, such 
as admission to the hospital, transfers within the hospital, and 
discharge from the hospital.’ 
Agency for 
Healthcare 
Research and 
Quality 
(AHRQ)156 
‘Medication reconciliation is a process to decrease medication 
errors and patient harm by comparing the patients current 
medication regimen against the physicians admission, transfer, 
and/or discharge orders to identify discrepancies.’ 
American 
Pharmacists 
Association 
(APhA) & 
American 
Society of 
Health System 
Pharmacists 
(ASHSP)157 
‘Medication reconciliation is the comprehensive evaluation of a 
patient’s medication regimen any time there is a change in 
therapy in an effort to avoid medication errors such as omissions, 
duplications, dosing errors or drug interactions, as well as to 
observe compliance and adherence patterns.  This process 
should include a comparison of existing and previous medication 
regimens and should occur at every transition of care in which 
new medications are ordered or existing orders are rewritten or 
adjusted or if the patient has added non-prescription medications 
to (his or her) self-care.’ 
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Table 2.3  Definitions of ‘medication reconciliation’ used in published 
papers 
Author Definition of medication reconciliation 
Bandres et al158  ‘The formal, standardised process of reviewing patients’ 
complete previous medication regimen, comparing it with 
current prescriptions, and analysing and resolving any 
discrepancies found.’ 
Boockvar et al159 ‘Medication Reconciliation involves creating a complete 
and accurate prior medication use list, identifying 
discrepancies between current and prior medication use, 
and ensuring prescriber awareness of current and prior 
medication use to inform prescribing decisions.’ 
Cua and 
Kripilani160 
‘The process of comparing the patient’s medication list to 
what he or she should be receiving, and resolving any 
discrepancies.’ 
Feldman et al70 ‘An active process that occurs at transitions in care 
(admissions, transfers in level of care, and discharge) and 
is designed to prevent medication errors as the patient 
moves across the continuum of care.’ 
Schwarz and 
Wyskiel161 
‘The process by which an accurate list of a patient’s home 
medications is compiled and compared with admission, 
transfer and discharge orders.’ 
Mergenhagen et 
al162 
‘The practice of reviewing and comparing a patient’s 
medication regimen throughout care transitions to prevent 
unintentional discrepancies.’ 
Meyer et al163 ‘The process of comparing a patient's medication orders 
to all the medications that he or she has been taking.’ 
Miller et al164 ‘A process to reduce errors and harm associated with 
loss of medication information as the patient enters and 
moves through a new healthcare system.’ 
Paton et al10 ‘To ensure that medicines prescribed on admission to 
hospital do not differ unintentionally from those that the 
patient was taking immediately prior to admission.’ 
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Author Definition of medication reconciliation 
Rogers et al165 ‘Reconciling medications is a formal process for creating 
the most complete and accurate list possible of all pre-
admission medications for each patient and comparing 
the physician’s admission, transfer and/or discharge 
orders against that list.  Discrepancies are brought to the 
attention of the physician and, if appropriate, changes are 
made to the orders. Any resulting changes are 
documented.’ 
Varkey et al64 ‘The process of identifying the most accurate list of all 
medications a patient is taking, including the name, 
dosage, frequency, and route of each medication, and 
using this list to provide correct medications for the 
patient anywhere within the healthcare system.’ 
Vira et al166 ‘A three step process of verifying medication use, 
identifying variances, and rectifying medication errors at 
interfaces of care.’ 
Yi et al167 ‘Medicines reconciliation accurately identifies all 
medications patients are taking – including drug name, 
dosage, frequency and route, and uses this list to provide 
correct medications for patients anywhere within the 
healthcare system.’ 
Zeigler et al168 ‘The process of comparing medications that the patient 
was taking prior to admission or entry to a new setting 
with those that the organisation will provide and prescribe 
at discharge.’ 
2.3.3  Models of medicines reconciliation  
Internationally various models and acronyms have been used to describe the 
medicines reconciliation process.  Originally it was described by the IHI in the 
US as VCR (Verification, Clarification, Reconciliation).2  Subsequently other 
organisations have tried to define the stages within the process and produce 
simplified models to assist medicines reconciliation (see table 2.4).  All involve 
the collection of the medication history, verification to ensure it matches what is 
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prescribed, documentation and communication, mirroring the components found 
within the cited definitions.  However, all describe it in slightly different ways, 
with two different organisations using the term reconciliation to describe 
completely different stages, one the verification of the history and the other the 
documentation.2,169 
Table 2.4 Models showing the stages of medicines reconciliation  
Description of 
stage 
Institute for 
Healthcare 
Improvement 
(IHI) (VCR)2 
National 
Prescribing 
Centre (NPC) 
(3Cs)80 
Joint 
Commission 
on 
Accreditation 
of Healthcare 
Organisations 
(JCAHO) 
(5 step 
process)43 
Society of Hospital 
Pharmacists of 
Australia 169 
(4 step process) 
Collection of 
medication 
history 
 
 
Verification  Collection  Develop a list 
of current  
medications 
Medication history 
Develop a list 
of medications 
to be 
prescribed 
 
Confirmation (with 
as many other 
sources as deemed 
appropriate) 
Verification of 
the medication 
prescribed to 
ensure it 
matches  
Clarification  Checking  Compare the 
medications on 
the two lists 
 
Reconciliation 
 
Make clinical 
decisions 
based on the 
comparison  
Documentation 
of changes  
Reconciliation    
Communication 
to next provider 
 Communicating Communicate 
the new list to 
appropriate 
caregivers and 
to the patient 
 
Transfer of verified 
information 
In the current study, medicines reconciliation is conceptualised as a process 
designed to ensure an accurate, complete list of medications is attained at 
transition points in patient care.  This incorporates the components found within 
the published definitions.  The transition points may occur within secondary care 
or primary care, or alternatively, across the interface. It is based on the UK 
NPC’s 3Cs approach; collection (collection of the medication history by doctors 
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at admission), checking (subsequent verification of the medication history by 
pharmacy staff) followed by communication to primary care.80  
Figure 2.2  Process map of verification of medication history taking 5 
(reprinted with kind permission) 
 
 
 
 
 
 
 
 
 
 
 
 
The stages of verification of the medication history are outlined in figure 2.2 and 
involve the review of a number of sources of information to create a BPMH 
which is compared to a prescription and any discrepancies identified deemed 
intentional or unintentional through reviewing the notes or discussing with the 
prescriber.  
The APhA & ASHSP state that medicines reconciliation should be performed 
when the patient undergoes a transition of care between care settings or 
transfer of care within a setting.  A transition in care can be described as:  
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‘the movement of patients between healthcare locations, providers or 
different levels of care within the same location, as their condition and 
care needs change.’170 
2.3.4  Classification of medicines reconciliation-related error 
In addition to the lack of definition, there is no universal taxonomy or 
classification system for discrepancies or errors associated with medicines 
reconciliation, making it difficult to standardise reporting of the types of error 
which occur. Studies have used varying categories to classify the 
discrepancies, with some more detailed than others.  All classifications include 
the omission and addition (sometimes referred to as commission) of 
medication.77,109,125,145,166,171-183  Apart from these common items, the 
classification schemes vary with some amalgamating UIDs such as alterations 
in strength form and dose into one category176,177 and others leaving them 
separate.145,184  These variations also make it difficult to compare discrepancy 
rates between studies. 
2.3.5  Scale of medication discrepancies at transitions 
Studies have used different measures, denominators and terminology to 
highlight the scale of error due to inadequate medicines reconciliation.  This 
makes it difficult to compare error rates between studies.  Most commonly the 
number of UIDs is measured, with some studies using the number of 
interventions as an outcome measure.  These are sometimes cited per 
medicines reconciliation,74 per patient185 or per number of drugs prescribed.6  
Other studies have used ‘drug related problems’ (DRPs).72,186,187  The lack of 
consistency with the measures used makes comparisons between studies 
difficult.   
There are few studies within the UK which record the proportion of patients who 
have their medication verified by a pharmacist post-hospital admission133 or the 
number and type of discrepancies that can occur, making it difficult to compare 
studies.  The largest published UK study which looked at unintended 
discrepancies at admission was conducted in 50 NHS hospitals by Dodds,77 it 
identified 11,366 unintended discrepancies over 8621 medicines reconciliations 
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averaging 1.32 unintended discrepancies per medicines reconciliation.  Results 
from other studies varied from 1.06 UID per patient to 1.83 UID per 6 
medications.48,74,172,185  Fertleman et al188 reported an even higher error rate of 
two interventions per patient, but it is unclear whether these were just 
associated with medicines reconciliation or included other clinical interventions. 
Internationally the number of UID per patient at admission varied from 0.62 per 
patient to 3.5 discrepancies per patient.145,175,189,190 Other studies presented the 
percentage of patients experiencing a UID which varied from 32 to 90% of 
patients.117,145,166,173,176,178,179,189,191-197 It is difficult to compare rates of 
discrepancies as the way in which they have been calculated and presented 
differs (see section 2.3.4). Linsky and Simon report a rate of 3.7 discrepancies 
per patient, but this is of those patients who had a discrepancy rather than the 
total within the study.173  Similarly, Forjuoh report a rate of 2.0 discrepancies per 
patient, however this also includes omitted OTC medication and CAMs.196  
Some international studies have also looked at the rate of omission at 
discharge, showing percentage of patients or discharge summaries with an UID 
to vary from 23.3% to 88.5%.109,111,126,174,177,183,198-200   
Both nationally and internationally, the single most common discrepancy found 
when reconciling medication is omission.77,109,125,145,166,171-183,201  A number of 
studies have looked at the rate of omission of medication at admission and 
discharge with figures ranging in the UK from 56% to 73%74-79 and 
internationally from 17% to 95% per patient.109,125,145,166,171-183,193,201  Most 
studies, however, report figures greater than 50%.70,145,167,180,181,194,195,202  
Missed information from the medication history has been shown to be clinically 
relevant and can include potentially fatal errors such as the omission of 
anticonvulsants and insulin.78  These errors would have been difficult to identify 
during a basic chart review, highlighting the importance of the medicines 
reconciliation process.78  Within the UK, studies associated with medicines 
reconciliation have been conducted in specialties, including paediatrics,88,128,203 
renal medicine,204 the intensive care unit (ICU),205 A&E and surgery,76 however, 
most medicines reconciliation studies have been conducted in medical 
admissions units (MAU). This range of UK specialty settings mirrors the 
international picture in terms of study settings.124,206-215  Transitions to care 
homes are not well studied within the UK or internationally in terms of medicines 
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management.  An Australian study showed that where patients transfer to 
residential care facilities doses can be missed or significantly delayed post 
discharge.216  
2.3.6  Severity of ADEs and pADEs related to medicines reconciliation  
A number of different scales are used within the literature to categorise the 
potential severity of discrepancies discovered during medicines reconciliation.  
Severity scales are historically derived from actual harm events. It is difficult to 
predict the actual severity of unintended discrepancies as often the 
discrepancies are discovered before they result in harm (see figure 1.5).  This 
provides no tangible or measureable outcome on which to measure severity, 
leading to a prediction rather than occurrence.  Irrespective of the scale used, 
all studies reported that the potential severity of the discrepancies found would 
either not cause harm or would cause minimal to moderate harm with few 
discrepancies potentially causing death or major 
harm.50,70,113,129,145,164,178,180,181,191,192,194,197,217   Only one study has looked at 
actual ADEs occurring from medication discrepancies. It determined that of 
1350 discrepancies; 65 (4.8%) resulted in ADEs.159 
The scales vary in their content and number of points on the scale (from 3 to 5). 
Some studies use degrees of severity when classifying ADE e.g. lethal, serious, 
significant, minor.65,210,218,219  Some look at discomfort and monitoring e.g. 
Climente-Martí et al189 and Arora et al.217  Others use the likelihood to cause 
harm e.g. unlikely, possible, and probable.183 For accurate measurement and 
comparison between studies it is important that the severity scales used reflect 
the potentiality of the harm and use the same point scale with common 
descriptors. 
2.3.7  Risk factors for experiencing medication discrepancy at transition 
points  
Numerous risk factors have been shown to contribute to an increased number 
of discrepancies at admission and discharge, although not within the UK.  The 
most common risk factor is the number of medicines a person is taking.  The 
higher the number of medicines the more likely the patient is to experience an 
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unintended discrepancy,70,109-111,117,145,173,177,180,181,183,197,212 with the odds 
increasing by 10% for every additional medication taken prior to admission (OR 
1.10; 95% CI 1.06-1.14).117 Some studies found that where patients are taking 
greater than four197 or five109,111,212 medications their risk increases, especially 
where these are for gout, muscle relaxants, lipid-lowering medication, 
antidepressants or respiratory medicines, however, this is a single study.145 
Cornu et al demonstrated using binary logistic regression demonstrated that if 
the patient was taking ≥ five medicines then their risk was 2.85 times higher 
than fewer medicines (P=0.01).  For every additional medication listed in the 
discharge letter the likelihood of experiencing one or more discrepancies 
increased by 20%.109  Using multivariate analysis they demonstrated that more 
than five drugs increased the likelihood of experiencing more than one 
discrepancy by a factor of 3.22 (95% CI 1.40-7.42; P=0006).  Manias et al212 
demonstrated 12.22 greater odds for the same phenomenon and Feldman et al 
found that each additional medication increased the odds by 8.7%.70  Similarly 
Wong et al183 found that if taking between one and nine medicines UID 
averaged one per patient and where taking between 10 and 19 medicines they 
averaged two  discrepancies per patient.  Linsky and Simon found that it was 
specifically commissions and duplications which increasingly occurred the more 
medications the patient is taking.173 In contrast, Nelson et al,126  Cornish et al50 
and Climente-Marti et al189 found no link between the number of medicines 
taken and the number of discrepancies found.  The reasons for this are unclear. 
As well as the number of medicines, Pippins et al145 found the number of 
medication changes during the patients stay had an impact on the number of 
discrepancies; greater than or equal to six changes making an impact at 
discharge.  Coffey et al197 also looked at the types of medication which, if a 
person is prescribed prior to admission, may increase the chances of a 
discrepancy; they found that both narcotics and antiepileptics increased the risk.  
As the number of medications a person is taking is likely to increase with age, 
220 this would suggest a potential positive correlation between the number of 
discrepancies and the patient’s age, as well as the number of medications a 
person is taking.  Several studies found no link with age.70,109,117,125,126,177,221  but 
others did.111,180,189,212  In the US, Linsky and Simon specifically found that 
patients aged over 65 were more likely to experience an omission.173 The 
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frequency of outpatient visits within the three months prior to admission also 
increased the risk of discrepancies with greater or equal to 13 outpatient visits 
having an impact and non-locally dispensed medication increasing the risk of 
duplication.173  No studies found a link between gender and the number or types 
of discrepancy,109,117,126,177,221 except Lau et al179 who determined that women 
were more likely than men to experience a discrepancy.  Although this is a 
single study, the findings may have some validity due to women taking on 
average more medications than men.220  Nevertheless, further study would be 
required to demonstrate any clear association between the two variables. 
No link between the number of discrepancies and the time50 or day180 of 
admission was found.  But, if the patient was seen by the hospital doctor within 
an hour of shift change they had 3.7 times greater odds of experiencing a 
medication discrepancy.145 Moreover, for each additional minute wait to see a 
physician the odds increased by a factor of 1.01. Manias et al suggest various 
reasons for this including a potential link to high workload. They conclude that 
further work needs to be undertaken to try to explain wait times as a risk factor.  
Hellström determined that if the medication was reconciled more than four days 
following admission then there was also an increased risk.  Although, where 
patients were reconciled on days four to eleven some admission errors had 
already been corrected.117   
The patient’s usual place of residence was not a risk factor,109 yet, Hellström et 
al117 found that patients at home with no care support were at a higher risk of 
discrepancies, suggesting that living at home is not generally a risk factor but 
lack of carer or family support may have an influence. This mirrors other 
findings which suggest that living alone increases health risks, potentially 
meaning an increase in medication.143 Pippins et al found that a medication 
history taken from a family member or carer increased the risk of a 
discrepancy,145 which contradicts findings by Porter et al and Morrison et al who 
determined that carers played a pivotal role, these studies, however, were in 
paediatrics.88,222     
The majority of studies have been conducted within one clinical specialty, 
therefore, few have been able to look at the relevance of specialty as a risk 
factor for patients experiencing a discrepancy.  One study showed that surgical 
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patients were more likely than general medical patients to suffer a 
discrepancy,125 in contrast, Grant and Larsen195 found the opposite, however, 
their study was conducted in paediatric ICU.  A further study looking at 
prescribing within psychiatry discovered that discrepancies occurred equally in 
psychiatric versus non psychiatric medicines, however, omissions were higher 
in non-psychiatric medicines 80% versus 20% in psychiatric medicines. 
Eijsbroek et al223 found that medication started in ICU to control acute 
symptoms were sometimes not stopped at discharge, including Proton Pump 
Inhibitors (PPIs), sedatives and psychotropic medication. Paradoxically, chronic 
therapy is often stopped205 or omitted at admission to ICU224 then not restarted 
at transfer or discharge.  This is not unique to ICU, also surgical patients were 
at risk of having long-term therapy, especially warfarin, unintentionally 
discontinued due to not being re-started post-surgery225 and patients with end 
stage renal disease frequently experience high numbers of medication related 
problems specifically related to gaps in medication information at transitions in 
care.226 
Prescribing for children at the interface between primary and secondary care, 
can be more complex than for adults as children often need unlicensed or ‘off-
label’ medicines which present challenges with shared care arrangements and 
obtaining supplies post-discharge,227,228 although, prescribing for children at the 
interface has not been demonstrated as an increased risk factor for medicines 
reconciliation related error.  Huynh et al found that only 67% of pharmacists in 
the UK would carry out medicines reconciliation in all children and that only a 
third had policies for medicines reconciliation in children.130  
The evidence for length of patient stay as a risk factor is mixed, with Hu et al111 
determining it as a positive predictor for increased likelihood of discrepancy and 
Nelson et al126 finding no link.  The following factors have also been shown to 
increase the risk of discrepancies: visual deficit,212 the need for an interpreter 212  
level of education,70 low patient understanding,145 known allergy,212 medication 
history taken by an junior doctor,145 and those patients who are eligible for 
benefits.212  The following do not appear to be risk factors: race,70,126 marital 
status,70 primary payer (the insurance company who pays the healthcare bill in 
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the US), 70 severity of illness,70 direct admission to the ward without transfer 
from another ward 117 and destination at discharge.212 
2.3.8  Time taken to complete medicines reconciliation 
Time is considered within the literature from two different perspectives.  The first 
is the time between admission and the patient having their medication verified 
by a member of pharmacy staff.  The second is the amount of time taken by the 
HCP to verify the medication history.  The WHO1 and NICE & NPSA6 state that 
patient’s medicines should be verified by a member of pharmacy staff within 24 
hours of admission to hospital, although the evidence base for this is unclear.  
There is little evidence which demonstrates whether the suggested timeframe is 
being achieved in practice, or studies which suggest interventions to accomplish 
this target.  One UK study by Badham et al132 showed that 53% of patients 
taking anticonvulsant medication had their medication histories taken within 24 
hours of admission.  A further study, in 2008 from Kings Hospital London, 
showed only 55% of patients had medication histories taken, with 79% 
conducted within 24 hours.133  Similarly, Aljamal et al229 (UK) showed that 
approximately half of patients had their medicines reconciled, 80% within 24 
hours.   
The average length of time taken to verify a medication history varies within the 
literature from between 12.5 minutes up to 45 minutes where counselling is 
included at an average of 11 minutes (see table 2.5).  The variation in time is 
potentially due to the patient’s knowledge and the complexity of their 
regimens230 or maybe due to the HCPs approach, although this has not been 
studied.  HCPs have shown concern about the lack of adequate time within their 
daily routine to gather appropriate medication histories.230,231  Both studies, 
however, were based on nurse perception and it is unclear whether this is a 
reflection of other HCP opinion. 
2.3.9  Sources of information used during medicines reconciliation  
Various sources are used within a secondary care setting to try to establish an 
accurate medication history.  These include GP medication list printouts, repeat 
prescribing slips, patient’s own drugs (PODs), communication with patients or 
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carers, previous discharge summaries, medicines administration record (MAR) 
charts from social and care home settings, community pharmacy records and 
monitored dosage systems (MDS). In 1995, Leape et al identified that the most 
common cause of medication error was a lack of access to accurate information 
about either the medicine or the patient.232 It can be difficult, especially out of 
hours or in an emergency, to obtain appropriate information.78  Previously the 
receipt of a list of current medications the person is taking from the GP, via fax 
has been untimely and sometimes has to be requested on more than one 
occasion,76 there is nothing to suggest this has changed. 
Worldwide, many studies have looked at how to elicit appropriate information 
from patients through medication histories and have identified the sources of 
information which can contribute to accurate reconciliation, for example EHR or 
MAR charts.49,50,145,166,233-235  There is no one source more accurate than 
another.  It is acknowledged that a range of sources must be used to verify the 
list of medication a patient is taking.76  Medication histories should be collected 
from the most recent and reliable source and where possible, information 
should be cross-checked and verified against another source.76,80 There is 
evidence, however, from Denmark to suggest that a second interview with the 
patient following the initial medication history, using GP records, added to the 
medication history in two-thirds of cases.121  The extent to which different 
sources are used is not widely published in the literature.  
It is often wrongly assumed that the GP record is the most accurate source of 
information.76,78  GP referral letters can include incorrect information.78  Dutton 
et al found that over reliance on the GP letter was responsible for some but not 
all of the errors in medication histories.78 There were still prescribing errors in 
52% of patients who had accurate GP letters, compared with 77% with an 
inaccurate or no letter, reinforcing the importance of using more than one 
source to verify a medication history.78 Collins et al found that 5% of medicines 
the patient was taking were found not to be on either the GP or nursing home 
record.76  Also GP doses were sometimes prescribed as directed, making it 
difficult to confirm the intended dose;76  although this was 10 years ago, there is 
nothing to suggest this has changed.  It is also contrary to national prescribing 
guidance.236  
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Table 2.5  Time taken to conduct medicines reconciliation per patient in 
hospital 
 
  
  Author Country Time Medication 
History and/ or 
Reconciliation 
Coffey et al 
(2009)197 
Canada Mean 18 mins (2-75mins) 
More than 4 medications took 
mean 31 mins (range 10-75mins) 
Medication 
History and 
Reconciliation 
Cornish et al 
(2005)50 
Canada Mean 24 mins Inter-quartile 
range (IQR) (20-30mins) 
Medication 
History and 
Reconciliation 
Feldman et al 
(2012)70 
US Mean 11.2±8 minutes 
(medication history) 
29.3± 30.2 mins (Reconciliation) 
Medication 
History and 
Reconciliation 
 
Geurts et al 
(2013)200 
Netherlands Mean 45 mins (inc 11mins 
counselling) 
Medication 
History and 
Reconciliation 
Kent et al 
(2009)237 
Canada Mean 23 mins Medication 
History and 
Reconciliation 
Lessard et al 
(2006)194 
US 30 mins per patient including 
clinical check 
Medication 
History Only 
Miller et al 
(2012) 184 
US >80% medication history took 
less than 15 minutes 
Medication 
History Only 
Quélennec et al 
(2013)238 
France Mean 36.4±12.1 Medication 
History Only 
Remtulla et al 
(2009)239 
Canada Mean 12 minutes (range 2-
48minutes) 
Medication 
History Only 
Vira (2006)166 Canada Median 15 mins IQR 10-21 Medication 
History and 
Reconciliation 
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Collins et al concluded that ‘currently there is no ‘gold standard’ medication 
history available other than a list of medicines taken from the patient who is 
deemed reliable.’76 Discrepancies in GP EHRs are not unique to the UK.  Orrico 
in the US commonly found medication recorded in the EHR but not taken by the 
patient or conversely not recorded in the EHR but taken by the patient; most 
commonly analgesia.240  More recently Schmiemann et al found that 41% 
patients in Germany were taking at least one medication not on the GP health 
record, in 90% of cases for one of the following reasons: the GP had knowledge 
of what the patient was taking but it was not documented, the medication was 
documented in the history but not in the medication list, or it was an OTC 
medication therefore not prescribed, the medication was issued by a 
specialist.241 This mirrors other findings by Tulner et al (Netherlands) and 
Staroselsky et a (US).242,243 
Green et al warns that patients may potentially have up to four lists of 
medication (including repeat prescription lists, GP letters, GP printout 
summaries, patients own lists, MAR charts and specialist service records), 
emphasising that they should be interpreted with caution and assessed in 
conjunction with other sources of information, especially the patient and/ or 
carer.244  Green et al suggests an IT solution.   In Denmark, Foss et al found 
that a median of one to three discrepancies per patient were identified in seven 
paired source comparisons including primary healthcare records, hospital 
departments, health insurance data and patient interviews.  Full agreement was 
only found in 8% of patients.245  
Numerous factors can affect the validity of the information source.246  The age 
of the source, especially if greater than one year, corroborating the need to 
ascertain the date of the source. The presence of acute and ‘when required’ 
medications decreased the accuracy. The researchers also found that 
discharge information was more likely to be valid than outpatient information.   
In many instances it is the patient who provides relevant information,78 however, 
some authors are of the view that their reliability can be unclear, despite this not 
having being studied in depth.76  It is almost 30 years ago since Price et al 
suggested that patients should be encouraged to bring in their medicines on 
admission to hospital.247 This was reinforced in Pharmacy in the future: 
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implementing the NHS plan.248 Over the years this has improved and there has 
been a recent drive in many NHS Hospitals to encourage patients to bring their 
own medication with them on admission.249 The role of the patient in medicines 
reconciliation will be discussed further in Part 3 of this literature review. 
Other sources used to verify the list of medications a patient is taking include 
the community pharmacy patient medication record (PMR), MAR charts and 
MDS.  Whilst it is unclear the extent to which these sources are used in the UK, 
Wilcock and Lawrence107 found that the community pharmacy PMR would have 
added value to the medication history in 4% of cases and some value in up to a 
third of cases.  This study only looked at systemic medication, rather than 
topical which has been recognised to be prescribed inappropriately during 
hospital stays.107 
Internationally some countries have central repositories which host medication 
lists e.g. Sweden, Denmark, Canada and Ireland.250-253  These national 
databases have been shown to be relatively accurate and contemporaneous 
sources of information which can add value in approximately 10 to 28% of 
cases (up to 1.1 medicines per patient).251,252,254  Although useful these have 
also been shown to contain inaccuracies in information in some cases.119,250 
The databases are limited where certain medicines are not contained in them, 
for example, medicines which are prescribed and dispensed in hospital e.g. 
cancer and tuberculosis (TB) medicines, OTC medicines and CAMs.  This can 
depend on the country as community pharmacy records in Denmark were 
shown to add value especially for the identification of OTC medicines and 
CAMs.254  This would not be the case in the UK as OTC and CAMs are not 
routinely recorded within community pharmacy. Like all EHRs, national 
databases rely on accurate data entry and being kept up-to date. Inaccuracies 
in health records can be of significance especially where there are potential 
interactions.255 
In countries where private healthcare is more mainstream the number of 
different physicians a patient sees may be increased. Balon and Thomas 
showed that 41% of patients were seeing three or more doctors.256 The 
advantage of countries with health insurance is that the claims databases often 
contain complete information.  Where they were found to lack information is 
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where the patient did not get reimbursed or bought their own OTC medication or 
CAMS.147   Conversely, Olsen et al showed incongruence between the claims 
databases and the primary care provider medication lists.257   This is not as 
significant an issue in the UK as patients are registered with one general 
medical practice, however, on occasion they may be seeing multiple hospital 
consultants.  
In a UK study by Oborne and Luzac, 64% of patients used OTC/CAMS 
medication, however, only 5% of these were recorded in the medication history 
at admission to hospital.149 This is supported by Cockayne et al who showed 
that 58% patients took CAMs prior to admission with only 28% being 
documented in the medical record.258  The recording was improved through 
education of HCPs.  In the US, Holmes et al have gone further to identify a list 
of herbal medicines and supplements as a useful tool to identify potentially 
harmful medication (specifically in the hospice setting).259 There is nothing in 
the literature which looks at the use of illicit substances and whether this should 
be included as part of the medication history.  In a letter to the British Medical 
Journal (BMJ), Kinney points out that illegal drugs should be considered in the 
differential diagnosis as they can cause derangement of Liver Function Tests 
(LFTs) and other symptoms.260  
The NPC divides sources into those which are more reliable and those which 
are less reliable, stating GP medication list printouts, repeat prescribing slips, 
PODs, patients or carers, and previous discharge summaries to be more 
reliable than MAR charts from social and care home settings, community 
pharmacy records, single assessment process documentation and MDS for 
gaining a true account of a patient’s medication.80 It is unclear how these have 
been categorised as there is insufficient UK evidence to suggest that any one 
source is more reliable than another when used in isolation, and although items 
like the MAR and MDS may not include medication which the patient’s GP 
thinks they are taking, it is more likely to be a true reflection of what they are 
actually taking.  This is contrary to findings by Fitzimmons et al in Ireland who 
found that community pharmacy and GP staff were the most available and 
accurate sources of information compared with the patient/carer, PODs, GP 
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letter, GP surgery, community pharmacy (CP), past inpatient Kardex and 
discharge summaries, nursing home lists and staff.140  
With improved IT systems there are a number of studies from the US which look 
at the accuracy of computerised PAML builders as a source of information 
although the accuracy of these can also vary.  Peterson et al found that most 
commonly they included false positive entries i.e. the patient was not taking the 
medication despite it being listed.141 
2.3.10 Impact of medicines reconciliation on readmissions to 
hospital 
The NPC suggests that accurate medicines reconciliation can lead to a 
reduction in re-admissions caused by harm from medicines, however, there is 
little evidence to support this.80 No single intervention alone has been shown to 
reduce the risk of rehospitalisation within 30 days, however, several common 
interventions have been studied as part of a ‘bundle’ of care, including patient 
education, medicines reconciliation, discharge planning and follow up.67,100,261  
Most commonly these include discharge education and counselling with follow 
up.67,87,100,105,123 Lack of meta-analysis and inadequate description within the 
studies does not allow the success of any single intervention to be determined 
(see also section 2.3.1). 
Al-Rashed et al showed twenty fewer readmissions in the study versus control 
group following pharmacist intervention, which included pharmacist counselling, 
provision of discharge summary plus reminder chart together with a follow up 
visit.100 The role of the individual component of the intervention is unclear, or 
whether it was a combination of all four aspects which produced the effect.  
Community liaison pharmacists, who facilitate pharmaceutical care during the 
transition between hospital and home (including medicines reconciliation at 
admission and communication at discharge),  have also been shown to reduce 
readmission rates from 8.8% to 6.4%, producing cost savings of £83,484 per 
annum based on an average of 7.7 days stay per patient.75  A similar model has 
been demonstrated to work in the US262 although the actual cost savings were 
not highlighted within the study.  Such interventions are supported by a model-
based review paper showing that they are a cost-effective use of NHS 
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resources, with pharmacist led medicines reconciliation being the most-cost-
effective.263  This is especially important since the introduction of the 30 day 
readmission policy where hospitals may not be reimbursed for readmissions 
within 30 days of discharge.264  Estimated costs of ADEs range from 900 to 
1800 Euros.263 However, it is difficult to know how many discrepancies go on to 
cause actual harm.125  There are few studies which have undertaken cost 
analysis on medicines reconciliation or associated interventions to determine 
their cost effectiveness.   
Conversely, in the US Hansen et al found no link between the presence of an 
accurate medication history at admission and readmission rates nor a link 
between the timeliness of receipt of discharge and rates of readmission.265  This 
is supported by a Swedish study that also found no impact on readmission 
following accurate medicines reconciliation.266 Similarly, in the UK, Nazareth et 
al found a comprehensive discharge plan had no effect on re-admission 
rates.105 
2.3.11  Improving patient safety and measuring quality 
The international drive to improve medicines reconciliation has led to the 
implementation of several patient safety programs, different suggestions of 
indicators which may demonstrate quality within the process and a range of 
standards.6,7,43  It comes at the same time as many countries promote and 
implement general patient safety programmes to ameliorate avoidable harm.267-
269 
The international High 5’s project, a WHO initiative supported by health 
ministries focuses on five distinct patient safety topics including medicines 
reconciliation.268  Canada led the development of a guide to implement standard 
operating procedures for medicines reconciliation which has been trialled in 
participating countries.5  Through this campaign the Netherlands has shown 
that inaccuracies in a patient’s current medication history can be reduced by 
90% within one to five months of the introduction of a toolkit to improve 
medicines reconciliation.  However, it is unclear exactly how changes were 
implemented and whether any improvement methodology was used.   Similarly, 
the IHI in the US previously developed a ‘how-to-guide’ to support the reduction 
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of medicines reconciliation error as part of their 5 million lives campaign.2  Its 
success in terms of medicines reconciliation is unclear, however, it did raise the 
profile of medicines reconciliation internationally. 
Relevant indicators must be used to identify whether the changes to medicines 
reconciliation being made in practice are leading to improvement.80 This allows 
providers to feel their efforts are worthwhile and gives commissioners data to 
support informed decisions.  Various audit tools for medicines reconciliation 
have been developed by the NPSA (UK) and IHI (US) to help support 
improvement.2,6  Also in the UK, Aljamal et al has generated ideas for quality 
indicators for medicines reconciliation on admission, using a group of practising 
pharmacists in Manchester, however, this was based on pharmacist 
experience, not on evidence and the quality indicators were not detailed.270  The 
NPC suggests that organisations should use procedural measures, such as the 
presence of written policies and procedures, and the percentage of patients that 
have had their medicines reconciled within 24 hours.80  As well as procedural 
measures, they also suggest a further number of impact measures, such as the 
number of medication discrepancies in patients whose medicines have been 
reconciled. This mirrors terminology used within patient safety which classifies 
measures in terms of structure, process and outcome.141 There is currently little 
in the way of structure, process and outcome measures for medicines 
reconciliation.  This study will look at defining appropriate standards that 
potentially could be used as measures within the process. 
Many countries have set national targets for medicines reconciliation.  Within 
the UK, NICE & NPSA issued joint guidance which specified that all healthcare 
organisations must put policies in place for medicines reconciliation at 
admission to hospital.6  The policies must specify standardised systems for 
collecting and documenting information about current medications, and should 
ensure that pharmacists are involved in medicines reconciliation as soon as 
possible after admission.  The responsibilities of pharmacists and other staff in 
the medicines reconciliation process should also be clearly defined.  It also 
stipulated that strategies to obtain information about medications for people with 
communication difficulties be incorporated. NICE & NPSA agreed with the WHO 
that 24 hours is an appropriate target for organisations to include in their 
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policies.1,6 The US have also specified standards on medicines reconciliation 
within their NPSGs since 2005.  Since then the NPSG for medicines 
reconciliation have slowly evolved.  The Institute for Safe Medication Practices 
(ISMP) in Canada chose medicines reconciliation as one of three medication 
safety indicators to prioritise for reporting, recognising that in some ways it is 
different to other medication safety indicators such as venous thromboembolism 
(VTE) prophylaxis and antibiotic prophylaxis as it focuses on overall system 
integration rather than a specific clinical practice,therefore not as easily linked to 
patient outcomes.  Methodological difficulties also occur with capturing 
standardised data through which to compare different organisations e.g. 
common definitions, and appropriate numerators and denominators.271 
2.3.12  Human Factors and their role in Medicines Reconciliation 
The study of human factors in relation to medicines reconciliation is not 
previously well explored.    Where it is, it looks at human factors in relation to 
the design of IT systems to enhance medicines reconciliation.272,273  Monkman 
et al determined that the advantage of involving IT into medicines reconciliation 
is that process standardisation and specific constraints can be embedded into 
the system to ensure steps are performed sequentially, in a timely manner and 
that all tasks are completed fully to eliminate variability.273  Also important are 
the workflows and roles and responsibilities associated with the process. 
Lesselroth et al used human factors specifically to review medicines 
reconciliation workflow to determine how patient-centred technology should be 
designed to collect a medication history.272  They identified system themes and 
design constraints that influence the quality of the medicines reconciliation 
process to be able to subsequently design new technology to support medicines 
reconciliation. 
2.3.13  Summary Part 1 
A vast amount of literature has been published on the subject of medicines 
reconciliation.  These studies thoroughly explore the scale of error and 
discrepancies associated with inadequate medicines reconciliation, especially in 
the US; less studies look at the scale within the UK or interventions which have 
been implemented to reduce medicines reconciliation-related errors and/or 
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discrepancies.  The lack of clear definition, taxonomy and measures makes it 
difficult to compare studies or for organisations to benchmark their progress.  
Various models exist which summarise the medicines reconciliation process, all 
of which contain the same main steps; collection of medication history, 
verification of the medication prescribed, documentation of changes and 
communication to the next provider.  
Although there is consensus that understanding human factors are vital to 
reducing human error and harm to patients,22 there are few studies which look 
at the role of human factors in the medicines reconciliation process. Neither are 
there any empirical studies of the safety of the entire process when undertaken 
as part of routine practice.  It is evident that to reduce the incidence of 
medicines reconciliation-related errors and/or discrepancies, a structured 
systematic approach to medicines reconciliation is needed to ensure an 
accurate and detailed medication history.274,275  The next section of the literature 
review will go on to explore medicines reconciliation-related processes and 
interventions which improve the accuracy and safety of medicines 
reconciliation, taking into account the HCP role in the process.  
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2.4  Part 2 - Medicines Reconciliation Process and HCP Involvement 
Medicines reconciliation relies on the patient being subject to many small 
interdependent processes, for example, medication history taking on admission, 
prescribing, transcribing IMCs, counselling at discharge and processing 
discharge information, all of which feed into a larger overall process. The NPC 
identifies the movement of the patient through the healthcare system as the 
‘patient’s medicines management journey’ (p1) and although the NPC depict the 
patient as the ‘end-user’ (p8), the commonality between each different stage is 
clearly the patient, making it logical to describe the process flow in terms of the 
patient journey through the healthcare system.80 The former Royal 
Pharmaceutical Society of Great Britain (RPSGB) illustrated the start of the 
patient’s medicines reconciliation journey as the admission to hospital, whether 
planned or in an emergency, via A&E or direct to a ward. 276  
The WHO suggests that healthcare organisations should assign clear roles and 
responsibilities to HCPs for all steps in the medicines reconciliation process to 
ensure accountability, however, the WHO do not make any suggestion as to 
what these roles and responsibilities should be and to whom they should be 
assigned.1   The NPC goes further to suggest personal, professional and 
corporate levels of responsibility, highlighting key skills needed for effective 
medicines reconciliation which include effective communication, technical 
knowledge of processes and therapeutic knowledge.80 They also recommend 
that levels of staff competency should be agreed, and the responsibility for 
carrying out medicines reconciliation should ideally be included in job 
descriptions and personal development, endorsing it as a multidisciplinary 
effort. The NPC stipulates that there needs to be enough competent people 
available to undertake medicines reconciliation at all times and that restricting 
the responsibility for medicines reconciliation to one professional group could 
make it difficult for some organisations to provide a reliable service, especially 
‘out-of-hours’ provision.80  The level of staff competence and availability within 
current practice is unknown.  One previous review has looked specifically at 
pharmacist and IT interventions but no other HCPs nor stages of the process 
outside hospital.59 The review determined that successful intervention included 
intensive pharmacy staff involvement and targeting interventions to a high-risk 
patient population. 
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The earlier section within the literature review (Part 1) identified the scale and 
severity of the problems inherent in medicines reconciliation.  This section (Part 
2) goes on to identify the interventions which have been shown to improve 
medicines reconciliation at different stages of the patient journey within the 
hospital (admission, during stay, discharge) and primary care, taking into 
account HCPs’ roles. 
2.4.1  The medicines reconciliation process 
The complexities associated with the medicines reconciliation process are a 
result of the number of people and care settings involved in the process.61  
There are few papers that provide evidence or even state how medicines 
reconciliation should be conducted or how a medication history should be taken 
leaving it to national bodies to provide guidance and organisations to implement 
local policies and procedures.  There are also few papers that study the 
medicines reconciliation process as a whole or the role of the entire multi-
disciplinary team (MDT).  The majority focus on isolated aspects of the process 
or individual HCPs.  Various diagrammatical representations of the patient’s 
journey through hospital with respect to medicines reconciliation exist with 
varying degrees of detail (see figures 2.3 and 2.4).  All include three distinct 
stages: admission, during stay and discharge.  This section of the review will 
discuss the process at each of these stages, continuing to discuss post-
discharge, within primary care.  In practice, within the UK, many medicines 
reconciliation tasks are conducted uniquely by one individual HCP, hence the 
role of each individual HCP will be compartmentalised and considered at each 
stage.  It is sometimes difficult to isolate interventions specifically related to 
medicines reconciliation from overall packages of care, which can incorporate 
other interventions such as counselling and follow up (sometimes referred to as 
bundles of care).  Interventions relating to the patient have also been 
incorporated into the table for comparison.  These will be discussed separately 
in Part 3.  There are some areas where medicines reconciliation is important 
which do not exactly fit the patient journey through hospital into primary care, for 
example, in outpatient clinics. There are various studies which also demonstrate 
the value of the pharmacist at specialty outpatient clinics; oncology,277 
cardiac,278 and Parkinson’s disease,279 all of which include improvement to 
medicines reconciliation.   
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Figure 2.3  Algorithm for medicines reconciliation from admission 
through discharge160 (reprinted with kind permission) 
 
 
 
 
 
 
 
 
Some studies have redesigned the medicines reconciliation process to 
improve quality and decrease medicines reconciliation error103,280-282 or 
utilised management techniques to improve medicines reconciliation,283-286  
although only one within the UK.287  Methods such as Failure Modes and 
Effects Analysis (FMEA),283,285 Plan, Do, Study, Act (PDSA) cycles,161,287 
Lean methodology284 and Six Sigma286 have been used. One quality 
improvement programme in the UK, led by the prescribing observatory for 
mental health, to improve the uptake of medicines reconciliation and 
number of sources used, showed modest improvement increasing the 
percentage of medicines reconciliations undertaken from 71% to 79% at 
re-audit with an increase in interventions from 25-31%.10  This involved 
nationally supported implementation of audit, detailed provision of audit 
results, action planning and re-audit.  All service improvement studies 
which focus on the use of management techniques have been conducted 
within secondary care and are lacking within primary care.288  Although this 
is a deficiency in the research evidence, it is at least clear that successful 
leadership supplemented by local champions and evidence based tools, 
are imperative to ensuring a robust medicines reconciliation system.97,281   
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Figure 2.4 Diagram adapted from the WHO High 5s campaign by 
Fernandes et al289 (reprinted with kind permission) 
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2.4.2  Admission to hospital 
2.4.2.1 Background 
Patients can be admitted to hospital via one of three main routes; via A&E, GP 
referral or through an outpatient clinic appointment (elective and non-elective 
admission).  These three paths are different in approach, however, irrespective 
of the path taken, the patient will be admitted either through an admissions ward 
or direct to a specialty ward where a medication history will be gathered, usually 
by a doctor.  Approximately 20% of patients presenting at A&E will be admitted 
to hospital.290  Following arrival at A&E the patient goes through a variety of 
steps outlined in figure 2.5.  Although this model is based on a study from the 
US, the system is mirrored in the UK. Here, a medication history is usually 
taken in A&E, although the main goal of emergency medicine is to stabilise the 
patient.  A&E staff members are predominantly interested in determining those 
medications which may be having an acute impact on the patient’s state, 
leaving a more complete and accurate medication history to be conducted once 
the patient is stabilised, usually on an admissions or specialty ward (Wood, T. 
A&E Matron. Bradford Teaching Hospitals NHS Foundation Trust. Personal 
communication. 15th April 2011).  Where the patient’s admission is planned they 
will often be seen within a pre-admission clinic where their medication history 
will be documented.  Sagripanti et al suggests that given the large number of 
changes which can occur in the time between pre-admission assessment and 
admission the chart should not be written in advance nor the medication 
supplied; although, it is unclear whether this is happening in practice.291  
At some point following admission the patient may have their medication history 
verified, usually by a member of pharmacy staff.  The majority of intervention 
studies focus on admission.  Several interventions have shown improvement in 
medicines reconciliation at admission which are not specific to a particular HCP; 
most commonly a medicines reconciliation form to accurately document the 
medication the patient is taking prior to admission (see table 2.6) 63,64,292,293. 
They all showed a reduction in discrepancies at admission. Most, however, 
were undertaken in specific specialties e.g. paediatrics, making their general 
applicability to other specialties unclear.  Educational interventions which either 
reinforce the process or provide feedback on discrepancies have also been 
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shown useful,63,92 as well as interventions which facilitate the gathering of 
medication information at admission e.g. the use of pre-visit questionnaires294 
and aide-mémoires.295 
Figure 2.5 Workflow for medicines reconciliation in A&E284 
 
 
 
 
 
Discharge/ transferred
Tests performed/ Treatment administered
Doctor assesses patient and makes clinical decision
Nurse takes patients to treatment room and clinically assesses
Patient waits in waiting room
Triage nurse evaluates patient
Patient waits in waiting room
Patient arrives in A&E and checks in
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2.4.2.2 The role of the doctor at admission to hospital 
Hospital doctor 
At admission the junior doctor will take an account of the presenting complaint 
and past medical history from the patient, including any medication they were 
taking prior to admission.  This is known collectively as clerking.  Once a 
medical and medication history is obtained, the doctor makes a decision in the 
context of the presenting complaint regarding which medication must be 
prescribed for the patient during their stay.  This includes both acute and regular 
medication.   Few UK studies have looked at the role of doctors in the 
medicines reconciliation process. More frequently medicine reconciliation 
studies investigate doctors’ accuracy in medication history taking compared with 
other HCPs, namely pharmacists.  These studies, however, have been 
conducted in the US rather than the UK.68,208,301,302,309  A study conducted in St 
Mary’s Hospital Portsmouth by Dutton et al78 found that approximately 40% of 
doctors felt their accuracy when taking medication histories was between 50 
and 75%, with 17% feeling they were less than 50% accurate.   In Nigeria, 
Yusuff and Tayo found that the doctors specialty also affected the recording of 
the medication history in the patients’ notes with doctors recording more 
frequently and in greater depth those medications that may aid the diagnostic 
task.311  These findings are similar to those of Ziaeian et al, in the US, who 
determined that medications relevant to the primary diagnosis were more likely 
to be accurate.336  Nigerian doctors also felt that more emphasis should be 
placed on the medical history rather than the medication history.337  It is unclear 
whether these findings are applicable in the UK and it would be worthwhile 
conducting similar studies. 
In an attempt at improving the accuracy of medical prescribing generally, the 
British Pharmacological Society have identified learning outcomes which should 
be incorporated into the undergraduate medical prescribing curriculum using a 
Delphi approach.338  Many of these outcomes were associated with medicines 
reconciliation.  The evaluation or the extent to which these have been 
embedded and/or adopted into the curriculum, however, is unclear. 
Internationally, a variety of different educational interventions have been 
evaluated to improve medication history taking amongst medics. In the US, 
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curricula which specifically focus on medicines reconciliation at transition in care 
and medication history taking have been implemented which led to 
improvements in confidence, knowledge and skills.93,96  Simulations for second 
year students to improve medication history taking have been piloted in 
Chicago328 and an educational intervention programme in New Zealand, where 
reconciliation errors found were fed back in real time.329  The American Medical 
Association has produced a guide for the role of the doctor in medicines 
reconciliation, it highlights issues, strategies and safe principles on 
implementation of good processes, stress that the doctor should take the lead in 
embedding safety into the medicines reconciliation process.339 This contradicts 
guidance from the APhA and the UK NPSA which states that pharmacists 
should take the lead.6,340  One study by Peyton et al showed that although 
educational intervention of doctors and nurses increased the accuracy of 
medicines reconciliation, it only improved from 14.4% to 18.9%.118  
The lack of interventions which focus on improving medication history taking 
amongst doctors is surprising given the rate of error reported in 
studies.77,109,125,145,166,171-183,201 Those interventions which do exist all aim to 
improve the doctor’s medication history taking accuracy.150,297  One of these 
interventions focuses on standardisation using an allergy questionnaire to 
improve the structure of consultation and standardise the information 
gathered.150 The second demonstrates that feedback, then praise following 
good performance can reduce the number of discrepancies at admission.297  It 
would appear that further work is needed to establish the role and 
responsibilities of doctors plus effective interventions aimed at doctors to 
improve medication history taking. 
General practitioner (GP) 
There is little evidence looking at the role of the GP or their practice staff in 
communicating about medicines at admission to hospital.  Often general 
medical practices are contacted when one of their patients is admitted to 
hospital to determine which medication they are usually prescribed in primary 
care.  There is evidence to suggest that the information held on the GP EHR is 
not always up-to-date or accurate (as discussed in section 2.5.11) therefore 
non-contemporary information is sometimes communicated.  Where patients 
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are referred by the GP to hospital and are admitted directly to a ward the GP 
will send a referral letter with the patient.  There are no studies that look at the 
accuracy of the medicines related information within these letters within the UK, 
however a study in Zurich shows high numbers of omissions in admissions 
letters, for example, 12% patients had their medication information missing and 
less than 50% of patients taking more than four medications had any directions 
stated.341 
2.4.2.3 The role of hospital pharmacy staff at admission to hospital 
Currently within the UK pharmacy staff are predominantly involved in verifying 
medication histories taken by doctors (and occasionally nurses) post admission.  
(This has previously been described in Part 1 – see figure 2.2).  This does not 
happen in isolation and will usually go hand in hand with other clinical checks of 
the patient’s IMC.  Thus errors discovered may be amongst a number of 
different error sources outwith reconciliation. The activities undertaken by 
pharmacists within the hospital setting are not unique to the UK and are similar 
to that of Ireland,342 the US343 and Australia.344  The number of patients seen by 
pharmacy staff varies from hospital to hospital, with some potentially not having 
their medication history verified throughout their whole hospital stay.  Articles in 
the Pharmaceutical Journal dating back to 1982 suggest that the ward 
pharmacist is the best placed to elicit the medication history from the patient.345  
There is a wealth of evidence both within the UK39,66,74,296 and 
outside49,69,71,118,122,124,162,208,237,239,277,278,300-321,346-348 which demonstrates the 
effectiveness of pharmacists and pharmacy technicians undertaking medicines 
reconciliation and improved medication history taking in comparison to doctors 
162,208,309,349,350 and nurses.208,301  There are also suggestions from a range of 
international papers that pharmacists writing IMCs on admission can improve 
patient care.208,210,211,303,306,308,351  This is more limited within the UK. 66,79    
A substantial body of evidence also demonstrates the benefit of pharmacists 
and pharmacy technicians conducting medicines reconciliation within 
A&E.69,208,302,303,306,308,314,318,347,348,352  A small survey carried out in 2010, in a 
specialist workshop assessing the role of pharmacists within A&E found that 
most UK A&E departments had some level of pharmacy service. Roles were 
similar across all A&Es, and included guideline development and review, 
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training and preparing Patient Group Directions (PGDs).353  Less than half of 
these pharmacy roles, however, included medication history taking, with only 
8% of respondents writing IMCs.353 Another UK study, in the same year, looking 
at the role of a pharmacist independent prescriber in A&E, demonstrated 
decreases in prescribing errors and an associated reduction in potential and 
actual harm.230  It showed that moving the pharmacists’ work (medication 
history taking and initiating the in-patient chart) to A&E, transfers their input to 
the start of the patient journey and applies their knowledge and skills to the 
patient’s benefit.66 In contrast, nurses have expressed discomfort with eliciting a 
medication history at triage in A&E. 
Kwan et al124 and George et al321 also looked at the role of pharmacists within 
surgical pre-admissions clinics in the UK, demonstrating increased quality and 
decreased discrepancies.  Pharmacists have also demonstrated skills in other 
areas which contribute towards improved communication about medication at 
care transitions including the production of pharmaceutical care plans at 
admission (US).73  Further work in all specialties to establish the impact of 
pharmacists taking the initial medication histories and writing IMCs at admission 
is needed, although both pharmacists and nurses have been shown to make 
clinically appropriate prescribing decisions.354 
The majority of evidence relates to pharmacists although a small number of 
studies provide evidence which promotes the use of support staff such as 
pharmacy technicians138,239,313,315,355,356 and pharmacy students.71,323-326  
Increasingly, within the UK, pharmacy staff, other than registered pharmacists, 
play a role in the medicines reconciliation process.  They are familiar with the 
dosage forms and strengths and usual dosing schedules of a wide range of 
medicines.239  They may undertake roles such as medication history taking and 
patient counselling.  There is no UK evidence which explores the role of these 
pharmacy staff within the process, however, evidence from outside the UK 
suggests that pharmacy students and pharmacy technicians can play a valuable 
role in identifying drug-related problems, allergy information and admission 
discrepancies which equal that of the pharmacist,138,322,324,325,357 not only on the 
wards, but also in pre-admission clinics322 and within A&E356 respectively.  
Through changing the focus of the pharmacy service, pharmacy staff can be 
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better utilised in the medicines reconciliation process.103  Remtulla et al 
suggests that pharmacist expertise is better utilised in assessing the 
appropriateness of therapy rather than technical tasks of compiling the 
BPMH.239  Guidance from NICE & NPSA6 suggest involvement from both 
pharmacists and technicians.  Their guidance is specifically targeted at 
admission; however, there is no reason to suggest that this is not applicable to 
other areas.  As the roles of pharmacy staff change, more evidence is needed 
to determine how best to utilise their skills in practice. 
2.4.2.4 The role of nurses at admission to hospital 
The role of nurses in medicines reconciliation in the UK has not been examined 
although it is known that, where admission is planned, nurses often undertake 
medication histories at surgical pre-admissions clinics although the accuracy is 
unknown.358  Outside the UK, especially in the US, nurses more commonly take 
medication histories at admission to hospital.208,301 A survey of nurses, 
conducted in Canada, identified that clearer roles and responsibilities would 
improve medicines reconciliation together with improved communication at 
handover.231  In interviews conducted by Candlish et al nurses expressed their 
desire not to take a medication history at admission suggesting an appreciation 
for the help they received from pharmacists.230 Good practice guidance on 
medicines reconciliation in hospital produced by NHS Greater Glasgow and 
Clyde suggests that nurses maintain an overview of whether patients on their 
ward have had their medicines reconciled at admission, prompting relevant 
HCPs to take action as required; administer medication as directed on the 
admission chart; incorporate medicines reconciliation into handover procedures 
when patients transfer care and at discharge and where the prescribers are 
nurses ensure that prescriptions are accurately and legibly recorded.359  
2.4.2.5 The role of the community pharmacist at admission to hospital 
Studies both within the UK107 and internationally327 have shown that the 
community pharmacist has a role in providing information about the patient’s 
medication regimen taken within primary care.  In Canada, Dersch-Mills et al 
determined that 24% paediatric patients could have had their medication 
clarified by a community pharmacy; the rest were either not on any medication 
or used multiple pharmacies.139 They also determined that following an 
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informed interview community pharmacy records were the most accurate 
source followed by the provincial prescription database.  However, often the 
pharmacist is unaware that the patient has been admitted to hospital.360   
2.4.2.6 The role of ambulance staff at admission to hospital 
For those patients who come to hospital via ambulance the ambulance staff can 
play an important role in bringing the patient’s medication in with them to 
hospital.  They can be involved in ‘green bag schemes’, where green plastic 
bags are used by paramedics to bring medication into hospital.361  Although 
such schemes have not been evaluated in the UK other than locally,249 they 
have been shown to work in Australia333,334 and have recently been backed 
internationally by the WHO.1   
2.4.3  During the patient’s stay 
There are a number of tasks which occur during the patients stay which may 
impact on medicines reconciliation. These include prescribing, altering 
medication, transcribing and ward rounds.  There are few studies which look at 
medicines reconciliation interventions during this stage, the only interventions 
relating to pharmacists. 
2.4.3.1 The role of the hospital doctor during the patient’s stay in hospital 
During the patients stay the patient’s progress is reviewed by a doctor, usually 
on a consultant-led ward round.  Medication may be withheld, stopped, started 
or changed.  This usually occurs following discussion on the ward round and 
relevant amendments are made to the prescription chart by a relevant 
prescriber, usually a doctor although this may be a non-medical prescriber.  Any 
amendments to existing medication regimens must be documented and 
communicated appropriately to ensure medicines reconciliation can be 
conducted at transitions in care.  There were no studies which investigated the 
proportion of medications stopped, started and changed or the documentation 
of medication changes using the search terms. 
It is likely that a patient will have their medication transcribed at some point 
during their hospital stay, usually by a doctor.  Within the acute setting, 
transcribing is undertaken when medication is copied onto an IMC from a 
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patient’s medical record, when the in-patient chart is re-written because the 
administration records are full or when discharge information is copied from the 
IMC to the discharge advice summary.  There is currently no widely accepted 
definition of transcribing. Hobson and Sewell have described it in their study as 
‘the process where a list of drugs that has been prescribed by a doctor is copied 
from one chart to another chart or prescription’.362  Within their study they were 
specifically looking at pharmacist transcribing, however, it is recognised that it 
may include other HCPs, such as doctors and nurses.    It is recognised that 
transcribing carries a substantial risk of errors,78,177 with a suggested overall 
error rate of 1% in the UK associated with rewriting charts and writing discharge 
prescriptions.52  This is significantly lower than a more recent Australian study 
which demonstrated approximately 12% errors in transcribing, the majority 
being omissions, although this specifically looked at transcribing at discharge.363  
Transcribing errors may go unnoticed, then transfer to the next care setting. A 
study from Denmark demonstrated that transcription errors affected all main 
groups of medication equally and were not associated with age, gender, or 
number of medications.  The applicability of these international studies to the 
UK is unclear.  With such a low number of pharmacists transcribing discharge 
notes and guidance from the Nursing and Midwifery Council (NMC) stating that 
nurses should only transcribe in exceptional circumstances,364 it is left to the 
doctor to transcribe in the majority of cases.    
2.4.3.2 The role of pharmacy staff during the patient’s stay in hospital 
The pharmacist will conduct regular clinical checks on the IMC during the 
patients stay.  The only interventions found which related to the patient’s stay, 
involved pharmacists either attending ward rounds or transcribing charts.  
Within the UK, hospital pharmacists have been shown to add value, both to the 
MDT78,88,102,185 and during the post-take ward round (PTWR),74,188,296 making 
significant interventions, providing cost savings, reducing errors and preventing 
major incidents.  Improved working relationships have overcome previous 
impressions of pharmacists being prescribing critics and have led to the 
pharmacists playing a more proactive role in medicines management.102 This is 
supported by doctors who have proposed that pharmacists should always verify 
medication history and should be available on the ward round to advise on 
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medication problems.78  Pharmacist attendance on ward rounds has been 
shown to save money through interventions made in the US.365 
2.4.3.3 The role of the nurse during the patient’s stay in hospital 
Medication is administered to the patient during their stay by nursing staff and 
the IMC annotated to signify that a dose has been given.  When medication is 
accidentally omitted from a patient’s prescription chart there is no indication to 
the nurse that it is required. There are few studies which look at nurse 
involvement in medicines reconciliation related processes. One study by 
Maxson et al299 demonstrated that bed to bed handover increased 
communication about the patient’s medication regimens.  Further work on the 
knowledge, roles and responsibilities of nurses in the medicines reconciliation 
process, especially within the UK, is needed. 
2.4.4 At discharge from hospital 
The decision to discharge a patient is usually made during the consultant ward 
round.  Following this decision, the patient’s discharge medication is prescribed 
on a discharge advice summary, transcribed from the patient’s medication chart 
and a copy sent to the patient’s GP.  Junior medical staff have previously been 
reported to prepare nearly all discharge prescriptions with hospital pharmacists 
adding value to the process.88,366  It is unclear how much discharge prescribing 
by hospital pharmacists has increased since the introduction of pharmacist 
prescribing in 2006.367  At discharge patients are counselled on their medication 
to varying extents. A review by Spinewine et al87 showed that education and 
patient counselling reduces the risk of ADEs and readmission in some but not 
all studies. 
Discharge communication has been cited as a problem for nearly 35 years.40-
42,368  Despite a number of improvements, for example, the introduction of 
discharge advice summaries (a discharge note that doubles as a prescription 
for medication),369,370 there are still a number of outstanding issues.  In the 70s 
and 80s, Price et al247 Parkin et al368 and Harding42 identified that changes to 
medication during the hospital stay are not communicated effectively to either 
the GP or the patient.  This was reinforced by Munday et al371 and 
Brackenborough,41 who determined that HCPs, in primary care, would like 
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information on reasons for medication changes to enable good continuity of 
care, suggesting that the discharge prescription be modified to include reasons 
for these changes.371 A more recent review, in 2007, by Kripalani et al372 show 
that communication has not significantly improved and there are still deficits in 
communication and information transfer at hospital discharge that can adversely 
affect patient care.  There have been on-going suggestions that communication 
can be improved through the use of technology373 (see section 2.2.6 Role of 
Information Technology (IT)).   
Care transitions are defined by the American Geriatric Society as ‘a set of 
actions designed to ensure the co-ordination and continuity of healthcare as 
patients transfer between different locations or different levels of care within the 
same location.374  Corbett et al375 suggests that successful transitional care 
models have a focus on medicines management and include improving patient 
knowledge of medication, providing a list of medication, follow-up post 
discharge and simplification of the medication regimen (see figure 2.6)  Often 
medication forms part of a larger transition intervention or ‘bundle of care’.376  
Laugaland et al categorises interventions which have led to successful 
transitions of care (see table 2.7),377 with Corbett et al incorporating elements 
specific to medication (see figure 2.6).375  
Table 2.7  - Interventions which lead to successful transitions in care 377 
Commence at an early stage of hospitalisation and are maintained throughout the stay 
and the post discharge period 
Discharge co-ordinator 
Patient participation/ and or education 
Interventions that involve family/caregivers 
Multidisciplinary approach 
Curriculum interventions (post graduate and undergraduate) 
Pharmacy interventions 
Standardised reports/ discharge summaries 
Comprehensive transitional care programs with multi – interventional components. 
A review by Hesselink et al which looked at handovers between primary and 
secondary care found that most effective discharge interventions incorporated 
those activities which focused on reconciling discharge information.378 There is 
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no evidence that one single intervention is regularly associated with positive 
effects on a single outcome measure.  Most studies are for a multicomponent 
intervention with various outcome measures reported in various ways that 
makes comparison difficult (see table 2.8). 
Figure 2.6 Elements of transitional care models375  (reprinted with kind 
permission) 
The accuracy of the medication history taken at admission can affect the 
accuracy of discharge communication.  If medication is not recorded on 
admission it may be accidentally omitted by either the patient or GP at 
discharge.379  It can sometimes be difficult to tell whether medication has been 
purposefully stopped or whether they were never recorded on admission.379  
The WHO specifies that hospitals should have a process in place for ensuring 
Successful 
Transitional 
Care Model
Improving 
patient family 
knowlge of 
medication prior 
to discharge
Providing user-
friendly 
medication 
lists/tables at 
discharge
Follow-up post 
discharge via 
home visits &/or 
telephone calls
Scheduling 
follow-up care 
appointments 
prior to 
discharge
Simplifying post-
hospital 
Medication 
regimen
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that, at discharge, the patient’s medication list is updated to include all 
medications the patient is to take following discharge, including new and 
continuing medications and previously discontinued medications that are to be 
resumed.1 The NPC states that discharge information should be clear, 
unambiguous and legible and should be available to the GP (or other primary 
care prescriber) as soon as possible post-discharge.80 The NPC goes on to 
suggest that ideally discharge information should be available to the GP within 
two working days of the patient’s discharge from hospital.80  There is limited 
evidence to determine whether this is happening in practice.380  Legibility of 
discharge communication has previously been reported as poor especially if it is 
the third carbon copy of a discharge prescription or a handwritten document.80  
The legibility is improved where pharmacists write the discharge summary.79   
The method of delivery of discharge information varies between NHS hospitals 
and may include posting by the ward or pharmacy, hand-delivery by the patient, 
faxing and electronic means, or a combination of these.103,366  Postal 
communication is currently the most popular method of receipt of discharge 
information in general practice.  This is very slowly changing as electronic 
discharge is being introduced. Sexton et al suggests that through increasing the 
amount of medicines supplied at discharge, time pressures can be 
decreased.366 Alternatively, time is saved if the pharmacy sends a copy of the 
discharge information to the GP rather than the ward, although only few NHS 
hospitals reported doing this.101  
Outside the UK, both Paquette-Lamontagne381 and Bedard et al292 show that 
the introduction of a medicines reconciliation form at admission improves 
consistency in data collection which can lead to the improvement in quality of 
the discharge information. In 2008, Midlov108,114 showed that the addition of 
specific information highlighting which medication has been stopped, started 
and changed led to significant reduction in medication errors.  The alignment of 
primary and secondary care formularies can also reduce miscommunication 
and decreases discrepancies at discharge.382 
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2.4.4.1  The role of the hospital doctor at discharge from hospital 
Junior medical staff are responsible for preparing nearly all discharge 
prescriptions in the UK.366  There are few interventions, however, that look at 
reducing the number of discrepancies made at discharge on discharge advice 
summaries; all come from outside the UK.  Structured and standardised 
interviews by doctors informing the patient of their discharge information have 
been shown to significantly increase the patients’ knowledge.383 Also a 
dedicated geriatrician provided discharge package which incorporated 
medicines reconciliation assessment of ADEs and difficulties managing the 
regimen and optimisation of the medication regimen reduced readmission at 
three but not six months post-discharge.67 
2.4.4.2  The role of the pharmacist at discharge from hospital 
Sexton et al showed wide variation within hospital pharmacy practice within the 
UK relating to medicines at discharge.366  Thirteen years on this wide variation 
still exists.384,385 
A number of pharmacist-led interventions have demonstrated an improvement 
in the discharge process within the UK, improving communication with the 
patient and other HCPs, timeliness of discharge and bed management.82,100,103  
This is mirrored within international studies in a variety of 
specialties.187,219,310,312,386-388  Pharmacists reviewing the discharge summary 
and providing feedback on any errors has been shown to reduce medication 
errors at discharge in Sweden and the US.73,389 US pharmacists co-ordinating 
paediatric discharges have also improved ability to obtain supplies post-
discharge.390 
In contrast, Shaw et al found that discharge planning in mental health did not 
lead to any significant improvement in patient knowledge.106  It is difficult to tell 
whether this was due to the specialty or the type of mental illness within the 
intervention and control groups which were significantly different as the groups 
were not stratified for diagnosis. There were fewer medication problems post 
discharge in the intervention group; however, this was not shown to be 
statistically significant.  Brookes et al suggests that pharmacists should also 
counsel patients at discharge and provide written information to reinforce 
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information provided.75 Intensive pharmaceutical care including discharge 
counselling and explanation of changes to medication regimens has been 
shown to improve the patients understanding and recall of their medication,82 
however, there is conflicting evidence on whether this impacts on readmission 
rates.  In the US, Wilkinson et al showed a significant decrease of 
approximately 6% in 30 day readmission rates,406 however, in the UK  no 
decrease in readmission rates within six months nor a change in deaths, visits 
to the outpatient or general practice were seen.105  When combined with 
medication review and follow up post discharge, counselling also led to 
decreased ADE within 30 days.123 
Campbell et al suggested the widespread utilisation of pharmacists to bridge the 
continuity gaps at admission and discharge and improve communication 
between primary and secondary care.48  Various terms are used to describe 
pharmacists who co-ordinate and bridge the gap between primary and 
secondary care, including community liaison pharmacists75,101 and transitional 
care pharmacists.262  These roles are not dissimilar to nurse discharge 
coordinator roles, however, they focus on medication use.  These pharmacists 
may do more than plan the discharge of patients they may also follow the 
patient up in primary care.  They have demonstrated  clear benefits in achieving 
seamless care within the UK75,88,101 and internationally, 262,414,419 undertaking 
activities such as preparing discharge information, counselling at discharge and 
communicating with other HCPs, demonstrating both cost savings and reducing 
readmissions.75  Discharge plans written by hospital pharmacists in Canada 
have been shown to decrease a number of drug related problems at discharge 
and allow community pharmacists to make relevant interventions.410  Both Elliott 
et al412 and Tran et al411 have demonstrated improved communication and 
reduced discrepancies through the production of MAR to send to care homes 
post discharge; neither of these were conducted in the UK. 
2.4.4.3 The role of the nurse at discharge from hospital 
Within the UK, it usually falls to the nurses to inform patients about discharge 
medication, including what it is for, when and how to take it and how to obtain 
further supplies.106,420  Studies from the US show that nurses are well placed to 
identify reconciliation discrepancies, especially at discharge, and, when working 
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in collaboration with pharmacists, increased discrepancy resolution can be 
seen.375,413  Nurse co-ordinated discharge and case management including 
counselling and follow up post hospitalisation have also proven to improve error 
rates 391 and decrease rehospitalisation within 30 days of discharge.403   
2.4.4.4  The role of the community pharmacist at discharge 
Community pharmacists can find it difficult to know whether a patient has been 
in hospital.360,421  Supplying community pharmacists with a copy of the patient’s 
discharge has been shown within the UK to reduce unintentional medication 
discrepancies,316 however, in the US Lalonde et al found that supplying the 
community pharmacist and the GP with the discharge medication did not 
decrease the amount of medication discrepancies.398 Communication between 
hospital and community pharmacists can prevent incorrect medication histories, 
create awareness of current issues or problems at home, prevent unintentional 
changes and ensure continuity of supply, allowing problems to be resolved 
before a patient arrives at their community pharmacy,422 however, UK 
community pharmacists rarely receive discharge information and where they do 
it is often for a specific reason for example where special formulations for 
example oral liquids for patients with dysphagia or compliance aids are 
required.40,360,366,395  Some GPs support the notion of community pharmacists 
receiving discharge information;423 inclusion of the community pharmacist in 
communication would contribute towards effective, seamless care.  
Community pharmacists report that patients present to them before going to 
their GP following hospital discharge.  This can be especially true in the case of 
MDS.360  The lack of provision of discharge information to community 
pharmacists is common.  Community pharmacists would like to receive 
medication information on discharge,75,107,360,424 especially medication changes, 
special requirements, ADRs and allergies. 
It has been claimed that patients do not use the same community pharmacy 
within the UK,40,425 making it difficult to know where to send discharge 
information or for the hospital to know who to liaise with.  Yet, there is much 
evidence to suggest that this is not the case with many patients being loyal to a 
single pharmacy.75  It is unclear, however, whether a patient’s loyalty is 
75 
 
proportional to the number of medicines a patient is prescribed, their age or the 
locality they live e.g. near a town centre versus village. 
2.4.5  Post-discharge (in primary care) 
At discharge the patient may move to their own home, a care home or 
intermediate care, with their discharge information being passed to a number of 
different people, most definitely the GP and in some cases district nurses, 
community pharmacist, social services, care home staff or intermediate care.  
The recipient must then process the information they have received.  In the UK, 
Akram and Urban found that 80% of discharges were received within 7 days 
and took four to nine days to be actioned by the general medical practice.380  
This is similar to previous findings by Coleman et al who found that 96% of 
discharges arrived within eight days, with outpatient letters arriving within 21 
days in 92% of cases.373 The delay in receipt of discharges is not unique to the 
UK; a study in Australia showed that 33% of GP respondents felt the discharge 
summaries were not always received in a timely manner.426  Also, a study in the 
Netherlands showed 75% of GPs experienced a delay.427  One Australian study 
showed that within 30 days post discharge 71% of patients will visit their GP 
and 86% their community pharmacy, making it important for primary care HCPs 
to receive the discharge within this time.428  Similar studies have not been 
conducted in the UK.   
2.4.5.1 The role of the GP post-discharge 
The GP is the central record holder in primary care within the UK and on receipt 
of discharge, information should review and update their records appropriately. 
Ultimately these records then may inform the patient’s medication history if they 
are readmitted.  Crowe et al suggests that general medical practices use an 
information processing model to process correspondence from secondary 
care.429  This involves six stages: receipt of information, dissemination, 
amendment of records, reading and actioning recommendations, scanning 
information and informing the patient. There is often pressure within primary 
care to turn prescriptions around in a timely manner,75 especially where patients 
are requesting further supplies.  Delays in processing can be caused by work 
patterns, working over split sites and prioritisation of other tasks.430  Prior to the 
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re-issue of medication post discharge, the GP may see the patient in primary 
care, however, this is not routine and often dependent on the practice or 
individuals within the practice.429  In Sweden, Rahmner et al found that GPs had 
differing perceptions of their responsibility for the patient’s medication list with 
some feeling they had responsibility for all the medication the patient was on, 
others just those that they prescribed, and further GPs a shared or imposed 
responsibility with other healthcare providers.431  
Unintentional changes in medication, especially dose instructions, omissions 
and additions occur in supplies obtained post-discharge rather than at 
discharge,379,432 with medication being accidentally discontinued or added in 
primary care. This can cause further problems if the repeat medication list on 
the GP system is not updated appropriately.379,430  It is often unclear whether 
discrepancies post-discharge are a result of error on discharge or poor 
medication history taking on admission, supporting the cyclical nature of 
medicines reconciliation and the dependence of subsequent stages on the 
accuracy of previous stages. Despite the age of these studies there is nothing 
to suggest that this has changed. Repeatedly, general practices rely on the 
patient, their relatives or their carers to inform them of information, especially 
where it is conflicting. GPs also frequently rely on hospital discharge information 
to indicate how long patients should continue specific medication but this 
information is often not present on the discharge summary.88,101  One US study 
suggests that within care homes, nursing staff with varying qualifications 
perform medicines reconciliation post discharge, with the process they use 
varying.  It is unclear what currently happens in the UK and further work is 
needed to understand what happens in these areas and whether staff have 
appropriate skills to accurately process the discharge information. 
Crowe et al discuss the amending and updating of records post discharge as a 
task exclusively carried out by GPs themselves,429 whilst in practice this is 
sometimes conducted by pharmacists and in some instances administrative 
staff, who do not necessarily have appropriate competencies.80  Duffin et al 
found that often changes post-discharge could not be contributed to a 
conscious clinical decision,433 and, although using administrative staff to amend 
records post discharge reduces delays, it can leave room for error, especially if 
there is no requirement for the GP to see the letter before records are updated.  
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The extent to which this is still practice is unclear.  The NPC specifies that 
medication lists must first be reviewed by the GP, the practice nurse, or the 
practice pharmacist, with the untrained person only taking responsibility for the 
administrative side of the process.80  A systematic review from 2009 concluded 
that there was no good quality evidence demonstrating effective medicines 
reconciliation interventions in primary care and that further studies looking at 
this area were needed.434  
2.4.5.2  The role of the community pharmacist post-discharge 
There is evidence from Europe to suggest that community pharmacists can 
usefully counsel patients following discharge.416,417  Although there is little 
evidence to support it, some hospitals in the UK are encouraging patients to 
visit their community pharmacy for a Medicines Use Review (MUR)d post-
discharge to inform them about their medicine.435 The national target groups for 
MURs includes those patients recently discharged from hospital who have had 
medication changes made.436  This is supported by the Royal Pharmaceutical 
Society (RPS)437 and has more recently been introduced as an advanced 
service in Wales.438  One published abstract shows improved Functional 
Independence Measure Scores in patients receiving a locally commissioned, 
enhanced domiciliary MUR service within seven days post discharge,439 
although this was part of a wider discharge programme. A similar scheme 
(Home Medicines Review) in Australia has proven successful and popular with 
patients.440,441 
2.4.5.3.  Role of other staff within primary care 
The literature search did not reveal any studies which discussed the role of the 
practice pharmacist, practice nurse or administrative staff in relation to 
medicines reconciliation within primary care, however, it is known in practice 
that these personnel can be involved in the processing of discharge information.   
                                            
d MUR is an advanced service offered by pharmacies in the United Kingdom. It is part of the 
contract pharmacies hold with the National Health Service (NHS).  The patient is provided with 
an opportunity to discuss their medicines use with a qualified pharmacist. 
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2.4.6 Standardisation of the medicines reconciliation process 
Throughout the entire process many interventions describe standardisation as a 
way of minimising error associated with medicines reconciliation.  It is clear that 
more complete accurate documentation of medication histories is required.76 
Standardisation of documentation or proformas have been shown to aid the 
medication history taking process within the UK101,442 and Canada,292 providing 
appropriate boxes and prompts to aid information gathering.401  Previously, in 
1993, the RPSGB produced an admissions and discharge checklist to support 
communication between primary and secondary care.443  Although evaluation 
deemed it useful to indicate when regimens had changed, there was a lack of 
awareness by pharmacists of its existence,425 highlighting the need for 
appropriate promotion and dissemination of information.  In Australia, Smith et 
al developed a multidisciplinary form to try to capture information about 
medication discrepancies occurring across the interface to standardise the 
reporting.92 Whilst this was only tested using vignettes and not in practice, the 
level of agreement on completion made it a potential solution to standardising 
the collection of information on the type of discrepancies occurring at the 
interface.  It was ultimately validated in a study by Corbett et al who used 
nurses to identify discrepancies at transition from hospital to home.375  
It was suggested by Mottram, in 1994, that although discharge letters contained 
more information than a discharge summary they were often poorly structured 
and it could be difficult to extract key information; necessitating an improvement 
in the design of the discharge forms, completion of the forms and administrative 
systems to dispatch the forms.369 Subsequently, the inclusion of structured cues 
and standardisation of discharge summaries has improved communication as 
long as they are completed in full.101  This has the potential to be improved 
through the use of IT (see section 2.4.7). 
Nevertheless, there remains inter-hospital and intra-hospital variability of forms 
which can cause confusion when employees move areas of work. The WHO 
have appealed for health-care organisations to put in place clear policies and 
procedures, plus standardised systems to collect and document information for 
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each patient to provide to the next caregiver at each care transition point, 
whether at admission, transfer, discharge or outpatient visit.1  
2.4.6.1  Minimum data set for medicines information provided at 
discharge 
In 2007, with the aim of standardisation, the WHO suggested a minimum 
dataset which should be included in discharge information.1 This included 
details of started, stopped and changed medication including reasons and the 
intended duration of treatment.1  This was added to by the NPC, who suggested 
the minimum dataset should also include complete and accurate patient details 
including NHS number, weight if under 16 years, consultant, ward, dates of 
admission and discharge, presenting condition plus co-morbidities, procedures 
carried out, a complete list of all medicines the patient should take following 
discharge, the dose, frequency, formulation and route of all the medicines listed, 
allergies and patient information provided such as corticosteroid record cards, 
and anticoagulant books.80 In 2010, one primary care trust (PCT) liaised with 
their general medical practice system supplier to be able to extract the relevant 
data included in the minimum data set to provide to hospitals when one of their 
patients was admitted.444 
More recently the RPS has also published a minimum dataset which mirrors 
that of the NPC but also includes GP details, usual community pharmacist, 
specialist nurse, description of allergy reactions, generic and brand name 
(where relevant), the indication, duration, on-going monitoring requirements, 
requirements for adherence support, special product information, how 
information has been given to a representative or carer (where appropriate) plus 
details of the person completing.445  The extent to which this is embedded in 
practice is unclear.  An audit of discharge information carried out in four general 
medical practices in Surrey, UK found that the NPC minimum data set were not 
being met or fully completed.446  This is supported by a further audit in Central 
Manchester University Hospitals NHS Foundation Trust suggesting that 
compliance with the standards varied between 19 and 100% with medication 
changes not being documented routinely.447  Although the majority of these are 
essential in effective communication, with the amount of information required, it 
is not surprising that often information gets overlooked.  The lack of completion 
of discharge documentation is not uncommon either within or outside the UK.448-
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450  Legault et al determined that 95% of discharge summaries failed to include 
recommendations regarding medications in dysphagia.451  
2.4.7  The role of information technology (IT) 
Table 2.9  Summary of IT interventions relating to the different stages of 
the patient’s journey through hospital 
 Admission During Stay At Discharge Primary 
Care 
UK studies Using EHR as 
source during 
medication 
history 235 
No 
intervention 
studies 
Standardised 
discharge form. 
293 
e-discharge452 
No 
intervention 
studies 
International 
Studies 
Web based 
system to 
improve 
information 
provision from 
nursing homes at 
admission453 
Computer 
physician order 
entry (CPOE) 
454,455 456* 
Kiosk to collect 
medication 
history90,457,458 
Using EHR as a 
source 
Using electronic 
prescription 
records as a 
source119,252,459,460 
Electronic 
medicines 
reconciliation too 
l461-470 
Electronic 
communication471 
e-prescribing472 
Pre-admission 
medication list 
(PAML) builder 
142,463,464 
No 
intervention 
studies 
Electronic 
discharge 
summaries363,473 
Electronic patient 
list474 
No 
intervention 
studies 
*no significant effect seen following intervention 
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Technology has the ability to improve existing clinical and administrative 
processes in health475 and mitigate vulnerabilities at transitions in care (see 
table 2.9).476  In 2010, a review by Bassi et al showed that IT can and has been 
used to facilitate aspects of the medicines reconciliation process, including 
decision support software, electronic health records and electronic 
prescribing.477 Despite these suggestions, eight years on from the survey by 
Hobson and Sewell,362 it is uncertain how much the use of IT has increased.   
The NPC suggests that the full implementation of electronic transfer of patient 
information between healthcare settings will make the reconciliation process 
much simpler, however, they also acknowledge that until such times as it is fully 
operational, organisations will need to develop robust procedures for medicines 
reconciliation and establish them within everyday work patterns.80  Whilst 
electronic means of communication are likely to reduce errors they will not take 
away the need for trained personnel to check that medication has been 
prescribed accurately.6  Data completeness is important for patient safety.475  
Once implemented, IT can ensure information is uniformly available and can 
address active and latent failurese, reducing error for example by using forcing 
functions and alerts to ensure fields are not left blank.475,478  HCPs have also 
expressed the importance of a simplified, streamlined computer entry 
process.230 
The systematic review commissioned by NICE & NPSA concluded that 
improvements in IT were likely to reduce medication errors in medicines 
reconciliation, going further to suggest insufficient evidence to promote one 
particular method.6,48  This was supported by a report from the WHO 
Information Technology for Patient Safety Expert Working Group which 
examined the role of IT in improving patient safety in healthcare, reinforcing the 
need for increased use of IT to improve patient safety.475  This report focused 
on the management of information, especially where there was need for 
integration of different types of data. This is especially pertinent to medicines 
reconciliation as information from a variety of sources is assimilated and 
transferred between care settings.  There is, however, a gap in evidence 
                                            
e An active failure is an unsafe act (error or violation) committed by those with direct contact with 
the patient.  A latent failure is an organisational or managerial failure for example lack of policy 
and procedures 
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regarding the significance of IT interventions and the associated cost-benefits 
for medicines reconciliation within the UK.  The few studies which exist are 
international (mainly from the US) and focused at admission, making the role of 
IT in medicines reconciliation somewhat vague.48,475,479    
In contrast, other studies have recognised the significant limitations of IT in the 
reduction of errors, for example the ability to override warning messages or the 
complexity of the software.475,480,481  Huckvale et al suggests that the 
introduction of new tools can disrupt existing processes introducing sources of 
risk or facilitating unsafe behaviours.475 There can be variance in the level of 
accuracy of the information due to the accuracy of input and the maintenance of 
records; Samaranayake et al describes these as socio-technical errors as often 
they were due to poor interface between the user and the computer.482 The use 
of technology allows for novel solutions such as timeline displays to allow 
visualisation of the medication history483 and intelligent systems which can 
predict the likely omitted medication using collaborative filtering 
approaches.484,485 
At Admission 
Various electronic medicines reconciliation tools have been shown to improve 
and standardise data collection and reduce discrepancies at admission to 
hospital in the US465,468 and Spain.467  In the US, PAML builders have been 
evaluated.142,463,486,487  These are applications which create a PAML from 
several electronic sources and, although not perfect due to limitations in the 
system, have been shown to decrease the number of unintended discrepancies.  
Difficulties arise integrating and interfacing the different existing electronic 
systems and sources available.488   
Various US studies have also looked at Computerised Physician Order Entry 
(CPOE) (also sometimes referred to as Computerised Provider Order Entry or 
Computerised Provider Order Management).455,456,466,489 CPOE systems are 
designed to replace a hospital's paper-based system. They allow users to 
electronically write the full range of orders, maintain an online medication 
administration record, and review changes made to an order.  They can also 
incorporate elements of e-prescribing systems such as Computer Decision 
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Support Software (CDSS) and interaction alerts. They have shown to be 
important in the reduction of medication error through decreasing transcribing, 
and thereby increasing seamless care.455  There are some studies which 
integrate PAML builders with CPOE to improve process, information flow and 
decrease transcribing error.466,470 
Lesselroth et al take automation and IT one stage further, allowing the patient to 
verify their medication history themselves using an automated patient history 
intake device (APHID).90,457,458,490 This proved cost-effective and allowed the 
identification of relevant discrepancies.  Medication lists are retrieved from an 
EHR and the patient verifies the information using a kiosk, making additions and 
amendments to the list where appropriate.  Of course, there are still limitations 
for those who are unable to interact with the system due to e.g. cognitive, 
locomotor, or visual impairment. 
An accurate medication history needs to be easily accessible. The idea of a 
common shared record between secondary and primary care has been 
discussed for 25 years.247  Sexton et al suggests that given the wide access to 
electronic banking it is surprising that there is not access to an up to date 
patient regimen.366 This has been somewhat addressed in the UK with the 
national summary care record, although it also has limitations and is not being 
utilised to its full potential.491  Locally within Bradford Hospitals NHS Foundation 
Trust, the shared EHR has been shown to reduce medication error when used 
in conjunction with other sources, primarily the patient or carer.153  In the 
Netherlands, Van der Kam471 showed that the electronic sharing of records 
between the GP and community pharmacist resulted in better agreement 
regarding their current medication, although did not eliminate totally the problem 
of dissimilar information.  More recently the experiences of the shared EHR in 
Sweden highlighted the differences between access to data and information 
and access to knowledge.91  Data and information within the EHR must still be 
reviewed; this relies on HCPs interpreting the information within the EHR 
accurately.  Finally, national electronic prescription records have shown to add 
value,252,460 as well as computerised outpatient and inpatient dispensing data459 
(see section 2.3.11). 
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During Stay 
Electronic prescribing was introduced into general medical practices in the UK 
in 1990s to try and improve the accuracy and efficiency.492  In hospital, 
however, progress has not been made at the same pace.  A UK survey in 2010 
of 63% hospitals showed that just 8% of hospitals had access to electronic 
prescribing with variability in the systems used and compatibility with other 
systems (32% of all hospitals for chemotherapy prescribing).385  Four years on it 
is unclear how this has changed.   
At Discharge  
Communication of information at discharge can be improved through computer 
generated discharge summaries and standardisation.293,372,408,409,473  However, 
Callen et al found that electronic summaries contained more errors than 
handwritten, concluding that it is not necessarily that electronic discharge 
summaries are of higher quality than handwritten ones but that information is 
less likely to be omitted due to forcing functions.493  
A survey by Hobson and Sewell,  in 2003, concluded that 79% of NHS 
Hospitals used paper based discharge systems, once again showing the limited 
use of IT systems within secondary care.362  Traer and Madhaven argue that 
there is no obvious joined up approach to the implementation of electronic 
systems within secondary care in the UK.492 The recent extent to which 
electronic discharge systems have been embedded within the hospitals is 
unclear.   
2.4.8  Summary Part 2 
The patient’s journey into hospital starts at admission where the doctor clerks 
the patient, takes a medication history then prescribes for the patient.  
Pharmacy staff then verify this medication history.  During the patient’s stay the 
patient may be seen several times by different doctors and medication altered.  
At discharge a discharge summary is written and transferred to primary care 
once the patient is discharged.  The scale and severity of discrepancies and 
error seen in Part 1 are a result of the complexities of the health system and the 
involvement of many different HCPs. 
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Many interventions lead to a level of reduction in medicines reconciliation error 
at admission and discharge.  By targeting both admission and discharge 
together, error can further be reduced.122  With evidence that pharmacists are 
more likely to write legibly, counsel more effectively, take more accurate 
medication histories and identify both allergy status and OTC medications than 
other HCPs,78,79 it could be argued that they should undertake many of the 
processes associated with medicines reconciliation within the healthcare 
system.  There is scope to increase the input of pharmacists and their support 
staff at admission to hospital,342 undertaking tasks such as taking the initial 
medication history and prescribing IMC.  The role of nurses and primary care 
staff is less well defined and need further exploration, although it is clear that 
they need accurate and timely information to be able to effectively continue care 
post-discharge.  There is potential for increased community pharmacy input at 
admission and discharge. 
Varying educational interventions have tried to improve medication history 
taking accuracy and reduce discrepancies.  Although these are usually targeted 
at one particular HCP there is nothing to suggest that these are not 
transferable.  There is scope for inter-professional education of medical and 
pharmacy students to take medication histories as previously shown to work by 
Greene et al.494  Further work on the impact of medicines reconciliation on 
readmissions is needed together with better quality economic evaluation of 
medicines reconciliation interventions to enable cost-effective recommendations 
to be made.495  A range of different IT solutions have been tried and tested, 
nevertheless, further work is still needed to support the use of IT for medicines 
reconciliation 
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2.5 Part 3 The Role of the Patient in Medicines Reconciliation 
2.5.1  Overview 
Accurate medicines reconciliation at transition points in care is extremely 
important to ensure patients receive the correct medication.  As patients age 
they are more likely to have at least one chronic disease which requires 
treatment and to be on several medications.220   As discussed previously, these 
complex medication regimens can lead to increased medication discrepancies 
at hospital admission resulting in potential harm to the patient.70,109-
111,117,145,173,177,180,181,183,197,212  Self-management of their medication relies on the 
individual patient being able to understand their medication.  This can involve 
obtaining supplies, understanding changes and knowing when to ask for help.  
Various factors have been shown to affect the patient’s ability to manage their 
medication effectively. These include low health literacy, management of 
multiple medications and increased frequency of administration.496-500  
Ultimately, this poor medication management can affect recall of medication 
history, leading to discrepancies at admission. 
Over the last five years there has been an international drive to empower 
patients, make them central to healthcare2,475,501 and include them in improving 
patient safety;502,503 medicines reconciliation being no exception.  The WHO 
suggests that to be optimally effective, patients and their families must be 
involved in the medicines reconciliation process and their participation 
encouraged.1  Yet, patients are not aware of the medicines reconciliation 
process and that they have a clear role within it,332,504,505 nor do HCPs appear to 
encourage active partnership with patients.506 
2.5.2  The potential of collaborating with the patient and/or patient 
representatives to reconcile medication  
The patient is the common factor within the medicines reconciliation process 
and can play a pivotal role in accurate transition of information about their 
medicines.507,508 The NICE & NPSA,6 IHI,2 WHO1 and the NPC80 all suggest 
that the patient is utilised as a source of information during medication history 
taking at admission to hospital.  This is not surprising as patients are in the best 
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position to provide information on precisely what medication they take/use and 
how they take/use it, as well as being aware of the medications prescribed. 
Discussions with the patient are important as some patients may decide to stop 
a medication or not to take it as intended by the prescriber, often without 
consultation with a HCP.509  This could lead to the addition or omission of 
medication on prescription charts at admission if the patient is not consulted.  It 
is thought that between 33 and 50% of people do not take their long-term 
medicines as recommended.510 This can lead to increased medication 
discrepancies.497-499 One US study showed disagreement in 86% of cases 
between what the doctor thought the patient was taking and what they were 
actually taking.511  A further US study in 2008 reported 97% discrepancy rate 
between the medical record and what they were actually taking.512  Thirty-two 
per-cent had an allergy or ADR discrepancy.512  Also, some patients admit that 
they would fail to tell their GP if they chose not to have their prescription 
dispensed.513 Conversely, an Australian study demonstrated that only 20% of 
patient-completed medication histories were accurate in surgical patients.514 
The NPC describes two categories of source, those which are more reliable and 
those which are less reliable;80 classifying patients as a more reliable source, 
however, their rationale is unclear.  There is no evidence to suggest that the 
patient is more accurate than other sources, although Glintborg et al determined 
that patients' self-reports are reliable when estimating recent use of 
cardiovascular and antidiabetic medication.507 Patient collaboration can also be 
used to recognise opportunities to improve medicines management services 
through feedback questionnaires at discharge.89  Involving the patient can 
reveal a significant amount of extra information not provided by other 
sources.78,121  Cochrane et al showed that a quarter of patients were taking 
regular OTC medication; information which cannot be gained from additional 
sources.379  These various studies demonstrate patients to be an important 
indicator of precisely what they are taking/using at admission.   
In some cases, patients rely on relatives or carers to supervise medication379 
and often would not notice themselves if anything was changed or omitted.515 
Yet, where patients self-administer their own medications at home, their ability 
to recall their medications can be superior to that of other patients.515  It is 
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therefore, widely acknowledged that a range of sources must be used to verify 
the list of medication a patient is taking including the patient. 49,50,76,145,166,233-235   
Some patients may not be able to recall their medication history without relevant 
prompts such as the use of a list or the medication in front of them.163,516 
although Witting et al found that 70% of patients being admitted to A&E could 
accurately complete a self-administered  medication form.517  The use of a pre-
clinic questionnaire combined with a clinical interview has shown (in the UK) to 
improve the accuracy of a patient’s current medication list compared with either 
method alone as a source of information.294  This has also been demonstrated 
in Canada518 and the US.331   
Nearly 30 years ago, both Mageean519 and Harding42 found that the GP often 
received important details from the patient, before any formal hospital discharge 
information was received.  Although the timeliness has been improved by the 
use of the discharge advice summary,446 it is not clear from the literature 
whether this has improved. Cromarty et al demonstrates that the provision of 
any discharge advice summary to the patient at discharge is valued by the 
patient and also decreases the incidence of medicines related problems post 
discharge.392 Despite the evidence to suggest the patient’s usefulness as an 
information source, there is little evidence to show how widely they are involved 
in medicines reconciliation and what role they should play. 
2.5.3  Potential limitations of collaborating with the patient to reconcile 
medication 
There may be a number of challenges and limitations when using the patient 
during the medicines reconciliation process, including an appropriate 
assessment of their competence to provide accurate information.  Sometimes 
the patient may be away from the bedside, such as having investigations or 
procedures, making them inaccessible, even so, every attempt must be made to 
include the patient in their care.  There is little UK evidence which ascertains the 
proportion of patients who do not have the ability to contribute to an accurate 
medication history or the proportion who actually do contribute. 
NICE & NPSA6 recognise the difficulties obtaining accurate information from 
patients about their medication, which may be caused by their acute condition, 
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sensory/cognitive impairment, lack of support or language barriers.  It is 
supported by previous literature which highlights the challenges of patients 
being drowsy, asleep, confused or unable to recall names of medication.76 
Patients may not be able to communicate or may feel so unwell that medication 
is not of interest.82  Patients may also be more vulnerable at different stages for 
example immediately post-discharge.520  Collins et al found that even when the 
patient had verbalised their list of medication to the pharmacist, it was often 
revealed through a further source that there were additional medications the 
patient was taking.76 Both Meyer et al163 and Lingeratnam et al332 showed 
approximately half of patients providing a medication lists from memory were 
accurate, reiterating the importance of relying on more than one source.80  
Certain patient populations e.g. the homeless provide other challenges where 
due to their unstable living environment they are unlikely to have an accurate 
medication list.521 
Low understanding by patients,145 along with lack of knowledge about what they 
are taking522 and why they are taking it523 can all lead to medication error.  A 
review by Ostini and Kairuz suggests a possible U-shaped relationship between 
non-adherence and health literacy where people with low health literacy are 
more often non-adherent, often unintentionally; people with moderate health 
literacy are most adherent; and people with high health literacy can be non-
adherent due to intentional non-adherence.524  Cognitive ability and health 
literacy can contribute to the person’s ability to recall information during 
medication history taking and to follow prescribed regimens.496-499 This is 
supported by the work of Marvanova et al who determined that lower health 
literacy and lower cognitive function and higher number of medications all 
independently contributed to lesser understanding of the intended medication 
regimen.500  Patients must be able to translate knowledge into safe practice.  
Hain et al525 showed patients’ lack of self-awareness of the problems they were 
having with medication.  During telephone interviews 87% responded that they 
had no difficulties with their medication regimens, however, on home visits 52% 
had at least one issue with their medication. This was complemented by Cain et 
al526 who determined that patients reported having all the information they 
needed, however, this did not translate into appropriate medication 
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management.  Patients often expressed uncertainty about their medication 
regimens such as when and how to take/use medication. 
Whilst many patients show an active interest in their care, some do not want to 
be involved with decisions about their medication,332,527 making it important to 
tailor information to individual wants and needs.528  With all this in mind, there is 
debate whether it is reasonable to expect patients to identify error and to query 
medication changes or discontinuations.78  Although some patients may take an 
active role in their care, questioning changes to their treatment, others have a 
more passive role, expecting changes and assuming they are deliberate.527  
This is supported by Lingaratnam et al who identified three types of patient 
group: those who were confident with their medicines management and 
perceived themselves to cope well; those who desired greater involvement, 
irrespective of their level of confidence; and patients who were reluctant to 
participate. 
Much of the evidence relates to the secondary care setting and whilst most of 
the principles are likely transferable to the primary care setting, systematic 
study is necessary for any corroboration.  
2.5.4  Role of patient representatives/caregivers in the provision of 
information 
Care givers have an important role and can provide an independent source of 
information which may improve documentation of medication histories.  
Caregivers such as relatives, friends and paid carers often take responsibility 
for medication supply and administration. However, in practice carers are often 
not involved in counselling, with this being directed toward the patient rather 
than establishing who will be managing the medication.  Pippins et al145 found 
that relying on family members or caregivers as a source was a risk factor for 
PADEs when used by the medical teams but were a source of accurate 
medication information when used by the study pharmacists.  There was no 
explanation provided for this. 
In the case of children, it is expected that the parent will play a central role in 
the provision of information about their child’s medication and they have been 
shown to be effective in ensuring seamless pharmaceutical care through the 
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delivery of the discharge summary to the community pharmacy and GP.88  This 
has been supported by Porter et al529 who demonstrated that parents could 
recall the name of the medication their child was taking approximately 80% of 
the time.  Though, recall of the route, form and dose was less accurate. This 
was, nevertheless, greater than a subsequent study which demonstrated that 
only 50% of families were able to provide complete medication information 
when asked.  Kimland et al530 demonstrated the importance of asking children 
about their medication showing 40% used prescribed medication, 65% OTC 
medication and 8% CAMs. 
2.5.5  Collaborative interventions which support accurate medicines 
reconciliation  
Several UK and international studies have concentrated on patient focused 
interventions that demonstrate the benefits of active patient involvement in 
medicines reconciliation.  These include patients bringing their medication into 
hospital, self-administration of medication, patient completed questionnaires 
and patient counselling.116,334,405,416  These will be discussed below.  
2.5.5.1  Bringing medication into hospital 
Price et al suggested in 1986, that patients should play an active role by 
bringing their medicines into hospital at admission.247  More recently many NHS 
Hospitals are encouraging this further in line with NICE & NPSA 
recommendations. Methods such as the ‘green bag scheme’ are used, where 
green plastic bags are distributed at pre-admission clinics and used by patients 
and paramedics to bring medication into hospital.361  Although such schemes 
have not been evaluated in the UK, they have been shown to work in 
Australia333,334 and have recently been backed internationally by the WHO.1  
The extent to which patients bring their medication into hospital is not widely 
cited within the literature; Daji and Urban531 found that it only occurred in 50% of 
patients, most of these being elective patients.  This was mainly due to a lack of 
awareness of the need to bring them in by the patient.  The use of PODs can 
produce demonstrable cost savings to hospital drug budgets, improve the 
accuracy of medication history taking78,400 and improve the patient’s ability to 
accurately describe the medication they are taking.247,515 Despite these 
advantages, only 50% of doctors stated that they always use PODs during 
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medication history taking.78  There can be reluctance from patients to bring their 
own drugs into hospital for fear they may be lost and not returned at 
discharge.75  Failure to bring medicines into hospital can lead to the potential for 
discharge medication and home medication to be taken concurrently post 
discharge.  There is further work needed on the education of both patients and 
HCPs on the value of bringing medication into hospital.531  
2.5.5.2  Self-administration 
Self-administration of medication by the patient during their hospital stay has 
been shown by Shaw et al106 to increase the patient’s knowledge and maintain 
it three months post-discharge.  This highlights the potential success of 
involving the patient in self-medication programmes prior to discharge.  
2.5.5.3  Communication and patient counselling  
International studies show that half of patients will have a medication change 
whilst in hospital with the majority of older patients having at least one 
medication change whilst in hospital.532,533  Lack of communication about these 
changes and poor patient understanding can lead to error during inpatient stay 
and post discharge.372,534,535  One study showed that a quarter of patients were 
never told by their physician that they were starting new medication, despite the 
feeling by physicians that they communicated with the patient.536 Another, 
showed patients had no understanding of two-thirds of medication changes.336  
Further work looking at the frequency of communication about medication 
changes and relevant interventions to improve communication are needed. It is 
also known that where patients or their carers are given specific instructions 
they are more likely to follow them,88 however, the extent to which information is 
currently provided varies. 
It has been established for over 30 years that patient medication counselling 
alone or with written information improves patient understanding, reduces the 
number of errors made by patients and leads to improved compliance.368,537  
Counselled patients have been shown to have increased knowledge and to 
display fewer errors than uncounselled patients in recalling information about 
their medication82,383,395,424,537 which is imperative if patients are to be used as a 
source of information within the medicines reconciliation process.  It has also 
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been shown in the Netherlands that it can assist with identifying discrepancies 
on discharge as patients are able to challenge perceived errors.405  This is 
reinforced by the WHO, who suggest patients be educated about safe 
medication use as part of medicines reconciliation and provided with access to 
reliable, relevant, and understandable information about their medications.1  
Borgsteede et al528 go further to suggest that medicine information is tailored to 
the individual needs of the patient depending on their health beliefs and prior 
knowledge. Recently, the RPS445 has issued guidance on when and how to 
counsel patients about their medicines in the UK, although their evidence base 
is unclear.  
Ensuring good communication with patients, however, can be time 
consuming424 and effective medication counselling has been shown to take up 
to 30 minutes.100  MacDonald et al537 suggested a member of staff, preferably a 
pharmacist, should spend approximately 15 minutes with elderly patients prior 
to discharge to ensure they fully understand their medication regimen. This was 
supported by Al-Rashed100 who found that pharmacist counselling linked to a 
medicines reminder chart and information discharge summary led to better 
knowledge and compliance compared to nurses counselling. A survey in 
2000,366 found that in the majority of NHS Hospitals a pharmacist counselled 
fewer than 10% of patients about their discharge medication and in 82.2% of 
NHS Hospitals fewer than 20% of patients received written discharge 
information. Sexton et al went on to state that pressures on staffing and 
resources can often make services such as medication counselling at discharge 
unlikely.366  Almost 10 years on, there is little to demonstrate that this has 
changed.  
There is evidence from Europe to suggest that community pharmacists can 
usefully counsel patients at discharge.416 Some hospitals in the UK are 
encouraging patients to visit their community pharmacy for a Medicines Use 
Review (MUR) post-discharge to inform them about their medicines, which is 
supported by the RPS437 although there is currently no UK evidence to support 
the effectiveness of this.  Similar Home Medicine Reviews (HMRs) have been 
shown to work in Australia.523  
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2.5.5.4  Hand-held information 
Sandler et al400 suggests patients should carry up to date written hand-held 
information around with them at all times to assist medication history taking.  
There is substantial evidence to suggest that the provision of hand-held records 
or information to patients improves their recall regarding details about their 
hospital stay, reason for admission, and medication, with patients often using 
the information as an aide-memoire.400  Both Irvine et al204 and Brackenborough 
41 found that patients themselves did not think hand-held information would be 
useful which is contrary to findings by Sandler et al400 and Chae et al402 where it 
was found to have some use and improved actual and perceived patient 
knowledge respectively.    
The APhA refers to this hand-held information as the patient medication list and 
defines it as ‘a record of current medications that an individual carries across 
the continuum of care to stimulate conversation between the individual and his 
or her healthcare providers regarding the patient’s current medications.’538  The 
provision of hand-held information allows patients to read it at home in their own 
time and not feel rushed. Many patients will also share this information with 
others including spouse, relatives and GP post discharge.400  Hand-held 
information is not intended to replace discharge information, rather to reinforce 
it and has been found to be particularly useful if combined with a regular 
medication review with a pharmacist.204   
Hand-held records rely on information being kept up to date.  This can be 
difficult and lists are often updated incorrectly or include omissions,204,332 putting 
some onus on the patient to prompt HCPs.41  Where hand-held records have 
been introduced, patients often did not carry their booklet or keep it up to date 
for a variety of reasons, including simply forgetting, disinterest and the belief 
that doctors already had access to this information.204   
2.5.5.5  Self-completed questionnaires 
Evidence suggests that although patient-self completed questionnaires at 
admission are not always complete and accurate, they can help to improve the 
accuracy of medication histories when combined with a clinical interview 
compared with either method alone.294,331,514,518  In France, Roulet et al tested a 
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questionnaire in which patients documented self-medicating behaviours.  This 
identified double the number of self-medicating drugs compared with 
interviewing alone.  It also had the potential to reveal iatrogenic conditions that 
were being self-treated, although this was not tested.330  Patient completed 
questionnaires need to be studied further to understand their role within the 
medicines reconciliation process. Marvanova et al500 suggests the use of a 
medication understanding questionnaire to establish the ability of a patient to 
understand their medication and give an indicator of their reliability. This would 
allow HCPs to exercise greater caution when using patients as a source of 
information.   
2.5.5.6  Access to personal electronic health records (EHR) 
Two studies from the US have demonstrated decrease in medication 
discrepancies through patient-access to their medication information prior to 
their doctor consultation,539,540  one via electronic access540 and the other a 
printed form.539  Schnipper et al found greater concordance between the 
documented and patient reported lists and fewer unexplained discrepancies 
when patients had access, in the study population.540  Webb et al determined 
that 80% of patients had some form of discrepancy on their EHR.539  In both 
studies, the prior access to the information encouraged patients to document 
their problems, concerns and queries, highlighting any discrepancies prior to 
review with the doctor. 539,540  Other patients, care givers and health providers 
have shown interest in this approach.541 
2.5.6  Summary Part 3 
Involving and engaging patients and/or their carers in the medicines 
reconciliation process should not be undervalued.222,529  They are the 
omnipresent link between all healthcare settings and HCPs.  Patients, family 
members, and caregivers should be encouraged to participate in their care, 
bringing in their medication when they are admitted to hospital and keeping and 
maintaining an accurate list of all medications.  This list should be updated and 
reviewed at each care encounter, and should include prescription and non-
prescription medications, herbal and nutritional supplements, immunisation 
history, and any allergic or adverse medication reactions.1,64,402  Patients can 
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only do this if they are engaged and educated by HCPs so they understand 
their medication.522  HCPs must utilise patients as a source of medication 
information whilst recognising the patient’s individual limitations and taking into 
account their health beliefs.  Whichever medicines reconciliation processes are 
established within an organisation, it does not reduce or eliminate the need to 
speak to the patient and verify the medicines they are actually taking or using.  
Further studies are needed to more clearly define the roles and responsibilities 
of patients within the medicines reconciliation process and to understand their 
usefulness and potential limitations.  
2.6  Overall Summary Chapter 2 
The scale of error associated with inadequate medicines reconciliation is well 
defined within the literature, and, although there is limited data on discrepancies 
at transition points from the UK it is recognised that there is a significant 
problem.  It is also acknowledged that the overall process of medicines 
reconciliation consists of four key stages. Yet, the finer detail of the activities 
and systems which make up each stage or the roles of HCPs in the process are 
not clearly described.  Without a clear understanding of practice and the stages 
within the medicines reconciliation process, as well as the surrounding context, 
it is difficult to assess where and how errors or other problems arise.  This limits 
the ability to design reconciliation interventions, which ideally would be based 
on knowledge of the overall process so that any improvement in the quality and 
safety of reconciliation at one stage in the process (e.g. admission) contributes 
to reconciliation at the next and so forth.  The patient has a role to play in the 
medicines reconciliation process, however, the extent to which they are 
currently involved and the precise nature of their input is not described in detail.  
The studies within this thesis explore the current frequency and type of 
medicines reconciliation discrepancies within the UK (Chapter 4) and look at the 
entire process of medicines reconciliation within secondary (Chapter 5) and 
primary care (Chapter 6) , including the role of the HCPs and their interaction 
with the patient. 
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CHAPTER 3 METHODOLOGY 
3.1 Introduction 
The overall study comprised three distinct stages, sequential in design (see 
figure 3.1). The first, a literature review to provide an evidenced-based picture 
of current practice and highlight any gaps in evidence; the second, a 
quantitative, multi-centre, descriptive, prospective study to determine the type 
and severity of discrepancies at admission to hospital; lastly the qualitative 
exploration of National Health Service (NHS) staff undertaking tasks associated 
with the transfer of information about medication.  The third stage used both a 
framework of evidence-informed practice (deductive, evaluative approach) and 
complementary observation (inductive approach) to examine the process of 
medicines reconciliation and the interaction of individuals within the process to 
better understand the context in which medicines reconciliation errors and 
discrepancies occur.  It elaborates and expands on the results found in the first 
two stages to determine broad ideas and concepts and explain the data 
gathered to establish a clearer understanding of the contributory factors which 
lead to error and error reduction within medicines reconciliation.  This mixed-
method approach542 was used to quantify, explore and explain medicines 
reconciliation-related errors and/or discrepancies which occurs at transition 
points in care. This chapter will justify the use of mixed-methods within the 
study, clarify the reasons for using each method, outline the nature of the data 
generated and signify how this relates to methodological theory.  More 
emphasis is placed on the qualitative aspects of data collection within this 
chapter due to the differing theoretical perspectives compared with quantitative 
approaches (see section 3.2.1) and the associated application of rigour and 
reflexivity needed (see section 3.5).  The weighting is also proportionate to the 
extent of qualitative data gathered within this study compared with quantitative.  
The specific methods employed and limitations of each method will be 
discussed further within Chapters 4, 5 and 6. 
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Figure 3.1 – Sequential study design   
 
3.2  Rationale for Methodology 
3.2.1  Theoretical perspectives 
Various theories exist in the methodological literature which describe the 
philosophical assumptions that influence research design.  These are based on 
the researcher’s ‘world view’ (epistemology) and how they view existence within 
their world (ontology). They include objectivism, social constructivism and 
subjectivism.  Objectivism assumes that the world exists independent of human 
belief and consciousness, therefore is deemed measureable. In contrast, social 
constructivism assumes the world is socially constructed in order for groups to 
make sense of the world, therefore multiple realities exist.  Subjectivism 
assumes an individually constructed world where reality is experienced by each 
person. Crotty describes an inter-relationship between the researcher’s world 
view and the methods they choose to use.543 Theoretical perspectives exist 
which are congruent with these differing epistemological views.  These 
theoretical perspectives lead to a variety of different methodologies and 
ultimately, methods (see figure 3.2). 
  
Stage 1 - Literature review (Chapter 2)
Stage 2 - Multi-centre, descriptive prospective study of 
type and severity of errors (quantitative approach -
Chapter 4) 
Stage 3 - Multi-centre, observational study of medicines 
reconciliation and related communications at care 
transitions (Qualitative approach - Chapters 5 & 6)
Stage 4 - Application to theoretical framework and 
practice recomendations (Chapters 5 &7)
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Figure 3.2  Relationship between epistemology, theoretical perspectives, 
methodology and research methods. Gray544 adapted from 
Crotty543  
Objectivism gives rise to post-positivism, testing ideas and hypotheses through 
gathering data, evidence and rational consideration. Those who are true to 
post-positivism hold the philosophy that cause directly influences outcome, and 
truth and reality can be gained.  It is an objective approach and produces 
quantitative data which can be measured, deeming an egalitarian researcher-
subject relationship. Conversely, social constructivism and subjectivism 
assumes that humans engage with the world to produce meaning and prioritise 
understanding based on their experience. This viewpoint lends itself to 
qualitative research which seeks to understand the complexity of a situation in 
the context of the participants. With this, truth and meaning are constructed and 
created by an individual’s interaction with the world, rather than meanings 
based on the objective measurement of reality valued in post-positivism. 
Although the theoretical debate about the strengths and qualities of the different 
approaches to research is less polarised, no specific method of data collection 
is perfect nor are any disregarded as inappropriate for obtaining evidence 
through applied research.  Barbour agrees with this notion, reiterating that to 
ensure good quality evidence-based medicine the methods chosen must have 
the ability to address the research question’s relevance to practice.545 
Pragmatism is not committed to one specific philosophy; instead it focuses on 
solutions to problems, allowing segments from both quantitative and qualitative 
methodology to be considered when designing research.  It allows methods and 
techniques to be chosen which best meet the needs, purpose and 
Epistemology
• Objectivism
• Constructivism
• Subjectivism
Theoretical 
Perspective
• Positivism
• Interpretivism
• Critical Inquiry
• Feminism
• Post-modernism
Methodology
• Experimental 
research
• Survey research
• Ethnography
• Phenomenological 
research
• Grounded theory
• Heuristic inquiry
• Action research
• Discourse Analysis
Methods
• Sampling
• Statistical analysis
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• Observation
• Interview
• Focus Groups
• Document Analysis
• Content analysis
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understanding of the research, provided that these can be justified and a sound 
rationale made. It recognises that each method has its own set of strengths and 
weaknesses dependant on the aims and practical constraints of the phenomena 
under study.  It can be achieved either through the use of individual research 
paradigms or alternatively through the employment of multiple research 
strategies (mixed methods).546  This research study takes a pragmatic 
worldview.542  
3.2.2  Justifying mixed-methods 
Using mixed methods has been defined as:  
‘the collection or analysis of both quantitative and qualitative data in a single 
study in which the data are conducted concurrently or sequentially and 
involve the integration of data at one or more stages in the process’ 547 
As previously described, a divide has been seen between the use of qualitative 
and quantitative research with many researchers being specifically loyal to one 
or the other.  They argue that the methods are mutually exclusive as they arise 
from different ontological and epistemological positions (see section 3.2.1).  In 
contrast, Newman and Benz describe quantitative and qualitative approaches 
as different ends on a continuum rather than polar opposites.548  In the middle 
of this continuum resides mixed-methods, incorporating elements of both 
qualitative and quantitative research.542  Mixed-methods 542,549,550 is gradually 
being recognised as the third research paradigm551 and is becoming 
increasingly common in health research.552 
Combining methods produces different kinds of data on the same topic which 
allows events to be seen from differing perspectives and can provide alternative 
or confirmatory explanations, enhancing the validity of the data.  It provides a 
richer more complete and comprehensive picture than that achieved by one 
method alone553 and allows the biases within one method to be counteracted by 
the strengths of another. With this aim, it is important that the methods chosen 
complement and support each other to add value to research.  
A well-documented advantage of mixed methods is the opportunity for 
triangulation.  Two or more independent processes of measurement reduce the 
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uncertainty of data interpretation, thus any variance is likely to be that of the trait 
under study and not due to the method.554  Methodological triangulation has 
been defined by Denzin [555] as ‘the combination of methodologies in the study 
of the same phenomena’.  It reduces the sources of error by gathering data 
from multiple sources or using different approaches. For these reasons mixed 
methods were employed in this study. The different methods, however, remain 
autonomous (see section 3.5).  
Sieber proposes that fieldwork can help to interpret relationships and clarify 
unusual findings found using quantitative methods, shedding light on 
phenomena.556 This is reinforced by Jick who adds that it can also capture a 
more complete holistic and contextual portrayal of the phenomena under study 
and may add to the transferability of the qualitative findings.557  Mixed-methods 
can therefore not only examine multiple perspectives, but also enrich 
understanding.  This is summarised by Greene et al who demonstrates the five 
main reasons to combine quantitative and qualitative research.558 These 
include: 
1) Triangulation – to seek corroboration 
2) Complementarity – seek elaboration, enhance, illustrate and clarify the 
results of one method with another 
3) Development - the results from one method are used to develop/inform 
another method 
4) Initiation – seeks contradictions/new perspectives through the use of 
another method 
5) Expansion – extend the breadth of inquiry 
This study integrates quantitative and qualitative methods to generate an 
improved understanding of current practice concerning medicines reconciliation, 
enhancing the validity, credibility and trustworthiness of the findings.  The initial 
data collection in Chapter 4 outlines the scale of the current problems of 
medicines reconciliation, providing some context and helps to focus the rest of 
the study on the predominant issues. The subsequent stage (Chapters 5 & 6) 
allows expansion so as to gain a wider knowledge surrounding medicines 
reconciliation practice, analysing and explaining the findings in the initial study 
to provide a more detailed picture. Creswell defines this as ‘sequential 
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explanatory strategy’ where qualitative data is used to build and expand on the 
quantitative findings.542  Overall, the empirical work here draws upon a 
qualitative rather than quantitative methodology so as to explore and appraise 
the behaviours, actions, systems and practises at different stages within the 
medicines reconciliation process.   As demonstrated in the literature review, 
much is known about the scale and severity of the errors made at transitions in 
care, emphasising that medicines reconciliation sometimes fails or does not 
take place at all.  The majority of evidence published to date is, therefore, 
quantitative with several interventions which demonstrate improvement in error 
rates and quality of medicines reconciliation. There are few published qualitative 
studies, nor are there any studies looking at the contributory factors which may 
lead to medicines reconciliation error and error at transitions in care. 
3.2.3  Exploring quantitative and qualitative approaches 
3.2.3.1  Quantitative approaches 
Quantitative data by definition is numeric and if the measurement process is 
accurate, data are confidently used to objectively report reality.  Although there 
is some inherent risk of bias with quantitative data (e.g. attrition bias; selection 
bias) it is thought not as inevitable as with qualitative data.559 Quantitative data 
can be used to define the characteristics of a population (e.g. epidemiology or 
prevalence) or relationships between variables (cause and effect). The 
outcomes can be statistically generalisable based on whether the study has 
been powered correctly and whether the sampling strategy is robust.  The 
quantitative data collected during the second stage of this study (described in 
Chapter 4) provides information on the number type and perceived severity of 
discrepancies experienced by the patient.  This establishes the scale of the 
problem and determines the accuracy of the medication history taken at 
admission by the doctor and also the sources used by pharmacists to elicit 
information regarding medication being taken by the patient prior to admission.   
However, any emerging questions as to why these problems are occurring may 
only be answered through qualitative research.  Quantitative research involves 
little or no contact with people in the field setting.544  This is clearly apparent in 
Chapter 4.  Only the charts of the patients rather than the interaction, decisions 
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and processes which lead to the production and verification of the IMC and 
discharge were studied at this stage.  The complexity and inter-relationship 
between the many different aspects of medicines reconciliation presents a 
particular challenge to the researcher; hence the third stage (a qualitative 
approach) was critical to understanding the detail, context and contributory 
factors which may impact and influence the medicines reconciliation process.  
3.2.3.2  Qualitative approaches  
Qualitative research, in contrast to quantitative, is highly contextual and 
conducted through intense contact with the field, in a ‘natural’ real life setting.544  
It aims to identify, describe and analyse which allows the researcher to gain a 
holistic or integrated overview of the phenomenon being studied in order to 
understand the ways in which people act and account for their actions.560  
Gantley et al561 describe qualitative data as ‘the what?’, ‘the why?’ and ‘the 
how?’ rather than ‘the how many?’ or ‘how frequent?’ found in quantitative data.  
This is explained further by Thorne, who illustrates that qualitative methodology 
is often used to understand phenomena through deconstruction, i.e. the 
distinction between explaining how something operates (explanation) and why it 
operates in the manner it does (interpretation).562  The qualitative methods 
employed search for patterns and inter-relationships rather than the specified 
set of variables in the quantitative stage.  Qualitative data can also determine 
whether any statistical significance determined in the quantitative stage is due 
to random variation or systematic differences.  This is important here in 
triangulating the quantitative findings in Chapter 4 with the qualitative 
observations in Chapter 5.   
Qualitative research is more suited to studying process i.e. how outcomes are 
achieved and the mechanisms involved. It can help to understand why 
interventions may be successful or fail and can help to understand issues with 
communication and interpersonal co-operation.  The qualitative approach is, 
thus, better suited to the exploration of the medicines reconciliation process and 
its associated systems.   Qualitative methods can also explore outliers (often 
called deviant cases) to determine why they diverged in the quantitative 
sample.542  It therefore captures those results which, although are not 
statistically significant, may be clinically significant and can inform  
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for practice.564  Barbour concludes that ‘qualitative research methods can 
provide useful data on a range of topics and research questions which are not 
amenable to study using conventional quantitative methods.’’564  (The 
quantitative and qualitative methods used within this study are shown in table 
3.1) 
3.3  Data Collection Methods  
Empirical data were gathered during the 2nd and 3rd stages (see figure 3.1), 
each set of data informing the next stage.  All data were collected prospectively. 
Quantitative data were collected in the second stage; the method and results 
are described in Chapter 4.  Qualitative data were collected using observation in 
the 3rd stage; the method and findings are discussed in Chapters 5 and 6. 
3.3.1  Survey methods 
Survey is a general term for a design which aims to collect the same set of data 
for every case within a study. Survey methods are used when the researcher 
wants to obtain factual information and are the design of choice for descriptive 
quantitative research questions.  Observational surveys are used to make 
detailed, factual records of specific behaviours, events and settings.  They 
usually employ a systematic tool.  They focus on what people actually do rather 
than say and can be used to look at particular events e.g. when they occur and 
how often.  They are usually designed to record things objectively.  Most people 
think of questionnaires when discussing survey methods, however, where 
previous studies have recorded the prevalence, type and severity of medication 
discrepancies, the authors have described their study method as a 
survey.182,193,196  Survey methods are rooted in positivist epistemology and are 
therefore usually associated with quantitative data.  In Chapter 4 a prospective, 
descriptive observational survey is used to collect data on the frequency, type 
and severity of discrepancies plus the frequency and type of sources used. 
3.3.2  Observation 
Observation is the systematic viewing of people’s actions followed by the 
recording, analysis and interpretation of their behaviours.544  It is primarily 
descriptive of settings, people and events, and the meanings that the 
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participants assign to them. In this case, the healthcare setting (namely the 
ward environment) and the actions and interactions of staff within the healthcare 
settings; all in the context of medicines reconciliation.  The choice to use 
observation stems from the view that rich multidimensional data is needed to 
examine the medicines reconciliation process and contributory factors 
associated with medicines reconciliation error.  Observation is often used to 
understand cultures and behaviours and is useful when individuals would be 
unable to provide objective information about the phenomena being studied.559 
The researcher can determine what actually occurs in practice rather than 
relying on second-hand information or participant’s perception of what occurs; 
the type of data that would be elicited using, for example, focus groups or 
interviews.  Accurate retrospective accounts of interactions in particular settings 
(e.g. those found in interviews and focus groups) can be impossible to achieve 
because the situational dynamics are often not reported by those who 
participate in them.  They may not hold an objective view and may only have 
partial knowledge or understanding, based on the role they play in the setting; a 
non-holistic picture.  It is felt that observation occurs in a ‘natural’ context rather 
than being reconstructed, although some argue that it is reconstructed by the 
researcher during data analysis which may cause bias.565 
Within this study, observation was chosen as the researcher felt that 
interactions, actions and behaviours and the way people interpret these were 
central to explaining the findings in stage two.566  Also observation in the 
context of the setting was important to determine any relevant human factors 
associated with the task, the individual and the organisation.  Pragmatically this 
data cannot be acquired using alternative methods.   
The observational methods used have some similarities with ethnography as 
the researcher spent much time in the field.  Ethnography studies cultures and 
groups using a holistic approach which looks at processes, relations, 
connections and interdependency amongst component parts.567  In this study, 
however, the researcher’s main aim was not to examine the characteristics and 
cultures of the HCPs and patients within the hospital setting, rather to study the 
systems and processes used to reconcile medication together with the HCP’s 
interaction with the process.  Ethnography looks to provide a more 
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multidimensional picture, with richer description and attempts to see things from 
the observed party’s point of view in more depth than studied here.   
The study also draws on some phenomenological principles, where the patient’s 
interpretation of events gives explanation to their experience.  Phenomenology 
accepts that things can be seen in different ways by different people at different 
times, with alternative explanations being equally valid.   Although this is not the 
main aim of the research, drawing on these principles goes someway to 
explaining the phenomena seen. The researcher needs to understand their 
thinking to interpret and understand their actions.  Miles and Huberman560 
suggest that research must be specific and focused, and that the looser the 
initial design the less selective the data will be during the observation.  With this 
in mind the observation focused on medicines related tasks which may impact 
on medicines reconciliation and the medicines reconciliation process itself to 
ensure that the most appropriate and relevant data were collected. 
Most observational data collection is overt, where the participants are aware 
that the observation is taking place.  Most agree that it is unethical to conduct 
research in a covert or deceitful manner.  Although it is accepted that 
researchers may choose to reveal/inform participants as they see fit, as it is not 
always possible in a setting to inform everyone of the researcher’s presence or 
intentions.   All observation within this study was overt within the hospital ward 
setting, however, there were some staff on the ward who may not have been 
aware of the researcher’s presence e.g. housekeeping and administrative staff. 
3.3.2.1  Deduction and induction 
This study used both an inductive and deductive approach.  This is supported 
by Gray who suggests that inductive and deductive approaches are not 
mutually exclusive.544  Deductive approaches take a prior theory, often with pre-
defined measures and manipulate an independent variable e.g. increasing the 
number of sources used to illicit a medication history to test the impact of a 
potentially dependent variable e.g. the number of discrepancies found.  
Whereas in the inductive approach, theory arises from the research; data is 
collected and analysed to see whether patterns emerge which suggest 
relationships between phenomena e.g. the observation of medication history 
taking. This study incorporated a quantitative, deductive element that focused 
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on the frequency and type of medication discrepancies (Chapter 4) and a 
framework against which to measure medicines reconciliation during the 
observational stage (Chapter 5).   An unstructured inductive element was also 
employed in Chapter 5 which embeds the medicines reconciliation process in a 
social context of how people interact and behave.  
Deductive approach 
Deductive reasoning starts with general theory on the topic being studied and 
utilises this to form a hypothesis that can be tested to determine whether it fits 
with the original theory (see figure 3.3).  Within this study, a deductive approach 
is used to develop the data collection tool used to collect data on the type and 
severity of discrepancies within Chapter 4 and the evidence-informed 
framework used during the observations in Chapter 5 and 6.  In both cases they 
determine how current medicines reconciliation practice fits with the relevant 
evidence base.   The structured approach used allowed the systematic 
collection of data, and increased the consistency of approach within 
organisations thus increasing reliability.568  Structured observation is more 
economical as it allows a high focus and systematic checking of elements of 
behaviour which can be replicated by the same researcher or others at a later 
date.  It also allows data to be collected at the time it occurs, however, this 
relies on the observer being present when it does occur.544  Gray suggests 
seven stages in the deductive process highlighted in table 3.2.544  
 
Figure 3.3 Deductive reasoning569  
 
 
  
Theory Hypothesis Observation Confirmation
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Table 3.2  Seven stages in the deduction process applied to this study 
(based on the work of  Gray544) 
Stage in deduction process How it was deduced within this 
study. 
1.  Organisational mission To determine an evidence based 
framework which looks at the factors 
that should be incorporated into the 
medicines reconciliation process 
2. Theory Gathered and synthesised during the 
literature review (stage 1)  
3. Hypothesis Current practice does not mirror 
recommendations outlined in recent 
literature 
4. Operationalise Devise data collection tool (stage 2) 
and observation framework (stage 3) 
to assist data collection 
5. Testing by corroboration or 
attempted falsification 
Data collected and tested against the 
theoretical frameworks 
6. Examine outcomes  Data is analysed to reject or confirm 
hypothesis 
7. Modify theory if necessary Determine reasoning through 
inductive approach 
 
Inductive approach 
Inductive reasoning works in the opposite way to deduction, moving from 
specific observations to broader generalisations and theories (see figure 3.4).  
Inductive reasoning begins with specific observations and measures to detect 
patterns and regularities, which can then be utilised to construct 
generalisations, relationships and theories.  It does not set out to corroborate or 
falsify a theory, instead it attempts to establish patterns, consistencies and 
meanings. Although much is known about the frequency and type of medicines 
reconciliation discrepancies occurring in practice, there is little evidence as to 
why they occur.  An inductive exploratory component is used within this study to 
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try and investigate contributory factors which can lead to medicines 
reconciliation error and determine how these fit in with the human factors 
approach. During the observation, initial description was used to set the scene 
and gain an overview, followed by more focused observation to concentrate on 
the processes and problems associated with medicines reconciliation, with 
tasks specific to medicines reconciliation being carefully observed. Inductive 
approaches can lead to a detailed, descriptive or narrative account rather than a 
critical or analytical insight.  The use of case studies or stories can be useful to 
illustrate specific points, however, overall themes must be sought to enable 
comparison with theoretical frameworks.  
Figure 3.4 Inductive reasoning569 
  
3.3.2.2  Participant and non-participant observation 
Often, a very clear divide is seen between participant and non-participant 
observation. In non-participant observation the researcher is not involved in the 
activities of the group.  They remain a passive observer, watching and listening 
to activities, then drawing conclusions.  In contrast, participant observation 
enables the researcher to participate in the same manner as those being 
observed, with or without them knowing.570 The researcher must maintain a 
position where they are considered part of the group without becoming 
immersed.571  
Both Mason566 and Gillham,572 however, argue that no observation is entirely 
non-participant and the researcher must participate in some form if the subjects 
are aware of the presence of the researcher.  Similarly, Atkinson and 
Hammersley state  
‘in a sense all social research is a form of participant observation as we 
cannot study the world without being part of it’ (p249).567  
Observation Pattern
Tentative 
Hypothesis
Theory
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Being entirely non-participatory can also lead to the researcher’s actions and 
behaviours being interpreted as unhelpful or cold.  The observation described 
within Chapter 5 is non-participatory.  However, the potential conflict of interest 
between the investigators role as a researcher and their role as a HCP means 
there were times when the researcher had to move from a level of moderate 
participation (acknowledging the patient and explaining the study) to active 
participation, depending on the situation.  Active participation included 
interventions in collaboration with the HCP where the researcher noticed 
something which could cause potential harm to the patient.  Depending on the 
potential patient harm, the researcher intervened either at the point of noticing 
the potential harm or following completion of observation of the particular 
activity being undertaken. 
3.3.3  Possible alternative methods 
Rather than observation other qualitative methods could have been considered 
to explore and explain the phenomena being studied.  Questionnaires would 
have provided greater anonymity, however, would have presented participants 
perceptions rather than reality with the potential for low response rates, self-
selecting bias, lack of opportunity to clarify issues and non-spontaneous 
responses.  Although observation sometimes leads to observation biases the 
busy nature of the NHS does not allow sufficient time for clinicians to reflect too 
deeply on their behaviour in the care setting.  Alternatively, interviews would 
have provided the chance to explore more in depth and allows explanation and 
probing to gain more complete answers, although these reveal participant 
perception rather than actual practice. 
3.4  Recording Data 
Various methods can be employed to record data during observation.  These 
include field notes, video and tape recording. Field notes are ‘writings produced 
in or in close proximity to the field.’573  Proximity means they are written almost 
contemporaneously with the events and experiences that they describe and 
recount’.573  Emerson points out that there are different ways to produce field 
notes which reflect the theoretical and methodological orientation.574 For 
example, they may be recorded as raw data which is gradually built up or 
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alternatively they might be used to record hunches, everyday perceptions or 
interpretations. Bailey suggests that field notes develop out of an analytical 
process; the researcher mentally captures as much detail as possible which 
assists recall and interpretation of jotted notes.575  The way in which field notes 
are recorded determines how they are read later during analysis i.e. whether 
they are literal, interpretative or reflexive. Mason believes it is important to make 
explicit the researcher’s interest (see also section 3.5 Reflexivity), framework 
and how these will be recorded.566  With field notes there is more chance that 
the researcher may be selective and choose what they deem important to 
document. This is where the use of recording equipment would be beneficial as 
the researcher can return to the tapes or transcripts at any time to re-define 
categories. Some participants may feel uncomfortable being recorded; which 
makes any observed interaction less than a true reflection of the situation.576  
The choice of data recording within the hospital ward setting is further limited 
due to ethical considerations.  It would be unethical to video or tape record in 
the ward setting without explicit consent and relevant ethical approval.  This is 
difficult to obtain due to the many people who pass through a hospital ward, 
hence in this study contemporaneous field notes were used throughout.   
3.5   Ensuring Rigour - Concepts of Reliability and Validity 
Reliability is the capability of the research instrument to produce consistent 
results or measurements which are dependable.  The researcher could, 
however, use two different instruments to produce the same outcomes; or the 
same instrument could be administered by two different researchers.544  When 
the instrument is a human and the setting is characterised by regular human 
interactions, as is often the case in social research, the results are of course 
unlikely to be replicated. The researcher being the main instrument of data 
collection is more responsive to the situation and they are able to adapt to any 
changing conditions.  In qualitative research, the level of reliability is often 
referred to as ‘trustworthiness’ and is assessed through the detail with which the 
data collection methods are described and the reflexivity which the researcher 
has applied so as to counteract any a priori assumptions.559   The researchers 
feelings were documented simultaneously to the data collections and were then 
reflected on to ensure observations remained as objective as possible 
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Researchers conducting qualitative descriptive studies should seek to 
accurately account events that most people observing the same event would 
agree is accurate ‘descriptive validity’ and accurately assign meaning that 
others would agree was accurate ‘interpretative validity’.577    Validity is defined 
as the degree to which the researcher has measured what (s)he has set out to 
measure.578  It is often further subdivided into ‘internal’ and ‘external’ validity; 
internal validity being the confidence that the conclusions drawn are reliable and 
external validity being the extent to which the results of a study can be 
generalised to other situations or to other people. Generalisability is more 
commonly associated with quantitative methods.   Although qualitative research 
findings are not statistically generalisable, they can be theoretically 
generalisable which refers to the capacity to apply the findings to other 
situations.564 Lincoln and Guba suggest the use of the word transferability rather 
than generalisability in the context of qualitative data.579 Within this study 
generalisability is referred to when discussing quantitative data and 
transferability, qualitative data. 
Various threats to reliability and validity exist depending on the type of study 
and methods used.  Johnson and Harris suggest that universally agreed 
standards for achieving reliability and validity within qualitative research have 
not been established due to the variable nature of qualitative research and 
individual study design.580 Some researchers argue that reliability is only of 
concern in quantitative research and that if social reality is constantly changing 
then reliability is not important. However, taking into account that a single social 
reality is a controversial assumption it would be neglectful not to triangulate or 
cross-reference findings with other studies in the same field.559   
Using the framework developed and commonly cited by Campbell and Stanley 
(1963) the main threats to validity within this study are sample bias, Hawthorne 
effect, halo effect and experimenter or observer bias.581  The latter three 
consider the conscious and unconscious influences of both the participant and 
observer (cognitive biases).  The Hawthorne effect takes into consideration that 
participants being observed may alter their behaviour in an attempt to appear 
more efficient. This means that any findings are likely to be real and a best case 
scenario, but may be an underestimate. The potential Hawthorne effect could 
be minimised through covert observation, though this is not usually deemed 
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ethically acceptable.  Previous observers of health-related situations have noted 
that their impact is often minor due to the complex, demanding work needed to 
be undertaken in a timely manner. Strong observed that his own impact on the 
setting was likely to be minimised by the presence of multiple other audiences 
including nurses, other doctors, medical students and so on.582 The researcher 
was only one small part of the audience in the setting under study.  Recently the 
interpretation of the original work which uncovered the Hawthorne effect is also 
being questioned due to the quality of the methods used in the original study 
and the conclusions drawn from the data.583  The Halo effect is a cognitive bias 
where the judgments of a person’s character is influenced by the overall 
impression of him or her by the researcher and the values of the researcher.584  
Observer bias is sometimes confused with the Hawthorne effect.  It 
acknowledges the potential contamination effect of the researcher’s 
preconceptions. Silverman (1993) highlights that the researcher will always 
enter the field with some perspective or broad focus and it is important to be as 
explicit as possible about this.  The researcher must be aware of their own 
cultural assumptions and any preconceived ideas especially given the 
researcher’s additional, ongoing role as a pharmacist.  This can be countered 
by being reflexive.   This will be discussed further in Chapter 5. 
Maxwell (1992) also highlights further areas which may affect validity in terms of 
qualitative data.577  These include description, interpretation and theory. 
‘Descriptive validity’ refers to the accuracy of the data and how well it reflects 
what the participant has said or done.577 This means any transcription must be 
an accurate account or portray the events in an accurate manner. Descriptive 
validity is the base on which all the other types of validity are built.  Without an 
accurate account of the initial data, all else is thought to be irrelevant.585 
‘Interpretive validity’ describes how well the researcher reports the participants’ 
meaning of events, objects and/or behaviours.577 The interpretations must not 
be based on the researcher’s perspective, but that of the participant, which 
presents very particular challenges in observational studies such as the stage 3 
study here. This was addressed where possible by asking questions of the 
participants to clarify observations. Lastly theoretical validity ‘goes beyond 
concrete description and interpretation’(p291) and addresses the theoretical 
underpinnings that the researcher uses or develops during the study.577 
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Threats to reliability and validity can be minimised through the employment of 
different strategies such as mixed-methods where the findings can be 
triangulated and corroborated as previously discussed (see section 3.5), 
providing credibility (internal validity).  Denzin [555], however, also highlights the 
importance of within-methods triangulation to enhance claims on the validity of 
the conclusions drawn (see table 3.3).  
Table 3.3  Types of triangulation described by Denzin (1978) and their 
application to this study555 
Type of 
triangulation 555 
Further division of types of 
triangulation586 
How triangulation is achieved 
within the study 
Data 
triangulation 
 
Time triangulation – collected 
on the same phenomena over a 
period of time 
Data were collected over an 8 
week period at each different 
site 
Space triangulation – from 
multiple sites 
Four sites were included within 
the study 
Person triangulation – 
collected at three levels e.g. 
individual, group, department 
Individual HCP group, specialty 
Individual HCPs and patients 
were observed.  The data were 
also analysed by professional 
group, by hospital and specialty 
Investigator 
triangulation 
Using more than one observer  
to reduce observer bias 
Co-raters were used to minimise 
observer bias 
Multiple 
triangulation 
A combination of multiple 
methods data types, observers 
and theories are combined 
within the same investigation 
Medicines reconciliation 
literature was used to develop 
an observational framework. 
This was used with other 
relevant theories e.g. human 
factors to analyse the data 
Methodological 
triangulation 
Between method where a 
variety of different methods are 
used i.e. quantitative and 
qualitative 
Both quantitative and qualitative 
approaches were used 
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3.5.1  Reflexivity 
Qualitative research is inevitably influenced by the researchers values.587  
Reflexivity looks at the effect that the researcher’s background attitudes, values 
and beliefs have on the research process.  It recognises that the researcher is 
not a neutral observer and may be part of the setting or context that they are 
seeking to understand.  Miles and Huberman suggest that any researcher 
enters the field with some orienting ideas, motivations and tools.560  These are 
subsequently implicated in the data gathering and construction of knowledge.  
Self-reflection is therefore needed to determine any bias that may occur, and 
inadvertently influence the research process.  Other influences, such as gender 
and appearance, must be also considered in observational research. Warren 
suggests female fieldworkers have greater communicative skills and are less 
threatening than their male counterparts, potentially giving them greater access 
to the field.588 This may have potentially improved access within this study.  The 
researcher documented any potential feelings which they felt may bias the 
observation or analysis within the field notes. 
3.5.2  Inter-rater reliability and minimising observer bias 
During observation humans are used as a part of data collection.  This can lead 
to questions about the consistency between recordings and the potential 
misinterpretation of phenomena being observed.  The potential for different 
researchers to view phenomena differently when observing the same event can 
be reduced through more structured observation, and investigator triangulation 
to ensure inter-rater reliability.  Within this study inter-rater reliability was 
addressed through a process of co-rating.  This is described in further detail in 
Chapter 5.   
Inter-rater reliability when coding data (also known as multiple-coding) aims to 
counteract potential subjectivity during data analysis.589  The nature of any 
disagreement is important together with any subsequent discussion that leads 
to the refining of codes. Also inter-rater reliability is also tested within Chapter 4 
to determine the extent of agreement between the pharmacists categorising the 
potential severity of the medication discrepancies.  In both cases a statistical 
approach was taken; the agreement between co-raters is measured using 
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weighted Kappa coefficient in Chapter 4 and Kappa coefficient in Chapter 5. 
These are described further within each chapter. 
3.6  Sampling and Sample Size 
Brannen550 explains that statistical sampling (associated with quantitative data) 
and theoretical sampling (associated with qualitative data) strategies can be 
used in combination to determine which cases are representative. Several 
considerations regarding quantitative and qualitative sampling are discussed 
below. 
3.6.1  Quantitative sampling 
In quantitative research, two main factors influence the conclusions drawn from 
a sample.  The first is the sample size and the second the extent of variation in 
the sampling population.  The general rule is the larger the sample size the 
more accurate the findings, however, the greater the variation in the study 
population the greater the uncertainty – in statistical terms the greater the 
standard deviation the greater the standard error.590  A power calculation must 
be undertaken to calculate the minimum sample size required so that it is likely 
to detect an effect of a given size.   Quantitative sampling and power 
calculations are used in Chapter 4 to determine an appropriate sample size 
through which the number and type of discrepancies can be quantified. 
3.6.2  Qualitative sampling 
Various sampling methods can be used to elicit qualitative data; the approach 
used is influenced by the research methodology.  Non-probability sampling 
techniques are more often used in qualitative research.  This follows the theory 
that qualitative research is one of discovery rather than hypothesis testing. 
However, the argument for generalisation or transferability is stronger when 
findings are observed with different participants in different settings.  Non-
probability sampling methods include quota, purposive, theoretical, snowball 
and convenience sampling. 
Purposive sampling (theoretical sampling) was used within this study as it offers 
some degree of control and allows the judgement of the researcher to 
118 
 
determine who can provide the best information and value to achieve the 
objectives of the study.591  It also allows information-rich cases to be identified 
which can be studied in depth.592  Instead of selecting a cross section of the 
population using probability-sampling methods such as random systematic and 
stratified sampling, purposive sampling aims to produce a variety of cases; 
mainstream and potentially extreme cases. This sampling method is not 
concerned with representativeness but with representing the diversity within the 
concept being studied.559 It deliberately seeks to include outliers or deviant 
cases.591  It is useful to describe a phenomenon or develop something of which 
little is known, in this case medicines reconciliation.  Thus, the hospitals 
included in the study varied in size, patient population profile, teaching hospital 
status and medicines management systems. 
Whilst it was known which hospitals and wards were going to be investigated at 
the outset, it was unknown how many HCPs and patients would be observed 
throughout.  The sample was ‘emergent and sequential’ as decisions were 
made as the research progressed as to which parts of the process and which 
HCPs required further study and where attention should be focused during 
observation.   Participants were continually selected until the research reached 
theoretical saturation when the data started to confirm the analysis rather than 
provide anything new.559  There were a large number of observed patient 
encounters.  This, however, was necessary to identify cases which provided the 
richer data.  The researcher, as well as looking at common occurrences and 
similarities in process, needs to look for the outliers and include ‘special 
instances’ which are more extreme. Within medicines reconciliation the aim was 
to gain ‘maximum variation’ and a broad spectrum of problems which arise as 
well as the more mainstream day to day difficulties which occur.  
3.6.3  Patient specialties observed during the study 
Three specialties were chosen for the overall study; elderly care, renal medicine 
and general medicine. Elderly patients were chosen as they are often 
prescribed four or more medications,220 making it more difficult to capture a 
complete and accurate list of medication.145,177,197 Elderly patients may also 
exhibit a number of attributes including problems with recall, communication 
and comprehension which can make medicines reconciliation challenging.  The 
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elderly, those with memory problems and those with increased number of 
medicines have been shown more likely to experience medicine related 
problems.593  General medicine was chosen to draw comparisons with a 
younger population, who are generally prescribed fewer medications and whose 
memory and comprehension usually, on average, greater functionality.  In 
contrast, renal specialties were included, as through the nature of their 
condition, these patients often have complex medication requirements and are 
frequently admitted to hospital requiring continuous communication between 
primary and secondary care.290  Patients with end stage renal disease 
frequently experience high numbers of medication related problems specifically 
related to gaps in medication information at transitions in care.226  A significant 
proportion of DRPs have been shown in haemodialysis patients and medicines 
reconciliation has been shown effective in identifying and rectifying errors in this 
population.319,594   
3.7 Access and Recruitment 
‘Gate keepers’ are key people who can grant permission and can be negotiated 
with for access to places and facilitate contact, for example, within the hospital 
between the researcher and study group.595 The NHS is a public service but in 
a private setting (i.e. no public access) with various gatekeepers.   Formal 
gatekeepers include managers e.g. matron or sister on a ward, whilst informal 
gatekeepers do not have institutional powers but may exert influence over the 
setting e.g. consultant physician of a medical team do not manage the ward, 
however exert influence over the management. Patton et al suggests a 
reciprocity model of gaining entry where both parties see mutual advantage in 
the research.592 In this case, many HCPs approached were keen to improve 
their medicines reconciliation practices.  Observational methods can create 
particular challenges for host organisations.  These include intrusion of privacy 
and disruption, additionally a study focussed on patient safety such as this, may 
be seen as a form of scrutiny, however, the HCPs’ willingness to improve 
patient safety predominated.  Access during this research project was an 
ongoing process. The research occurred over a long period of time and the 
researcher required periodic access to various settings, people and professional 
groups.  Access was gained by approaching relevant ‘Gate keepers’ for 
example the consultant, ward manager or practice manager.  Specific 
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approaches for each part of the study are discussed further in the methods 
sections of Chapters 4, 5 and 6. 
3.7.1 Relationships in the research setting 
Whether or not those who routinely inhabit the research setting have a 
knowledge of social research, they are likely to be concerned with the 
researcher’s personality and behaviour.  Berg suggests a number of strategies 
for successful observation which includes familiarisation with the environment 
and the process of observation but also the development of rapport with the 
participants.596   
Developing relationships can be difficult as the researcher may be seen as 
over-friendly, intrusive, suspicious or threatening.  Inevitably, the researcher will 
relate better to some participants than others, which can lead to a key informant 
being adopted.565 The various relationships must not adversely affect the 
researcher’s credibility or the focus of their attention. Termination of 
relationships once the researcher departs from the setting must be considered 
and whether any enduring contact is to be maintained, which could affect the 
subsequent data analysis.   
3.7.2  Informed consent 
It is considered unethical to collect information without the participant’s 
knowledge. Researchers must have consent from all participants prior to data 
collection. Informed consent demands that subjects are made adequately aware 
of the type of information being gathered, the reason for collection, the purpose, 
how they will be expected to participate, and how the research may affect them.  
Consent was collected from all participants involved in the observational 
studies.  Specific information regarding consent for each of these studies is 
discussed in Chapters 5 and 6. 
3.8  Data Analysis 
As a mixed-methods paradigm is used within the study, both quantitative and 
qualitative data are generated.  It cannot be assumed that qualitative data is 
exclusively generated through qualitative research.562  For example, open 
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ended questions included in questionnaires can produce qualitative 
components.  It is the inductive reasoning used to interpret the significance and 
importance of the data which largely makes a study qualitative.562  Data is 
differentiated according to the assumptions and principles regarding truth and 
reality discussed earlier in the chapter.  General principles regarding 
quantitative and qualitative data analysis are discussed below.  Data collected 
during each stage has been analysed individually in Chapters 4, 5 and 6 and 
conclusions drawn separately.  The findings from both studies are then brought 
together and discussed collectively in Chapter 7. 
3.8.1  Quantitative data analysis 
Quantitative data is used to describe data that can be measured and expressed 
numerically. The data focuses on numbers and frequencies rather than 
descriptions.  It can be analysed statistically to determine relationships between 
variables. This is demonstrated in Chapter 4. 
3.8.2  Qualitative data analysis 
Qualitative analysis looks at relationships and links within data, the researcher 
attempts to understand why these linkages occur and then considers them in 
the context of other knowledge and literature.597 Various qualitative data 
analysis methods exist which either stem from the theoretical position e.g. 
interpretive phenomenological analysis (IPA)598 and grounded theory585 or 
methods which are independent of theory and can be applied across all 
approaches e.g. thematic analysis. Dey describes qualitative analysis as a 
circular process which involves continual describing, classifying and connecting 
the data (see figure 3.5).599 In a more detailed paper, Morse describes four 
intrinsic cognitive processes which occur irrespective of the qualitative data 
analysis method used: comprehending, synthesising, theorising and re-
contextualising.597  
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Figure 3.5  Dey’s model of qualitative analysis 599  
 
 
This study uses thematic analysis which Braun and Clarke600 argue is widely 
used but rarely acknowledged. It is a method for identifying, analysing and 
reporting themes within data.  A theme captures something important about the 
data in relation to the research question.  They can be identified at an explicit 
(content) or latent (interpretive) level, producing either descriptive or analytical 
codes. 
Chunks of raw data are open-coded and as the codes take shape the 
researcher looks for relationships between the codes.  This involves reading 
and systematically labelling data including key, essential, striking, odd and 
interesting items.601  Links and associations allow certain codes to be listed 
under broader headings where some codes seem more significant than others 
(axial codes).  As codes emerge a hierarchical coding scheme with higher level 
themes containing a series of sub-themes are developed, eventually arriving at 
core codes to determine concepts that help to explain what is happening in 
practice. This determines how the categories relate to each other and explains 
why things happen as they do.  Quantification of the qualitative data allows 
comparison with the quantitative data and also adds weight to the significance 
of the themes.  This is also part of triangulation of the data. The coding process 
is summarised using Braun and Clarke’s phases of thematic analysis in table 
3.4.600 
Qualitative 
analysis 
Describing
  
Connecting Classifying 
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Table 3.4  Six phases of thematic analysis 600  
Phase Application to study 
1) Familiarisation with the 
data  
Repeated active reading of the data 
searching for meanings and patterns 
2) Generating initial codes Work systematically through the entire data 
set to produce initial codes from the data 
3) Searching for initial 
themes 
Codes are sorted into potential themes and 
considered how they may combine to 
provide overarching themes and subthemes 
4) Reviewing themes Themes are reviewed and refined.  May 
become evident that some themes are not 
themes and may collapse into each other 
5) Defining and naming 
themes 
Define and further refine themes – identify 
the essence of what each theme is about 
and determine what aspect of the data each 
theme captures 
Identify the story that each theme tells and 
consider how it fits into the broader overall 
story in relation to the research question 
Identify whether they contain sub-theme(s) – 
provides structure to particularly complex 
themes 
6) Producing the report Concise and clear with evidence to support 
the themes and related to research question 
Theoretical saturation is achieved through constant comparison of incidents 
until no new themes or dimensions are emerging and was aimed for within the 
study.552,602 This could not be predicted accurately at the start of the research 
but was reached when data collection ceased to contribute anything new to the 
codes categories or concepts developed. Specific details on the methods used 
for qualitative data analysis are discussed further in Chapters 5 and 6. 
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3.9  Ethical Considerations 
All professions are guided by a code of ethics, especially within health.  All have 
common principles such as avoiding harm, ensuring confidentiality and using 
information properly. These principles apply to the research process, from the 
collection of data, through analysis, to the dissemination of findings.  This is 
enshrined in legislation to protect both participants and researchers. It includes 
respecting participants’ rights and dignity, avoiding harm and behaving with 
honesty and integrity.  Participants must not experience any detrimental effects 
from the research process; and the long-term impact of the research on the 
participant should be considered including physical harm, psychological harm 
(discomfort and anxiety), and a sense of being intruded.575  Researchers must 
avoid deception and misrepresentation; providing factual and truthful 
information about the nature of the investigation and the role of the participants 
in the research before any involvement is considered. 
Mason suggests that researchers need to develop a self-conscience and not 
simply, or indeed blindly, follow a strict ethical code.566 Within the NHS the 
ethical approval process is designed to protect the patients, staff and 
organisations within it.    
Ethical approval for this study was considered separately at each stage of the 
research.  The data collection described in Chapter 4 was considered within 
each organisation as a service improvement activity as it measured the rate of 
discrepancies and number of sources used against standards within the 
literature and facilitated a benchmarking opportunity for those involved. Thus 
formal ethis approval was not required for this study. 
Ethical approval was sought and received from Bradford, Local Research Ethics 
Committee (LREC) on 21st March 2011 for the observation and documentary 
analysis phases of the study (Chapters 5 and 6) (see Appendix A). Additional 
university ethical approval is not required where NHS LREC approval has been 
obtained, however, the study was logged with the University of Bradford Ethics 
Department as per institutional requirements. Subsequently, applications were 
also sent to relevant NHS R&D departments to gain site specific approval for 
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each of the hospitals sites and the general medical practices.  This was 
received from:  
 NHS Bradford and Airedale – 5th May 2011 (see Appendix B)  
 Calderdale and Huddersfield NHS Foundation Trust – 16th June 
2011 (see Appendix C)  
 Bradford Teaching Hospitals NHS Foundation Trust - 23rd June 
2011(see Appendix D)  
 Airedale NHS Foundation Trust - 10th January 2012 (see 
Appendix E) 
 The Leeds Teaching Hospitals NHS Trust – 22nd August 2013 
(see Appendix F) 
However, during data collection, the rules regarding the ethical requirements for 
involving HCPs in research changed nationally and the study no longer fell 
within the remit of the LREC. A letter was received 21st August 2012 excluding 
their involvement (see Appendix G). See table 3.5 for summary of approval. 
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CHAPTER 4 STUDY 1: OBSERVATIONAL SURVEY OF 
MEDICINES RECONCILIATION FOLLOWING 
ADMISSION TO SECONDARY CARE 
This work has been published in Research in Social and Administrative 
Pharmacy (see Appendix H):  
Urban R, Armitage G, Morgan J, Marshall K, Blenkinsopp A, Scally A.  Custom 
and Practice: a multi-centre study of medicines reconciliation following 
admission in four acute hospitals in the UK. RSAP. 2014. 10 (2) 355 – 368. 
4.1  Introduction 
Many studies have highlighted the high number of errors in medication history 
taking at admission which led to subsequent unintended discrepancies on 
IMCs.48-50,145,189,603,604  The most common error has consistently been the 
omission of clinically relevant medication from in-patient charts with an 
incidence of 39 to 72%.74-79,247,442  Despite the number of interventions which 
have shown to decrease error, 48,53,64,74,185,300,329,477,603 there is little to suggest, 
however, that practice has significantly changed over the last 15 years within 
the UK, creating the need for further improvement to try to reduce the number of 
medication errors which occur at admission.   
Current UK guidance on medicines reconciliation is based on error rates from 
one Canadian and one US study, making its relevance and applicability to the 
UK uncertain.48,50,189 This chapter determines the current picture of unintended 
medicines reconciliation discrepancies within the hospitals studied.  It compares 
these to existing data within national and international literature to contextualise 
the scale of problems with medicines reconciliation and highlight the relevance 
of national guidance.  It quantifies the number and type of sources used to 
verify medication histories and measures the type and potential severity of UIDs 
identified during the process.   Recognising that medicines reconciliation may 
be open to various interpretations, this chapter addresses the first two stages 
(according to the NPC’s 3Cs approach); collection (collection of the medication 
history by doctors at admission) and checking (subsequent verification of the 
medication history by pharmacy staff).80 
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4.2 Aims and Objectives 
4.2.1  Aim 
To determine current medicines reconciliation practice within one region of the 
UK and compare it to published best practices. 
4.2.2  Objectives 
 Determine the time taken for medicines reconciliation to occur following 
admission 
 Determine the number and type of sources used  by pharmacy staff to 
verify the medication prescribed at admission 
 Quantify the number and type of UIDs discovered by pharmacy staff 
during verification of the medication history (post-admission) 
 Determine the potential severity of unintended discrepancies identified 
during verification of the medication history (post-admission) 
4.3  Method 
This is a prospective multi-centre observational survey conducted by 
pharmacists during the verification of medication histories at admission. 
4.3.1  Participants 
Organisations were purposively selected based on their status e.g. teaching 
hospital, patient population and their approach to medicines reconciliation e.g. 
pharmacy technician involvement and use of electronic discharge, identified 
through discussions with various hospitals.  Consequently, a cross-section of 
four NHS acute hospitals in one region of the UK, including one of the largest 
university teaching hospitals in Europe, two district generals and a further 
teaching hospital, were recruited to increase the representativeness and 
diversity of data. 
 Ethical approval was not sought following agreement with the hospitals that this 
was a service improvement initiative. 
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4.3.2 Data collection 
4.3.2.1  Development and piloting of data collection proforma 
A data collection proforma was compiled using existing literature and  validated 
audits.6,77  It included a taxonomy of medicines reconciliation discrepancies 
developed by the universities of Sydney, Leeds and Wisconsin (David Alldred. 
Senior Lecturer in Pharmacy Practice, University of Bradford.  Personal 
communication 2011), which focuses on the categorisation of medication 
discrepancies, rather than the categorisation of medication error (see Appendix 
I).  The indicators were chosen based on those which were most commonly 
cited in the literature and in discussion with experts in the field (Linda Dodds, 
Associate Specialist Lecturer, Medway School of Pharmacy, Personal 
communication, 21st October 2010 and David Alldred, Senior Lecturer in 
Pharmacy Practice, University of Bradford, Personal communication, 8th 
February 2011).  Guidance notes were also developed to assist completion of 
the data collection proforma and to ensure consistency. The data collection tool 
and guidance notes were reviewed within the supervisory team plus also by two 
hospital pharmacists.  Minor amendments to wording were made to increase 
clarification.  Also, the data collection proforma was changed from landscape to 
portrait orientation to ease completion.  The data collection tool was also piloted 
in 5% of sample (10 patients) by the researcher and two further hospital 
pharmacists,  then data reviewed to check face validity.  
4.3.2.2  Collecting the data 
Prospective data were collected from the four hospitals (Hospitals A, B, C and 
D) from elderly care, medical and renal wards, over a total of 3 days per 
hospital, during the weeks commencing 5th and 12th September 2011.  This data 
collection period was selected as it was deemed sufficient time to reach the 
calculated sample size needed to power the study. Hospital C was a single 
hospital split over two sites, data were collected from both.  A period of two 
weeks was chosen to allow for natural fluctuations in working patterns and 
patients admitted to the ward. 
Data were collected by 23 pharmacy staff undertaking routine medicines 
reconciliation post-admission. For each patient, the pharmacy staff initially 
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recorded the length of time between admission and when medicines 
reconciliation was conducted. (It was classified as being within 24 hours if the 
medication history was collected the same day or the next day). Next, the start 
and finish times, plus time taken were recorded.  If the staff member had to 
break off to wait for information from general medical practices or for 
information to be confirmed by other HCPs, this time was deducted to give an 
adjusted time. The number of sources used to ascertain current medication and 
the number, type and severity of unintended discrepancies between the sources 
used and the medication history documented were also recorded (see Appendix 
I).  An unintended discrepancy was recorded where no intentional reason for a 
difference between the medicines the patient was taking prior to admisson and 
the medicines prescribed on admission was identified. Guidance notes were 
provided with the proforma to ensure consistency of recording, together with a 
completed example proforma (see Appendix I). In addition, the study was 
explained verbally by RU (the principal investigator), either in person or by the 
telephone, to each staff member prior to any data collection. 
4.3.3  Classifying severity 
As discussed in the literature review, a number of different scales are used 
within the literature to rate the severity of error and or potential error. Some use 
severity i.e. lethal, serious, significant, minor65,210,218,219  Some look at 
discomfort and monitoring e.g. Climente-Martí et al189 and Arora et al.217  Others 
use the likelihood to cause harm e.g. unlikely, possible, probable.183 Each scale 
was reviewed for appropriateness and relevance. Ultimately a scale was 
chosen which assessed discomfort and monitoring e.g. Climente-Martí et al189 
and Arora et al.217 as this was deemed the easiest to predict the potential 
severity.  The scale chosen for this study reflects the potential impact rather 
than drawing on those scales which have routinely been used to establish the 
level of harm or the likelihood of recurrence (the traditional risk matrix) in an 
ADE. The severity scale used within the data collection proforma (Appendix I) 
was adapted from the work of Climente-Marti by adding in the prefix ‘If left 
unchanged, the discrepancy is likely to…’ to recognise that not all discrepancies 
result in harm and that some may be identified before they reach the patient.   
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The severity scale was pre-tested using a convenience peer group comprising 
four community pharmacists and four hospital pharmacists who were 
independent of the pharmacy staff involved in data collection.  During the pre-
test each pharmacist was asked to categorise 30 discrepancies which may 
arise during medicines reconciliation, according to their potential severity.  This 
determined where they should fall within the scale and highlighted any 
difficulties using the scale. Participants were instructed to conduct the task 
individually, without discussion with other colleagues, so as not to influence 
their answers.  The categorised discrepancies were used as examples in the 
guidance notes.  A consensus or majority was reached in 28 of 30 
categorisations, the remaining two were excluded. Following the peer 
categorisation, the wording within the guidance was amended from ‘would 
cause injury’ to ‘could cause injury’ on the severity scale to take into account the 
potential rather than actual risk. 
During the data collection period, staff categorised the potential severity of each 
discrepancy.  Categorisation was based on the assumption that had medicines 
reconciliation not taken place, and the discrepancy not detected then there 
would be impact on the patient (see Appendix I).  At the end of data collection, 
all data sheets were collected and passed to RU for analysis.   
The classification of severity was validated by taking 10% of each organisation’s 
data and verifying with the peer group of 8 pharmacists who had originally 
categorised the discrepancies to determine a consensus or majority. Each 
pharmacist rated the data from all four sites.  Where the severity had not been 
recorded by a pharmacist during data collection the peer group reviewed the 
description of the discrepancy and classified the severity. The level of 
agreement between the peer group and the pharmacists collecting the data was 
calculated using Weighted Kappa.  
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4.3.4  Sample size estimation and data analysis 
Using a sample size of 250 patients, each taking an average of 8 items, 
approximately 2000 prescribed items needed to be observed to detect relevant 
discrepancy rates between the four sites.  Using previous studies the true 
discrepancy rate was estimated to be approximately 20% i.e. 400 discrepancies 
(95% CI ± 2%) providing an exact binomial confidence interval of (0.18 - 
0.22).49,50,77 
Data distribution was examined using box plots then data were tested for 
normality using Kolmogorov-Smirnov. Differences between hospitals were 
analysed using non-parametric tests (Kruskal-Wallis analysis of variance and 
Pearson’s chi-squared test.)  Two outlier values were excluded from the ‘time 
taken’ data which were disproportionate to the other results (i.e. >500minutes). 
All tests were conducted using Stata® version 9, using a significance level of 
P<0.05. 
4.4  Findings 
A total of 250 medication charts were reviewed from the four hospitals (54 
Hospital A, 61 Hospital B, 69 Hospital C, 66 Hospital D).  In some cases the 
pharmacy staff did not complete the full data set.  As a result the denominator 
varied for the number and type of sources used, the number and type of 
discrepancies and the categorisation of severity of the discrepancies. The 
denominator used is defined at the beginning of each relevant section. (See 
table 4.1 for hospital demographics). 
4.4.1  Length of time before medicines reconciliation is undertaken post-
admission 
The majority of medication histories assessed were verified by a member of 
pharmacy staff within the first 24 hours post-admission with similar figures in all 
hospitals except Hospital A which was significantly lower (Fishers exact test, P 
= 0.005) (see figure 4.1).  
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Figure 4.1  Percentage patients with medication history verified by a 
pharmacist 
 
4.4.2  Time taken to undertake medicines reconciliation  
The mean total time recorded for the pharmacy staff to complete the verification 
of the medication history from start to finish was 35.4 minutes.  The mean 
adjusted time, after time taken waiting for information from other HCPs (e.g. the 
GP) was deducted was 14.8 minutes, a mean time difference of 21.0 minutes. 
The total time taken minus the adjusted time represented a total of 83 hours 
and 6 minutes. Seventy-five percent of medicines reconciliations took less than 
an hour to complete in Hospitals A, B and C from the time they were started to 
the time they were complete (adjusted time) (see table 4.2).  The total time 
taken by Hospital D was significantly different to the other hospitals (excluding 
the outliers) (P=0.0001, Kruskal-Wallis) taking up to 2 hours in 75% of cases.  
The adjusted time between the hospitals was also significant (P=0.0117, 
Kruskal Wallis), however, this result may be spurious as a large proportion were 
reported at 10 minutes by Hospital A suggesting the time was not measured as 
precisely in this hospital.  The distribution of data for adjusted time was very 
similar, demonstrating a degree of consistency (see table 4.3). 
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Table 4.2 Descriptive statistics for total time taken to conduct 
medicines reconciliation (minutes) 
 Hospitals 
A B C D 
Minimum 5 5 5 5 
Lower Quartile (Q1) 5 5 5 10 
Median 10 20 20 30 
Upper Quartile (Q3) 60 60 60 120 
Maximum 120 100 1440 360 
 
Table 4.3 Descriptive statistics for actual time taken to conduct 
medicines reconciliation (minutes) 
 Hospitals 
A B C D 
Minimum 2 2 5 5 
Lower Quartile (Q1) 5 5 5 5 
Median 10 15 15 15 
Upper Quartile (Q3) 25 30 30 30 
Maximum 45 45 35 60 
 
4.4.3  Sources used to conduct medicines reconciliation 
The number and type of sources used were recorded for 247 patients. The 
number of sources used to reconcile medicines varied (see figure 4.2).  Only 
one source of information was used in 36.8% (91/247) of cases, however, 
overall, Hospital D used significantly more sources than the other hospitals 
(P<0.005).  The patients’ own medication was used in less than half of 
medicines reconciliations (110/247, 44.5%) (see figure 4.3), with no significant 
difference between the participating hospitals (P=0.130, Pearson’s Chi-
squared).  Discussions with the patient occurred in less than half of all 
medicines reconciliations (113/247, 45.7%) and there was a significant 
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difference between hospitals with Hospital D utilising the patient more often 
than other hospitals (P=0.001, Pearson’s Chi-squared). 
Figure 4.2  Number of sources used to reconcile medication within each 
hospital  
 
Information from the general medical practice was used in 57.5% (142/247) 
patients with Hospitals C and D using the general medical  practice significantly 
more than the other two hospitals (P<0.005, Pearson’s Chi-squared) (see figure 
4.3). This included information received over the telephone, via fax or in a letter.  
Hospital D also used significantly more ‘Other sources’ than hospitals A - C. 
(P=0.048, Pearson’s Chi-squared).   
Other sources included hospital pharmacy records, mental health hospital 
records and the community pharmacy records (see table 4.4)  
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Figure 4.3 Type of source used to reconcile medication in each hospital 
 
Table 4.4 Other sources used to reconcile medication across all four 
hospitals 
Source Number of times used 
Patient’s own list              
Hospital pharmacy  
Patient notes                
Community pharmacy   
Pharmacy ward technician            
Mental Health Trust  
Private hospital chart 
Liverpool Care Pathway (LCP)                 
Warfarin clinic      
Previous inpatient medication 
chart (IMC)   
Renal unit records  
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4.4.4  Number and type of discrepancies identified 
The frequency and type of discrepancy were recorded for 245 patients.  The 
mean number of prescribed medicines taken per patient was 8.4.  A total of 420 
discrepancies were recorded. Of these, seven were omitted as they were 
documentation errors rather than unintended discrepancies e.g. missed 
strength of inhaler and 8 were reclassified as they fitted within the other 13 
categories, leaving a total of 413 discrepancies from 2013 items.  This yields a 
discrepancy rate of 19.6% (95% CI [0.180, 0.214]).  The mean number of 
discrepancies per patient was 1.69.  This varied between hospitals from 0.95 to 
2.31 discrepancies per patient (see figure 4.4).  The percentage of patients 
experiencing at least one discrepancy on their IMC was 37.6% (92/245).  This 
varied between hospitals with nearly one in two patients experiencing at least 
one discrepancy in Hospital A (25/54, 46.3%) and Hospital B (28/61, 45.9%) 
(see figure 4.5). The difference, however, was not statistically significant (P 
=0.061, Pearson’s Chi-squared).  Of the 413 discrepancies, 351 were 
categorised into discrepancy type with omission being the most frequent 
(237/413, 57.4%) (see table 4.5).  The number of omissions per patient 
reviewed varied from zero to thirteen.  The pharmacists recording the data 
provided detail of which medication was omitted in 169 cases.  Inhalers (24/ 
169, 14.2%) were the most commonly missed individual drug class, with pain 
relief (14/169, 8.3%) then nutritional and blood supplements e.g. ferrous 
sulphate and calcium D3 (10/ 169, 5.9%), proton pump inhibitors (10/ 169, 
5.9%) and antidepressant next (10/169, 5.9%) (see figure 4.5).  The more 
medicines a patient was taking the more likely they were to experience an 
unintended discrepancy (P<0.001, linear regression).  
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Figure 4.4  Number of discrepancies experienced per patient within each 
hospital  
 
 
Figure 4.5  Percentage of patients experiencing at least one discrepancy 
on their inpatient medication chart (IMC) 
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Table 4.5  Number of discrepancies identified and categorised by type  
 All Hospitals Hospital A Hospital B Hospital C Hospital D 
 n % n % n % n % n % 
Drug Omission 237 57.4 55 57.9 34 58.6 59 52.7 89 60.1 
Dose 
Decrease 20 4.8 3 3.2 6 10.3 3 2.7 8 5.4 
Difference in 
timing 18 4.4 4 4.2 1 1.7% 5 4.5 8 5.4 
Drug Addition 17 4.1 4 4.2 6 10.3 5 4.5 2 1.4 
Formulation/ 
route of 
administration 15 3.6 2 2.1 3 5.2 1 0.9 9 6.1 
Dose Increase 12 2.9 5 5.3 1 1.7 3 2.7 3 2.0 
Frequency 
Increase 7 1.7 2 2.1 1 1.7 1 0.9 3 2.0 
Other 6 1.5 0 0.0 1 1.7 3 2.7 2 1.4 
Drug 
Duplication 4 1.0 1 1.1 0 0.0 1 0.9 2 1.4 
Therapeutic 
class 
substitution 4 1.0 2 2.1 2 3.4 0 0.0 0 0.0 
Strength 
Decrease 4 1.0 3 3.2 0 0.0 0 0.0 1 0.7 
Frequency 
Decrease 4 1.0 1 1.1 1 1.7 1 0.9 1 0.7 
Strength 
Increase 2 0.5 1 1.1 0 0.0 0 0.0 1 0.7 
Change in 
Brand 1 0.2 0 0.0 1 1.7 0 0.0 0 0.0 
Uncategorised 62 15.0 12 12.6 1 1.7 30 26.8 19 12.8 
Total 
Categorised 351 85.0 83 87.4 57 98.3 82 73.2 129 87.2 
Total 
discrepancies 413 100 95 100 58 100 112 100 148 100 
There was borderline significance demonstrating the more sources used, the 
higher number of discrepancies discovered (P=0.0727, Kruskal-Wallis). There 
was no significant difference between the proportions of different types of 
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discrepancies within the hospitals except the difference in administration times 
where Hospital D was significantly higher than other hospitals (P=0.011, 
Pearson’s Chi-squared). 
4.4.5  Severity of discrepancies identified 
Three hundred and forty-four discrepancies were categorised according to their 
potential severity if left unchanged.  The remainder (69) could not be 
categorised due to incomplete datasets. In Hospitals A, B and C the severity of 
discrepancies was most frequently categorised as potentially causing reversible 
injury which requires increased monitoring or intervention to preclude harm; 
however, the potential severity of discrepancies in Hospital D was most 
frequently categorised as not causing injury which may have skewed the overall 
results (see figure 4.6).  
Figure 4.6  Categorisation of severity of discrepancies 
 
1* If left unchanged, the discrepancy would not cause injury  
2* If left unchanged,  the discrepancy could cause reversible injury with no changes to 
care 
3* If left unchanged, the discrepancy could cause reversible injury which requires 
increased monitoring or intervention to preclude harm 
4* If left unchanged, the discrepancy could cause reversible injury which would require 
additional care e.g. increased hospital stay, medication 
5* If left unchanged, the discrepancy could cause irreversible or disabling injury 
6* If left unchanged, the discrepancy could cause death 
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Overall, there were four discrepancies that could have potentially caused 
irreversible injury or death. These included omission of insulin, anticoagulant 
therapy and prescribing penicillin in a penicillin allergic patient.  Inter-rater 
reliability between the pharmacists recording the data and the professional 
panel was tested using Weighted Kappa (K=0.4048, std. err. 0.0483), showing 
moderate agreement. 
4.5  Discussion 
The results found varying levels of compliance with current UK guidance on 
medicines reconciliation.  All participating centres strongly relied on GP-based 
sources, with this type of source being the only one used to ascertain the 
medication history in a substantial proportion of cases.  This is against 
recommendations that information should be cross checked and verified.80  
Patients were not involved in the majority of reconciliation encounters despite 
recent research indicating that patient involvement can improve safety.121,502  A 
significant number of discrepancies was identified by the pharmacists, of which, 
omission was the most common.  Importantly, a minority of these discrepancies 
had the potential to cause harm to patients and therefore potentially increase 
the utilisation of healthcare resources.  
4.5.1  Time taken to complete medicines reconciliation  
The WHO recommends that medication histories should be verified by a 
member of pharmacy staff within 24 hours of admission.1 This occurred for the 
majority of patients included in the current study.  Medicines reconciliation by 
pharmacy staff was often interrupted with the time from start to finish being 
much longer than the time spent on the task itself.  It is unclear whether this 
time was spent waiting for information, whether the member of staff had been 
interrupted to undertake another task or some other reason.  The idea of 
sharing access to the patient’s medical record between primary and secondary 
care could improve the time taken to reconcile medication, although this is not 
without its own difficulties.235 It could also be argued that the clinical significance 
of the time taken to verify a medication history is greater than the statistical 
significance as this may ultimately lead to delayed or omitted medication.   
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4.5.2  Sources of information used in medicines reconciliation  
Many studies have looked at how to elicit appropriate information from patients 
through medication histories and have identified the sources of information 
which can contribute to accurate reconciliation 49,50,145,166,233,603. The current 
study demonstrates variability in the number and type of sources used within 
each hospital to reconcile medication, with some hospitals routinely using fewer 
sources. Although there was no statistical correlation between the number of 
sources used and the number of discrepancies found, there may be clinical 
significance in ensuring there is triangulation between sources.  This is 
supported by Collins et al and Andersen et al, both of whom demonstrated the 
benefits of referring to a second source to corroborate the first during 
medication history taking, plus guidance from the National Prescribing Centre 
(NPC) which indicates that information should be cross-checked and 
verified.76,80 
All four centres demonstrated a strong reliance on GP-based sources.  Indeed, 
this was the only source in a substantial proportion of cases. It is often assumed 
that the GP record is the most accurate source of information; however, they 
have been shown to contain incorrect information and omissions.76,78,244    
Collins et al76 found that 5% of medicines the patient was taking were on neither 
the GP nor nursing home record, and Green et al244 identified that 26.6% of 
discrepancies were attributable to inadequate or incorrect primary care 
information. This reinforces the need to utilise more than one source of 
information. Further work to identify whether the specific GP source used e.g. 
the repeat prescribing slip, GP printout or direct access to the patient’s GP 
electronic health record had an impact on accuracy may be useful. Hospital D 
used significantly more sources than the other hospitals which may account for 
the increased length of time taken to reconcile medication within that hospital.   
‘Other sources’ were rarely used to verify the list of medications a patient was 
taking.  These included the community pharmacist, mental health hospitals and 
warfarin clinics. Use of community pharmacy records has been shown to add 
value in some patients and is worthy of further attention to determine the 
reasons for low usage.107  
145 
 
4.5.3  Patient involvement in medicines reconciliation  
Although early research indicates that safety can be improved through patient 
involvement, this study found that patients were not involved in the majority of 
reconciliation encounters.121,502  Patients have been encouraged since 1986 to 
bring their medicines in on admission to hospital as it reduces hospital 
expenditure, can increase the accuracy of medication histories and can improve 
the patient’s ability to accurately describe the medication they are taking.247 
Over the years the percentage of patients doing so has increased and there has 
been a recent drive in many NHS hospitals to encourage patients to bring their 
medication, using methods such as the ‘green bag scheme’.249,361   Although 
such schemes have not been evaluated in the UK, promotional interventions 
have been shown to encourage ambulance staff to bring patient’s medication 
into the hospital setting in Australia which directly impacted on the increased 
accuracy of prescribing at admission and have recently been endorsed for 
international use by the WHO.1,333,334  Within the current study, patients’ own 
drugs were used in less than half the medicines reconciliations, with no 
significant difference between the participating hospitals.  It was not possible to 
determine whether this was all patients who had brought their own medication 
into hospital or whether some patients’ own medication was available but not 
used.  A subsequent study has shown that approximately 50% of patients bring 
in their own medicines to hospital which suggests the former.531    There is 
sometimes reluctance from patients to bring their own drugs into hospital for 
fear they may be lost and not returned at discharge.75  Leaving current 
medicines at home can, however, lead to the potential for discharge medication 
and home medication to be taken concurrently post-discharge.  
The WHO suggests that to be optimally effective, patients and their families 
must be involved in the medicines reconciliation process.1  There is no evidence 
to suggest that the patient is more useful or accurate than other sources, 
however, involving the patient can reveal information not provided 
elsewhere.78,503  Studies of patient compliance have shown rates of 30-50% 
non-adherence, and demonstrated that, non-adherence can lead to increased 
medication discrepancies.194,288,499,605 Cochrane et al showed that a quarter of 
patients were taking regular OTC medication and that often the patient decides 
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themselves whether to stop or continue prescribed medication; information 
which cannot be gained from additional sources.379 Patients are best placed to 
be aware of all medication prescribed by multiple caregivers including self-
purchased medication and are likely to know exactly what they are currently 
taking.    It is unclear whether the patients who were not asked about their 
medicines were unable to communicate, asleep, lacked capacity, challenges 
previously highlighted by Collins et al or whether there was some other 
reason.76  Further research is therefore needed in this area. 
4.5.4  Medication discrepancies identified 
Within this study, the hospital which discovered the largest number of 
unintended discrepancies per patient did use more sources than the other 
hospitals; however, the statistical correlation was borderline between the 
number of sources used and the number of discrepancies found. This lends 
some support to the suggestion that more than one source should be used, but, 
further study is needed.  Overall, four in ten patients experienced at least one 
discrepancy with a mean of 1.69 discrepancies per patient, (range 0.95 to 2.31 
across hospitals).  This is higher than a previous studies in the UK, the US and 
Canada.6,49,50,77 The UK guidance is based on the latter two.6,49,50  
The results show that the more medicines a patient is taking the more likely 
they are to experience an unintended discrepancy, confirming findings by 
Duggan et al and Irvine et al.204,432  The most common discrepancy found was 
the omission of medication, which is in line with previous UK and international 
studies.74-79,247,442   The present study found a higher number of omissions than 
other studies, however, omissions were approximately 10% lower than two 
previous UK studies.49,50,76-79 It is unclear whether the hospitals with higher 
rates of discrepancies have poorer prescribing on admission or whether 
pharmacy staff are better at identifying the discrepancies. 
Some omitted medications were potentially fatal e.g. insulin and warfarin, 
supporting previous findings.76,442  A number of studies have looked at common 
omissions in medication histories, the most frequently reported being the 
contraceptive pill, inhaled corticosteroid strength, type of inhaler device, brand 
of medication (where clinically significant), CAMS and OTC medication.76,79,432  
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The WHO suggests information should be collected on both prescription and 
non-prescription (OTC) medications including vitamins, nutritional supplements, 
potentially interactive food items, herbal preparations, and recreational drugs 
together with the dose, frequency, route, and timing of last dose of medication.1 
The frequency of different types of medication omitted may have been higher 
but it was difficult to extrapolate this due to the lack of recording of type of 
medication omitted.   
4.5.5  Severity of discrepancies identified 
Although the majority of discrepancies were not classed as severe, a minority, 
importantly, had the potential to cause significant injury to patients or require 
increased monitoring of the patient.  This may have meant an increased 
hospital stay or subsequent readmission, enhancing hospital expenditure, as 
well as increasing the distress of patients and undermining their confidence in 
existing systems.59 The findings in this study are similar to findings of Climente-
Marti et al and Karkov et al but more severe than those cited by Lessard et al 
who determined that the majority of medication discrepancies identified were 
unlikely to cause harm to the patient.189,194,218 
 4.5.6  Strengths and limitations of Study 1 
This part of the study demonstrates a number of strengths, most importantly 
that it was multi-centre and involved a range of specialties.  This ensured that 
different patient groups and organisations were represented.  However, 
hospitals B and C did not distinguish between general medical and elderly 
patients as their hospital admission wards contained mixed patient populations.  
This created insufficiently defined data to enable robust comparisons to be 
drawn between specialties.  Within the other two hospitals the patient numbers 
within each specialty were too small to draw any conclusions. Further work 
looking at comparisons between specialties would be beneficial. 
These data may also be limited as they were collected voluntarily by employees 
of the hospitals involved, relying on their engagement with the data collection 
and subjectivity in categorising the severity of the discrepancies identified.  The 
varying level of engagement led, on occasion, to incomplete data.  Alternative 
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methods could have been employed, e.g. the retrospective review of the 
medication charts and notes, however, due to differences in systems the 
relevant data was not always routinely captured within the hospitals.  This would 
make retrospective evaluation difficult. The sample size in this study was 
relatively small - with fewer centres in comparison to the UK study conducted by 
Dodds et al.77  However, it does explore the nature and type of discrepancies in 
greater depth.  Furthermore, the study had a larger sample size and more 
centres than the work of both Gleason et al and Cornish et al – both cited within 
national guidance.6,49,50  
Additionally, the data collected were predominantly on admissions wards which 
may have skewed the results as patients often do not stay on this ward longer 
than 24 hours.  It does though, give an indication of different practice within the 
hospitals in reviewing patients immediately post-admission.  Ideally, studies of 
this nature should gather data from a wider cross-section of the hospital and 
including downstream wards, backed up with observational data of current 
practice.   
It was acknowledged that the severity of discrepancy may be affected by a 
variety of factors including the patient’s profile, the specific medicine, strength, 
indication and co-morbidities, however, this was not taken into account for ease 
of categorisation and comparison.   
4.6  Conclusion 
This is the first UK study to present a detailed analysis of the medicines 
reconciliation process across four centres.  Higher rates of unintended 
medication discrepancies per patient were found than in other studies; the 
majority were omissions, consistent with other research.  None of the four 
centres adhered to current UK guidance on medicines reconciliation.  Despite 
the evidence suggesting that at least two sources should be used to confirm the 
medication history, this is not happening in practice, with high reliance on data 
from general practices.  The patient and patient’s own medication were used in 
less than half of all medicines reconciliations with much time being spent 
waiting for information from general practice. There is an increased need to 
educate staff involved in medication history taking on common omissions from 
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medication histories, particularly inhalers.  Further qualitative research needs to 
be conducted on the barriers to obtaining information, including the reasons for 
utilising only one source.  This chapter has provided baseline data to compare 
practice within the study population with published literature.  It explains what is 
happening in practice, but does not explain why.   To ascertain the reasons for 
the findings within Chapter 4 and to look at why these errors are occurring 
further more comprehensive observational work is needed.  This will be 
explored in Chapter 5. 
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CHAPTER 5  STUDY 2:  OBSERVATION OF MEDICINES 
RECONCILIATION IN SECONDARY CARE 
Work within this chapter has been presented at the Health Services Research 
and Pharmacy Practice (HSRPP) and Royal Pharmaceutical Society (RPS) 
conferences and published in the International Journal of Pharmacy Practice.  It 
has also been used to inform the national RPS Medicines Optimisation 
guidance.  
Urban RL, Armitage G, Morgan J, Marshall, K. Is electronic discharge the 
answer? IJPP 2012, 20 (Suppl. 2): 40-1 
Urban RL, Armitage G, Morgan J, Marshall K, Blenkinsopp A. Communicating 
about medication: Who, what, where, when, how? IJPP. 2013, 21 (Suppl. 1): 
20-1. 
RPS (2013). Medicines Optimisation: Helping patients to make the most of 
medicines. Good practice guidance for HCPs in England. 
5.1  Introduction 
The previous chapter identified the scale of error at admission to hospital from 
inadequate medicines reconciliation during the first two stages of the National 
Prescribing Centre’s (NPC’s) 3 C’s approach; collection and checking.80 It 
described the type and severity of discrepancies, which occurred between the 
medication the patient was taking prior to admission and the medication history 
taken at clerking, and, the sources used to verify the medication history.  The 
findings demonstrated a high number of discrepancies of varying type and 
severity at admission to hospital within the study population. They were in 
keeping with previous UK and international literature which demonstrates high 
numbers of discrepancies, especially omission of medication.77,109,125,145,166,171-
183,201  Although Chapter 4 determined the scale of error within the health 
economy being studied, it did not identify the reasons why these errors were 
occurring or what was contributing to medicines reconciliation related 
discrepancies.  The observation reported in this chapter seeks to explain the 
findings within the previous study and literature review, using observational 
methods. It will also build on the previous study by looking at the third ‘C’ within 
151 
 
the NPC’s 3C approach; communicating.80  Previous studies have examined 
stages of the medicines reconciliation process in isolation, focusing on one 
specific transfer point.  They have segregated primary and secondary care, 
rather than looking at the impact on safety across all interfaces, and transitions 
of care.   This chapter will look at the entire medicines reconciliation process 
within secondary care to identify contributory factors and defences which may 
lead to or ameliorate error associated with medicines reconciliation.  The 
subsequent chapter will look at primary care and the interface.  HCPs were 
systematically observed whilst undertaking the tasks that impact on the 
accuracy of medicines reconciliation: nurse handover, medicines administration, 
ward rounds, pharmacy staff verification of the medication history, patient 
counselling, prescribing & transcribing and the writing of discharge summaries. 
5.2  Aims and Objectives 
The aim of this chapter is to describe current medicines reconciliation practice 
within four acute hospitals together with the role of Health Care Professionals 
(HCPs) and patients.  The specific objectives were to: 
 Identify the process and stages of reconciling medication within 
secondary care 
 Determine the roles of secondary care staff and patients with respect to 
medicines reconciliation 
 Identify contributory factors which may lead to error associated with 
medicines reconciliation  
 Identify any practices and solutions which enhance the accuracy of the 
process or defences which prevent error 
5.3  Method 
5.3.1  Overview 
This study employed qualitative observation using both deductive and inductive 
approaches to determine current practice within medicines reconciliation.  The 
methods described here are based on the qualitative methodological theory 
described in Chapter 3; a pragmatic observational approach.  
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5.3.2  Sample  
The four hospitals previously studied in Chapter 4 were used as the study sites.  
HCPs including doctors, pharmacy staff and nurses, were observed within these 
hospital settings undertaking the different stages which contribute to medicines 
reconciliation.  Each stage was observed at least once in each area of each 
hospital being studied. The study used maximum variety sampling, therefore 
different participants were observed doing the same task, or different tasks.  
5.3.3  Access to hospitals and recruitment of healthcare professionals 
(HCPs) 
The researcher met with key personnel within each hospital to discuss the study 
prior to making an NHS Research and Development (R&D) application.  Staff 
were assured that the tasks being observed were in line with the researcher‘s 
usual role as a pharmacist, bound by the GPHC Standards of Conduct, Ethics 
and Performance, which also contains a code of confidentiality.606  If a potential 
or actual, error or discrepancy, were noticed they were relayed to the relevant 
HCP.  Post R&D approval the researcher then met with relevant personnel in 
the area/department being studied, for example, the ward sister, consultant, 
other relevant managerial staff, to explain the study and agree involvement.  
Prior to the observation, the researcher (where possible) identified members of 
staff scheduled to work during the study period and invited them to participate.  
The researcher also attended team briefings or similar to explain the study to 
staff members, and sought guidance from the ward sister or other managerial 
staff for an appropriate time to recruit participants. Consent was taken by the 
researcher prior to any observation.  The study was explained verbally to the 
participant, supported by a written information sheet (see Appendix J).  Their 
right to withdraw from the observation at any point and their right to refuse to 
answer any questions was explained.  The researcher answered any questions 
the participant had and asked them to sign the written consent form (see 
Appendix J).  Particular care was taken to ensure staff consented voluntarily 
and did not feel they were being coerced into participating.  All data collected 
were anonymised.  Unique identifiers were used to maintain anonymity and to 
enable the cross-reference of the consent forms with the data collection.  
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5.3.3.1  Participants 
Consideration was given as to whether it was most appropriate to observe the 
HCPs undertaking medicines reconciliation tasks or the patient’s journey and 
experience through their hospital stay.  It was felt that by observing the HCPs 
as the participant, it would capture the experiences of the patients without the 
difficulties of consenting patients.  The observation of HCPs eliminated 
considerations such as mental capacity and provision of information in other 
languages which would have been necessary through the observation of 
patients.  As this part of the study involved the observation of staff and did not 
directly involve the observation of patients, service users or their carers were 
not directly involved in the research process.  Although by the nature of the 
study and the patient being the common factor in all the tasks observed they 
were indirectly involved. 
Staff were recruited from three specialties: care of the elderly, renal and medical 
(see Chapter 3 for rationale), based on their job roles i.e. if they undertook an 
aspect of medicines reconciliation as part of their role, and their willingness to 
participate. Staff were also recruited in A&E within one hospital as it is known 
that for 20% of patients this is the start of their journey through hospital.607  
Participants included doctors (all grades including consultants), nurses, 
pharmacists and pharmacy technicians within A&E and on the hospital wards.  
No HCPs refused to participate. The grade of the doctors was recorded as their 
freedom to act is linked to their grade, whereas with the other HCPs observed 
the same competence level is expected irrespective of their period of 
employment or level of experience. 
5.3.4  Observation schedule development and pilot 
5.3.4.1  Deductive approach 
A Secondary Care Observation Schedule (SCOS) was developed, using 
findings from the literature review to evaluate tasks associated with medicines 
reconciliation within secondary care.   Evidence-informed practices use the best 
available research and practice knowledge to guide program design and 
implementation. This informed practice allows for innovation while incorporating 
the lessons learned from the existing research literature.  Where evidence was 
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available evidence was used.  Where national policy was available national 
policy was used.  Lastly where expert opinion and consensus was published 
this was applied.  Failing this, professional judgement and knowledge was 
applied by the researcher to enable a pragmatic approach to the observation.   
It incorporated ten sections: organisational policy, training, audit, admission, 
taking a history, prescribing the IMC, verifying the medication history, transfer, 
discharge and patient education (see Appendix K). Each section was divided 
into various standards or criteria which should be incorporated into a medicines 
reconciliation process, informed by the literature.  The structured approach 
allowed systematic collection of data, and increased the consistency of data 
collection and analysis across organisations. The organisation’s policies, 
protocols and procedures were gained in advance and their content compared 
with the evidence based observation schedule to identify and include any 
relevant items not on the schedule (see Appendix L for e-mail request). In fact, 
no additional items were found in the policies, protocols or procedures.  The 
SCOS was piloted through the observation of a pharmacist and consultant (for 4 
hours in total) who were not likely to be involved in the study to ensure it was 
manageable and feasible to complete during observation.  No amendments to 
content were made, but following the pilot the document’s sections were saved 
as separate files to allow easier navigation rather than as one large document.  
5.3.4.2  Inductive approach 
During the pilot and early observations it became apparent that there were non-
process related observations which potentially impacted on the medicines 
reconciliation process and information gathering; nuances and ways of working 
which pertained to the individual.  Thus, any observation associated with 
medicines reconciliation which fell outside the parameters of the schedule was 
recorded using field notes.  Field notes also included observations related to 
tasks which were not incorporated into the schedule due to lack of current 
evidence in the literature, for example, nurse administration and ward round. 
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5.3.5  Observation process 
Wards were observed Monday to Friday between 7.30am and 6.00pm.  The 
researcher arrived on the ward for nurse handover which usually occurred at 
7.30am.  The study was explained to everyone working on the ward that day.   
Handover was observed followed by nurse administration of medication.  From 
this point forward the researcher would either join the ward round or observe 
pharmacy staff verifying medication histories depending on what was happening 
on the ward at the time; consenting HCPs as appropriate.  Writing discharge 
summaries, transcribing and clerking usually happened post ward round, often 
in the afternoon.  Patients were often discharged late afternoon once their 
medication had arrived from pharmacy.  A typical observation day would usually 
last 8 hours with half an hour lunch break.  Lunch was usually taken at the 
same time as the doctors as the majority of medicines reconciliation 
observations were reliant on them being on the ward. 
Observations within A&E were conducted weekdays and weekends at various 
times throughout the day between 8.00am and 10.00pm. These were chosen 
based on discussion with the A&E Matron to observe the busiest periods to 
obtain maximum data.  The sister in charge was notified on arrival, then the 
researcher chose an area of A&E to observe depending on activity.  This 
included the high dependency unit, triage, minor injuries, and main A&E. 
On the wards and in A&E, when observation was not taking place, the 
researcher stood near the nursing station to wait for the next opportunity to 
observe.  The researcher chose what to observe based on their knowledge of 
hospital processes.  The routines on the ward, e.g. ward rounds and medication 
administration, were most often at fixed times, compared with pharmacists 
verifying medication histories and discharge advice notes which were ongoing 
throughout the day.  The researcher also looked for potential red flags based on 
their clinical knowledge e.g. if they had observed an alteration to the patients 
medication on a ward round then observation of their discharge summary 
preparation would be observed, if possible. Often the staff would notify the 
researcher if they were about to undertake a relevant task which facilitated 
observation.  
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The researcher followed and observed each HCP conducting separate stages 
of medicines reconciliation.  Each observation of an individual varied from 0.5 to 
4 hours, and for no longer than 8 hours in total per individual over the course of 
a week.  The same participant was observed single or multiple times, 
conducting the same task or different tasks, for example, a doctor may be 
observed admitting a patient to the ward, then observed discharging the same 
or a different patient.  
During observation HCPs were asked non-leading questions to clarify and 
document the process accurately, their replies documented in field notes, 
verbatim where possible, or described in detailed notes if the response was 
lengthy and required clarification and/or probing.  There was potential 
inconvenience to the participant being observed as they had to answer 
questions between caring for patients.  This was minimised through grouping 
questions together, not interrupting important tasks and keeping questions to a 
minimum. In theory, participants may have found being observed stressful but 
were able to opt out of the observation at any time if they found it intrusive or 
felt it may affect the care of their patient.  This did not happen during the 
observations.   
Whilst observing, criteria were marked as met or not met and other identified 
practices, together with answers to specific questions were noted. Participants 
often vocalised and shared their thoughts with the researcher which gave a 
useful insight into the thought processes and allowed some conclusions to be 
made on potential contributory factors and defences to poor medicines 
reconciliation practice. 
Patients were asked by the HCP being observed if they would object to a 
pharmacist researcher present during their consultation.  No patients refused.  
There were several occasions where the researcher felt it appropriate to 
remove themselves from the consultation with a patient, for example, during 
intimate examination.  During this time the conversation could still be heard, and 
was duly documented if pertinent to medicines reconciliation.  
Within the inductive part of the study, observation was conducted until 
theoretical saturation of information had been achieved and no new themes 
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emerged.552  This was when the information was adding to the bulk of the coded 
data rather than the theory.  If new categories emerged half way through and 
these became theoretically saturated then it indicates nothing has been lost by 
not having coded this theme in the first half of the data.559 
5.3.6  Recording of data 
Data on the process were recorded against the SCOS using a combination of 
tablet with handwriting recognition and paper-based notes.  The researcher also 
contemporaneously recorded anything of note which contributed or potentially 
contributed toward successful or unsuccessful medicines reconciliation using 
field notes on the reverse side of the SCOS or in a separate Word® document if 
recording electronically.   Field notes were unstructured other than ensuring the 
date, HCP being observed, and setting of the observation was noted.  
Abbreviations were used where possible to make recording easier. Also, where 
appropriate, any relevant verbal data were recorded verbatim during the 
observation e.g. where HCPs explained their rationale for conducting a task a 
certain way.  These included the participant thinking aloud or offering 
information which they felt helpful, either spontaneously or in response to 
questions.  The time the medication history was started and finished was also 
recorded. The researcher asked further questions to increase clarity and extract 
further information from the participants, also paraphrasing information to 
ensure information had been interpreted correctly.  
5.3.7  Data analysis 
The data were analysed and categorised using three frameworks.  Firstly, using 
the SCOS at individual stages of three medicines reconciliation process (a 
deductive approach).  Secondly at a theoretical level, using a human factors 
approach, specifically the Yorkshire Contributory Factors Framework (YCFF) 
developed by Lawton et al.608  The YCFF takes a human factors and systems 
approach, identifying potential factors which may contribute to error e.g. patient 
factors and physical environment etc.  It summarises factors (active and latent 
failures) contributing to patient safety incidents in hospital settings (see figure 
5.1 and table 5.1).608 Their ultimate aim was to review the literature and to 
identify potential areas where interventions could be targeted.   
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Figure 5.1 The Yorkshire Contributory Factors Framework608 (reprinted with 
kind permission) 
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Table 5.1 Yorkshire Contributory Factors Framework (YCFF) Criterion 
Definitions608 (reprinted with kind permission) 
Factor Definition 
Active Failures Any failure in performance or behaviour e.g. error, mistake, 
violation of the person at the ‘sharp-end’ (the health 
professional) 
Communication 
Systems 
Effectiveness of the processes and systems in place for the 
exchange and sharing of information between staff, patients, 
groups, departments and services.  This includes both written 
(e.g. documentation) and verbal (e.g. handover) 
communication systems 
Equipment and 
Supplies 
Availability and functioning of equipment and supplies. 
External Policy 
Content 
Nationally driven policies/ directives that impact on the level of 
quality of resources available to hospital. 
Design of 
Equipment and 
Supplies 
The design of equipment and supplies to overcome physical 
and performance limitations. 
Individual Factors  Characteristics of the person delivering care that may 
contribute in some way to active failures. Examples of such 
factors include inexperience, stress, personality, attitudes. 
Lines of 
Responsibility 
Existence of clear lines of responsibility clarifying accountability 
of staff members and delineating the job role. 
Management of 
Staff and Staffing 
Levels 
The appropriate management and allocation of staff to ensure 
adequate skill mix and staffing levels for the volume of work. 
Patient Factors Those features of the patient that make caring for them more 
difficult and therefore prone to error.  These might include 
abnormal physiology, language difficulties, personality 
characteristics (e.g. aggressive attitude). 
Physical 
Environment 
Features of the physical environment that help or hinder safe 
practice.  This refers to the layout of the unit, the fixtures and 
fittings and the level of noise, lighting, temperature etc. 
Policy and 
Procedures 
The existence of formal and written guidance for the 
appropriate conduct of work tasks and processes. This can also 
include situations. 
Safety Culture Organisational values, beliefs, and practices surrounding the 
management of safety and learning from error. 
Scheduling and 
Bed Management 
Adequate scheduling to manage patient throughput minimising 
delays and excessive workload. 
Staff Workload Level of activity and pressures on time during a shift. 
Supervision and 
Leadership 
The availability and quality of direct and local supervision and 
leadership. 
Support from 
Central Functions 
Availability and adequacy of central services in supporting the 
functioning of wards/units.  This might include support from 
Information Technology and Human Resources, portering 
services, estates or clinically related services such as 
radiology, phlebotomy, pharmacy. 
Task 
Characteristics 
Factors related to specific patient related tasks which may 
Make individuals vulnerable to error 
Team Factors Any factor related to the working of different professionals 
within a group which they may be able to change to improve 
patient safety 
Training and 
Education 
Access to correct, timely and appropriate training both specific 
(e.g. task-related) and general (e.g. organisation-related). 
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The YCFF was used to categorise codes identified by the researcher through 
thematic analysis.  As well as using the YCFF to categorise contributory factors, 
the factors were also used to categorise those elements which may act as a 
defence e.g. patient factors such as hearing impairment may act as a 
contributory factor but involving the patient in the consultation may act as a 
defence.  Some of the qualitative data were quantified to contextualise the 
observations, for example counts of the numbers of discrepancies observed or 
reasons for stop, starting altering medication. Thirdly, a range of interpersonal 
communication was explored and a health professional-patient consultation 
models was employed as a framework to organise themes associated with 
specific medicines reconciliation communication between the healthcare team 
and their patients (see 5.3.7.1).   
5.3.7.1  Communication systems - Verbal and written information 
analysis 
It is well established that lack of communication, amongst other issues such as 
inaccurate information, contributes to error, in particular medication error.  It is 
one of two contributory factors within the YCFF (the other being ‘safety culture’), 
that intersects all other factors (see figure 5.1).  This is because communication 
issues can arise at an individual, team or organisational level and may be 
influenced by an individual’s actions or by the team and their organisational and 
team cultures.  Lingard et al provide a typology of communication failures within 
the healthcare setting,  however, the contributory factors or defences which may 
contribute to these failures are not discussed.609  Furthermore the YCFF itself 
does not provide a detailed exposition of communication or safety culture 
because the systematic review on which it is based did not generate evidence 
to underpin this.  For data analysis in the current study it was considered 
necessary to gain a deeper understanding of the relationship between 
communication and medicines reconciliation.  
A number of communication models were considered and from these a 
framework was developed to categorise the inductive data relating to 
communication thus expanding on the YCFF.  The types of communication 
observed during medicines reconciliation were analysed (see table 5.2) to 
determine which communication models may be appropriate.  Two types of 
161 
 
communication were observed: written and verbal.  Written communication was 
one-way (i.e. provided in one direction), for example to provide information to 
the hospital (from primary care), within the hospital or from the hospital (to 
primary care). A detailed analysis of written information was not undertaken as 
the focus of the observation was to gain broad contributory factors which could 
then be explored through further work. It was not always practical for the 
researcher to see the notes during the observation as the researcher was trying 
to remain unobtrusive.  There is potential for the written communication 
observed in the study to be evaluated through information seeking models. The 
investigation of the notes may be better through a more focused study using 
documentary analysis with think aloud/cognitive processing techniques to 
understand the rationale and interpretation of assumptions being made whilst 
reading them. This was outside the scope of this thesis. 
Verbal communication was two-way, to either provide or gather information, and 
involved an interaction between two people.  This was either face-to-face or on 
the telephone.  HCPs communicated with either patients or with other HCPs 
that were either within their team and/or discipline or outside.   
Interaction between the HCP and the patient occurred at all points in the 
medicines reconciliation process.  There were times when this interaction was 
more structured e.g. during clerking, the ward round and verification of 
medication history by pharmacy staff.  These interactions could be described as 
a consultation, thus consultation models were explored.  The structure of 
clerking and the ward round follow the traditional medical model of consultation: 
history taking, examination, investigation, diagnosis, treatment and follow up.  
However, within these consultations the HCPs displayed nuances in content, 
approach and style, which potentially affected the quality of communication, not 
captured within the medical model.  The majority of consultation models 
encourage patient involvement from the viewpoint of improving patient 
satisfaction and shared decision-making, rather than from a patient safety point 
of view, making it difficult to find a single model.  Consequently, within the 
current study, a consultation analysis framework specifically relating to 
medicines reconciliation was developed based on the Clinical Observation Tool 
(COT) criteria610 (see table 5.3)  and essential communication skills for a 
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medication history interview611 (see table 5.4) to assess the interaction between 
HCP and patient. 
 
 
Table 5.2  Communication during medicines reconciliation  
 Type of Communication by HCP 
Written 
One-way – provision of 
information 
 
Verbal  
Two-way – provision & 
receipt of information 
(Face to Face or 
Telephone) 
 
Communicated to the 
Patient 
 
 
Aide Memoire 
Discharge Summary 
 
 
Consultation 
Counselling on 
Medication 
 
Communicated to the 
HCP 
(Same/ different 
discipline/team) 
 
Discharge Summary 
Patient Notes  
Medication Charts 
Observation Charts 
Proforma 
 
 
Seeking Giving Advice 
Information 
Case Discussion 
Referral 
Delegation 
Handover 
Education/ Mentoring 
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It was more difficult to determine a suitable model to analyse the HCP-HCP 
interactions as this is not well explored within the literature.  Thistlethwaite and 
Spencer suggest a number of interactions which occur outside the consultation 
room based on doctor interaction.612  These would be appropriate for any HCP 
but only categorise the types of interaction not how they may fail or be 
successful (see table 5.5).  The frameworks were applied post-coding to 
determine whether the criteria within the frameworks were met during the 
consultation.   
Generic communication models were also explored, including the linear model 
suggested by Shannon & Weaver613 and the interactive model suggested by 
Schramm614, though these only described the sender and the receiver rather 
than what was being communicated and how.  Berlo’s model of communication 
was considered further as it had some potential to apply to one-way 
communication (see figure 5.2).615  However, during two-way communication 
the patient and HCP interchange positions between sender and receiver making 
Berlo’s model difficult to apply.  It would also need the researcher to have more 
detail of the content of the documentation to analyse the message for content 
and structure etc. which was outside the scope of this study.  This again could 
be explored through further work. 
Table 5.3 COT assessment criteria adapted for medicines reconciliation 610 
The HCP encourages the patients contribution at appropriate points in the consultation 
The HCP responds to signals/cue that lead to a deeper understanding of the problem 
The HCP uses appropriate psychological and social information to place the complaints 
in context.   
The HCP explores the patients’ health understanding. 
The HCP asked sufficient information to include or exclude likely medication. 
The HCP appears to make a clinically appropriate working diagnoses. 
The HCP speaks to the patient in appropriate language and avoids jargon. 
The HCP makes effective use of resources. 
The HCP documents anything that needs follow-up or review. 
164 
 
Table 5.4  Essential communication skills for a medication history 
interview taken from Ellington et al611 (reprinted with kind permission) 
Skills  Definition  Example  
Formal 
form of 
address  
Use patient's title and last name ‘Good morning Mr. Smith.’  
Rapport  
 
Use active listening skills to 
confirm interest in a patient and 
help gain respect 
‘It's not easy being in the hospital 
away from friends and family.’  
Active 
Listening/ 
Empathic 
Responding 
Reflect on a patient's feelings or 
identify a patient's underlying 
message  
‘You sound unsure.’ OR`’Are you 
saying’  
Open-
ended 
questioning  
Patient is free to answer in any 
manner. This is useful when 
introducing a new subject.  
‘How are you taking your blood 
pressure medicine?’ 
Closed-
ended 
questioning  
Patient can answer with a single 
word, usually yes or no  
‘Do you take your blood pressure 
medicine in the morning?’  
Transition  Verbally closing off one subject 
and introducing a new one allows 
the patient to make a mental 
transition  
‘We have just talked about the 
prescription medications you take. 
Now let's talk about any 
nonprescription medications you 
may take.’  
Verbal 
Following  
 
Technique to get the patient to 
elaborate on a subject without 
asking more questions, but simply 
repeating the patient's last few 
words  
‘....dizzy spells?’  
 
Avoidance 
of leading 
questions  
Leading questions prompt the 
patient with a particular answer  
 
‘You don't smoke, do you?’  
REWORD: ‘Do you use any 
tobacco products?’  
Avoidance 
of ‘why’ 
questions  
‘Why’ questions can cause patients 
to get defensive. Rephrase 
questions to start with, ‘for what 
reason’  
‘Why were you taking the medicine 
in the morning?’  
REWORD: ‘For what reason...’  
Timing  Warn a patient that a series of 
questions will follow  
‘I am going to ask you a series of 
questions now.’  
Clarify 
Conflicting 
Information 
Always accept the blame for 
inconsistent information that the 
patient may tell you or write 
‘I must have written it incorrectly, I 
thought you had said....’  
Silence  
 
Allows the patient to show 
emotion, digest information, or 
gather thoughts  
Maintain nonverbal facilitation and 
stop speaking 
Answering 
Patient 
Questions  
Avoid definitive answers until a 
final drug therapy plan is devised  
Patient asks, ‘Do you think I should 
stop taking...?’  Pharmacist says, 
‘Well, I'll make a note and evaluate 
it with Dr. Smith.’  
Mentioning 
Previously 
Answered 
Questions  
If a patient answers a question you 
were going to ask later in the 
interview, jot it down  
‘You mentioned earlier that you 
occasionally take ibuprofen for 
headaches. Do you ever take 
anything else for aches or pain?’  
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Table 5.5 Breadth of doctor interactions outside the consultation room 
(adapted from Thistlethwaite and Spencer, 2008)612 (reprinted with kind 
permission) 
 Doctor-patient communication 
 Consultation by telephone 
 Letters and email to patients 
Doctor-patient's family/caregivers 
 Face to face with or without patient present 
 Telephone, letters, and email 
Doctor-doctor 
 Professional 
 Seeking or giving advice 
 Appraisal and mentoring 
 Doctor as patient 
Doctor-other health professional 
 Referral and delegation 
  Seeking or giving advice 
 Case discussion 
Within a team 
 Awareness of difference in professionals' language 
 Assume the roles and responsibilities of a team member and leader 
Writing medical records 
 Legal 
 Court appearances 
 Reports 
Working with media, authorities, other organisations and complaints 
 Against oneself including admitting error and apologising 
 About colleagues 
Whistle blowing 
Running meetings 
Teaching 
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Figure 5.2  Berlo’s SMCR Model of Communication616  
 
5.3.8  Validity and reliability of methods used  
The same researcher was used throughout the study to conduct the observation 
to eliminate inter-operator variability. Four different co-raters were used at 
various stages throughout the study to validate the data and the analysis of the 
data.  The process is outlined below and summarised in figure 5.3.  The co-
raters were selected to bring expertise relating to medicines and patient safety 
theory.  Three were qualified pharmacists and understood the complexities of 
medicines reconciliation and clinical processes surrounding medicines 
reconciliation.  One co-rater was a health psychologist with experience of 
patient safety research (see table 5.6). 
During observation on the wards, the researcher was observed by Co-rater 1 
who independently observed alongside the researcher for four hours to enable 
validity and reliability of the observations to be assessed.  Following the dual 
observation, Co-rater 1 and the researcher discussed and compared the 
observations to clarify interpretation. It was surprising to find no differences in 
observation were recorded.  This in part may have been down to the structured 
observation schedule. 
Once all data had been collected, emerging codes were recorded by the 
researcher using NVivo10®.  A sample of data (approximately 5% - 27 patient 
encounters) was then coded independently by a second co-rater (Co-rater 2).  
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This included a cross-section of hospitals and tasks; ward round, verification of 
the medication history by a pharmacist, administration of medication and 
clerking the patient.  The emerging codes were cross-checked with the 
researcher's codes and a consensus reached.  The codes relating to specific 
tasks associated with medicines reconciliation were categorised using the 
YCFF as to whether they were a potential defence or contributory factor. 
Approximately, 10% of the codes (83) were then also categorised by two co-
raters (co-rater 3 and 4) to determine inter-rater reliability.  The co-raters were 
provided with the definitions of the contributory factors as described by Lawton 
et al.608  
Table 5.6  Summary of co-rater characteristics 
Co-Rater 1 2 3 4 
Profession Pharmacist Pharmacist Pharmacist Health 
Psychologist 
Area of 
Practice 
Clinical 
Pharmacist 
(Teaching 
Hospital) & 
University 
Teacher 
Practitioner 
University 
Senior 
Lecturer & 
Clinical 
Pharmacist 
(Teaching 
Hospital)  
University 
Senior 
Lecturer  
Patient Safety 
Research 
Worked in 
Secondary 
Care 
Yes Yes No Yes 
Experience 
of Qualitative 
research 
Yes Yes Yes Yes 
Experience 
of Patient 
Safety 
research and 
Human 
factors 
No No No Yes 
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Co-rater 1 observes 
researcher to validate 
observation
All Data reviewed and 
emerging codes recorded 
by Researcher using NVivo 
10
Sample of data coded 
independently by Co-rater
2. Codes cross checked and 
verified with researcher 
codes
Codes categorised by 
researcher using the YCFF
Sample (10%) codes 
categorised by Co-raters 3 
and 4
Figure 5.3   Process of ensuring validity and reliability within the 
observation data 
 
5.3.9  Ethical considerations for Study 2 
The design of the study was discussed with members of the pharmacy 
department at Bradford Teaching Hospitals NHS Foundation Trust (BTFHT) and 
the National Institute for Health Research (NIHR) Programme Grant Patient 
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Panel at Bradford Institute for Health Research (BIHR).  The approach was also 
discussed and agreed with the NHS Hospital's Caldicott Guardianf.  Ethical 
approval was sought and received from the relevant LREC and R&D 
departments as outlined within Chapter 3.   
5.4  Results 
The data will be presented in four sections.  Where frameworks have been used 
the data will be presented following the structure of the framework:  
Section 5.4.1 Overview: hospitals and participants 
Section 5.4.2 Analysis using SCOS (deductive)  
Section 5.4.3 Analysis using YCFF (inductive)  
Section 5.4.4 Communication systems (inductive) 
5.4.1  Overview: hospitals and participants 
One hundred and forty-two HCP participants were observed during 674 patient 
episodes within four acute hospitals in West Yorkshire, between September 
2011 and November 2013.  The participants included doctors, nurses, 
pharmacists (see table 5.7) from a total of 15 wards and one A&E department. 
Non-qualified HCPs were also observed including both medical and pharmacy 
students.  The total observation time was 374 hours.  A patient episode was 
defined as an interaction which involved discussion with or about a patient. 
  
                                            
f A Caldicott Guardian is a senior person responsible for protecting the confidentiality of patient 
and service-user information and enabling appropriate information-sharing within an 
organisation.  
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Table 5.7  Number and Type of Participants 
HCP Number of 
Participants 
Consultant 24 
Specialist Registrar (SpR) 4 
Core Trainee (CT) 1-5 7 
Staff grade doctor 3 
GP Registrar 7 
FY2 16 
FY1 14 
Medical student 4 
Pharmacist 21 
Pharmacy student 3 
Pharmacy Technician 11 
Nurses 28 
Total 142 
 
5.4.1.1  Organisational information 
See table 4.1 Hospital Demographics Chapter 4. 
5.4.2  Analysis using secondary care observation schedule (SCOS) 
In this section, results relating to the SCOS (see section 5.3.2 and Appendix K) 
are presented. 
5.4.2.1  Organisational policy 
All hospitals had policies in place which comprised taking a medication history, 
reconciling medication, transcribing, prescribing, patients own medication and 
writing discharge information (see table 5.8).  These were accessible to all staff 
on the hospital intranet.  None of the policies clearly defined the responsibilities 
of different staff within the process, though the prescribing and transcribing was 
aimed predominantly at doctors and the verification of medication by pharmacy 
staff. Staff were required to sign to say they had read these policies and 
procedures in Hospitals B-C.  
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Three out of the four hospitals (B-D) used standardised documentation to 
record medication histories.  These included space to record the name, form, 
strength and dose of the medication, allergy status, sources of information 
used, an indication of whether the medication was stopped started or changed 
at admission, and the name of the person completing the form.  None of the 
forms had separate areas to record OTC or CAMs or any prompts within the 
form to ask about these.  None of the forms had space or prompt to record 
indication, compliance or height and weight of the patient as detailed in the 
SCOS.  In Hospitals B and C the medication history form was used throughout 
the hospital.  In Hospital D, the form was only used on the admissions wards, 
where it was incorporated into their clerking documentation.  On the renal ward 
the form was not used routinely; the pharmacy staff would occasionally use it.  
Hospital A compared sources directly against the IMC.   
All hospitals had a target to ensure medicines reconciliation was conducted 
within 24 hours laid out by NICE & NPSA.6  Within hospitals B–D there was a 
clear person accountable for improving medicines reconciliation within the 
hospital.  All hospitals had access to interpreting facilities if required although no 
staff used them during the observation, relying instead on family or other HCPs 
who spoke the same language. 
Hospitals B-D all had dedicated admissions pharmacists and pharmacy 
technicians on all of their admission wards.  Hospital A had a dedicated 
pharmacist on their elderly admissions ward, conversely, the general medical 
admissions ward did not have consistent cover and the role of the pharmacy 
technician on all wards within this hospital was being developed.   
5.4.2.2  Training and education 
Hospital A did not provide training for any of its staff on medicines reconciliation, 
Hospitals B, C and D had training programmes in place for their pharmacy 
technicians of which Hospital C and D’s were the most comprehensive.  None 
of the hospitals’ training was multidisciplinary and all involved only pharmacy 
staff. During the consent process for the observation, many HCPs (with the 
exception of pharmacy staff) had not heard the term ‘medicines reconciliation’ 
or if they had were unsure of its exact meaning. 
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5.4.2.3  Audit 
Hospitals B, C and D, had previously conducted audit to assess their medicines 
reconciliation.  The audits measured how soon post-admission the pharmacists 
were verifying the patient’s medication history in line with the WHO1 and the 
NICE & NPSA6 guidance of 24 hours.  In Hospitals C and D this was re-audited 
routinely, with Hospital B more ad-hoc. 
5.4.2.4  Overview of medicines reconciliation process 
Different process approaches were found in the four hospitals, with some 
similarities which occurred within all hospitals (see figure 5.4).  
Patients were usually admitted to hospital through one of 3 routes; via A&E, 
direct to an admissions unit (medical or surgical) or in the case of elective 
admissions via a pre-admissions assessment unit.  Whichever route the patient 
took, a medication history was conducted by the junior doctor during the initial 
assessment or clerking or, occasionally by a pharmacist.  None of the hospitals 
used nurses to take medication histories at acute admission to medical wards. 
Following the medication history taking, medication was prescribed, 
predominantly by junior medical staff.  Occasionally in Hospital D pharmacists 
would add medication which had been omitted if they were a qualified 
prescriber. All hospitals had pharmacist non-medical prescribers, although only 
hospital D had non-medical prescribers on the admissions wards.  Throughout 
the hospital stay the patient’s medication was discussed on the ward round and 
medication amended and changed as deemed appropriate.  Some patients had 
their prescription verified by a member of pharmacy staff at some point during 
their hospital stay. Patients were either discharged or transferred to a 
‘downstream’ ward for example from A&E to the admissions ward or 
alternatively from an admissions ward to a longer stay ward or home.   
The decision to discharge a patient was usually made during the ward round.  
The patient’s discharge medication was prescribed on a discharge summary 
sheet, transcribed from the patient’s IMC. A pharmacist checked the 
transcribing (where medication was being supplied), relevant medication was 
supplied to the patient (usually 7-14 days’ supply) and the patient was 
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discharged.  Where no medication was supplied the discharge note was not 
checked by a pharmacist.  It was unclear how often this was the case. 
The patient moved to their own home, a care home or intermediate care, with 
their discharge information being passed to a number of different people, 
always the GP, and in some cases the district nurses, community pharmacist, 
social services, care home staff, or intermediate care.   
This process was followed within each hospital unless specified otherwise. 
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Figure 5.4 
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5.4.2.5  Taking a medication history 
The initial medication history was taken by the doctor during clerking.  The 
medication history was then verified at a later point by a pharmacist or 
pharmacy technician.  There was no system for allocating whether a medication 
history was taken by the pharmacist or pharmacy technician in any of the 
hospitals, with often the pharmacist starting at the top of the bed list and the 
pharmacy technician at the bottom and meeting in the middle or vice versa.  
The length of time it took to obtain a medication history varied from patient to 
patient.  It was difficult to tell precisely how long the doctors took to take a 
medication history as it was often embedded in the clerking and medical history 
taking process.  Pharmacy staff took longer than the medical staff to take a 
medication history due to a more thorough approach more suited to eliciting a 
medication history (average 15-20 minutes compared with 5-10 minutes).  The 
medication history was documented in three out of the four hospitals on specific 
medicines reconciliation forms designed to standardise the process (used jointly 
by doctors and pharmacy staff).  None of the hospitals held electronic records, 
had e-prescribing or stored information about medicines reconciliation 
electronically. 
Sources 
The number of sources used to verify a medication history ranged from one to 
four.  The pharmacy staff used a wider variety of sources than medical staff who 
often only used the patient and a GP record or previous discharge summary in 
all hospitals observed.    In all hospitals, it was often apparent from the IMC that 
the doctor had used something to inform them of the medication but the source 
was unclear.  No HCPs asked about contraception.  Only one doctor was seen 
asking about OTC medication and CAMs and no pharmacists.  No HCPs 
routinely asked about compliance, if, though, there was a concern about 
compliance a discussion sometimes took place.  Similarly, none of the HCPs 
asked whether the patient had any difficulties taking their medication or whether 
they needed any help with their medication.  
Information was received from the GP in a variety of ways.  All hospitals 
received information by fax or occasionally from the patient in the form of an 
admissions letter. Often, if the patient was deemed reliable then further sources 
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were not utilised.  Hospitals differed in the consistency with which information 
received from the GP (either direct from the EHR or faxed) was filed in the 
notes. This was not mentioned in the policies. In Hospitals A and C faxes often 
had to be requested twice because the either had not been sent/received the 
first time or they had been misplaced.   
In hospitals where e-discharge was used this was used more frequently as a 
source of information, certainly by the pharmacy staff, and on some occasions 
the doctors.  One pharmacist ensured that they annotated the e-discharge with 
information on whether the medication had been reconciled so that, if it was 
used as a source in future, it was clear.  There were only seven of 158 
occasions when a primary care provider other than the GP was used as a 
source.  These were the community pharmacist, district nurse and practice 
pharmacist.  Community pharmacists were rarely contacted and where they 
were, it was predominantly for MDS patients.  The name and address of the 
patients’ usual community pharmacy was only documented routinely in Hospital 
D.  This was not prompted by existing systems, it relied on the pharmacy staff 
remembering to annotate the front of the prescription chart.  In the other 
hospitals it was only recorded where the patient used an MDS.  Sources were 
not always double checked with the patient and often GP lists were taken as 
being accurate.   
Two of the hospitals (A and B) had full access to the patient’s primary care 
electronic health record which included access to the medication they were 
prescribed within primary care. Hospital D had access to the patient’s Summary 
Care Record (SCR).  Where the hospital could not access the EHR, information 
was usually requested from the GP via the telephone, with some practices 
requesting a supporting fax request.  This may have been because the hospital 
did not have access (in the case of Hospital C), the patient had opted out of 
SCR or the practice did not have SCR.  Very occasionally a patient was 
admitted to hospital A or B from a different health economy where the EHR 
could not be accessed. In these instances the general medical practice was 
contacted. 
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In A&E the ambulance record was routinely looked at, however, once the 
patient was on the ward it was only observed being referred to once by the 
consultant during the ward round. 
Patients were not consistently encouraged to bring their own medication in 
following admission in any of the four hospitals. All hospitals had lockers at the 
side of each patient bed to ensure the secure storage of the medication was in 
close proximity to the patient. This facilitated medication history taking when the 
patient’s medication was used as a source as the HCP did not have to go 
elsewhere to gather the information and be able to use it with the patient to 
confirm the history. During medication history taking there was variation in 
whether the HCP asked whether the patient had either brought a list of 
medication or their actual medication into hospital.  Occasionally the patient 
would offer the information without being asked. Where present, family 
members and carers would sometimes assist with medication history-taking, 
intermittently contributing or interrupting the conversation. 
Where there were discrepancies between how the medication was prescribed in 
primary care and how the patient specified that they took their medication, this 
was not documented nor communicated back to primary care in any cases 
observed.  Nor was non-adherence ever explored with the patient.  On one 
occasion a history of non-adherence was identified by the pharmacist in a renal 
patient who had just undergone transplant.  This had the potential to lead to 
rejection of the kidney.  It was documented in the notes to not discharge the 
patient until this had been discussed.  The following week the pharmacist 
reported that the patient was discharged over the weekend with no discussion 
of her non-adherence. 
On no occasion was a specific interpreter used with non-English speaking 
patients, however, healthcare staff interpreted on three occasions and family 
members on four occasions. 
This part of the SCOS (Taking a Medication History) also included identification 
of certain communication skills which will be considered in section 5.4.3.6. 
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5.4.2.6  Prescribing medication 
Within this study only doctors were observed prescribing on IMCs in Hospitals 
A-C, even though they all employed non-medical prescribers.  Within Hospital D 
non-medical prescribing was observed, only to add medication that was omitted 
rather than the whole medication chart.  The pre-admission medication was 
initially prescribed by the junior doctors (Foundation Year 1 [FY1] and 
Foundation Year 2 [FY2]) without consideration as to whether the medication 
was clinically necessary, e.g. seasonal medication such as antihistamines, or 
continuing need and on occasion without knowing why the medication was 
prescribed.  These were identified later by the consultant who stopped the 
medication or were identified by the pharmacist during a clinical check.  
Decisions to stop, start or withhold medication were left to more senior 
members of the medical team, predominantly the consultant but on occasion, 
the registrar.  However, initially all medicines were prescribed and the patient 
may have had a dose (of the ultimately changed/stopped medication) 
administered.  Involvement of more senior medical staff depended on when the 
patient was admitted relative to the post-take ward round, which happened 
twice a day on admissions wards in Hospitals B-D.  In Hospital A it only 
happened once a day on the elderly admission ward but twice a day on the 
general medical admission’s ward. 
Prescribing decisions were not always documented in the notes and often 
lacked detail.  Medication stopped at admission was not always documented, 
nor was the reason for it being stopped.  Sometimes it was difficult to tell 
whether medication had been omitted, stopped or prescribed intentionally.  
Some medical staff would prescribe it then withhold it by annotating the chart, or 
cross through the prescribed item to demonstrate the patient was taking it prior 
to admission.  Others would annotate the notes or the IMC, though, this was on 
the minority of occasions.  None of the hospitals had pharmaceutical care plans 
in place for their patients.  Sometimes, even where it was clear that medication 
had been stopped, the reason why was not clear to the HCP.  
On several occasions where the prescriber was unsure about a dose or 
regimen they used relevant information sources such as the (British National 
Formulary) BNF or local hospital guidelines e.g. for antibiotic prescribing.  The 
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duration of treatment was usually documented for antibiotics.  The form or type 
of device was often omitted from the prescription, especially with inhaled 
medicines.     
5.4.2.7  Verification of the medication history by pharmacy staff 
Pharmacy staff attended the wards to undertake a variety of roles.  For 
pharmacists, this included, clinical checking of the prescription charts, ordering 
medication, answering clinical queries and verifying the medication history.  For 
pharmacy technicians, this included ordering medication, answering technical 
queries and also verifying the medication history. 
Pharmacy staff verified the medication histories of patients following admission.  
In all hospitals this stage was referred to as medicines reconciliation, including 
within policies and procedures.  Hospital D’s policy broke it down further into 
‘full’ and ‘basic’ reconciliation to denote the verification undertaken by the 
pharmacist and the medication history taken by the doctor respectively.  All 
hospitals had a full complement of pharmacy staff on the wards during the 
working week 9.00-5.30 but only Hospital D had pharmacists working on the 
wards at the weekend, even so this was still a diminished service. This meant 
that only a proportion of patients were seen by pharmacy staff, either during or 
outside standard working hours.  Some patients were not reviewed at all, for 
others it was over four days from admission and others at discharge.  Pharmacy 
staff annotated the front of the chart to indicate that a medication history had 
been verified.  For three of the four hospitals (B-D) a complete medication 
history could also be found in the notes.   Discrepancies identified during 
verification of the medication history were predominantly resolved with the 
doctor at the time of identification.  Occasionally messages were left with the 
nurse where the doctor was not available.  Some discrepancies were resolved 
with the patient or family member/ carer, the care home or the GP. 
Queries were communicated in a variety of ways.  These included writing in the 
patient notes, writing on the front of the IMC or speaking to the relevant HCP.  
Hospital C had a green communication slip which was attached to the front of 
the medication chart using sticky tape which notified the doctor of any queries 
or discrepancies.  All HCPs including the nurses were aware of the form and 
182 
 
were alerted to it by its colour and prominence on the front of the chart.  It would 
be noticed during administration rounds by the nurses who would then notify the 
doctors to resolve the query.  During verification of the medication history, a 
clinical check was also often carried out (see also Section 5.4.3.7 
Communication). 
5.4.2.8  Transfer of patient care 
When a patient was transferred to another ward within the hospital or to 
intermediate care, the medication chart was transferred with the patient for 
continuity in all four hospitals.  The nurse also rang the destination to hand over 
information which they deemed relevant.  This did not always involve 
information about medication. 
5.4.2.9  Ward round 
This was not included in the SCOS as there were no guidelines or empirical 
literature concerning the impact the ward round had on medicines reconciliation 
at transition points. However, because the literature shows that changes to 
medication in hospital are common,532,533 it was important to observe ward 
rounds.  All ward rounds were led by the consultant except for two (out of 32); 
one of which was led by the registrar and the other by the FY1 and FY2 doctors. 
No decisions about treatment change and investigation could be done without 
the consultant’s approval, unless they were to stabilise the patient in an acute 
situation. 
Stop, starting, changing and withholding medication 
One hundred and thirty eight out of 193 patients had alterations made to their 
medication during the ward round or clerking; 63 had medication stopped, 34 
started, 28 changed and 13 withheld.  Medication was stopped started changed 
or temporarily withheld for a variety of reasons (see table 5.9).  This usually 
occurred during the consultant ward round although it occasionally occurred 
during clerking by the junior medical staff where the patient was on medication 
which may affect their acute condition.  Sometimes medication was stopped 
then restarted within the same admission and vice versa.    
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Medication was crossed off the patient’s chart (stopped) for a variety of 
reasons.  Most often to stabilise a patient in an acute situation e.g. 
hypoglycaemics or antihypertensives, or where the risk of continuing medication 
was considered to outweigh the benefit e.g. warfarin. A medicine would also be 
crossed off at the end of a short course of treatment e.g. antibiotics or if the 
patient needed palliative care and unnecessary medication was stopped.  As 
well as stopping medication to stabilise a patient some medicines were also 
started.  Often these medicines were for acute use and were stopped before 
discharge e.g. fluids or converted to oral/maintenance doses e.g. antibiotics 
(see table 5.9). 
5.4.2.10  Medication administration 
Medication administration was not included in the SCOS as there were no 
guidelines or empirical literature which looked at the interventions which could 
be made during medicines administration associated with medicines 
reconciliation or the nurses role in medicines reconciliation.  During medication 
administration rounds seven patients highlighted to the nursing staff medication 
which had been omitted from the prescription chart or alternatively medication 
which had been stopped and the medication no longer taken.  Two examples 
were seen on one of the elderly wards: 
‘Nurse:  Do you want some olive oil in your ears? 
Patient:  No I don’t use that anymore.’ 
     Nurse 7, Elderly Ward, Hospital B 
 
‘Nurse:  You are written up for tramadol 
Patient:  I usually take that at home.   
Nurse:  Oh do you?  
Patient: Yes.   
Nurse:  Did you bring it in with you?  
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Patient:  Yes.   
Nurse:  Is it in your locker?  
Patient:  Yes.  I also usually take quinine at night but I didn't get any 
last night.’ 
The nurse gets the medication out of the locker but is unable to 
administer it to the patient as they are prescribed tramadol 50-100mg 
when required whereas they usually take tramadol 200mg M/R which is 
what is in the POD locker. 
     Nurse 7, Elderly Ward, Hospital B 
One nurse identified three discrepancies which were not communicated to the 
doctor for resolution following the administration round.  These included the 
omission of a blood pressure medication highlighted to the nurse by the patient, 
the incorrect antipsychotic medication dose and the omission of eye drops. 
5.4.2.11  Discharge 
All hospitals produced a discharge summary to communicate medication lists to 
the next care provider.  They were all completed by doctors, though 
pharmacists added to them where information was deemed incomplete.  All 
observed wards wrote the discharge summary on the day of discharge except 
two wards, one in Hospital A and one in Hospital B.  They were both elderly 
wards who were often waiting for patients to be assessed for social needs.  
Discharge summaries were written by a doctor on all wards as they acted as a 
prescription for the provision of discharge medication.  In three Hospitals B-D, 
these were electronic making them legible.  The legibility of the handwritten 
discharge summaries (in Hospital A) was variable, especially on the 4th carbon 
copy which was usually given to the patient.   
All discharge summaries had space to record medication information (name, 
form, strength and directions), allergies, name of person completing the form 
and reason for admission.  Adherence and any special formulation information 
was not recorded.  All summaries also had space to provide information about 
medication that had been stopped, started or changed during the stay, whether 
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paper or electronic.  This, however, was not always completed.  Only one e-
discharge system (Hospital C) used forcing functions to ensure it was 
completed for each medication the patient was taking prior to discharge.   
On most occasions, it was the GP who received discharge information from all 
four hospitals.  Infrequently the community pharmacy would receive a faxed 
copy if the patient was on a MDS.  The district nurses on two occasions 
received verbal information via the telephone from ward nurses about the 
requirements of their patients post discharge; the administration of insulin and 
Vitamin B12.   
The pharmacist’s role at discharge was to check the transcribing of the 
medication from the chart on to the discharge summary, clinically check the 
discharge summary and to verify the medication history in cases where it had 
not been done.  If the patient did not need any medication supplying at 
discharge, pharmacy staff would not see the discharge summary before it was 
sent to primary care.  It was unclear whether this led to error, but given the 
amount of discrepancies being identified, it is likely. 
‘Blanket orders’ e.g. not itemising each item on a discharge summary and 
writing ‘No changes’ or ‘as previous’, were never used.  No patients on ‘special’g 
medications or non-standard preparations were observed.  If a medication 
prescribed at discharge was only intended for a specific time period e.g. 
antibiotics or steroids, the duration was more likely to be completed on the 
electronic discharge as it was prompted by the forcing functions in the electronic 
discharge software used in Hospitals B-D.  In contrast, the handwritten 
discharge information relied on the prescriber remembering to add the 
information. 
All hospitals ensured that the patient had at least one week’s supply of 
medication at discharge.  The HCPs reported that discharge summaries were 
transmitted electronically in Hospitals B-D and via the post in Hospital A, 
although transmission was not observed during this study.  There was no 
                                            
g 'Specials' are special-order unlicensed medicines made to meet the needs of an individual 
patient. 
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specified timescale for sending and it was unclear how soon after discharge 
they were received in primary care. 
5.4.2.12  Counselling patients 
Patients were not advised during any of the observations to carry an accurate 
list of medication with them, however, during clerking and verification of the 
medication history the patient was often asked if they had brought the list with 
them which might serve as a prompt to the patient in future, although this was 
not standard practice.  Discharge counselling was rarely observed because 
medication was received by the ward from pharmacy in an ad-hoc fashion 
making it difficult to observe the nurses providing the patients with their 
medication.  It was only observed on four occasions.  Nevertheless, the 
researcher asked the nurse on each ward to talk through the process.  Patients 
were predominantly counselled by nurses at discharge in the form of a simple 
reiteration of the dose instructions documented on the discharge summary 
rather than specific counselling points relevant to the medication.  Rarely, the 
consultant was observed explaining the medication changes to the patient on 
the ward round but this varied from consultant to consultant and consultant to 
patient.  If medication was more complex, counselling would be conducted by 
the pharmacist e.g. warfarin or a specialist nurse e.g. insulin or inhalers. 
All patients were given a copy of the discharge summary at the point of 
discharge.  No other patient information was seen e.g. leaflets, aide-memoire 
etc. except on the renal ward in Hospital D, (post-transplant) where a 
comprehensive, personalised booklet on anti-rejection medication was 
provided.  All patients newly initiated on warfarin were provided with relevant 
information including the NPSA yellow book. 
No patients were observed being advised to speak to their community 
pharmacist regarding any medication changes although a pilot study was about 
to commence on one admission ward in Hospital A to provide the community 
pharmacist with a slip which indicated which medication had been changed 
during inpatient stay.  Sometimes staff would ensure relevant family members 
were there before relaying information, especially in the case of warfarin.  It was 
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not clear whether this was related to the specific medication type or the patient 
or some other reason. 
Patients were rarely asked during any observations of any practical problems 
taking their medication.  Patients were asked to demonstrate whether they 
could use their medication on two occasions – these were both related to 
inhaler technique in Hospital A. 
5.4.3  Analysis using Yorkshire Contributory Factors Framework (YCFF) 
The findings in the subsequent sections are presented according to each of the 
factors described in the YCFF.  Each section discusses the individual 
contributory factors which may lead to medicines reconciliation-related error and 
or discrepancies followed by potential defences which may prevent such errors. 
As described in section 5.3.8, 10% of the codes were categorised by two co-
raters and the kappa coefficient calculated to determine inter-rater reliability.  
The kappa coefficient for agreement as to whether the code was a defence or 
contributory factor was high (0.88, P=0.00).  Using the YCFF, there was some 
level of agreement (P < 0.05) for the following categories: communication 
systems, equipment and supplies, individual factors, patient factors, physical 
environment, policy and procedures, staff workload, and training and education. 
Agreement was strongest for patient factors, physical environment and staff 
workload (see table 5.10). (Some of these were limited by the number of codes 
falling into each category e.g. for equipment and supplies there was only one 
code categorised and all raters agreed.) 
A kappa value (K) was also calculated to examine agreement between 
individual co-raters to determine any significant differences i.e. co-rater 1 and 2, 
co-rater 2 and 3 co-rater 1 and 3.  The two pharmacist co-raters had a 
significant kappa (K=0.48) for policy and procedures (Which led to a significant 
overall kappa value for that contributory factor but it was not significant between 
the either of the pharmacists and the psychologist).  This would seem 
reasonable given the potential unfamiliarity of the psychologist with pharmacy 
policy and procedure which came out in the discussions post-categorisation. 
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 Table 5.10 Inter-rater reliability of categorisation using YCFF categories  
Contributory Factor Kappa 
Coefficient 
(K) 
P value 
Active Failures 0.18 0.01 
Communication systems  0.40 <0.005 
Equipment and supplies  1.00 <0.005 
External policy -0.03 0.59 
Design of equipment and supplies -0.02 0.59 
Individual factors 0.38 <0.005 
Lines of responsibility -0.03 0.66 
Management of staff and staffing levels -0.03 0.59 
Patient factors 0.65 <0.005 
Physical environment 0.58 <0.005 
Policy and procedures 0.13 0.02 
Safety culture -0.04 0.68 
Scheduling and bed management Too few 
variables 
specified 
 
Staff workload 0.47 <0.005 
Supervision and leadership -0.03 0.63 
Support from central functions -0.03 0.59 
Task characteristics 0.07 0.15 
Team factors 0.08 0.14 
Training and education 0.25 <0.005 
 
Conversely for the team factors (which did not produce a significant overall K 
value) there was more agreement between the pharmacist researcher and the 
psychologist (K=0.48) (both with more experience of human factors) compared 
with the pharmacist.   
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5.4.3.1  Active failures – Mistakes, lapses and violations 
YCFF Definition: Any failure in performance or behaviour e.g. error, mistake, 
violation of the person at the ‘sharp-end’ (the healthcare professional) 
Contributory factors 
It was difficult to identify slips, mistakes and lapses through observation as the 
HCP’s thought processes cannot be observed and thus were unknown.  It is 
probable that where HCPs have read the organisation’s policies and procedures 
and do not follow them that this is likely to be an active failure i.e. the HCP has 
either accidentally overlooked part of the task, or has purposefully not carried 
out that part (a violation), especially in the hospitals where they sign to say they 
have read the policies. 
Some actions were definite violations, for example, using another person’s log 
on details to access the e-discharge system.  Staff knowingly gave their logon 
details to facilitate access when other staff had been logged out.  Other 
violations occurred because tasks were openly deemed too onerous: 
‘Work out which insulin she's on and then reduce the dose – Don’t 
bother clerking. Just find out what drugs she’s on and then reduce them.  
Get X [FY1] to check with doctor [GP] after 9.00 am the patient’s dose.  I 
don’t want the doctor to see them just confirm dose.’ 
Consultant 8, Elderly Admissions Unit, Hospital A 
‘Often the nursing homes don’t send the patients with anything as they 
have to fill out a lot of paperwork and the ambulance may be in a rush to 
take them.’ 
Pharmacy Technician 1, MAU, Hospital B 
Defences 
There were no observations which were categorised as defences for active 
failures.  
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5.4.3.2 Situational factors 
a) Individual factors 
YCFF Definition: Characteristics of the person delivering care that may 
contribute in some way to active failures. Examples of such factors include 
inexperience, stress, personality, attitudes. 
Contributory factors 
Different HCPs approached tasks associated with medicines reconciliation 
differently.  Doctors always read the notes first, whereas some pharmacy staff 
would speak to the patient first and others would read through the notes.  It was 
not always clear why the HCP chose to do things in a specific way but seemed 
to be a result of knowledge or experience that they had gained previously. 
Whilst reading the notes some looked at the medicines first whilst others look at 
the patient’s context.  One pharmacist explained their rationale: 
‘If you look at the medicines first- sometimes you get a false picture.  I 
first read through the notes to get a feel for what’s going on.’ 
     Pharmacist 12, Elderly Ward, Hospital C 
Nevertheless, all HCPs appeared to work systematically through the tasks they 
were conducting. Some were more conscientious than others for example 
ticking an item as it was cross checked.  The HCPs would also double check 
and clarify information where needed to gain a fuller picture or to confirm their 
understanding.  This happened irrespective of the task being undertaken or the 
HCP conducting the task.  For example, some doctors would double check that 
they had transcribed the IMC correctly once complete and cross the items off as 
they were re-prescribed.  Or they would count the number of items prescribed 
on the discharge prescription and check that it matched the number on the IMC.  
Some would use the patient in the checking process: 
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‘I will usually show the patient the PODs and go through each one and 
ask how they take it or whether they know how to take it.’ 
   Pharmacy Technician 1, MAU, Hospital B 
The way in which information was clarified varied depending on what required 
confirmation.  Sometimes it was a discrepancy between two sources, in which 
case this was clarified with the patient or the owner of the source, most 
commonly the general medical practice. On two occasions, information was 
verified with other hospitals, following recent inpatient stays.  Other specialties 
were sometimes contacted for information or a second opinion, often where the 
patient was already under the care of another specialty. 
Most staff had an opinion on what was the ‘best’ way to manage reconciliation 
and pointed out what to look out for when taking a medication history, some of 
these beliefs were incorrect or not evidence based, for example: 
‘I like to use more than one source.  I usually go with the most recent 
source as the accurate one’ 
    Pharmacy Technician 2, MAU, Hospital B 
‘The GP history is a better source than dossett box’  
Pharmacy Technician 5, MAU, Hospital C 
‘I usually use two sources unless it is a MAR chart. The MAR chart 
indicates what the patient has actually been taking or is administered’  
Pharmacist 7, Elderly Ward, Hospital B 
HCPs also passed comment on the ability of other groups to conduct 
medication histories, stating their inferiority and lack of accuracy.  This was 
usually the pharmacist but sometimes the doctors:  
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‘Some techs [technicians] pick up more than others, like this [medication 
not being ordered], I’ll have to order it. It takes up your time.’ 
    Pharmacist 17, Elderly Ward, Hospital D 
‘The doctors are not very good at completing where they have collected 
the information from. It is generally worse at night’ 
     Pharmacist 1, MAU, Hospital B 
 ‘The ambulance service can’t spell any drugs’ 
  Doctor 16, Specialist Registrar, A&E 
Staff were not always aware of the limitations of their knowledge or competence 
or the potential for this to lead to harm or may not have wanted to admit that 
they were unsure about medication.  On one occasion the doctor prescribed 
medication without knowing its indication: 
‘At the start of the ward round the junior doctor is interrupted by a nurse 
who has been administering medication. 
Nurse 1: The patient is adamant that they want to take these can you 
prescribe them. Cetirizine 10mg [the nurse shows the junior doctor the 
packet] and Terazosin 2mg - she's on 2 of those [shows the junior doctor 
the second packet]. 
The doctor starts to prescribe them. The consultant questions the junior 
doctor asking if she knows what they are?  She doesn't. The consultant 
gives the junior doctor a disapproving look to indicate that she should 
know what they are before prescribing them.  The consultant asks the 
nurse to check that the patient’s BP [blood pressure] is ok before it is 
administered’ 
    Field Notes, MAU, Hospital B 
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Other staff knew their limitations, for example some doctors chose to write 
notes during clerking so they did not forget details. 
On 14 occasions the HCP made an assumption about the patient or their 
medication which may or may not have been correct.  This was often about the 
number of medicines a patient was on or the ability of the patient to be able to 
recall their medication history based on age. 
 ‘She’s only young so there is no reason she won’t be able to tell me.’ 
    Pharmacy Technician 21, MAU, Hospital D 
‘This means I'm probably not going to get much from the patient’. [The 
pharmacist pointed to the patient’s age – 88] 
Pharmacist 7, Elderly Ward Hospital B 
One pharmacy technician indicates how she uses assumptions to determine 
whether she has captured an accurate medication history: 
‘I look at their age or whether they are pregnant and therefore assume 
that the patient isn't on  a lot of meds.  A 94 year old just on Simvastatin 
rings alarm bells.’ 
   Pharmacy Technician 5, MAU, Hospital C 
Other assumptions were made based on what had been documented by 
previous departments or staff (see also communication section 5.4.3.6). 
‘You can see from this one that they are on lots of varying medication 
therefore it is likely to be a clear history but no sources have been 
documented’ 
Pharmacist 1, MAU, Hospital B  
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‘It assures me if the ambulance man has written thiamine and vitamin B 
and Senna that a full medication history has been taken’ 
      D16 SP Registrar, A & E, Hospital A 
On one occasion the HCP told the researcher that there was no point in 
observing clerking as A&E had recorded that the patient was not taking 
anything.  The researcher explained that they would like to observe and 
continued to observe.  A&E had omitted four medications including one for 
hypertension and warfarin.  The HCP stated:   
‘I suppose that illustrates your point as she’s on more medication. I never 
trust what A&E write.’ 
    Doctor 51, MAU, Hospital D 
Defences 
Many of the HCPs observed had developed their own ways of working, based 
on their knowledge and previous experience which they believed helped them 
to elicit an accurate medication history.   
‘It’s quite useful to look at previous discharge notes to get an idea of the 
patient’s past history.  It’s also useful to tell you what medication people 
are on as often when patients come in they don’t bring in their medication 
and with the elderly they can be confused.’ 
Doctor 1, FY1,MAU, Hospital B 
 ‘I always ask about herbal and OTC medicines.  I went to X university 
and we had a lecture from the X unit and they stressed about the 
interactions.  Ever since then I always check.’   
Doctor 40, GP Registrar, Elderly Medical Unit, 
Hospital D 
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‘The way I work is I get all the information first before I speak to the 
patient. Different people do it differently but that’s the way I do it’.  
    Pharmacy Technician 21, MAU, Hospital D 
Doctors would try to prescribe medication as soon as possible after clerking 
before the medicines ‘got lost.’ Two doctors in A&E made sure they gave the 
patient’s own medication back to the patient so that it got transferred safely to 
the ward. This was similar for pharmacy staff.  
‘I try to write it when the dossett [MDS] is seen, as now it’s gone missing’ 
Pharmacy Technician 7, Elderly Admissions Unit, 
Hospital D 
‘I ensure medicines are put back in the patient’s bag because sometimes 
they get left and the nurses have to pod them up to the ward’ 
      Doctor 15, A&E, GP Registrar, Hospital A  
‘Sometimes tablets get left on MAU and we have to chase them.’  
Nurse 7, Elderly Ward, Hospital B 
Observation of pharmacy staff and pharmacists’ responses during observation 
showed how they act as a ‘safety net’ (or defence) in many instances.  This 
relied on the pharmacist having knowledge of individual policies and procedures 
plus working systematically and not missing any cues or vital information.  
Some pharmacy staff described getting a ‘funny feeling’ that something was 
inaccurate.  
‘I just get an inkling that something is not right, for example, if the patient 
has co-morbidities listed but are not on any medication.’ 
     Pharmacist 8, Elderly Ward, Hospital A   
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Some HCPs were more observant than others in noticing the patients’ 
surroundings.  This led to additional useful information being elicited, for 
example that the patient used an inhaler or that the patient needed their hearing 
aid to communicate. 
The HCPs were not deviating from any of the hospitals’ policies and procedures 
despite their differences in practice.  This in the main was due to lack of detail in 
the policies and the need within the policies to allow for interpretation and 
clinical judgement. 
 b) Team factors 
YCFF Definition: Any factor related to the working of different professionals 
within a group which they may be able to change to improve patient safety 
Contributory factors 
No contributory factors relating to team factors were observed. 
Defences 
There was inter and intra-hospital variation in systems which had been 
implemented to improve working and make things safer between wards, teams 
and disciplines. For example, the handover sheet for each ward varied 
depending on the information they found useful within their specialty.  Different 
disciplines and teams had also developed their own methods of communicating, 
for example some wards had a ‘master jobs list’ for their doctors contributed to 
by all the doctors.  Even then, ‘the master jobs list’ this would differ between 
wards with some annotating the ward patient handover sheet, some the bed 
board and others using a separate list. Some wards had developed aide-
memoires to help them with tasks: 
‘It’s a balance between providing enough information and not enough 
information.  Some wards have a list up of what you need to include and 
what not to include [on the discharge summary].’ 
      Doctor 3, FY1, MAU, Hospital B 
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c) Patient factors  
YCFF Definition: Those features of the patient that make caring for them more 
difficult and therefore prone to error.  These might include abnormal physiology, 
language difficulties, personality characteristics (e.g. aggressive attitude). 
Contributory factors 
Several patient factors impacted on the patient’s ability to be involved in a 
consultation with a HCP, which arguably contributed to the lack of 
contemporaneous information at reconciliation.  These included hearing 
impairment (7 patients), visual impairment (4 patients), communication 
difficulties e.g. language difficulties (8 patients), the patient’s current condition 
(2 patients) and treatment and their capacity e.g. dementia diagnosis (14 
patients). On one occasion on one of the elderly wards out of 15 beds only 
three patients were able to fully communicate.  This occasionally frustrated the 
HCPs:  
‘You should have observed the last one but there would have been no 
point as she couldn’t speak and I couldn’t take a history!’ 
   Doctor 40, Specialist Registrar, Elderly Medical Unit, 
Hospital D 
The patient might be asleep (7 patients) or unavailable (8 patients), for example 
they were away from the ward perhaps for an operation or investigation.  When 
the patient was asleep the doctors would rouse them for a discussion, whereas, 
the pharmacy staff, in the majority of cases, would leave the patient to sleep 
and return later.  In some cases the member of pharmacy staff forgot to return 
to the patient or ran out of time.  It could be argued that the patient should be 
woken.  Irrespective, it shows a difference in professional practice.  Sometimes 
it was the patient’s condition which made them drowsy or confused, especially 
where they were taking sedating medication, had severe acute infection, were 
palliative or had previously been diagnosed with a condition such as dementia. 
Where the patient was away from the ward the patient notes were taken with 
the patient including the medication chart.  In these cases, it was impossible for 
pharmacy staff to verify a medication history.  On one occasion the patient was 
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unavailable because they had already gone home and a family member was 
calling back for the medication later. This highlights the risks with patients with 
communication difficulties. Hospitalisation itself may contribute to a patient’s 
state of mind, highlighted by one pharmacist: 
‘These [renal] patients are used to being in a healthcare setting, whereas 
for some others it is the first time they have been in a hospital and we 
forget because we are so used to being here, but it can be quite daunting 
for patients.’ 
Pharmacist 19, Renal Ward, Hospital D 
One patient seemed frightened as the doctors approached her bed stating ‘I am 
Gujarati speaking’ in broken English. When the patient was upset or agitated on 
occasions it distracted the HCPs from their usual work whilst they took time out 
with the patient.  It also meant that the patient was distracted which potentially 
could affect the way they interacted with the HCP making it important to 
address the patients ideas, concerns and expectations to ensure a successful 
consultation.617 
Patients sometimes had different concerns or priorities to the HCPs: 
‘Following a long conversation with a patient who had just been informed 
by the consultant that she had had a heart attack, the consultant asked 
whether she had any questions.  The patient replied ‘Yes, will I get 
breakfast?.’ 
   Field Notes, MAU, Hospital D 
Patients’ knowledge of their medication varied.  Some patients could remember 
all their medication with strengths.  Other patients were vaguer, remembering 
some, with a few not remembering any at all, or being able to describe them but 
not remember their name.  Some patients relied on a carer to administer their 
medication, therefore, had no recollection of the medication they were taking.  
Sometimes the patient would communicate irrelevant, superfluous information 
which the HCP had to filter to make sense of what the patient was trying to 
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communicate.  Occasionally the patient would not understand the questions 
being asked: 
Doctor: Are you eating as normal?  
Patient: I haven't been for three days 
Doctor: Are you drinking as normal?  
Patient: Yes four cans a day   
Doctor 8, FY2, A&E, Hospital A 
 
Defences 
The patient, relative or carer often acted as a defence when medicine-related 
information could not be ascertained from the patient during medication history 
taking, ward rounds and medication administration (sometimes invited to do so 
by the HCP, in other cases chipping in), e.g. clarifying doses of medication, 
highlighting any medication that had been recently altered and informing staff of 
delayed or omitted medication. A relative or carer was observed to add value in 
15 consultations.  They added information which could not be drawn from 
another source, for example, the way in which the patient took their medication. 
Some patients and/or their carers raised concern during various tasks, for 
example, during the administration of medication round, which could prevent 
errors occurring where acted on by HCPs.  Others took active participation in 
decisions about their care.  Five patients informed the nurse during the 
administration round that they usually took a medication that they had not been 
given.  These included blood pressure medication, pain relief, PPIs and 
antihistamines.  One patient also informed a member of staff that they had also 
been unable to take their medication because they had no thickener to take the 
medication with.  On other occasions the patient provided information that they 
no longer took a particular medication: 
‘Patient 294 had two IMCs.  Aspirin was prescribed on the second chart.  
The nurse almost missed seeing it as she had not seen the second chart. 
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‘She administered it in a separate beaker.  As it wasn't in with the other 
medication the patient asked what it was.  The nurse responded “It's your 
aspirin.” The patient replied “Oh I don't take that it's been stopped.”  The 
nurse discarded it.  It was unclear whether she brought this to anyone’s 
attention later on to be crossed off the medication chart.’ 
Field notes, Observation of Medicines Administration, MAU, 
Hospital C 
Self-administration of medication (mainly insulin and inhalers) was promoted on 
one of the wards to maintain patient independence and to ensure that the 
patient was competent and understood their regimen when they were 
discharged.    
d) Task characteristics 
YCFF Definition: Factors related to specific patient related tasks which may 
make individuals vulnerable to error 
Contributory factors 
The task of collecting a medication history for a patient at admission to hospital 
requires gathering data from a number of sources because there is more than 
one source of primary care medication and variance in the patients’ adherence 
to treatment.  Obtaining an accurate medication history not only depends on the 
content of the source used but also the HCP’s interpretation of the information 
within the source.  This individual interpretation could be a potential basis of 
error. One pharmacist gave an example of a patient who had iron sulphate 
supplied in primary care three months previously.  Some HCPs may assume 
that the patient was no longer taking it; however, they had received four months’ 
supply.  Another example provided was of a doctor not taking notice of the date 
when the summary care record (SCR) was created, therefore using a record 
which was 3 months out of date.  Each HCP taking a medication history 
chooses the sources they wish to use.  This may lead to relevant information 
being overlooked if the wrong source is chosen.  The tasks also rely on 
accurate contemporary information. 
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Defences 
There were no observations which were categorised as defences for task 
characteristics. 
5.4.3.3  Local working conditions 
a) Lines of responsibility 
YCFF Definition: Existence of clear lines of responsibility clarifying 
accountability of staff members and delineating the job role. 
Contributory factors 
It was clear who was responsible for taking the initial medication history (doctor) 
and who was responsible for verifying the medication history.  What was less 
clear was who was responsible for documenting the alterations in medication on 
the ward round in the medical notes.  Within all hospitals tasks were delegated 
from one member of staff to other members of staff.  Most often from a more 
senior member of staff to a more junior member of staff e.g. the consultant 
delegating to the junior doctor to write in the notes or to write the discharge 
summary.  It was unclear in some cases whether the delegation was 
appropriate and whether the staff being delegated to were competent to 
undertake the tasks devolved or were clear that they had been asked. In two 
cases, in Hospital D, the doctor asked the pharmacist to take a medication 
history rather than the junior doctor.  There was sometimes a difference 
between the staff who line managed an individual HCP and those who 
supervised a HCP undertaking a specific task e.g. pre-registration pharmacy 
students. 
Defences 
There were no observations that were categorised as defences under lines of 
responsibility. 
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b) Staff workload  
YCFF Definition: Level of activity and pressures on time during a shift 
Contributory factors 
Staff workload varied from day to day and it was difficult to predict whether the 
day was going to be busy with either admissions or discharges. The admission 
wards have a constant turnover of new patients. On one day of observation the 
ward had 23 new patients out of 30 beds.  Several participants from different 
professions specified that it was easier if you were present on the ward the 
previous day as the patients were more familiar, raising the importance of the 
continuity of staff.  None of the pharmacy services ran a full complement of staff 
over the weekend, therefore a higher workload was experienced in all hospitals 
studied on Monday morning (see also management of staff and staffing levels).  
The extent of medical cover at weekends was not determined. 
Defences 
Workload was managed centrally through rotas (see management of staff and 
staffing levels) and also locally on the ward depending on the number of new 
patients, staff availability and other tasks.  Where there was more than one 
member of a discipline or team on the ward there was often a negotiation or 
delegation of which jobs each member of staff would undertake (see also Lines 
of Responsibility 5.4.3.3(a)).  One pharmacist described how a previous hospital 
he worked in managed their workload and improved their target for completing 
medicines reconciliation within 24 hours in line with the NPSA & NICE 
guidance: 
‘I worked at X [hospital] previously.  Pharmacists provided 
comprehensive ward cover between 8.00am and 7.00pm.  Sometimes 
pharmacists saw the patient before the doctor.  Patients also had 
medication dispensed on the wards.  It provided quicker turnaround of 
patients.’ 
Pharmacist 7, Elderly Ward, Hospital B 
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The principal strategy for dealing with workload observed was prioritisation.  
Consultants on the admissions wards prioritised new patients so they could be 
seen with the night staff who clerked them.  Staff also prioritised jobs deemed 
as ‘urgent’.  Discharges were usually given a high priority, still, occasionally 
other tasks needed to be prioritised instead, for example, acutely unwell 
patients.  The pharmacists also prioritised new patients (not only on the 
admission ward).  On the long stay wards there was more time to plan different 
tasks, for example, the renal team in Hospital D did not review medication every 
day because their patients usually stayed at least 72 hours if not longer: 
‘We did a big ward round yesterday and reviewed the medication so we 
won’t be looking at the charts as much today.’ 
Doctor 47, Specialist Registrar, Renal Ward, Hospital D 
In Hospitals B-D the pharmacy technicians carried bleeps (rather than just the 
pharmacists) so they could be contacted and work assigned or delegated rather 
than being left to consider their own workload.  This also assisted prioritisation.   
c) Supervision and leadership 
YCFF Definition: The availability and quality of direct and local supervision and 
leadership  
Contributory factor 
It was left to the doctors to decide when to go for lunch.  Doctors would go for 
lunch breaks together, with no staggering and often without notifying the nursing 
staff.  This left wards with no medical cover which impacted when pharmacy 
staff required a doctor to make amendments to an IMC.  Within Hospital A there 
were pharmacy technicians allocated to some wards and not to others.  The 
amount of time they spent on the ward was variable and they were still trying to 
establish the role they should undertake.  This was potentially due to lack of 
supervision and leadership with no one person taking responsibility for the role 
of the pharmacy technicians on the wards. 
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Defence 
There were no observations that were categorised as defences for supervision 
and leadership within this study. 
d) Management of staff and staffing levels 
YCFF Definition: The appropriate management and allocation of staff to ensure 
adequate skill mix and staffing levels for the volume of work.  
Contributory factors 
Pharmacists often had to cover other wards (other than their usual ward) due to 
holiday and sickness, or do ‘on-call’ taking time away from their regular ward 
commitments and diluting their input on the wards.  Pharmacy staff in all 
hospitals complained about not being able to ‘do a good job’ when they were 
covering staff shortages.  Pharmacists also experienced a high volume of 
patients to see on a Monday morning due to lack of weekend rota with no 
increased staffing levels to compensate.  At times the junior doctor ward cover 
was also lacking.  Junior doctor training was scheduled for all junior doctors at 
the same time leaving some wards with no medical cover.  As mentioned 
previously, it was left to the doctors to decide when to go for lunch, which again 
left wards with no medical cover.  This impacted when pharmacy staff required 
a doctor make amendments to an IMC and potentially also reflects a lack of 
supervision leadership and management (see section 5.4.3.3(c)). 
Defences 
There were both central and local approaches to the management of staff and 
staffing levels.  In each hospital, each HCP had a rota to indicate where they 
were working on a daily basis.  For the nurses this was done at ward level.  For 
the doctors it depended on their grade; the junior doctors being organised 
centrally and the more senior doctors within their specialty.  The pharmacy staff 
rotas were devised by the pharmacy department to ensure the service had 
some level of cover at all times.  Each ward had at least one pharmacist 
allocated to it for some part of the day.  The length of time the pharmacist spent 
on the ward varied within each hospital depending on the pharmacist’s role and 
the other duties they were expected to conduct during the day, for example, 
aseptic or dispensary slots.  Hospitals B-D all had pharmacy technicians 
206 
 
routinely allocated to the wards.  Within Hospital A there were pharmacy 
technicians allocated to some wards and not to others.  The amount of time 
they spent on the ward was variable and they were still trying to establish the 
role they should undertake.  At least one pharmacist was allocated to each 
admission ward in all hospitals; in the morning, this was sometimes doubled 
together with a pharmacy technician.  In Hospital D in the afternoon a co-
ordinating pharmacist carried a bleep for the four acute admissions wards to 
respond to any orders and processing of discharge summaries. 
In Hospital D, there was a higher number of doctors allocated to the admissions 
wards and higher grades than the other hospitals.   
Table 5.11 Staff allocation on medical admissions unit (MAU), Hospital D 
MAU Bay 1 
(8 beds) 
Bay 2 
(8 beds) 
Bay 3 
(8 beds) 
Core Trainee 
Doctors 
1 1 1 
Foundation 
Year Doctors 
1 1 1 
Qualified Nurse 1 1 1 
Healthcare 
Assistant 
1 1 1 
They had six doctors, three core trainee doctors (CTs) who were senior and 
three foundation year doctors (FYs) who were junior.  The doctors are allocated 
two per bay one junior and one senior (to 8 patients).  Each bay also has one 
qualified nurse and one healthcare assistant (HCA). Only CTs and above 
clerked the patients, compared with other hospitals where lower grade staff 
were allowed to clerk patients (see table 5.11).  Despite Hospital D having more 
allocated staff, many staff expressed how they still felt the pressure of workload: 
 ‘Monday mornings are horrendously busy seeing new admissions’ 
Pharmacist 15, Elderly Admissions Unit, Hospital D 
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‘I can’t do four things at the same time, I have to prioritise’ 
Pharmacy Technician 8, MAU, Hospital D 
 ‘At the weekend there is one doctor on call to 160 beds’ 
     Doctor 45, FY2, Elderly Ward, Hospital D 
One doctor, in Hospital C, described how different the UK staffing systems and 
skill mix were compared with US systems. He said:    
‘We never took blood - the phlebs came down.  There are no social 
issues to sort, someone else does that and Drs don't write discharges 
they just get paid to think, someone else scribes.’ 
Doctor FY1, Elderly Ward, Hospital C 
e) Equipment and supplies 
YCFF Definition: Availability and functioning of equipment and supplies 
Contributory factors 
HCPs relied on IT to undertake a number of tasks for example computers for e-
discharge, faxes for receiving information from general medical practices.  
Hospitals B-D had implemented electronic discharge systems all of which were 
different in the way they functioned.  This variation itself,  due to lack of 
familiarity, could potentially be a contributory factor to error as doctors rotate 
around the different hospitals within the region. Reliance on IT caused a 
hindrance if the systems failed as medication histories could not be completed.   
This included inability to log on, and being locked out of computer systems 
which forced staff to violate information governance policies.  Staff were still 
getting used to the new ways of working which came with the introduction of IT:  
‘In some ways it’s easier and in some ways it’s not – for example it’s 
easier to cross check with a paper version to make sure you have got all 
the medications, it is more difficult on the screen. Paper ones [discharge 
summaries] used to go missing though and you’d have to re-write them.’  
Doctor 46, GP registrar.  Elderly Ward, Hospital D 
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Variance in the completion of discharge summaries between HCPs was 
observed on both paper and electronic discharge in all hospitals, with some 
HCPs (especially the seven GP trainees) providing more information than 
others.  The electronic discharge increased the amount of information the HCP 
provided, nevertheless, it did not appear to eliminate the variance in quantity 
and quality between prescribers, for example, some would add in test results 
which they felt were relevant and others would not. 
There were mixed feelings and lack of understanding by some prescribers of 
the potential added safety of electronic discharge versus paper discharge.  
Some preferred the method, despite the increased length of time taken to 
complete the electronic discharge summary. Occasionally, discharge 
summaries were amended by hand which led to inaccuracies in the electronic 
system. Where the prescriber did not logout correctly from the computer system 
they were unable to re-access the prescribing software for 30 minutes, 
disrupting work flow and resulting in the sharing of logon details and passwords 
between prescribers. 
Understanding the e-discharge software was sometimes confusing for staff.  On 
one system, in Hospital D, the name of the person who originally wrote the 
prescription appeared against the medication, yet, when it was amended and 
changed by anyone including doctors and pharmacists their name then 
appeared which could lead to difficulties in interpreting accountability.  One 
pharmacist described the complexity of amending e-discharge summaries once 
they have been written: 
‘At the outset most pharmacists felt it took more time then it got easier 
although it still takes time.  You can’t just get the doctor to add things on 
to it, you need to send It back.  Doctors don’t always understand this 
especially when you have it open on your screen and they want to hop 
on and change it and you have to tell them to log out and log back in so 
its not on your log on.  It is better for patients on a large number of items 
like 15 meds as the doctors don’t try to squash them all on to one sheet’  
Pharmacist 17, Elderly Ward, Hospital D 
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Electronic discharge allows the hospital formulary to be embedded within the 
software to promote cost effective prescribing. However, incorporating only 
formulary medicines caused the prescribers to free type non-formulary 
medication details e.g. the name, dose, form and strength; this could lead to 
typing errors and the compounding of prescribing errors.   
Defences 
Three out of the four hospitals (B-D) employed electronic discharge summaries. 
A number of advantages and disadvantages were observed relating to 
electronic discharge summaries during the study. Electronic discharge software 
incorporated forcing functions i.e. mandatory fields, to ensure the prescriber 
completed all relevant fields on the discharge summary.  This included 
amendments and changes to medication with the reasons for change, creating 
an advantage over paper discharge and improving patient safety through better 
communication with primary care.  Safety is further improved as the electronic 
discharge summaries were always legible and could be completed at a 
computer terminal away from distractions i.e. not written during the ward round 
(although it was not always the case that the terminals were away from 
distractions).  E-discharge software also allowed discharge summaries to be 
written in advance and saved, without the risk of multiple versions existing as it 
did with the paper-based system. 
‘We try to start them and update them as we go along as it is like a 
“Journal”.  It's more suitable for an elderly ward as patients tend to hang 
around longer. When a patient has been in  a long time, trying to follow 
what has happened to them is difficult especially if they have stopped 
and started medication, for example it may say stop codeine but later on 
in the plan, it is re-started!’ 
Doctor 5, FY1, Elderly Ward, Hospital B  
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Hospital D had introduced a single access portal, various e-forms and 
databases to their intranet for easy access to information and to allow key 
performance indicators (KPIs) to be recorded.  The hospital portal allowed all 
correspondence and test results for a specific patient to be accessed through 
one logon screen, including discharge summaries and outpatient letters. This 
was observed on numerous occasions being utilised by the whole MDT. One 
consultant described it as ‘revolutionary’.   
HCPs felt that there was a greater potential for IT within the hospital especially 
electronic patient records and electronic prescribing. 
‘Electronic prescribing would make transcribing not an issue’ 
Doctor 6, FY2, Elderly Ward Hospital B 
‘Electronic notes/prescribing would be better especially for medicines as 
it could flash up interactions and tell you which cause hyperkalaemia, for 
example we had a patient last week who was on a number of medicines 
and we had to trawl through the BNF to determine if anything may have 
caused it.  One of the items was Fortisip and we couldn't determine what 
was in it’ 
Doctor 5, FY1, Elderly Ward, Hospital B 
 
5.4.3.4  Latent organisational factors 
a) Training and education  
YCFF Definition: Access to correct, timely and appropriate training both specific 
(e.g. task related) and general (e.g. organisation related) 
Contributory factors 
All HCPs observed were registered with a professional body.  The majority of 
HCPs observed had undertaken an undergraduate programme or equivalent in 
either nursing, pharmacy or medicine.  The exception was the pharmacy 
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technicians who were either ‘grandparented’h or had undertaken a pharmacy 
technician qualification (they are still registered with a professional regulatory 
body).  The extent to which medicines reconciliation was embedded into any 
HCPs programme of study was unknown.  The medical and pharmacy students 
observed during the study were all part way through their programme of study.  
They seemed to have received very little educational preparation regarding the 
importance of medicines reconciliation and how to elicit a medication history 
within their studies.  One student clarified: 
Medical Student:  You get taught nothing [about medicines history 
taking], except that you have to ask about 
medication.   
Resea rcher:   What do you get taught to say?  
Medical Student: Are you on any medication? 
We are told to structure our clerking as follows:  
Presenting Complaint 
    History of Presenting Complaint 
Past Medical History 
Drug History 
Family History 
Social History 
And that’s it! 
Final Year Medical Student, Hospital C  
                                            
h The ‘grandparenting’ arrangements for pharmacy technicians were put in place to ease the 
transition to regulation for pharmacy technicians. Up until midnight on the 30 June 2011 an 
individual with the relevant work experience and qualifications could apply to register as a 
pharmacy technician. 
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Post-qualification the HCPs gained education and training from a variety of 
places; some mandatory depending on their role e.g. GP trainee programme 
and some optional.  All the pharmacists observed had undertaken or were 
undertaking a post-graduate diploma in clinical pharmacy or had equivalent 
knowledge which was a pre-requisite to them working in hospital. 
None of the hospitals provided medicines reconciliation training to their 
pharmacists; Hospitals B-D did so for their pharmacy technicians. The training 
covered taught workshops on taking an accurate medication history and a 
competency assessment.   Hospital A had no formal medicines reconciliation 
training.  None of the hospitals provided medicines reconciliation training to their 
doctors e.g. how to take an accurate medication history or how to write a 
discharge summary.  Training for this was learned ‘on-the-job’ by trial and error, 
or with help from more senior colleagues; often the FY2s teaching the FY1s.  
This led to intra-professional variation as their knowledge was learned from 
peers. Both bad and good habits were passed on.  This was observed during 
the FY1s’ first day as a doctor on the wards and during supervision of medical 
students: 
‘It is the FY1s first day, post qualification.  They have not been shown 
how to use the e-discharge software and are navigating their way around 
it themselves.  The FY1 has been informed how to fill in the discharge 
summary from the previous FY1 who has progressed to being an FY2. 
One FY1 has been told to copy test results on to the discharge summary 
the other hasn’t’   
     Field Notes, Observation of Writing Discharge  
Prescription, Elderly Ward, Hospital B 
‘A fax is received from a general medical practice.  The medical students 
document the medication the patient is taking from the fax. The junior 
ward doctor advises the medical student to check the last issued date to 
check it has been recently issued.’ 
Field notes, Observation of Clerking Patients, 
Elderly Admissions Unit, Hospital A 
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The complexities and multiple scenarios of medicines reconciliation make it 
difficult to teach and to learn.  One pharmacy technician explained: 
‘It is difficult when learning as you can't always follow a patient from start 
to finish.  There are also lots of different scenarios which you can come 
across’ 
    Pharmacy Technician 5, MAU, Hospital C 
Training, whilst important, also interrupted the management of workload on the 
wards as the doctors had to leave the ward to attend their teaching, on one 
occasion, in Hospital A, this resulted in the consultant being left to do the ward 
round alone.  One pharmacist felt there should be re-training or re-assessment 
of competency following return to work e.g. post maternity leave or after long 
period of illness, for all tasks including medicines reconciliation. 
Defences 
All hospitals provided an induction for their staff when they started.  The extent 
to which information relating to medicines reconciliation was incorporated was 
limited.  Most provide information about prescribing, however, nothing specific 
to taking an accurate medication history. 
Pharmacy technicians were provided with training in Hospitals B-D.  This was a 
pre-requisite for working on the wards.  Within hospitals B and D there were two 
different levels of pharmacy technicians on the ward.  Those which were able to 
conduct medication histories and counselling (NHS Band 5) and others which 
provided a POD and stock checking service (NHS Band 4).  
‘Different techs [technicians] are taught to different levels.  I have had 
training on drug history training, discharge process, medicines 
reconciliation and counselling’ 
    Pharmacy Technician 1, MAU, Hospital B 
In Hospitals A and C only NHS Band 5 pharmacy technicians went on to the 
ward; their role, to take medication histories (see table 5.12). 
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Table 5.12 Level of ward pharmacy technician training 
 NHS Band 4 NHS Band 5 
Hospital Present 
on Ward 
Duties Present 
on Ward 
Duties 
A X -  Medication 
History Taking 
B  POD and Stock 
Check 
 Medication 
History Taking, 
Patient 
Counselling 
C X -  Medication 
History Taking 
D  POD and Stock 
Check 
 Medication 
History Taking, 
Patient 
Counselling 
The consultants and more experienced doctors sometimes used the ward round 
to teach their students, asking them questions and getting them to look up 
information; occasionally this would relate to medicines reconciliation e.g. 
withholding medication crossing out medication rather than crossing it off the 
IMC entirely.  One GP registrar stated: 
‘l always make students look things up. That way they remember what 
they have looked up and that they need to look things up.’ 
     Doctor 15, GP Registrar, A&E, Hospital A 
b) Support from central functions  
YCFF Definition: Availability and adequacy of central services in supporting the 
functioning of wards/units.  This might include support from Information 
Technology and Human Resources, portering services, estates or clinically 
related services such as radiology, phlebotomy or pharmacy. 
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Contributory factors 
There were no observations categorised as contributory factors within support 
from central functions.   
Defence 
The pharmacy departments themselves are central function which provide 
support to pharmacy and non-pharmacy staff regarding medicines management 
and the implementation of relevant policies and procedures (see 5.4.2.1 
section).  The pharmacy departments were responsible for any policies and 
procedures associated with medicines reconciliation, together with any training.  
c) Policies and procedures 
YCFF Definition: The existence of formal and written guidance for the 
appropriate conduct of work tasks and processes. This can also include 
situations  
Contributory factors 
All hospitals had policies and procedures in place which covered varying tasks 
associated with medicines reconciliation.  The content of the policies varied 
significantly with some containing more detail than others (see table 5.8). 
All hospitals had a medication formulary in place, however, the formulary in 
Hospitals B-D was more restricted (i.e. had fewer items), which meant that at 
admission to hospital a patient was more likely to have their medication 
switched to a medication which was therapeutically equivalent e.g. PPI.  This 
risked the medication not being switched back at discharge and being changed 
in primary care.  This is important as certain medications may not be as cost-
effective in primary care due to differences in drug pricing systems in primary 
and secondary care. 
Defences 
The policies led to standardisation of practice throughout the hospitals with 
pharmacists where possible, reconciling medication post-admission and at 
discharge.  Hospitals B-D used standardised forms to collect medication history 
information and specified that a specific coloured pen should be used by the 
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pharmacist so that it contrasted. Various other standardised practice was also in 
place for example, signing the IMC to say medicines reconciliation was 
complete or using standardised handover sheets or feedback proformas.  
Hospital D also had a standardised renal medication regimen (see also section 
5.4.2). 
d) Physical environment  
YCFF Definition: Features of the physical environment that help or hinder safe 
practice.  This refers to the layout of the unit, the fixtures and fittings and the 
level of noise, lighting, temperature etc. 
Contributory factors 
There were times when the wards felt calmer than others, the opposite being 
indicated by the HCPs running around or in the way in which they spoke e.g. 
hurriedly or calmly. There were distractions, interruptions or obstructions which 
occurred on the wards.  This was increased on the admissions wards compared 
with the other wards due to many people coming and going (both patients and 
staff).  Noise levels varied depending on the time of day and other activities 
occurring on the wards.  Noise was greatest in the morning as numerous tasks 
were being undertaken simultaneously, for example breakfast, the ward round, 
medicines administration and washing and dressing the patients. It was the time 
when most healthcare teams came on to the ward (pharmacy staff, 
physiotherapists, occupational therapists, consultants, housekeeping).   Noise 
was also greater at other mealtimes and during visiting hours.  Gaining a 
medication history during visiting times could be very difficult due to the noise 
and relatives around the bed.  Conversely it could also make things easier when 
the relative or carer was there to provide missing information. 
On three occasions men from estates departments were on the wards 
conducting maintenance which involved noisy activities such as drilling or 
hammering. Cleaning, especially the deep cleans, could at times be disruptive.  
On one ward the medical team were barricaded when they emerged from a 
cubicle as all the beds had been pushed to the centre of the room, with no route 
through.  
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Often the only place to sit to undertake tasks such as transcribing and writing 
discharge notes (electronic or paper) on the wards was at the nurses’ station 
(see table 5.13). This was also where the telephones were located and where 
the doorbell sounded. Staff tended to congregate around the nursing station 
conversing.  One doctor said: 
‘The only place to sit is at the nurses station but I get constantly 
interrupted and find it distracting with the phones.’ 
    Doctor 24, GP Registrar, Elderly Ward, Hospital A  
On one ward, in Hospital B, the computers used to complete e-discharge were 
in the staff room where people sat to eat their lunch.  On another occasion in 
Hospital A, a local TV channel were filming a news feature which was 
distracting for the doctors trying to work at the nurses station. 
Table 5.13 Summary of ward layout in each hospital 
 A B C D 
Sites for 
Discharge 
Summary 
Writing 
Nurses station 
and during 
ward round 
Nurses station 
& staff room 
Nurses station 
& staff room 
Each 
discipline has 
own 
designated 
area  
Position of 
POD 
Lockers 
Next to bed End of Bay Next to bed Varied – next 
to bed, end of 
bay, moveable 
trolley with 
separate 
drawers for 
each patient 
HCPs were interrupted during medicines reconciliation tasks by patients and 
other HCPs.  The doctors were broken off to do other jobs e.g. to attend a 
deteriorating patient, to rewrite charts and to re-cannulate patients.  These 
needed to be prioritised effectively and often the discharge summary writing had 
to wait.  The pharmacists were also interrupted to answer clinical questions, for 
example, how to administer IV medication or whether medication can be 
crushed, to ask the whereabouts of discharge medication or to order 
medication.  In the main, it was the nurses that were distracted mostly by the 
routine needs of patients during medication administration round, with patients 
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requesting blankets, to be moved, to go to the toilet or to have a cannula 
adjusted etc.  On one occasion a pharmacist was interrupted mid-task to 
interpret for a patient who only spoke Punjabi. 
On occasion tasks could not be completed, for example, when all the phones 
were being used, the line was engaged or the notes/medication chart was 
missing or the patient was unavailable or the HCP had left a message on the 
district nurses’ answer phone and was waiting for a call back.  This interrupted 
the workflow and relied on good documentation to remember where each task 
had reached. 
Overall, during the observation HCPs were interrupted a total of 13 times by 
bleeps going off in the middle of the task.  In some instances the HCP would 
break off to answer the bleep, in others the HCP would wait until they had 
finished the task they were undertaking before answering.  It was unclear how 
the HCPs decided whether they answered the bleep or not.  On one occasion 
the doctor (FY2) was in the middle of documenting information in the patient’s 
notes when he was interrupted by his bleep.  The doctor (FY2) passed the 
notes to another doctor (FY1) to continue writing.  
Two pharmacists explained that the layout of the ward could also make it 
difficult to do medicines reconciliation:  
‘It is difficult on this ward as the POD lockers are not next to the bed.  It 
means that if you want to go through the medicines with the patient then 
you have to carry them all to the bed which can be difficult if there are a 
lot of them.’ 
     Pharmacist 14, Medical Ward, Hospital B 
‘It can be difficult to find charts – you end up running backwards and 
forwards between nurses station’ 
   Pharmacist 4, Renal Ward, hospital A 
All wards had side rooms to isolate patients for example due to infection control 
risk.  These patients were often left until last during all tasks.  The pharmacy 
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staff in Hospitals A-C would not enter the side rooms unless they felt they really 
must, usually reviewing the chart from outside the door without patient 
involvement. 
Defences 
For some hospitals the layout of the ward facilitated medicines reconciliation, for 
example, where the POD locker was next to the patients bed (Hospitals A and 
C).  Hospital D had a separate place for each of the healthcare teams to sit i.e. 
doctors, nurses and pharmacists leading to fewer distractions and less struggle 
for space and equipment (see table 5.13). 
e) Scheduling and bed management 
YCFF Definition:  Adequate scheduling to manage patient throughput 
minimising delays and excessive workload 
Contributory factors 
Some wards contained ‘outliers’i, patients who were allocated to a different 
specialty ward, not always appropriate to their clinical needs, often due to a bed 
shortage on the correct specialty ward.  The patient was looked after by the 
nurses and pharmacists who worked on the ward, though the medical team 
working on the ward did not tend to the patient who was the responsibility of the 
medical team who they were admitted under.  This created problems if there 
were any errors on the medication chart as the doctors on the ward would not 
make any amendments and the doctors from the relevant specialty had to be 
bleeped to come to amend a chart.  Sometimes the bleeped doctor arrived after 
the pharmacist had left the ward therefore liaison could not occur.  
  
                                            
i Hospital inpatients who are allocated a bed on a hospital ward which is not clinically 
appropriate for their illness due to a lack of inpatient beds are commonly named ‘outliers‟, 
‘sleep-outs‟ or ‘boarders‟. 
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On 12 occasions the patient was medically fit to be discharged but were 
awaiting social care input or an appropriate placement.  
‘Some patients have been here so long there are no medical issues 
they are just waiting to be placed’ 
Pharmacist 17, Elderly Ward, Hospital D 
This time period could provide opportunity for HCPs to ensure the patient had 
been counselled appropriately on their medication and knew which medication 
had been changed.  However, this was not observed. 
Mealtimes in all hospitals were protected, which meant that patients could not 
be approached during that time.  Also all nurses were occupied serving meals.  
As pharmacy staff were sometimes scheduled to the ward 9.00am -1.00pm and 
mealtime was served between 12.00pm and 1.00pm the pharmacists’ work 
could not always be completed. 
Defences 
Hospitals counteracted bed management issues through prioritising discharges, 
employing discharge liaison nurses and trying to forward plan discharge where 
possible.  Hospital A employed discharge nurses which covered all medical 
wards, compared with Hospital D who had discharge nurses specifically 
employed for the Elderly Admissions Unit. It was unclear what happened in the 
other hospitals, however, discharges were always prioritised in all hospitals 
observed.   
5.4.3.5  Latent external factors 
a) External policy content 
YCFF Definition: Nationally driven policies/directives that impact on the level of 
quality of resources available to hospital 
Contributory factors 
Little external policy content was observed having an effect as a potential 
contributory factor to error associated with medicines reconciliation.  All 
hospitals were subject to the four hour Emergency Care Standard which added 
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pressure for A&E to clerk quickly and the wards to discharge patients in a timely 
manner.618 Hospitals also had no control over undergraduate curricula and the 
content taught to their medical, nursing or pharmacy students.  There were a 
couple of occasions when poor communication related to medicines 
reconciliation processes led to readmission within 30 days.j The first was a 
patient who was not counselled appropriately at discharge resulting in the 
patient taking double the amount of blood pressure medication: 
‘A patient was admitted to hospital with low blood pressure. When I 
reviewed (reconciled) the medication the patient brought in with them, 
there were two boxes of the same blood pressure medicine in different 
packaging. After a recent hospital admission the patient had been 
discharged with a box of the medicine but because it looked different to 
the box they received from their community pharmacy the patient thought 
they were different and had been taking them both at home. This was an 
unnecessary readmission that could have been avoided if healthcare 
professionals had communicated more effectively with the patient and 
each other.’k 
    Pharmacist 5, Elderly Admissions Unit, Hospital A 
The second, was a patient who was discharged without communicating the 
medication changes to either the patient or the community pharmacy: 
‘I had an issue a few weeks ago where a patient was discharged - They 
were a repeat dispensing patient and their medication was stopped whilst 
they were in hospital.  No-one let the community pharmacy know and 
they supplied it when she was discharged. The patient did not know it 
had been stopped either.  They were re-admitted to hospital’l   
Pharmacist 1, MAU, Hospital B 
                                            
j In April 2011 the Department of Health introduced a policy of non-payment for emergency 
readmissions within 30 days.264 
k This quote is used twice in two different contexts, once as a latent external factor and the 
second as a communication factor. 
l This quote is used twice in two different contexts, once as a latent external factor and the 
second as a communication factor. 
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Both these examples are also discussed in section 5.4.3.6 Communication 
Systems. 
Defences 
All hospitals involved in the study were influenced by external policy associated 
with medicines reconciliation, namely the NICE & NPSA Technology Appraisal 
Technical patient safety solutions for medicines reconciliation on admission of 
adults to hospital6 and the NPSA Rapid Response Report Reducing harm from 
omitted and delayed medicines in hospital.619   As the implementation of these 
alerts is mandatory, all hospitals had policies in place regarding delayed or 
omitted medicines and a list of critical medicines for which there should be no 
delay.  These contained medication such as anti-epileptic medicines and anti-
Parkinson’s medication. 
Treatment plans were influenced by national guidance, in particular NICE 
guidance.  When patients were nearing end of life care the Liverpool Care 
Pathway (LCP) was followed and all patients’ non-essential medication was 
stopped.  The hospitals also had various Commissioning for Quality and 
Innovation (CQUIN)m targets in place which impacted on medicines 
reconciliation negotiated with the Clinical Commissioning Groups (CCGs)n e.g. 
Hospital A was about to introduce a target to send changes to medication 
electronically via SystmOneo to general medical practices post-discharge.  
b) Design of equipment and supplies 
YCFF Definition:  The design of equipment and supplies to overcome physical 
and performance limitations. 
                                            
m The aim of the Commissioning for Quality and Innovation (CQUIN) framework is to support 
improvements in the quality of services and the creation of new, improved patterns of care. 
n Clinical Commissioning Groups (CCGs) are NHS organisations set up by the Health and 
Social Care Act 2012 to organise the delivery of NHS services in England. They replace some 
of the functions of primary care trusts (PCTs) which ceased to exist in April 2013.   
o SystmOne is an electronic health record (EHR) predominantly used in primary care, mainly 
general medical practices.  Its unique feature is that it allows sharing of the patient’s EHR 
between HCPs and organisations. 
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Contributory factors 
As electronic discharge was new it was not embedded into practice; staff were 
still adapting to new ways of working which may make them more prone to 
error.  Despite three hospitals using e-discharge systems there were still 
differences between processes observed, for example, different fields within the 
different software systems. 
Defences 
All e-discharge systems used forcing functions to ensure relevant fields were 
populated.  However, this only ensured the box was populated not that the 
quality of information was high. This was most likely because they were unclear 
what was useful. Hospitals had also designed their own IT solutions which 
assisted medicines reconciliation related tasks, for example, a local database 
for renal patients shared across the region and a database of community 
pharmacy and general medical practice addresses within Hospital D. 
5.4.3.6  Safety culture 
YCFF definition: Organisational values, beliefs, and practices surrounding the 
management of safety and learning from error 
Contributory factors 
The junior doctors’ rotations meant they worked in all four hospitals through 
rotating around all the hospitals in the study, yet they admitted that they did 
things differently according to the hospitals that they were in.  Sometimes the 
same task was done with less rigour between hospitals due to the combined 
effect of lack of policy and procedure in place and the more senior doctors in 
the team being seemingly less concerned with how tasks which impact on 
medicines reconciliation were conducted.   
In Hospital A, discharge summaries were written on the ward round as the 
patients were being discharged because there was an organisational drive to 
discharge the patients quickly.  The junior doctors were observed to write the 
discharge summary balanced on the top of the patient’s IMC, flicking backwards 
and forwards between the chart and discharge summary.  Rarely would they 
access the notes and then only at the end of writing the discharge note to 
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confirm the diagnosis and co-morbidities.  They were also readily subjected to 
interruptions at that time. 
On four occasions when the pharmacy team (in Hospitals B and D) were 
working in the notes they were interrupted by others for access to the notes.  
On three occasions the notes or IMC were taken away from the pharmacy team 
as they were needed by the ward round.  In all hospitals staff using the notes 
would regularly be interrupted for a patient addressograph sticker.  On one 
occasion the ambulance crew arrived to take the patient before the nurse had 
time to handover to intermediate care which was then rushed, and consequently 
little information shared. 
Defences 
A greater safety culture and organisational leadership within Hospital D was 
apparent.  The organisational demonstrably placed high value on improving 
quality and practice. This was highlighted through observation of the 
infrastructure and the way HCPs within the hospital acted.  One member of staff 
explained: 
‘Pharmacist 17:  It is important that we document things to prove our 
worth.  Many of our activities contribute towards 
KPIs and with all these job cuts in the NHS it is 
important that we show what we do.  The message 
comes down from the top. 
Researcher:   From Pharmacy? 
Pharmacist 17:  Yes, we listen to the people on the ground and what 
they want and what they feel will work for them. 
What we do is often backed up with incidents which 
support the way in which we work for example we 
had an incident a while back with warfarin.  The 
patient was admitted with an INR of 24 and had 
taken a 1, 3 and 5 mg tablet.  Luckily the pharmacist 
had recorded that she had done a level 3 review and 
counselled the patient as he [subsequently] said he 
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hadn’t been counselled.  This shows the importance 
of documentation.  You notice the team-working 
more on the acute floor especially with the MDT 
[multidisciplinary team] meetings where everyone 
attends and you have your say and they ask your 
opinion.  
[Pharmacist 17 checks next IMC]  
For example, this man hasn’t had his VTE 
prophylaxis for two days.  There was another 
incident where a patient was admitted with a PE 
[Pulmonary Embolism], when they looked through 
his notes he had missed five days prophylaxis and 
the pharmacist had checked the chart every day, so 
now we all check. 
Researcher:   It sounds like incidents influence you a lot 
Pharmacist 17:  Yes, I think it is important that we learn from 
incidents especially where pharmacy is involved.’ 
Field Notes, Observation of Verification of Medication History 
Taking, Hospital D 
This demonstrates a culture of learning and sharing from incidents, plus striving 
to improve and deliver services.  The KPIs discussed were associated with 
quality and safety, for example, the percentage of medicines reconciliation 
undertaken within 24 hours post-admission.  There was also an increased level 
of respect for each different HCP within the MDT and an understanding of each 
other’s roles and responsibilities. It was the only hospital to have a daily 
formalised MDT (although only within the elderly specialty). There was less 
hierarchical structure compared to that seen in other three hospitals within the 
study.  There was increased communication and liaison between and within the 
disciplines with everyone asking everyone else for their input into patients, for 
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example, one pharmacist rang another to hand over a complex patient who was 
prescribed clozapine (an antipsychotic) and needed a blood test.p  The walls of 
the corridors were lined with key messages and patient improvement 
campaigns, for staff and visitors to see, for example: 
‘When we all work more closely together patients will benefit from higher 
quality and less duplication and a better well rounded service’ 
‘We need to get the communication right between the community and the 
hospital so people can get the care they need at the right time’ 
One ward had been involved in testing cooked breakfasts for patients on their 
wards.  The results were clearly displayed. Although this is not directly related 
to patient safety it demonstrated their ability to use PDSA cycles plus learn and 
share their findings.  
Hospital D also had various KPIs to drive quality and had developed a computer 
programme to record and monitor these.  Plus they had introduced a single 
access portal, various e-forms and databases to their intranet for easy access 
to information and to allow these KPIs to be recorded (see also section 5.4.3.3 
(e) Equipment and Supplies).   
The staff in Hospital D understood the consequences of their actions and ‘doing 
a good job’: 
‘If I do a good job on admissions then it is much easier on the base 
wards, this hospital puts a lot of emphasis on [verifying medication 
histories] admissions.’ 
Pharmacist 16, MAU, Hospital D 
Although one pharmacist felt the high standards set a precedence for the 
amount of medicines reconciliation which should be achieved:  
                                            
p Patients who are prescribed Clozapine require routine blood monitoring to ensure the 
medication is not affecting their immune system. Clozapine is tightly controlled and patients who 
have not had a blood test are not supplied with medication.  If two days medication is missed 
the dose must be re-titrated. 
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‘I feel that all I do is medicines reconciliation rather than have clinical 
input.  We have set a standard and now we can’t go back on it.’ 
    Pharmacist 15, MAU, Hospital D 
Although the other hospitals did not demonstrate as much in the way of safety 
culture, Hospital B did have a far greater amount of standardisation throughout 
the hospital.  This was in the form of standard operating procedures and 
proformas.  This was not limited to medicines reconciliation, but extended 
throughout all their processes.  This allowed staff to work across different wards 
and be familiar with their processes and procedures. 
5.4.3.7  Communication systems 
This section presents the data concerning communication. The YCFF does not 
explore communication in great detail as the systematic review did not uncover 
evidence to underpin it.  Therefore the HCP to patient interaction i.e. the 
consultation was analysed as described in section 5.4.3.7.1. using a 
consultation analysis framework specifically relating to medicines reconciliation 
based on the COT criteria610 and essential communication skills for a 
medication history interview611 to assess the interaction between HCP and 
patient. 
5.4.3.7.1  HCP to patient interaction – the consultation 
The extent to which the patient was included in the consultation or task varied 
between HCPs. Practice between individual HCPs ranged from actively 
involving the patient on most or all occasions to talking in front of the patient to 
colleagues without inclusion.   
Consultant 1:  Is he on regular meds they seem to have been 
omitted.  He needs to be given his regular meds. 
Patient:  [to the HCPs standing around the bed] I can tell you 
what I take 
[The HCPs ignore the patient] 
Junior doctor (D2): I got the list from the GP printout.  
228 
 
Patient:   Would you like me to tell you what I take?  
[The patient is ignored again] 
Consultant 1:  Does he have his meds with him?   
[The consultant speaks over the patient] 
Nurse 2:   You mean these?  
[The nurse points to his tablets held in a first aid box 
above his POD locker] 
The junior doctor writes the patient up for regular 
medicines without clarifying with the patient.  I 
checked with the technician later and the patient had 
been able to give a full history and indicate what he 
does and does not take. 
Field Notes, Observation of Ward Round, MAU, Hospital B 
The processes were also approached differently both inter and intra- 
professionally.  Doctors were more likely to use a systems based approach to 
eliciting the patients medication history during the medical history taking 
compared with the pharmacist who would ask questions specifically relating to 
the patients medication using a wider variety of sources.  This was a direct 
result of undergraduate training.   During clerking the doctors asked questions 
regarding medication in and amongst their past medical history using questions 
which filter for information, for example: 
‘Do you suffer from Diabetes? Heart Disease? Epilepsy’ [yes] ‘And do 
you take any medication for that?’ 
   Doctor 1, FY1, MAU, Hospital B 
There were various ways in which the HCP gained rapport with the patient, 
most commonly smiling, occasionally passing comment on how well the patient 
was looking. During clerking the doctor often did not acknowledge the patients 
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passing comments if they were irrelevant which appeared to be a tactic to keep 
the patient on track and not be distracted.  Sometimes this felt cold and as if the 
HCP was uninterested.  Many of the HCPs would come down to their level, or 
sit on the bed to talk to the patient despite the latter being against hospital 
infection control policy.   
HCPs used a mixture of open and closed questioning to elicit information from 
patients, for example, ‘Do you take any medication?’ or ‘Can you tell me which 
medication you take?’ Probing was used to follow up partially answered 
questions and to clarify information.  Where closed questions were asked the 
patient sometimes answered yes/no answers and on other occasions would add 
other information; sometimes useful and sometimes not.  Occasionally HCPs 
used leading questions and interrupted the patient before they had finished. For 
example, ‘Do you take these twice a day?’ rather than ‘How often do you take 
these?’.  Overall, on six occasions, the HCP asked multiple questions, not 
allowing time for the patient to answer, for example: 
‘Have you been using your nebules more recently? Do you use them all 
year round or just in summer?’ 
Pharmacist 4, Renal Ward, Hospital A 
The elderly patients often needed more time to process the questions and 
respond.  This required the HCP to be patient and remain silent whilst the 
patient answered.  Some HCPs were better at this than others.  Information was 
never repeated back to the patient to confirm understanding and occasionally 
relevant patient information was ignored with patient concerns not addressed 
(15 occasions).   Only one doctor used the medication with the patient to try to 
prompt them to remember their medication history. This was done more 
frequently with pharmacy staff, although not routinely.  Pharmacy staff also 
often prompted the patient to remember non-oral medication by asking them 
direct questions e.g. about inhalers, eyedrops etc.  On eight occasions the HCP 
prompted the patient when they could not remember the name of their 
medication and on only two occasions this was appropriate, conversely, on the 
other occasions there were a range of options it could have been rather than 
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the one offered which may have led to the wrong medication being prescribed, 
for example: 
‘Pt 461 Has had a medication history taken.  The doses of digoxin, 
warfarin and bendroflumethiazide are missing.  Consultant 17 examines 
the patient and takes a history.  The consultant asks the patient which 
dose of digoxin they usually take.  The patient tells the consultant they do 
not know.  The consultant prompts the patient asking ‘Is it 62.5 or 125 
[micrograms]?’  The patient responds ‘125 I think?’.  Consultant 17 fails 
to offer the 250 dose as an option.  It is unclear whether the patient is 
just choosing the higher of the two dose as they know it is not 62.5 
micrograms.’ 
     Field notes, Elderly Medical Ward, Hospital D 
 
The HCPs occasionally made wrong assumptions about the ability of the patient 
to be involved (see also section 5.4.3.2 (a) Individual Factors): 
‘It is lunchtime and patient X has not had an insulin dose yet today.  The 
pharmacist rang the DN [district nurse] this morning to confirm the 
patient’s dose and left a message on the answer phone.  The DNs have 
not returned the call.  Eventually the pharmacist tried asking the patient.  
The patient knows the dose name and dose.  It was assumed he would 
not know as he has a MDS and the DN usually administers his insulin.  
This is because the patient is blind.’ 
Field Notes, Observation of Pharmacist Verification of 
Medication History, MAU, Hospital C 
There were several occasions where the HCP did not pick up on cues that the 
patient either did not understand, had concerns that needed addressing or 
offered information which may have been important. 
‘The pharmacist was counselling the patient on warfarin, however, the 
patient did not respond or acknowledge the pharmacist.  After the 
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pharmacist had been talking for a few minutes the patient said- ‘l have a 
hearing aid somewhere.’ 
Field notes, Observation of Patient Counselling, 
Elderly Admissions Unit,  Hospital A 
HCPs often did not realise that they were using terms that the patient may not 
understand for example ‘SystmOne.’   One pharmacy technician, expressed a 
need for standardisation to improve communication and understanding. 
‘Patients often do not understand what we are asking when we ask if we 
can look at their GP record as everyone asks it differently.  I think there 
should be some set phrasing so that we all ask it the same so that the 
patients will understand.’ 
    Pharmacy technician 2, Elderly Medical Unit 
Hospital A 
Several previously discussed contributory factors hindered the communication 
within a patient consultation e.g. patient factors such as confusion, dementia, 
hearing impairment (see section 5.4.3.2(c)); physical environment such as noise 
on the wards and interruptions (see section 5.4.3.2(d)). Equally some previously 
discussed defences facilitated communication within the patient consultation 
e.g. relatives or carers supporting the patient and acting as a source of 
information. 
Communicating Medication Changes to the Patient 
Communication with patients about their medication was inconsistent.  Most 
patients were not informed about changes to their medication regimen during 
their stay or at discharge.  On 51 of 138 occasions when changes were made to 
a patient’s prescription, the HCP did not clarify with the patient which 
medication had been stopped, started, changed or withheld, or they told the 
patient that some medication had been changed but did not explain which or 
why.  If the HCP communicated changes to the patient this was done verbally.  
On two occasions the lack of information provided to the patient led to serious 
error:  
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‘Patient 671 is hyperglycaemic but is not acidotic. They have been put on 
variable rate insulin.…….. The consultant explains to the FY2 to 
administer half of his long acting insulin and to remove the sliding scale.  
She also asks the FY2 to explain to the patient. The FY2 hasn’t 
understood the consultant so I [the researcher] explain, half now and half 
tonight then back to the patient’s usual dose tomorrow.  I also ask the 
consultant whether the patient has been told to use his short acting 
analogue as normal.  The consultant snaps at me ‘well he will do’.  Later 
on the nurse finds the junior doctor to explain that the patient has a CBG 
[capillary blood glucose] of 24 – this is because he hasn’t had his short 
acting insulin with his lunch.’ 
Field Notes, Observation of Ward Round, 
MAU Hospital D 
‘A patient was admitted to hospital with low blood pressure. When I 
reviewed (reconciled) the medication the patient brought in with them, 
there were two boxes of the same blood pressure medicine in different 
packaging. After a recent hospital admission the patient had been 
discharged with a box of the medicine but because it looked different to 
the box they received from their community pharmacy the patient thought 
they were different and had been taking them both at home. This was an 
unnecessary readmission that could have been avoided if healthcare 
professionals had communicated more effectively with the patient and 
each other.’q 
      Pharmacist 5, Hospital A 
On five occasions the information the HCP gave the patient was vague and 
unhelpful requiring further clarification, for example: 
Consultant to junior doctor: ‘Stop metformin. Stop 
bendroflumethiazide. Restart Losartan 
at half dose.  Continue on simvastatin.’   
                                            
q This quote is used twice in two different contexts, once as a latent external factor and the 
second as a communication factor. 
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Consultant to patient:  ‘We are going to stop some of your medicines 
and change some of the doses’ [does not 
specify which]  
   Consultant 12, MAU, Hospital C 
On one occasion it was only because the patient asked the HCP if there had 
been any changes to their medication that information was given: 
Consultant: ‘Is there anything you want to ask about your medication?’ 
Patient:  ‘Is there anything that’s changed?’ 
Consultant: ‘Yes prednisolone and omeprazole the brother to 
lansoprazole’ 
Patient: ‘What about iron?’   
Consultant: ‘We don’t need to give you that because you can have it at 
dialysis’ 
     Pharmacist 19, Renal Ward, Hospital D 
Even when it was known that a medication had been changed, the rationale 
was not always clear to the patient or a HCP other than the one that made the 
change.  Often the HCP was left to make an assumption about the alteration:  
‘Consultant 17 is unclear why the patient has had their bisoprolol 
stopped.  He then notices she has had two falls recently.  He does not 
tell or ask the patient.  He annotates his handover notes for the MDT.’ 
    Field notes, Observation of Ward Round, Hospital D 
5.4.3.7.2  HCP to HCP communication 
Intra and inter-professional communication regularly occurred between 
pharmacists, nurses and doctors (GPs, junior doctors and consultants) 
regarding medicines-related issues.  These included both verbal and written 
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communication (electronic and handwritten), at handovers, on prescription 
charts, in patient notes, on discharge summaries and observation charts.  
HCPs liaised with a variety of other specialties, most commonly palliative care 
and psychiatry but also neurology, oncology, the pain team, ophthalmology and 
specialist nurses such as tissue viability, COPD and alcohol nurse. 
Verbal communication 
All HCPs including ambulance staff, nurses, pharmacists and doctors were 
involved in relaying information about patients to other HCPs usually of the 
same profession; mainly within secondary care but occasionally to primary or 
intermediate care.r  This occurred either at the beginning or end of the shift, 
during the ward round, when a patient had been reviewed by a different team/ 
HCP or when a patient transferred care setting e.g. either to a new ward or 
intermediate care.  Nursing staff would speak to district nurses to arrange 
medication administration in the community or care homes to ensure they had 
medication supplies.  Handovers were most often verbal, although, 
occasionally, this would be written in the notes, and in Hospital B on one ward 
the nursing handover was audio recorded.   
All nurses used the SBARs approach to handover information to their nursing 
colleagues. Despite this, there was variation in the amount of detail which was 
communicated.  Some nurses and wards provided more detail about medication 
than others.  Where medication was specifically mentioned during handover it 
was usually to provide information on medication which was regarded as 
potentially dangerous e.g. insulin and warfarin, medication which was being 
used in an acute situation e.g. Intravenous (IV) antibiotics and analgesia, or 
medication with which there was an issue e.g. the patient was addicted or 
                                            
r Intermediate Care is the term used for a range of services that deliver short term care, support 
or rehabilitation to patients. It bridges the gap between hospital and home, helping patients 
recover more quickly, so they can cope in their own home, preventing either unnecessary 
admission to hospital or allowing earlier discharge to patients who are medically fit but need 
some rehabilitation. 
s SBAR (situation, background, assessment, recommendation) is a structured method for 
communicating critical information that requires immediate attention and action contributing to 
effective escalation and increased patient safety  
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needed it prescribing.  One ward confirmed which ‘when required’ medication 
had been administered during the night and another also conducted a bedside 
handover with the IMC to handover medication administered. No other 
systematic methods of verbal communication were observed. 
Written communication 
The majority of wards had a typed handover summary, all of which contained 
allergy status and some of which contained medication related information 
especially of those patients which may need monitoring e.g. insulin and 
warfarin.  On one admission ward all the handover information was noted down 
by the individuals as the ward staff felt patients did not remain on the ward long 
enough to maintain typed information up-to-date.   Other HCPs as well as 
nurses would often use the ward handover sheets as a reference source and 
annotate them when they had conducted relevant checks on the patient or to 
annotate jobs which needed doing e.g. transcribing medication chart. 
Handovers between pharmacists included more detailed reference to 
medication plus an indication of which patients had had their medication history 
verified.  For all HCPs, communication usually included documenting that a task 
had been or needed to be undertaken e.g. medication review, medicines 
reconciliation or blood monitoring, alternatively that an intervention had been 
made e.g. dose adjustment or discrepancy identified.  
Several previously discussed defences facilitated written communication 
between HCPs within secondary care and between secondary and primary 
care.  These included equipment e.g. IT and discharge boards, plus 
standardised documentation and proformas e.g. handover sheets and 
discharge summaries, individual and team factors (see sections 5.4.3.2(c) & 
5.4.3.3(d)). 
Communicating medication changes to other HCPs (Both Primary and 
Secondary Care) 
Most frequently any changes to medication were communicated to HCPs 
through written documentation; on the IMC, in the notes or on discharge 
summaries.  HCPs would check the IMC and the patient notes to determine any 
changes to treatment since they last reviewed the patient.  The extent to which 
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medication changes were documented, however, varied. HCPs reported that it 
was often difficult to know why things had been stopped, started or changed: 
‘It’s not easy to work out why things have been crossed off as it is poorly 
documented in the notes. It’s very difficult if you haven’t been on the 
ward round.’ 
D33, FY1, MAU, Hospital C 
‘It's worse when you don't know the patient - you don't know why things 
have been started or stopped’ 
Pharmacist 12, Elderly Ward, Hospital C 
Information communicated was often inconsistent, incomplete or ambiguous 
(e.g.  L – Dopa).  Frequently, changes to medication would either not be 
indicated in the patient’s notes or would lack detail such as the name or 
strength of the medication, stating, e.g. ‘increase diuretic’ or ‘decrease BP 
medication’.  Rarely was the reason for the change explicitly stated. On 
occasion the medication was temporarily omitted on purpose e.g. antiplatelet 
medication when a gastrointestinal (GI) bleed was being queried or simvastatin 
when the patient was prescribed a macrolide antibiotic.  This was recorded in 
different ways.  Sometimes it was withheld on the IMC using 6’s, other times 
being crossed off completely or only being recorded in the notes.  One 
consultant told the junior doctor: 
‘Don't cross it out completely or it will never get restarted.’ 
Consultant 1, MAU,  Hospital B 
All discharge summaries had a place to communicate changes in medication, 
yet, on occasion the HCP would complete this without referring to the notes or 
seemingly being sure that there had not been any changes.  This seemed more 
apparent in Hospital A where there was a box which the doctor signed to 
confirm that there had been no changes.  On occasion this box was left blank.  
If noticed by the pharmacist they would prompt its completion or complete it 
themselves, though it wasn’t always noticed.  The electronic discharge system 
prompted boxes to be completed using forcing functions.  
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Discharge information was routinely communicated to the GP, yet other primary 
care providers receive the information ad-hoc.  This could lead to potential error 
if relevant HCPs do not receive infomation.  One pharmacist described an error 
which had occurred through the lack of communication with a community 
pharmacist:  
‘I had an issue a few weeks ago where a patient was discharged - They 
were a repeat dispensing patient and their medication was stopped whilst 
they were in hospital.  No-one let the community pharmacy know and 
they supplied it when she was discharged. The patient did not know it 
had been stopped either.  They were re-admitted to hospital.’t   
Pharmacist 1, MAU, Hospital B 
A further incident was observed where the patient had been taking an antibiotic 
for six months which usually would have been short term.  On investigation the 
GP had accidently continued the medication following a previous admission: 
‘The pharmacist P21 is checking a discharge summary and notices a 
patient Pt 660 has been on Doxycycline BD for 6 months.  He looks back 
through the patients discharges to try and find it.  He rings the GP to 
check the indication.  The doctor cannot clarify exactly he says it was 
added following instructions on the discharge letter in May. It was on the 
patients discharge in May as medication that they had come in on and 
the patient had been told to continue it at discharge. It was not listed in 
the medications that had been stopped started or changed. The 
pharmacist explains that the patient probably came in on it  - therefore 
was discharged on it.’   
Field notes, Observation of Discharge Summary 
Verification, MAU, Hospital D 
  
                                            
t This quote is used twice in two different contexts, once using the SCOS for analysis and the 
second using the YCFF. 
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Some hospitals had standardised systems for communicating about medication 
e.g. proformas, e-discharge or specific places to leave messages for the MDT, 
which improved communication. 
The discrepancies were communicated to the prescriber in a variety of ways 
including annotating the front of the medication chart or completing a green 
communication slip and attaching it to the front of the prescription chart. 
Pharmacists in Hospitals B-D also routinely wrote in the notes acknowledging 
that something had been done or needed doing.  Pharmacists rarely wrote in 
the notes in Hopsital A.  On two occasions relevant information written in the 
notes by a pharmacist was overlooked on ward round. 
GP Registrars tended to consciously complete the discharge summaries more 
fully and provide plenty of information as they had ‘seen the difficulties at the 
other side when the patient is discharged’ and felt it ‘obstructive’ and ‘frustrating’ 
if things were documented incorrectly. 
‘I feel I write more than others.  I've seen the difficulties at the other side 
when the patient is discharged’ 
Doctor 40, GP Registrar, Elderly Ward, Hospital C 
5.4.4  Errors and discrepancies observed 
Throughout the observation various errors and unintended discrepancies (UIDs) 
were observed. (For definition, explanation and classification of UID see section 
2.3.4 and Chapter 4) They were identified during ward rounds, nurse 
administration, and pharmacist verification of the medication history.  They were 
then classified using the taxonomy described in Chapter 4.  Medication 
omission was the most frequently occurring UID (67.3%), followed by addition of 
medication to the prescription (6.4%) and strength decrease (6.4%) (see table 
5.14).  A total of 50 patients had at least one omission on their medication chart.  
The number of omissions varied from one to six omissions per patient.  The 
most common omission was inhalers followed by nutrition and blood with 
laxatives then pain relief next most common (see figure 5.5).  On four occasions 
medication was omitted from the prescription chart that was not required whilst 
the patient was in hospital, nor were they recorded elsewhere within the 
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patients notes. These included antihistamines, Zoladex® injection and 
hydroxycobalamin injection.  
Table 5.14   Number of discrepancies identified and categorised by type 
in all hospitals 
 Number Percentage 
Drug Omission 115 67.3 % 
Drug Addition 11 6.4 % 
Strength Decrease 11 6.4 % 
Therapeutic Class 
Substitution 5 2.9 % 
Strength Increase 5 2.9 % 
Other 5 2.9 % 
Difference in Timing 4 2.3 % 
Change in Brand  3 1.8 % 
Dose Increase 3 1.8 % 
Formulation/ route of 
administration 3 1.8 % 
Dose Decrease 2 1.2 % 
Frequency Increase  2 1.2 % 
Frequency Decrease 2 1.2 % 
Drug Duplication 0 0.0 % 
Total 171 100.0 % 
The majority of discrepancies observed were not seen to cause patient harm.  
One, however, led to the patient suffering an epileptic fit.  
‘The patient usually takes a combination of two antiepileptic medication,  
lamotrigine and phenytoin.   The patient was given the dose of phenytoin 
at a different time in hospital and had suffered a seizure. The consultant 
had forgotten the patient had a previous diagnosis of epilepsy and was 
considering investigations as felt was as a result of stroke.  On 
questioning the patient the consultant realised what had happened.’ 
  Field Notes, Observation of Ward Round, Renal Ward, Hospital B  
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Figure 5.5  Percentage of medications omitted from inpatient medication 
charts (IMC) within Hospitals A-D 
 
On another occasion a patient was discharged with her INR still elevated.  The 
police had to contact her to bring her back.  
There were eight occasions when either medication (two patients) or a 
medication list brought in by the patient had gone missing (six patients).  On 
three occasions it was blamed on the paramedics, three the A&E staff and twice 
the ward staff.  This mislaying of medication and lists was not unique to one 
hospital. 
Documentation from the ambulance staff and A&E notes were often unclear. On 
three occasions they were completely illegible.  Two doctors stated that they 
never trusted what A&E wrote.  On one occasion an FY2 reported that he did 
not know that tinzaparin had been administered in A&E and consequently 
administered a second dose. 
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Allergy status 
The mandatory allergy status box on the IMC had not been completed on four 
occasions.  In all these cases the allergy box was completed by the pharmacist 
(apparent from green pen).  There were nine occasions when the allergy 
recorded on the patients medication chart did not match other sources, such as, 
the GP record, and four occasions when the patient was taking medication they 
were allegedly allergic to – two of these were an allergy to a constituent part of 
the medication they were taking. For example, for one patient the GP record 
stated that the patient was allergic to timolol, yet, they were using Cosopt® 
(which contains timolol); and another allergic to paracetamol when they were 
taking co-codamol (which contains paracetamol).  The extent to which these 
were communicated to primary care were unclear.  On eleven occasions the 
reaction was not recorded. On four of these, the reaction had been completed 
by the pharmacist (again identified by green pen).   
Comparison of discrepancy rates in Chapters 4 and 5 
The discrepancy rates identified within this chapter have been compared with 
those identified in Chapter 4.  Both quantitative (Chapter 4) and qualitative 
(Chapter 5) data collection determined that omission was the highest 
discrepancy type (see table 5.15).  However, the types of medication omitted 
appeared to be different in the qualitative observational study compared with 
the quantitative survey (see figure 5.6). Inhalers remained the most commonly 
omitted medication across both quantitative and qualitative studies, although 
the percentage of laxatives, eye drops, anti-hypertensives, pain relief and 
nutritional and blood supplements all appear much higher in the qualitative 
observation (see figure 5.6).  It is unclear what the potential reasons may be. 
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Table 5.15  Comparison of the types of discrepancies determined during 
the prospective observational survey and the observational 
study.  
  Baseline Data 
Chapter 4 
Observation Data 
Chapter 5 
Drug Omission 237 57.4% 115 67.3% 
Dose Decrease 20 4.8% 2 1.2% 
Difference in timing 18 4.4% 4 2.3% 
Drug Addition 17 4.1% 11 6.4% 
Formulation/ route of 
administration 
15 3.6% 
3 1.8% 
Dose Increase 12 2.9% 3 1.8% 
Frequency Increase 7 1.7% 2 1.2% 
Other 6 1.5% 5 2.9% 
Drug Duplication 4 1.0% 0 0.0% 
Therapeutic class substitution 4 1.0% 5 2.9% 
Strength Decrease 4 1.0% 11 6.4% 
Frequency Decrease 4 1.0% 2 1.2% 
Strength Increase 2 0.5% 5 2.9% 
Change in Brand 1 0.2% 3 1.8% 
Uncategorised 62 15.0% 0 0.0% 
Total Categorised 351 85.0% 171 100.0% 
Total discrepancies 413 100.0% 171 100.0% 
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5.4.5  Researcher interventions 
As previously discussed, there were times when the researcher had to move 
from a level of moderate participation (acknowledging the patient and explaining 
the study) to active participation depending on the situation.  This included 
intervention or collaboration with a HCP if the researcher noticed something 
which may have caused potential harm to the patient.  The interventions or 
communications with patients were anonymously logged and are summarised 
below. 
In total the researcher intervened in 17 out of the 674 patient episodes.  In 
seven cases this was because the researcher knew information which the 
observed HCP did not.  This was because the same patient had been 
previously seen by the researcher, for example, on a ward round.  This 
illustrates lack of joined up approach and continuity (see also section 5.4.3.3 (b) 
Staff Workload). Clinical advice was provided, when asked, in 11 cases, for 
example, whether it was the most appropriate course of treatment; technical 
advice in five cases, for example how to complete a discharge form; and advice 
on illegible handwriting in two cases.  In several cases, the patient would be 
asked a question by the HCP being observed, however, would answer the 
question to the researcher or look for reassurance from them.   
5.5  Discussion 
5.5.1  Policy, process and practice 
The overall patient journey within each of the hospitals observed was 
fundamentally the same for medicines reconciliation, although great inter and 
intra hospital variation in the detail of the systems and the processes was 
observed. This is similar to findings by McLeod et al who found great variation 
in medication systems within hospitals in England.384 Both the organisation and 
HCPs employed differing approaches to the process of medicines reconciliation.  
All organisations had policies and procedures in place which covered different 
aspects of medicines reconciliation related tasks plus standardised 
documentation to varying degrees.  The inconsistency in approach within and 
between organisations was particularly evident within the process, 
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communication and documentation, and whilst there was some standardisation 
there was definite room for improvement.  (Standardisation is discussed further 
in section 7. 7.1). 
All tasks were conducted methodically following the models suggested by the 
IHI2 and NPC80 (collection of the medication history, verification to ensure the 
history matches what is prescribed, documentation and communication).  Yet, 
different emphasis was placed on different aspects of the process by the HCP 
dependent on their knowledge and experience. This led to the implementation 
of individual ways of working which acted as a defence against medicines 
reconciliation-related errors and/or discrepancies. The interpretation of the term 
medicines reconciliation within the hospitals varied, which is unsurprising given 
the lack of clear definition within the policies and literature.  Whichever terms 
hospitals choose to use is irrelevant as long as all staff are clear of the 
meanings and tasks which it incorporates. 
The accuracy of the medication history is reliant on the use and accurate 
interpretation of relevant and up-to-date sources.  HCPs must recognise the 
reliability of each source and the potential limitations each may have.235  It is 
well-established that this should be part of the medication history, especially 
given that approximately 60% patients in the UK take OTC or CAMs.149,258 Yet, 
only one HCP confirmed whether the patient was taking any non-prescription 
medication (OTC or CAMs). There is suggestion that potential lack of 
knowledge and unfamiliarity with CAMs may prevent important discussions 
amongst HCPs and the patient.620  No HCPs asked about illicit medication use 
except doctors in A&E where it was suspected. Nor did anyone ask specifically 
about the contraceptive pill. This is similar to findings by Collins et al who found 
that the contraceptive pill was frequently omitted in surgical patients.76 
The introduction of the NICE & NPSA guidance in 2007 placed greater 
emphasis on ensuring medicines reconciliation was conducted within 24 hours 
of admission and that there was pharmacy staff involvement.6 This external 
policy influenced all organisations, demonstrated through the conduct of audit in 
all hospitals studied.  Although hospitals were trying to achieve the 24 hour 
target, the extent to which the hospitals routinely collected the data varied.  
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Greater emphasis on meeting the 24 hour target is needed; nevertheless, the 
need for quantity should not override quality.   
5.5.2  The impact of human factors 
To err is human published in 1999 recognised that human factors are essential 
to understanding patient safety and why errors occur in the healthcare setting.11 
Since then, the emphasis on understanding human factors and human error in 
healthcare has grown and is now more common-place within the UK.  This has 
been embraced by the NPSA who also believe that understanding the role of 
human factors is vital to reducing human error and harm to patients.22  Within 
this study various factors were identified which could and did contribute to error 
associated with medicines reconciliation.  These were countered by a number 
of defences which either existed or were performed by individuals. These are 
summarised in table 5.17 and discussed below.   
Individual and Team Factors 
Whilst all organisations had policies and procedures in place, the tasks 
conducted relied on the HCPs interaction with the patient and their 
interpretation of the information they were presented with.  The reliance on a 
HCP to interpret information adds a human element which introduces 
vulnerability in the system.  The main difference in approach was observed 
between the doctors and the pharmacists; the doctors using a body-systems 
based approach and the pharmacists using a medicines-based approach.  This 
was not a lack of systematic approach by the doctors by and large, but, what 
appeared to be an ill-fitting model to elicit an accurate comprehensive 
medication history; the doctors main aim being to stabilise the patient and gain 
a diagnosis.  The differences in HCP knowledge and experience impacted on 
individual and team performance.  An individual’s way of performing a task 
develops and evolves over time through their experience.  It also reflects an 
individual’s training prior to practice.  Some staff appeared more conscientious 
and thorough, with some recognising their limitations and others being unaware 
of what they do not know (unconscious incompetence).621 This was observed 
through participants openly explaining the processes they were undertaking to 
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the researcher which they believed were correct or best practice, not always 
recognising their inadequacies. 
Unconscious incompetence comes from the conscious competence learning 
theory or matrix (see table 5.16) which describes learners or trainees 
competence journey.  It begins at stage 1 ‘unconscious incompetence’, passing 
through stages 2 and 3 ‘conscious incompetence’ and ‘conscious competence’ 
arriving at stage 4 ‘unconscious competence’. There is the potential for HCPs 
who reach stage 4 to become complacent and automated in their actions, whilst 
those who remain at stage 1 may conduct tasks without insight into potential 
issues that may contribute to error.  This is supported by Abadel and Hattab 
who found variation in the way graduates self-assess their performance in 
comparison with the way they were assessed by experts.  Those in a younger 
age group in particular overestimated their clinical skills and competency.622 
Table 5.16 Conscious Competence Learning Model623 
 Competence Incompetence 
Conscious Conscious competence 
(Stage 3) 
Conscious incompetence 
(Stage 2 
Unconscious Unconscious 
competence (Stage 4) 
Unconscious 
incompetence (Stage 1) 
Throughout the observation there was a sense that the HCPs personality 
impacted on the interaction with the patient, demonstrated through the extent to 
which the HCP developed rapport with the patient or the willingness they had to 
‘do a good job’.  Unfortunately, this could not be measured within the study as 
the SCOS and other frameworks employed did not take this into account.  Nor 
did the data recorded provide enough depth for this to be analysed.  The impact 
of personality traits on job performance has previously been cited in the 
literature and its impact on patient safety is starting to be recognised. 624,625  
Studies have also found that empathy can make clinicians appear more 
competent and that the influence of gender of the person interviewing during 
medicines reconciliation can potentially influence the outcome of medication 
history taking with differences in the information elicited depending on the same 
sex or opposite sex interviews.  This was potentially due to a different set of 
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expressive, interactive and interrogative skills.626  Lively also found that 
interviewers with a higher risk taking propensity were the most effective at 
medication history interviews.627  
Occasionally, two types of assumption were seen within this study. The first 
stereotyping and the assumption the patient would or would not be able to 
participate or provide information; the second assumption due to lack of clear 
communication either written or verbal. In 1620, Francis Bacon proposed that 
the human mind assumes order and regularity to function daily.628 This maybe 
goes someway to explain the number of assumptions made by staff.  It can, 
however, be potentially dangerous as not all cases will fit the assumption.  It is 
therefore important that HCPs have an awareness of the assumptions they 
make.  Assumption is cited as a cause of error and potential harm.629 The 
medicines reconciliation process is complex and relies on staff working 
systematically, interpreting information correctly, and not missing any cues or 
vital information.  Due to the complexity of the process and the lack of 
embedded defences it is unsurprising that error and discrepancies occur. 
Teams and groups of HCPs such as doctors, nurses and pharmacists can 
exhibit different values, beliefs, attitudes, customs and behaviours630 which can 
manifest in ‘turfism’u or working within ‘silos’.v  Inter-professional collaboration 
has become increasingly necessary631 and is especially required in terms of 
medicines reconciliation as aspects of the medicines reconciliation process are 
managed by several professions throughout the patient’s journey. On occasion, 
more so within hospitals A-C there was a sense of ‘turfism’ and territoriality 
between wards and professions, especially towards A&E and ambulance staff. 
Barriers between professions need to be broken down to increase inter-
professional collaboration. 
 
 
                                            
u Turfism – Also known as territoriality 
v Silo – To work in isolation from others 
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Patient Factors and Patient Involvement 
Training and Education 
Within this study only the pharmacy technicians had received training on how to 
take an accurate medication history.  It is important that all staff involved in 
medicines related tasks understand the impact that it may have on reconciling 
medication, plus an awareness of the knock-on effects lack of communication 
can have on error and patient safety. This could be achieved through 
multidisciplinary training and education at both undergraduate and postgraduate 
level.  Successful interventions within undergraduate programmes which 
specifically focus on medicines reconciliation have been implemented in the US 
and have led to improvements in confidence, knowledge and skills.93,96,328  In 
the UK, The British Pharmacological Society have identified learning outcomes 
which should be incorporated into the undergraduate medical prescribing 
curriculum; many associated with medicines reconciliation.338   The extent to 
which these have been embedded and/or adopted into the medical curriculum, 
though, is unclear.  Training and education, however, are not always the 
solution to bad practice (This is discussed further in section 7.10).21   
IT 
Electronic discharge has many positive aspects, yet still it creates a number of 
further issues which need addressing, some of which are due to the software 
itself. Others can be attributed to the way in which IT is used by individuals, thus 
highlighting the need for standardisation and training.  Further work must be 
conducted to evaluate the role of IT within medicines reconciliation especially 
electronic discharge communication.  Three of the hospitals had access to 
primary care records (through SystmOne and SCR). These have been shown to 
facilitate medicines reconciliation.235 Nevertheless, like any sources these need 
to be interpreted correctly.  SystmOne was contemporary, however, the extent 
to which the SCR was up to date varied (in some cases up to three months old) 
which could potentially introduce error. 
Safety Culture 
Developing a culture of safety is key to improving patient safety and quality 
within the healthcare setting.11  The NPSA explains that safety culture is 
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achieved when staff within an organisation have a constant and active 
awareness of the potential for things to go wrong. Both the staff and the 
organisation are able to acknowledge mistakes, learn from them, and take 
action to put things right.22  It arises from a shared set of values, beliefs and 
norms related to patient safety.  A review by Weaver et al found that 
interventions to improve safety culture differed, however, often included team 
training, team communication tools, executive walk roundsw and 
interdisciplinary roundingx, some of which were seen in Hospitals B-D (but not 
all).632  The YCFF framework used, like communication, did not expand on 
safety culture nor explore its potential contributory components or ways of 
identifying safety culture within an organisation.  Further work is needed, 
potentially using markers of high reliability organisations to measure the safety 
culture. It is difficult to observe safety culture through tangible measures, 
therefore triangulation of observation with other methods such as interviewing, 
focus groups and questionnaires to elicit individual beliefs and values may be 
more appropriate.  (Safety culture is discussed further in section 7.9.) 
5.5.3  Communication 
The communication observed could be divided into that which occurred 
between HCPs and that which occurred between the HCP and the patient, 
including both verbal and written.  The appropriate use of open and closed-
ended questions in relevant context is important during information gathering.  
Open ended questions allow the respondent to express themselves freely 
provided they feel comfortable, resulting in a larger wealth of information.  
Closed questions provide information which lacks depth and variety.  There is 
greater chance of bias if closed questions are used as they may force the 
patient down a certain path and can condition the respondents thinking. 
Therefore, it may not reflect their true feelings. Multiple questions can be 
misleading and make it difficult to know which the patient has answered.  
  
                                            
w Visits by hospital executives to patient care areas to discuss patient safety issues with 
providers 
x The planning and evaluation of patient care with health professionals from a variety of other 
health disciplines 
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Communication regarding medicines-related issues was variable.  Consistency 
and understanding of information communicated could be improved through 
greater standardisation of procedures and documentation e.g. IT systems with 
forcing functions for mandatory fields, although this can potentially lead to 
assumption that the IT will act as a ‘safety net’.633 In addition to system 
changes, HCPs need to understand how the next person in the medicines 
management pathway is affected by the completeness and quality (or 
otherwise) of information provided and how error can contribute to preventable 
harm.  Where possible, patients should be given the opportunity for increased 
involvement in discussions regarding changes to their medication regimens to 
help to improve medicines optimisation.45  Feedback to primary care was 
lacking especially regarding the patient’s non-compliance and incorrect allergy 
status, preventing issues being addressed once the patient returns to their 
usual place of residence. 
The communication frameworks used for analysing the HCP-patient 
communication provide a useful model for teaching and observing medicines 
reconciliation interaction, although it does not examine the content of the 
consultation, just how it occurs.  To analyse the interaction fully the 
communication frameworks must be used in conjunction with a further 
framework which also explores the content of the consultation.  There is 
potential to combine the medication history taking section of the SCOS with the 
medicines reconciliation consultation framework to provide a comprehensive 
tool for analysis of the medicines reconciliation consultation. (This is discussed 
further in section 7.11) 
5.5.4  Error and discrepancy 
Similar to other studies omission was seen as the most frequent discrepancy 
during this part of the study and matches findings from Chapter 4 and in the 
literature. 77,109,125,145,166,171-183,201  No errors or discrepancies were seen to 
cause harm to the patient. Several, however, resulted in an ADE. It is surprising 
given the number of discrepancies and current practice that more events do not 
result in patient harm.  This has been recognised by Boockvar who looked at 
the number of ADEs occurring from medication discrepancies. He determined 
that of 1350 discrepancies, only 65 (4.8%) resulted in ADEs.159 
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The verification of allergy status is integral to the medication history taking, to 
determine the appropriateness of subsequent medication.  This sometimes 
lacked description of the reaction and was not always verified by the 
pharmacists.  Where it was, the information often conflicted with medication 
already prescribed.  This mirrors international studies which show that often the 
allergy is not described appropriately in both adults634 and children.635  As with 
any conflicting information source it is important that this is fed back to the 
source owner, in many cases the general medical practice, to resolve such 
discrepancies (see also communication).   
Outliers 
‘Outliers’ were more likely to have an unresolved discrepancy or have to wait 
longer for a discrepancy to be resolved.  The doctors on the outlying ward 
refused to make alterations to the patient’s treatment and the doctors from the 
patient’s admitting specialty had to be contacted to amend a chart.  There is 
little evidence looking at the increased risks associated with staying on an 
inappropriate ward whilst in hospital, however, previous work has determined 
that outliers are disadvantaged as they usually receive worse management517 
and less timely and thorough medical review.636  Goulding found that outliers 
doubled in the winter months and were more common in medical and elderly 
specialties.636 Within Goulding’s study outliers were also usually significantly 
older than other inpatients and would endure a significantly longer hospital stay 
and an increased number of internal transfers.636  This was not observed in 
within this study.  It was often the most challenging and unpopular patients 
including those that suffer confusion or dementia.636  It can be difficult to obtain 
a medication history for these patients, without the complication of them also 
residing on an inappropriate ward. Older patients, and those having longer 
stays in hospital, have been shown in some studies to be more likely to 
experience a medication discrepancy, potentially increasing the risk further if 
they are also an outlier.111,126,173,180,189,212  
5.5.5  Frameworks  
The SCOS provided a useful framework through which to measure the quality of 
current practice.  The SCOS was limited in that it did not contain sections on 
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nurse administration of medication or ward round.  For future use, these could 
could be added based on findings from this study, including standards to ensure 
where medication discrepancies are identified during administration of 
medication they are flagged to a relevant HCP and during ward round that 
medication which is stopped, started, altered or withheld is appropriately 
documented in the notes and communicated effectively to patients and other 
HCPs, including primary care and the community pharmacy.    Adaptation of 
this framework could be used to provide recommendations and as an audit tool 
to aid improvement.  (This will be discussed further in section 7.10.)  
The YCFF provided a framework to categorise contributory factors which may 
lead to medicines reconciliation error. This work also provided the first 
opportunity to test the framework in an observational study within a clinical 
setting.  It identified contributory factors which could and did lead to error in 
medication information gathered.  Defences observed could also be categorised 
using the contributory factors framework. Through identifying contributory 
factors and defences, potential solutions and interventions can be implemented 
to improve the accuracy of information.   It did not necessarily follow that a 
defence which counteracted a particular contributory factor would fall under the 
same heading, for example, lack of completion of a form may have been an 
active failure or individual factor, yet, a counteracting defence may be an IT 
solution with forcing functions i.e. design of equipment and supplies. 
An observed practice may appear to be both a contributory factor or a defence 
depending on its context.  For example, isolating a patient in a side room may 
be an infection control defence, however, it may be a contributory factor which 
leads to poor communication with the patient.  For example patients who were 
staying in side rooms were often left until last on the ward round as the HCPs 
had to wear personal protective equipment (PPE) such as aprons and gloves to 
enter the room. These patients were often then rushed and not all HCPs chose 
to enter the room to communicate with the patient because of the extra infection 
control barriers needed. There is often overlap between those elements 
considered to be communication factors or culture, and other contributory 
factors.  On many occasions, communication or safety culture (according to the 
YCFF) appear to be secondary to other underlying factors e.g. a health care 
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professional not completing the discharge summary in full may be due to an 
underlying contributory factor of lack of equipment e.g. inaccessible IT or a lack 
of leadership which results in poor safety culture may be down to individual 
factors. This results in a communication factor or safety culture factor but 
communication or culture cannot be confidently isolated as an original causal 
factor.  There is interdependency between the factors on the YCFF. In order for 
a process to be robust all the potential contributory factors must be considered.  
One might argue that the most robust system has fully engaged staff therefore if 
staff (and patients) fail to engage with the system appropriately, there is a clear 
potential for error. Staff engagement is one of the aims of high reliability 
organisations (HRO).y  These will be discussed further in section 7.9. 
Communication was analysed separately due to lack of expansion of the YCFF 
using consultation models.  Both of which have previously been used in the 
analysis of observation and which were directly applicable to medicines 
reconciliation.  
5.5.6  Strengths and limitations of Study 2  
As the strengths and limitations of the observational work are pertinent to both 
primary and secondary care data collection these will be addressed in Chapter 
6 (section 6.5.6), unless specific to secondary care.  These will now be 
discussed. 
Researcher intervention 
The researcher intervened on a number of occasions, to act in the best interests 
of the patient. This potentially affected some of the data, however, gives a 
useful insight and raises questions regarding what would have happened if the 
researcher was absent.  Many interventions occurred because the researcher 
was present during both the ward round and the verification of medication 
history which incidentally supports the argument for having pharmacists present 
on ward rounds.74 The researcher needed to maintain a balance between 
                                            
y An organisation that has succeeded in avoiding catastrophes in an environment where normal 
accidents can be expected due to risk factors and complexity. 
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remaining a neutral observer and gaining rapport.  This was achieved through 
courteous acts such as pulling the curtain round a patient’s bed, saying ‘hello’ to 
the patients, passing items when asked and relaying messages  e.g. if a patient 
needed to go to the toilet. The researcher also engaged in answering clinical 
queries if posed by HCPs, as again it was in the best interest of the patient but 
also maintained rapport.  The researcher additionally ensured the correct 
demeanour and appearance, as well as adhering to any hospital policies e.g. 
infection control and dress policy. 
Co-rating 
Using a mixture of pharmacists to co-rate the data could potentially introduce 
disciplinary bias.  Yet, the employment of a pharmacist demonstrated the 
importance of using someone who understands the medicines reconciliation 
process, whilst the health psychologist had a broader understanding of human 
factors.  This potentially demonstrates the importance of a MDT in application of 
the YCFF especially the involvement of clinicians.  An inherent weakness of 
applying the YCFF to observation is that not all of the contributory factors are as 
easily observable as others e.g. It is difficult to observe whether something is an 
active failure, however, others are more easily measurable e.g. the environment 
or layout of the ward. Medicines reconciliation is an objective process bound in 
social interaction and behaviours, therefore a combination for example, 
observation with follow up interviews, may be appropriate.  Think 
aloud/cognitive techniques may be a different option although this would 
decrease the spontaneity and flow of the HCPs actions.   However the 
documentary analysis did provide further insight into what the organisations 
intended the process to be. This may have accounted for some of the low 
Kappa co-efficients. 
Some argue that secondary analysis of data loses the original researcher’s 
connectedness with the data and other coders are unlikely to interpret the 
nuances in the data in the same way as someone who has directly experienced 
the field.564  Nevertheless, on balance it was felt that the increased inter-rater 
reliability and decreased interpretation would outweigh the above, to ensure that 
the researcher did not place more emphasis on certain aspects than others.  
Also, the most effective application of the YCFF as a data analysis tool 
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demanded that the person observing also carried out the analysis so that the 
context of the observation was understood.  This was demonstrated within the 
study as the co-raters asked for more context in certain circumstances to be 
able to categorise the data.  For example the co-raters asked for more detail 
regarding the isolation of patients in side rooms, the junior doctors writing in the 
notes and the patient having more than one IMC. 
 
5.6   Conclusion of Study 2 
This chapter has identified the key stages and roles of HCPs within the 
medicines reconciliation process, identifying where current practice lacks 
quality.  The medicines reconciliation within the hospitals observed was 
inconsistent and relied heavily on individual interpretation of information with 
lack of cultural driver and no real standard approach. Communication from 
HCPs to other HCPs and HCPs to patients was unreliable and often lacked 
essential detail.  This included varying provision of information to primary care.  
From the observations it was unclear how communication to primary care was 
being received in practice.  The next chapter will explore the receipt of 
information in primary care. 
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CHAPTER 6 STUDY 3: FINDINGS FROM PRIMARY CARE 
OBSERVATION 
 
Previous chapters have focused on secondary care.  They have identified the 
scale of medicines reconciliation issues at admission (Chapter 4) and described 
secondary care processes and HCP roles within the process (Chapter 5).  This 
chapter explored the receipt and management of medication-related information 
within general practice.  It looked at those members of general practice staff 
involved and how they interpret and process the information. 
6.1 Introduction 
Chapter 2 highlighted the difficulties which occur with medication post-discharge 
with the receipt, reconciliation and processing of medication information within 
primary care.  There is often lack of clarity whether discrepancies post-
discharge are a result of error on discharge or inaccurate medication history 
taking at admission. If the GP EHR (used as a source) is inaccurate, it can lead 
to an inaccurate medication history at admission.  The inaccuracies will still be 
present at discharge.  This demonstrates the spiral nature of medicines 
reconciliation and the inter-dependence of subsequent stages on the accuracy 
of previous stages. Unintentional changes made with medication, especially 
dose instructions, omissions and additions, occur in supplies obtained post-
discharge,379,637 with medication being accidently discontinued or added in 
primary care, especially where the repeat medication list on the GP system is 
not updated appropriately.379,430  Despite most of the evidence on poor 
communication at discharge being over 15 years old, there is little to suggest 
that it has changed.  This is supported by a systematic review by Bayoumi et al 
from 2009 who concluded that there was no good quality evidence 
demonstrating effective medicines reconciliation interventions in primary care434 
and that further studies looking at this area were needed. The continuing 
problem and lack of evidence make a clear case for empirical study and in turn 
this next part of the thesis. 
In common with the observational study in secondary care, this chapter uses an 
evidence-informed observation schedule but for primary care (Primary Care 
Observation Schedule [PCOS]) through which to observe and analyse the 
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processing of correspondence from secondary care.  The processing of 
discharge summaries within general medical practices is examined to identify 
good practice and any issues which arise, to determine areas where 
intervention may be appropriate.  It uses the information processing model by 
Crowe et al as a template on which to base the PCOS, which in turn was then 
used as a framework to analyse the results.429  This involves six stages: receipt 
of information, dissemination, amendment of records, reading and effecting 
recommendations, scanning information and informing the patient (see figure 
6.1).  
 
Figure 6.1 Information Processing Model429 (reprinted with kind permission) 
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6.2  Aims and Objectives 
The aim of this chapter was to examine the current medicines reconciliation 
practice within primary care together with the role of HCPs, administrative staff 
and patients within the process. The specific objectives: 
 To review the systems of reconciling medication within general medical 
practices in primary care. 
 To determine the roles of primary care staff with respect to medicines 
reconciliation. 
 To identify any practice which may lead to error and compromise patient 
safety. 
 To identify any practice and solutions which enhance patient safety 
related to medicines reconciliation in general practice. 
6.3  Method 
6.3.1  Overview 
The methods used within this part of the study were similar to those in Chapter 
5; a deductive framework plus inductive observation were combined to 
determine current systems within general practice associated with medicines 
reconciliation.  The same rationale for using observational methods in the 
secondary care observation applied to this part of the study, including lack of 
previous qualitative evidence in this area plus a need to establish the context of 
reconciliation. The methods described here are based on the methodological 
theory described in Chapter 3.   
6.3.2  Access to general medical practices and recruitment of staff 
A letter including information about the study and consent information was sent 
to all general medical practices within one PCT area to ask them to participate 
in the study (see Appendix M). The PCT was served by all the hospitals which 
participated in the previous parts of the study (seen in Chapters 4 and 5).  Study 
information was also placed in the PCT newsletter and emailed to key people 
for dissemination, for example, the Medical Director, Deputy Medical Director, 
and general managers to circulate amongst relevant groups. Following each 
practice’s agreement to participate, a date was arranged for observation and 
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they were asked to send their relevant protocols relating to medicines 
reconciliation to the researcher prior to the practice visit. Consent information 
was sent in advance for participants to read and ask any questions.  At the 
practice, staff were recruited for observation based on their job roles i.e. if they 
usually conducted an aspect of medicines reconciliation as part of their role, 
and if they were willing to participate. The staff were identified through a 
conversation with the practice manager on arrival at the practice.  The study 
was explained to the participant and written consent obtained.  
6.3.3  Ethical considerations in Study 3 
Ethics approval was gained via the LREC and relevant R&D departments as 
described in Chapter 3 (see Section 3.9 Ethical Considerations).  The same 
ethical principles regarding the observation of participants are relevant within 
this section of the study as those outlined in Chapter 5. 
6.3.4  Development of primary care observation schedule (PCOS) 
The reviewed literature described in Chapter 2 was used to develop an 
evidence-informed PCOS of good practice for processing medicines related 
information within primary care (see Appendix N) , using the same approach as 
for the Secondary Care Observation Schedule (see section 5.3.4).  The PCOS 
is divided into two sections: 
 Part A looks at practice details including policies and procedures, 
education and training and audit 
 Part B covers observations of processing information about medication, 
including receipt, dissemination, review, amendment, scanning, informing 
the patient and repeat prescribing through observing the relevant 
members of staff. 
Each section was further divided into criteria which should be met according to 
the literature e.g. where there is uncertainty information must be clarified.  The 
participating organisations were asked for any policies, guidelines, protocols or 
documents that related to the way in which information was processed following 
discharge.  This may include opening post, processing repeat prescriptions, 
scanning information etc.  These were emailed in advance to the researcher.   
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This structured approach allowed systematic collection of data, and increased 
the consistency of approach within practices. Where organisations had policies 
and documents in place associated with medicines reconciliation, these were 
obtained prior to observation and the content compared with the evidence 
based PCOS. Where a practice’s written policy and/or protocols include 
relevant items not already included in the PCOS these were added.  Due to the 
limited amount of evidence on medicines reconciliation within primary care, this 
part of the study tested the observation schedules in practice, serving as a 
small scale observational study, hence these forms were not piloted in advance 
of entering the practices.  
6.3.5  Data collection 
Criteria included in the PCOS were marked as met, not met or partially met.  
Other identified practices, plus answers to questions which clarified practice 
were noted during the observation.  The researcher determined the most 
relevant person within the general medical practice to assist with answering 
information on the demographics of the practice and the most appropriate 
people to observe with assistance from the practice manager or administrative 
staff managers.  The study was explained to the HCP or administrative staff 
member and consent obtained.  The participant was observed and the PCOS 
annotated as appropriate.  Where further observations were made which fell 
outside the PCOS, notes were made within the comments box or on the reverse 
of the framework, ensuring the corresponding criterion number was written by 
the side of any comments.  During observation the researcher asked non-
leading questions to clarify and document the process accurately.  The length of 
observation varied from 30 minutes per person in practices where several 
members of staff were involved in the process to four hours where one person 
processed all the information.  Observations were conducted on weekdays 
during September, October and November 2011.  This is a busy time of year for 
admissions to hospital, due to winter pressures, thus providing the potential for 
increased intervention of processing information post-discharge.638  The same 
researcher was used throughout the study to eliminate inter-operator variability. 
No patient identifiable data were recorded during the observations. 
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6.3.6 Data analysis 
There is a small amount of evidence within primary care that looks at the 
processing of information, which allowed the development of the PCOS, thus 
allowing framework analysis to be used for the majority of data produced.  
There is less evidence highlighting the difficulties with interpreting and reviewing 
secondary care correspondence, therefore where relevant observations fell 
outside the framework thematic analysis was used to interpret the data.  
Observation was conducted until the research reached theoretical saturation 
when the data confirmed the analysis rather than provide any new 
information.559   
6.4  Results 
6.4.1  Demographics of general medical practices 
Eight out of 88 general medical practices within one PCT in the health economy 
being studied agreed to participate. Two practices subsequently withdrew due 
to limited staff capacity, leaving six (Practices A-F).  Their practice populations 
ranged from approximately 3500 to 24,750 patients per practice and they were 
served by all four hospitals involved in the study to varying degrees 
(predominantly Hospitals A and C with some correspondence from B and D) 
(see table 6.1). Due to the number of employees in Practice C it had its own 
human resources and finance department.  The length of time the staff had 
worked at the practice ranged from two to 24 years.  The majority of participants 
were administrative staff with some GPs and pharmacists involved (see table 
6.2). 
6.4.2  Policy 
Each practice had general policiesz or protocolsaa in place for dealing with all 
communication received.  The processes conducted within each practice 
matched all the policies that were in place, however, the majority of documents 
                                            
z Policy - A statement of intent by an organisation to follow a particular course of action. 
aa Protocol - The accepted or established code of procedure or behaviour in any group, 
organisation, or situation 
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lacked content.  The policies varied in style, content and layout with some being 
more comprehensive than others and two including a visual flow diagram (see 
table 6.3).  The number of pages per protocol varied from one to six sides of A4.   
None were structured in the same way and all chose to focus on different 
aspects of the process.   
Table 6.1 Practice Demographics 
Practice Total 
Number 
of Hours 
Observed 
Number of 
Registered 
Patients 
Number of 
GPs 
employed 
(WTE)* 
Number of 
Hours 
Practice 
Pharmacist 
Employed 
per Week 
Number of 
Branch 
Surgeries 
Hospitals 
Liaised 
with 
A 6.0 6495 5.4 4 0 ABD 
B 5.5 7122 5.5 4 0 ABD 
C 6.5 24748 15.9 4 3 ABCD 
D 6.0 10833 8.1 4 0 ABD 
E 7.0 12137 10.8 4 1 ABD 
F 5.5 3508 2.0 4 0 ABCD 
*Whole time equivalent 
 
Table 6.2 Number of participants in study categorised by role 
Role Number of Participants 
GP 4 
Pharmacist 2 
Administrative staff 14 
Total 20 
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Within the policy three included step-by-step instructions on how to process 
information focusing predominantly on how to navigate the computer system.  
The other three provided a general overview of what happened with incoming 
information.  Three specifically mentioned the processing of discharge 
information and only one medication, the others focusing on the processing of 
incoming mail in general. None specifically included details on how medication 
information is processed.  Three protocols briefly mentioned who conducted 
which stage of the process but did not specifically state who could and could not 
process information about medication.  No policies were available on how 
information on medication is provided to other HCPs when requested e.g. on 
admission to hospital.  All practices had repeat prescribing policies in place due 
to a previous PCT KPIs.  The repeat prescribing policies described the roles 
and responsibilities of those involved in the repeat prescribing process e.g. 
prescriber, receptionist, pharmacy staff with reference to which members of 
staff can initiate or authorise medication within the practice.  The repeat 
prescribing policies had a date approved and review date with an appropriate 
review period, however, none of the other policies received contained this.  
There was no documentation which indicated whether staff had read the 
policies or whether they would adhere to the content. 
6.4.3  Training on medicines reconciliation related processes 
None of the practices specifically provided training for their staff on medicines 
reconciliation or processing of discharge information.  The participants 
described having completed ‘on-the-job’ training through shadowing others.  
Several staff had been on training courses regarding medical terminology, and 
summarising notes especially where it was deemed that this was required by 
their role.   
6.4.4  Audit  
Three practices had conducted an audit of their processes; two looking at the 
number of discharge summaries processed and the timescales, the third a more 
detailed audit looking at the error rates on discharge information.  No other 
aspects had been audited. 
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6.4.5  Receipt of information 
Each practice received information from a range of different healthcare 
organisations.  All practices received information from secondary care hospitals, 
in the form of discharge advice summaries and also outpatient or consultant 
letters.  Four reported receiving information from the community pharmacy, this 
was usually MUR forms and repeat prescription requests.  Practices would 
occasionally receive discharge information and repeat prescribing requests from 
the patient or representative e.g. relative, care home, in advance of the 
discharge advice summary being received by the hospital.  All practices 
reported that the patient would have a carbon copy of the discharge advice 
summary, which was often illegible as it was the last carbon copy of a 
quadruplicate. Practices sometimes received information regarding patients 
who were not registered at their practice and one practice stated that on two 
occasions the hospital had asked a patient to deliver someone else’s discharge 
summary to the practice because they were registered at the same practice, 
potentially raising data confidentiality issues. As well as information from the 
hospital, information was also received by other care providers such as tertiary 
care, mental health, or specialist screening services. 
 
The information was predominantly received via post (hard copy) twice daily.  
The amount of post received per day varied from approximately 30 items in the 
smallest practice (F), to 300 in the largest practice (C). Approximately half to 
two-thirds of these were discharge summaries.  From some specialty areas, 
however, e.g. diabetic retinal screening, A&E attendance and information from 
Women and Children’s services was received electronically.  As this was new, 
practices were cross-referencing the electronic with paper copies to ensure all 
information was received; ultimately the aim was to be paperless once 
secondary care was satisfied that the system was working.   Very occasionally a 
faxed discharge summary or letter were received.  The faxes varied in legibility. 
In all practices, the information was received by administrative staff and the 
paper-based letters opened and date stamped.  Processes within practices 
varied and often depended on the size of the practice and the amount of mail 
received.  Post contained information related to a variety of different clinical 
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issues not just relating to medication e.g. discharge summaries, letters, 
radiology reports, blood results, diabetic retinopathy and cytology reports.  
Three practices sorted their post into piles of similar sorts. These were all 
processed as a bundle of all the same type.  In one practice where photocopies, 
faxes and carbon copies were received they were kept on one side until the 
original is received then cross-referenced.  A practice may receive information 
from more than one healthcare organisation for each of their patients, especially 
where they had been referred to tertiary care or for specialist screening e.g. 
echocardiogram (ECGs) and bowel cancer screening.  The layout of the 
discharge summaries observed varied from all four hospitals.  The mental 
health discharge summary did not have anything to indicate whether any 
changes had been made to medication. 
The largest practice (C), which had four branch surgeries, acted as a ‘head 
office’ for their other branch surgeries, processing all of their information and 
booking their appointments over the phone. The administrative service ran in a 
similar way to a call centre and processing unit.   
The length of time between the episode of care and the information arriving at 
the practice varied.  A&E attendance was usually received within 24 hours.  
Practices reported receiving discharge summaries within a couple of days post 
discharge with follow up letters taking four to six weeks depending on factors 
including the workload and efficiency of the consultant and secretary, or 
whether the consultant is on annual leave.  On two occasions (out of 333) 
discharge summaries were observed arriving 10 days post-discharge.  The 
practices sometimes relied on the follow up letters to clarify issues in the 
discharge summary, however, these were not routinely linked or compared on 
arrival.  Occasionally duplications were received in the post.  Practice A 
described compiling a ‘flak’ list and ‘task’ list. A ‘flak’ list for problems or issues 
e.g. a patient requesting an item before the discharge summary arrived and a 
‘task’ list for prescription requests which were urgent and could not wait. 
Overall post was usually processed in 4 stages - Opening post, scanning, 
attaching to the patient record and read coding (new diagnoses or reason for 
admission).  Read codes are a catalogue of codes which represent clinical 
terms for example diagnoses and investigations.  They are used to record 
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patient findings and procedures in health and social care IT systems across 
primary and secondary care e.g. General Practice and pathology reporting.  The 
codes enable records to be searched for activity and audited. Correspondence 
was read coded either before or after the review stage depending on the 
individual practice.  In three practices, administrative staff read coded the 
information sent but did not make any amendments to the medication or 
patients record.  In the remaining three practices, the read coding was 
conducted by the GP or practice pharmacist. 
6.4.6  Scanning of information 
In all practices, correspondence was routinely scanned to the computer by 
administrative staff.  In Practice D the correspondence was annotated with a ‘s’ 
to denote it had been scanned.  The information scanned satisfactorily if it was 
on white paper and not a carbon copy.  Scanned documents were poor and 
illegible if on coloured paper which did not scan well.  It varied from practice to 
practice whether scanning was completed before or after review and 
amendment by a relevant clinician.  One practice said:  
 
‘We scan first in case they get lost’ 
     Administrative staff, Practice E 
All practices except one (Practice B) scanned the same type of correspondence 
together.  One practice articulated:  
‘You need to ensure sheets go through individually. If the letter is two 
pages they needed to be linked together within the EHR to ensure that 
they do not get missed.’   
    Administrative Staff, Practice F 
Once scanned, the file is attached to the relevant patient’s notes.  This was 
initially done manually, however, during the observation period the EHR system 
(SystmOne®) used in all practices within the PCT observed had a software 
upgrade.  This included writing recognition software, which recognised the 
name and NHS number of the patient and linked it to their record. Once 
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attached to the patient record, some manual tasks were conducted, for 
example, a date entered so it appeared in the record at the appropriate time 
and assigning the relevant type of correspondence e.g. discharge summary or 
x-ray report etc. so it was easily identifiable.  Different practices entered 
different dates to indicate the episode of care. Most used the date the discharge 
summary had been signed to represent the date of discharge. This could, 
however, have been before the date of discharge if the discharge summary was 
prepared in advance. One practice used the date the discharge summary was 
received which could be much later than discharge.  Practice A linked the new 
correspondence to any previous communication e.g. the referral letter so that 
the trail of information could easily be found.  This was the only practice to do 
this. 
Once scanned practices would shred the paper correspondence.  The amount 
of time the letters were kept for before shredding varied between practices.   
Some shredded straight away, others kept for a month to allow time for the 
patient to order a new repeat.  Practice E annotated the EHR with a blue flag 
once it had been scanned and assigned to ensure none were missed. 
In the smaller practices the scanning and read coding was usually done by the 
same person and all staff shared duties, for example, in one practice the nurse 
was also the summariser, and the receptionist a medical secretary and 
phlebotomist. 
6.4.7  Dissemination of information received 
The way in which information received was distributed between HCPs 
depended on the practice.  Two practices divided the work equally between the 
GPs, one allocated it to the doctor who last saw the patient or referred them to 
the hospital. If a doctor was not specified then it was allocated to the doctor ‘on 
call’ or ‘hot-doc’.  One practice disseminated all the letters received that day to 
the on-call doctor. In Practice C the majority of letters were addressed to the 
main partner therefore it was felt it would be an unfair allocation if he was to 
review all of them.  Practice F distributed to the relevant doctor (named on 
discharge), some still coming through to a doctor who had previously retired. In 
one practice the GP reviewed the information from a diagnosis point of view and 
to ascertain any follow up required, then, signed the corner and passed to the 
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pharmacist to process the medication related information. This practice and one 
other practice allocated anything medication related to the practice pharmacists 
for review although this was sometimes actioned by a doctor when a pharmacist 
was not available. 
 
One practice indicated that if the doctor was on maternity leave, one person is 
allocated to deal with their mail.  In practice C where the information was 
distributed between several doctors the member of staff indicated that  
 
‘Sometimes it is difficult to know who to send it [the information] to.’ 
    Administrative staff, Practice C 
In the practices where the information was scanned before review, the workload 
was shared amongst all GPs using a task allocation function on the EHR.  The 
work was shared equally, irrespective of whether they were part time or not.  
Sometimes the information was sent to one clinician for info and another for 
action. 
6.4.8  Review of information 
Who 
In the majority of cases communication about medication was reviewed by the 
GP although occasionally this was also done by either a nurse or the practice 
pharmacist.  The nurses had varied roles within the process.   In practice F, the 
nurse was also a notes summariser and in another (Practice D) the community 
matron who looked after a caseload of elderly patients reviewed discharge 
summaries. 
How 
Two practices separated the discharge summaries into two piles; those that 
need actioning and those that had no actions.  They relied on the hospital 
doctor completing the discharge summary accurately and indicating whether 
there had been any changes to the medication.  The rest of the practices 
reviewed all of the discharge information.  One pharmacist queried:  
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‘I don’t know how other practices do it? They just look at the [discharge 
summaries with] changes and take them [the discharge summaries] 
away’     
Practice Pharmacist, Practice D 
The clinician reviewing the discharge summary cross-referenced the medication 
on the patient’s repeat template in their EHR with the information on the 
discharge summary.  One pharmacist estimated that approximately 2/3rds of 
discharge summaries did not have any actions as the patient was young or had 
been admitted to the hospital as a day case. 
The clinician reviewing the information used their clinical judgement to 
determine whether any changes needed to be made to the patient’s medication.  
They looked at the diagnosis to see if the changes look reasonable e.g. addition 
of aspirin, statin and beta-blocker post myocardial infarction (MI).  One clinician 
added a review date to specific medications, for example, PPIs so the patient 
did not remain on a treatment dose and was reduced to a maintenance dose.  
Another stated: 
‘Where cardiovascular medication has been changed and they have 
seen a cardiologist I assume that they know what they are doing and the 
changes are correct.’ 
        GP, Practice C 
Five of the six practices had an electronic formulary embedded into their EHR 
which identified more cost-effective alternatives when medication was being 
prescribed for a patient.  The other practice relied on the clinician using their 
judgement and remembering to consider cost-effectiveness. 
Some clinicians were more thorough than others, checking blood results & 
monitoring.  The pharmacists took a more holistic approach than the doctors, 
reviewing other issues e.g. compliance.  The practice pharmacists would send 
tasks to the GPs to remind them to monitor patients e.g. urea and electrolytes 
(U&Es).  One of the pharmacists annotated the correspondence to say it had 
been reviewed and also read coded the fact that the hospital information had 
been reviewed. It varied within the practices as to whether the read codes were 
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checked by a clinician.  Practice B electronically highlighted on the scanned 
information what needed read coding. One GP from Practice A, routinely double 
checked the read codes were correctly allocated.  Often it was unclear whether 
the choice to review information in a specific way was unique to the clinician or 
the general practice. 
Two practices reviewed the allergy status recorded by the hospital to check it 
matched with their records.  Where the practices checked the allergy status 
they found that sometimes the two did not match or the patient was taking 
something their records said they were allergic to, for example, on one patient’s 
record it said they were allergic to codeine but they had been taking co-
codamol.  Often the nature of the allergy was missing. 
Error 
The discharge summary often contained omissions or changes in strength of 
medication with no indication on the discharge summary that anything had 
changed.  Of 25 discharge summaries observed, a total of 24 omissions were 
observed on 10 discharge summaries (ranging from one to six per summary).  
Three contained one addition each and three had a dose that was either 
increased or decreased compared with before admission.  For example, the 
discharge summary of one patient who used a MDS made no mention of a 
diuretic the patient took routinely, showed their morphine dose to be halved and 
a statin which they had not taken for three months to be restarted.  There was 
no indication on the discharge summary that there had been any changes to the 
patient’s medication.  In another case only two out of the eight medicines on the 
discharge summary matched the patient’s record.  Again the discharge 
summary was signed to indicate there were no changes.   The discrepancies 
included omitted insulin and the addition of one medication the patient had not 
had for six years.  Occasionally, the clinician reviewing the medication noticed 
obvious clinical omissions which were not in line with national guidance, for 
example the patient was prescribed triple therapy with no long term PPI or the 
patient had not been initiated on a statin post MI.  Where correspondence did 
state that a medication had been stopped sometimes the reason was unclear.  
The clinicians observed offered some suggestions why errors may occur.  One 
practice pharmacist indicated:   
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‘Occasionally medication which was prescribed acutely prior to 
admission is continued post-admission and added to the repeat.’   
     Practice Pharmacist, Practice A 
A GP stated: 
‘I do not trust hospital discharge information.  Sometimes the patient has 
been in hospital a long time therefore medication changes are not 
documented as they move from ward to ward.’ 
      GP, Practice B 
There were also five occasions where a patient’s calcium and vitamin D 
preparation had been switched to an alternative which was stocked by the 
hospital and not amended back at discharge and one occasion where the PPI 
omeprazole had been switched to a different PPI, lansoprazole. 
 
There was variation in the legibility of the information received, clinic letters, 
follow-up discharge letters (from all hospitals) and e-discharge notes (from 
Hospitals B, C & D) were typed which were easily read.  Hospital A used 
handwritten quadruplicate carbon copy forms, which could be difficult to read, 
especially the last copy. 
The information in outpatient letters from consultants were often the most 
difficult to interpret.  It was sometimes unclear whether the letter was just for 
information or whether the doctor needed to prescribe a supply for the patient, 
for example, one letter emphasised that Equasym XL (a controlled drug) had 
been working for the patient but it did not state whether the consultant was to 
continue to prescribe for the patient or whether any had been supplied.  This 
can also be the case when the patient is prescribed an unusual product e.g. 
special formulation.  In other cases it is unclear whether it is an acute course or 
long term.  One letter stated ‘Prescribe prednisolone’, but did not indicate 
strength or whether it was a short course or long term.  Some consultants left 
the choice of the medication to the GP or gave the doctor a number of options 
e.g. try X or increase Y. Another letter said ‘should you decide to treat with a 
non-volume depleting drug, avoid a calcium channel blocker’ but was not 
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specific as to what should be used or what the alternative options were.  If the 
letter included a medication history there was often inconsistency whether the 
form and strength were documented within and between letters. In one case, 
the medication which was specific to the specialty contained full details, 
however, for the others just the name was listed.   
There were two cases of misinterpretation by the clinician reviewing the 
information where the researcher had to intervene.  The first was 
misinterpretation of the annotation ‘POD’ on the discharge summary.  The 
clinician thought that it meant that the patient had been on the medication prior 
to discharge when it was used to mean that it could be found in the POD locker 
(part of the patient’s bedside cabinet where the medication is locked away).  
The second, misinterpretation of ‘continue until 2/9’ written on the discharge 
summary.  The clinician thought they had meant to put 2/7 (meaning 2 days) 
when they meant continue until 2ndSeptember. 
There was one case where the hospital had increased the medication of a 
patient not realising that the patient did not comply with his treatment.  The 
patient is regularly readmitted.  
Clarification of information 
Correspondence varied as to whether there was sufficient information to review 
the patient’s medication accurately.  Where there was uncertainty, information 
was not routinely followed up with secondary care.  The clinician reviewing the 
information rarely contacted the hospital to clarify any discrepancies as it was 
deemed ‘too difficult’, the patient’s notes had often left the ward, the doctor who 
treated the patient was off shift or it relied on the hospital doctor’s memory to 
clarify the question.  One GP highlighted:  
‘It can sometimes take several hours to resolve queries from 
discharge prescriptions.’ 
    GP, Practice B 
More often the clinician would make a decision or occasionally ring the patient 
to clarify.  In one practice, the discharge summary is put on one side until the 
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follow-up letter arrived, to see whether it added any clarification.  The GP 
makes sure the patient has enough supplies until then.  
6.4.9  Amendment 
After the information was reviewed, the relevant amendments were made to the 
EHR.  This was always conducted by a clinician in all the practices observed; 
either the GP, pharmacist or nurse all of whom had relevant access on their 
smartcards to enable this to happen.  Practices had previously been sent a 
letter from the PCT advising them to review the access administrative staff had 
on their smartcards, limiting prescribing and amending of prescriptions only to 
clinicians.  Although the practice managers had access rights to review and 
amend prescriptions, this was something which they definitively reported they 
did not do. 
Some GPs reviewed the read codes assigned by the administrative staff and 
checked any new diagnoses given. In the majority of cases the practice did not 
need to assign brand new read codes, they usually linked the episode of care to 
existing read codes assigned to the patient.   
 
A record of any shared carebb medication was annotated on the EHR as well as 
any medication the hospital prescribed.  There was no specific place to put this 
on the system therefore each practice assigned it in a different place.  If patients 
were issued warfarin by the hospital, Practices B, C and F put it on the repeat 
template, but made the quantity one tablet so anyone seeing the record would 
know and the system would highlight any interactions.  This was not necessarily 
a robust method. 
The time taken from receipt of information and making relevant amendments on 
the system varied depending on the way in which the information was received 
and who in the practice was reviewing the information.  If it was received 
electronically, it was usually reviewed and amended the same day.  Non-
electronic took 24-48 hours.  If the person reviewing was part time it could take 
                                            
bb Shared healthcare is a model of integrated healthcare delivery in which the collaboration 
among practitioners of different disciplines or with different skills and knowledge allows for the 
delivery of patient healthcare by the most appropriate healthcare practitioner 
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four days to a week.  The largest practice reported it took one to two days to 
scan plus a week to make amendments. 
6.4.10  Patient information 
Patients were not contacted routinely in any of the practices to inform them of 
changes to their medication.  Where they were contacted, it was more often by 
the practice pharmacist.  One practice pharmacist said: 
‘If they are elderly or likely to be confused I may ring or pass to 
nurse case manager.  I try to ring the patient but, where there is 
no answer, I write.’ 
Pharmacist, Practice D. 
In Practice F, the practice pharmacist put a note on the prescription to inform 
the patient.  They also rang a nursing home to reinforce that medication had 
been stopped.   
6.4.11  Repeat prescribing 
Only one practice reported regularly running a report to identify items on the 
repeat prescribing template that had not been recently ordered.  Each patient 
record identified was reviewed to check whether the item of medication should 
be removed including identification of any compliance issues.  If anything was 
identified the patient was asked to call in for a medication review.  This was 
carried out by the practice pharmacist. The pharmacist added:  
‘Community Pharmacists often order on behalf of the patient and 
are not aware there have been any changes.’ 
    Practice Pharmacist, Practice A 
Practice B had a system in place to notify the community pharmacy of changes 
to MDS.  They fax the changes to the community pharmacy and the pharmacy 
signs the bottom and faxes back to say they have made the amendments.  On 
two occasions repeat prescriptions had been printed before amendments had 
been made to the repeat prescribing template post-discharge. 
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6.5  Discussion 
6.5.1  Overall process 
All models which describe medicines reconciliation contain at least three 
stages; collection of medication history, validation of any existing medication 
lists and clarification.2,3,80,340 They are clearly more focused towards medicines 
reconciliation within secondary care.  The reconciliation undertaken within 
general medical practices does not incorporate all of these stages.  At 
admission to hospital information is gathered from a variety of sources before 
processing during the medication history stage.  However, although primary 
care receives the list of medication, they do not gather the information 
themselves, therefore the medication history taking stage is not applicable.  It 
could be argued that there needs to be a different model for medicines 
reconciliation within primary care or acknowledgement within the models as to 
how they can be applied within different settings.  Even the visual 
representations of the patient journey discussed in Chapter 2 considers 
admission, within a hospital stay and discharge but does not consider what 
happens in primary care.  
Practices have a role in the provision of medicines information at admission to 
hospital whether this is planned or unplanned or on referral to an outpatient 
clinic.  This was not observed whilst in primary care; furthermore, none of the 
practices had policies in place regarding this.  The accuracy of the medication 
history taken at admission can affect the accuracy of discharge communication.  
If medication is not recorded on admission it may be accidently omitted by 
either the patient or GP when the patient is discharged as they assume it is not 
to be taken.379 Similarly if GP records are not kept up-to-date it can cause error 
at admission. It was sometimes difficult to tell whether medication had been 
purposefully stopped or whether they were never recorded on admission.  This 
mirrors findings from over 20 years ago.379  Although practices all had their own 
individual approach to processing medicines-related information they all 
contained the key stages previously described by Crowe et al.429  It would not 
be appropriate to implement one-size-fits all approach to the processing, review 
and amendment of discharge information due to the differences in practice 
population, number of staff and amount of correspondence received. 
Nevertheless, as protocols lack information there is need for the practice 
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protocols to contain standardised sections and increased detail on all stages in 
the process.  This could be in line with the stages of the information processing 
model: receipt, scanning, dissemination, review and amendment.429  Also 
incorporating potential pitfalls and good practice recommendations, for example 
which member of staff is responsible at each stage and the provision of 
information to hospital at admission. Increased detail within the policies 
including visual flow diagrams would be beneficial.  Staff observed had little 
training, if any at all, on processing medication-related information.  This 
suggests there is increased need for staff to have appropriate training, plus 
competency assessment.  There were no records that staff had read the 
protocols employed.  Staff should sign to say they have read relevant protocols 
and practices should maintain an up-to date record.  Previous incentives to 
have robust repeat prescribing policies in general medical practices had proven 
successful within the area, with all practices having repeat prescribing protocols 
in place, based on an evidence-based template provided by the PCT.  The 
extent to which the practice matches the policies is, however, unclear. The 
successful implementation of repeat prescribing protocols in general practices 
mirrors previous research which indicates that financial incentives improve 
quality and therefore potentially patient safety.639 
6.5.2  Review of information 
The GP is the central record holder in primary care and on receipt of discharge 
information will review and update the patient’s records. Ultimately this then 
may inform the patient’s medication history if they are readmitted.  This study 
could not disprove or corroborate previous findings that medication is 
accidentally discontinued or added in primary care,432 or that medication is often 
added to existing regimens without previous medication being deleted or 
stopped leading to duplication of therapeutic effect.  However, it is easy to see 
where this may occur as the reviewing clinician sometimes made assumptions 
regarding information within the discharge summary.  This in turn may have led 
to the repeat medication list on the GP system not being updated appropriately, 
similar to findings by Cochrane et al and Burns et al.379,430  On occasion, within 
this study, general practices relied on the patient, their relatives or their carers 
to provide information, especially where discharge information is conflicting.  
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The patient can sometimes present before the discharge summary is received, 
similar to previous findings by Mageean and Harding in the 1980s.42,519  It 
seems unreasonable that nearly 30 years on, and with the technology available 
that discharge information cannot be received in a timely way in primary care. 
 
It is important that post-discharge amendments are made before repeat 
prescriptions are requested.  One Australian study showed that within 30 days 
post-discharge, 71% of patients will visit their GP and 86% will visit their 
community pharmacy within two weeks, making it important for primary care 
HCPs to receive and action the discharge summary within this time.428  
Practices could add in filter questions when patients request repeats to 
determine whether there are likely to have been any changes, for example, 
‘Have you been in hospital or had an outpatient appointment since your last 
preacription? Did they make any alterations to your medication?’ 
Work should be fairly allocated to staff on a pro rata basis.  The NPC stipulate 
that discharge information must be reviewed by someone with appropriate 
skills. Crowe et al429 discuss the amending and updating of records post-
discharge as a task exclusively carried out by GPs themselves, whilst this study 
found that in practice this is sometimes conducted by pharmacists and in some 
instances, nurses. This may have been due to the differences in timing and 
location of the studies.  The NPC notes that in primary care, responsibility for 
the process is sometimes inappropriately devolved to an untrained person, for 
example a receptionist, who does not have appropriate competencies.  
Administrative staff were heavily involved in the processing of discharge 
information, however, no evidence of administrative staff amending the EHR 
was found.   A systematic review by Burns et al in 2012 determined that 
accuracy of coding post-discharge lies between 80 and 90%, suggesting that 
routinely collected data is sufficiently robust to support its use for research and 
managerial decision-making.640  This still leaves 10 to 20% of patients with 
inaccuracies in their coding which could potentially lead to failure to identify 
them during routine audits.  Clinician involvement in coding has been suggested 
to improve accuracy.641  The  systematic review by Bayoumi et al434 highlighted 
the need for improved quality evidence demonstrating effective medicines 
reconciliation interventions in primary care.  This study identifies specific areas 
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where intervention may be appropriate e.g. improvement of procedures and 
protocols.  
6.5.3 Discrepancies identified 
A number of discrepancies on discharge summaries were observed.  Although 
there are few studies that look at the number of discrepancies within discharge 
information from a primary care perspective, there are studies conducted within 
the hospital that look at the number of discrepancies appearing on discharge 
information.  The findings within this section of the study are in keeping with the 
evidence that the omission is always the highest discrepancy found during 
medicines reconciliation.74-79  It was often unclear which medication had been 
stopped, started or changed during the patient’s stay in hospital.  There is a role 
for the hospital to improve the quality of their discharge summaries, to ensure 
accuracy and to clearly indicate changes.  This would assist the practices with 
reconciling medication for their patients.  There is also a need for more 
standardised outpatient letters, with clearer information as to whether the letter 
is for information only or whether the general medical practice must undertake 
an action.  A summary of action points within the letter would be helpful.  There 
is a continuum between medicines reconciliation and the review of medication 
at discharge as often the clinical appropriateness of the medication prescribed 
is reviewed by the clinician whilst they are processing the discharge summary. 
Only two of the six practices checked the allergy status on the patient’s 
discharge summary. This is important and should be included in the review of 
discharge information as one US study showed that approximately one-third of 
patients had a discrepancy in their allergy status.512  This could lead to 
medication being prescribed to which the patient was allergic or alternatively the 
patient being denied appropriate therapy because the prescriber believes the 
patient is allergic. 
6.5.4  Involvement of the patient in medicines reconciliation  
There is need for any changes to a patient’s medication to be communicated 
effectively and for the patient to be involved in their own care. Cromarty et al 
demonstrate that the provision of the discharge summary to the patient at 
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discharge was valued by the patient and decreased the incidence of medicines 
related problems post-discharge.392 It is also important that anyone else 
involved in the patient’s care is also notified e.g. community pharmacist, care 
home, relative or carer; all who may order repeat prescriptions on the patient’s 
behalf. 
6.5.5 Role of the hospital 
The NPC specifies that discharge information should be clear, unambiguous 
and legible and should be available to the GP (or other primary care prescriber) 
as soon as possible after discharge, preferably within two working days.80   The 
legibility of discharge communication within this study varied; the quality of the 
handwritten carbon copies was often poor.  This is similar to previous 
findings,41,401 especially where the correspondence is the third carbon copy of a 
discharge summary or a handwritten document.80  The majority of 
correspondence was received often before it was requested by the patient i.e. 
typically 11-14 days, however, there were occasions when this was not the 
case.  Similarly, a quantitative study by Akram and Urban380 conducted in the 
same health economy  found that 80% of discharge summaries were received 
within seven days and took four to nine days to be actioned by the general 
medical practice.  Other international studies have found similar.373,426,427  This 
timeliness is not in keeping with the NPC two day guideline.  The method of 
delivery of discharge summaries varied include posting, hand-delivery by the 
patient, faxing and electronically.  This was also found in previous 
studies.40,103,366  Although the proportion of faxed and postal receipt is 
decreasing as the amount of electronic transfer increases.  The move to 
electronic discharge summaries will reduce the issues with illegibility due to 
handwriting and quadruplicate carbon copies, plus reduce workload from 
opening post and date stamping plus other issues e.g. mis-filing and lost 
information.  The implementation of a standardised formulary across both 
primary and secondary care would also minimise the potential for 
discrepancies, e.g. duplication, as on occasion patients had been switched to 
alternative medication for the same therapeutic purpose at admission e.g. PPIs 
and calcium and vitamin D preparations.  The introduction of IT can potentially 
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introduce new issues as staff become familiar with new ways of working (see 
section 7.6 Information Technology) 
6.5.6 Strengths and Limitations of Study 3 and overall observation 
This section will discuss the specific strengths and limitations within this chapter 
and also the overall strengths and limitations of collecting observational data 
(relating to Chapters 5 and 6).   
Observer bias 
There are potentially a number of biases which can occur through observation 
e.g. the Hawthorne effect, the Halo effect and observer bias. These have 
previously been discussed within Chapter 3.  As discussed earlier, previous 
observers of health-related situations have noted that their impact is often minor 
due to the complex, demanding work needing to be undertaken in a timely 
manner.238 In a similar way, the medical staff did not appear concerned at being 
observed, stating they were ‘used to it’ because of various assessments and 
appraisals.  Staff were also very busy and often admitted to forgetting they were 
being watched.  On several occasions the participants asked the researcher 
‘How did I do?’ or ‘Did I pass?’.  One participant asked for personal feedback as 
they felt they did not usually receive peer review and thought it would be helpful 
to inform their practice.  Staff were regularly unconsciously incompetent, and 
therefore would conduct their tasks not knowing what they did not know and 
assuming they were conducting tasks appropriately, therefore appearing 
unconcerned by the observation.  Notably, the interpretation of the original work 
which uncovered the Hawthorne effect has been re-examined, having called 
into question the quality of the original methods used and the conclusions 
drawn, which ignites a debate as to whether the Hawthorne effect is a true 
phenomenon.583  Observation schedules were also used which provided more 
objective, structured observations. 
 
Data recording 
Observation alone cannot provide a full picture and only provides an illustration 
of what is happening at the time. Not observing for the whole day or ‘out-of-
hours’ created a potential to miss key events which could have provided a more 
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comprehensive view.  Field notes were used to record the observational data.  It 
is argued that this may not be as accurate as other means as it relies on 
documenting everything seen – almost instantaneously, however, ethical 
considerations would make it difficult to have used video or audio recording. As 
has been explained earlier, observations were recorded against an observation 
schedule where possible, plus included verbatim accounts rather than the 
researcher’s construct of a general sense of what was said to prevent the 
researcher opinion influencing the reporting.573  Furthermore, notes were 
expanded as soon as possible post observation to improve accuracy.   
 
Reflexivity 
The researcher needed an awareness of their own cultural assumptions and 
any preconceived ideas, especially given the researcher’s additional, ongoing 
role as a pharmacist.  This was countered by being reflexive and recording any 
feelings and opinions which were later reflected on e.g the researcher remained 
aware that she may observe the pharmacists more favourably due to being from 
the same profession (halo effect). Nevertheless, the researcher’s role as a 
pharmacist enriched the information gathered as they used their prior 
knowledge and experience to gain access, build rapport, understand the 
process and pose appropriate questions to the participants.  It also allowed the 
researcher to be flexible and make a judgement on what to observe.642  Miles et 
al 1998 have criticised the lack of collaboration between health service 
researchers and clinicians, suggesting a closer link is needed.643 Research-
practitioners can go some way to reduce this gap and may assist access to 
different areas of healthcare. 
 
Framework 
The SCOS provided a useful framework through which to measure the quality of 
current practice. There were some parts of the PCOS which on reflection 
maybe were not as relevant to medicines reconciliation, for example, some of 
the standards relating to repeat prescribing e.g. a designated area to process 
repeat prescriptions, although this is important in general for the governance 
and accuracy of repeat prescription generation. Adaptation of this framework 
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could be used to further observe general medical practice and also provide 
used as an audit tool to aid improvement and provide recommendations.   
 
6.5.7 Conclusion of study 3 
This chapter reviewed the systems of reconciling medication within general 
medical practices and determine the roles of primary care staff with reference to 
medicines reconciliation. It also identified practice which could lead to error and 
solutions which enhance patient safety related to medicines reconciliation in 
general practice.  Practices vary in their approach to processing information on 
medication received from other organisations.  This can depend on a number of 
factors including the size of the practice and the number of staff employed.  
Although it would be unrealistic to expect every practice to process medicines-
related information in the same way, this study has highlighted specific aspects 
of the process which may contribute to error.   Some practices and clinicians 
have embedded good practice into their processing, which could be shared with 
others.  There is a need for standardisation and improved policies and 
protocols, together with improved electronic communication, improved accuracy 
and timeliness of discharge information and standardisation of outpatient letters.  
Improvements are, however, necessary within both primary and secondary care 
to improve the overall process and to make the transitions between primary and 
secondary care seamless, including patient involvement to ensure medication 
changes have been embraced by the patient.   
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CHAPTER 7  GENERAL DISCUSSION AND CONCLUSIONS 
This thesis has utilised mixed-methods across multiple centres to examine and 
critically appraise the whole medicines reconciliation process.  The study 
followed the patient journey from admission, through to discharge, and into 
primary care.  Firstly, the study determined the type and severity of 
discrepancies occurring at admission to hospital. Then, subsequently, examined 
the context of these findings through a qualitative observational study of current 
medicines reconciliation practice in both primary and secondary care.  Two 
evidence-informed, observational schedules were developed and tested, and 
used as a framework for analysis.   The YCFF608 was also applied to identify 
potential factors which contribute to medicines reconciliation error/discrepancy, 
but also, outwith its intended role, to identify and categorise potential defences 
which could lead to the amelioration of such errors or discrepancies.  This 
chapter will discuss the major findings within the study and their implications for 
practice in the context of other published literature relating to medicines 
reconciliation.  The study limitations will also be discussed before considering a 
range of recommendations specific to practice and policy.   
7.1 Definition and Taxonomy of Medicines Reconciliation  
The literature review highlighted the lack of a standardised definition of 
medicines reconciliation, both internationally and within the UK.  This point was 
reinforced through the observational work and analysis of the policies and 
procedures in both the hospitals and primary care. Pharmacy staff were familiar 
with the term, yet, during the consent process many of the medical, nursing and 
support staff asked for further clarification.  This absence of a single 
standardised definition hinders the understanding of those undertaking 
medicines reconciliation, and consequently, makes it difficult to clarify process 
and the roles and responsibilities of the various HCP within that process.  It also 
influences valid and reliable measurement.  Furthermore, depending on the 
definition used, it could include or exclude certain stages within the process, 
some of which could be argued as essential, for example, reconciliation within 
primary care. It is also common in the literature to read ‘medication’ 
reconciliation in the US, Canada and Australia compared with ‘medicines’ 
reconciliation in the UK.  A standardised, internationally accepted definition is 
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important to ensure consistency in, and management of medicines 
reconciliation. This study used the IHI definition2 of medicines reconciliation and 
the NPC’s model (collecting, checking, communicating),80 as a starting point, to 
carry out both the literature review and the empirical work. This model and 
definition, however, are limited to the secondary care setting.  Any definition of 
medicines reconciliation must encompass and be applicable to all transitions of 
care, not just between secondary and primary care; for example the interface 
between general practice and nursing homes.   This study has led to a new 
definition which encompasses all stages and professions to enable process, 
roles and responsibilities to be more clearly defined.   
‘The retrospective assessment and evaluation of the patient’s recent 
medicines (e.g. inpatient medication chart or discharge prescription) at 
specific transition points in care and the resolution of any discrepancies 
found.  The aim is to ensure the information transferred accurately 
reflects the patient’s current treatment requirements (including drug, 
dose/strength, form, route, frequency).’ 
Medicines reconciliation error is also poorly defined, although one could claim 
that medicines reconciliation error in part is ‘a failure in the medication history 
taking process’. However, this does not encompass the errors in communication 
due to poor documentation when medication is altered.  A standardised 
taxonomy or classification system for discrepancy type (apropos definition) is 
imperative to be able to compare published work, measure progress and 
benchmark organisations, and ultimately increase quality.  The amended 
taxonomy of errors used within the descriptive prospective study (Chapter 4) 
and the observational study (Chapter 5) (initially proposed by the Universities of 
Leeds, Sydney and Wisconsin [David Alldred. Senior Lecturer in Pharmacy 
Practice, University of Bradford.  Personal communication 2011]), 
encompassed all discrepancies found during data collection. In the main, it was 
easily applied by the pharmacists collecting the data and would seem a suitable 
and fitting classification system for clinicians and indeed researchers.  However, 
some of the difficulties found by pharmacists using this proposed taxonomy 
were understanding the difference between dose, frequency and strength. They 
also struggled to recognise when a medicines reconciliation discrepancy or 
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error differed from a prescribing error. For example, prescribing the incorrect 
strength of a medication due to poor medication history taking would be 
classified as a medicines reconciliation discrepancy, however, prescribing the 
incorrect strength of a new acute medication would be a prescribing error.  The 
use of the taxonomy was assisted through guidance notes which accompanied 
the data collection tool, which could be further improved to clarify finer detail.  
This study was the first time the taxonomy has been applied in practice and has 
validated its use, enhancing confidence in its appropriateness.   Moving 
forward, the next stage of development would be to test the definition and 
taxonomy further, initially with a multidisciplinary professional panel followed by 
pilot implementation in practice. 
7.1.1 Defining Medication Reconciliation Error 
To be able to define medicines reconciliation and related tasks accurately, as 
well as measure error and/or discrepancies associated with medicines 
reconciliation, it is important to define whereabouts in the patient journey 
medicines reconciliation starts and ends.  The term ‘medication reconciliation 
error’ could be open to interpretation as many use the term medicines 
reconciliation solely to describe the act of verifying the medication history by a 
pharmacist.  Thus ‘medication reconciliation error’ would then refer to errors 
made by the pharmacist in verifying the medication history.  However, many of 
the definitions within the literature are much broader than this, also covering 
medication histories taken by doctors and nurses at admission, plus the 
reconciliation conducted in general practice post discharge.  Therefore within 
this thesis medicines reconciliation was considered as any retrospective 
assessment and evaluation of the patient’s medication at transitions (admission, 
during stay, and discharge) with medication reconciliation error being defined as 
any error arising from this retrospective assessment and evaluation. 
Medicines reconciliation error is independent of prescribing error.  Prescribing 
error is defined as ‘a failure in the decision-making process’.  Yet, with 
medicines reconciliation it is often less to do with the failure in the decision 
making process, rather the lack of awareness of the medications the patient 
was taking prior to the transition in care due to failure of systematic approach 
and failure to utilise and or interpret the sources of information correctly.  
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The term medicines reconciliation itself is problematic due to lack of clear 
definition and misinterpretation by HCPs.  It should therefore either be made 
redundant or used cautiously as a broad overarching term with the specific 
stages referred to individually as 1) medication history taking, 2) verification of 
the medication history, 3) reconciliation at discharge.  Consequently, to avoid 
confusion and to aid categorisation of so-called medicine reconciliation errors 
and prescribing errors, it would be easier to categorise the error according to 
the stage in the patient journey where the error arises.  This would allow the 
error at each of the stages to be more easily described and measured as they 
would describe more specifically where they occur eg verification error, 
medication history error, writing the IMC. 
7.2  Scale and Severity of Medicines Reconciliation Related Error and 
Discrepancy 
Medicines reconciliation continues to be a worldwide problem. Between starting 
and completing this study more than 200 empirical studies were published on 
the topic.  Most of the studies emphasised high rates of discrepancies with little 
improvement.  Some countries are further on their journey towards reducing 
error and/or discrepancies associated with medicines reconciliation than others 
for example the US, Australia and Canada, and are engaged in international 
campaigns e.g. WHO.268  The UK is also committed to the reduction of 
medicines reconciliation discrepancies and error and, whilst the UK is not as 
publically involved in international campaigns, the NHS and NICE & NPSA are 
continuing to drive the improvement of medicines reconciliation forward.  The 
rates of discrepancies found in the current study are in keeping with those found 
in other international studies and have been corroborated through both 
quantitative and qualitative data collection (Chapters 4, 5 and 6); omission 
remained the highest discrepancy type in all three studies, which is in keeping 
with the literature.77,109,125,145,166,171-183,201  The similarities in rate of discrepancy 
and their potential severity with the existing literature suggest the study 
conducted here has some generalisability and transferability. 
There are sufficient studies which explore and determine the rate of medicines 
reconciliation between primary and secondary care; this is well established. 
There now needs to be further studies which explore the scale of discrepancies 
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between other interfaces, for example, care homes, outpatient departments, GP 
referral letters, dental visits644 as well as more rigorously designed studies 
which look at interventions to reduce error.  This need for such studies, reflects 
an earlier literature which called for an increase in quality improvement and 
patient safety intervention especially in relation to medicines reconciliation.99,645 
The effect of medicines reconciliation error on readmission rates is not well 
evaluated, nor has it been explored here, within this study, or cost evaluated.  
However, it is not difficult to see how an improvement in medicines 
reconciliation could potentially impact on both readmission and costs.   The 
current study identified that there is a potential for some (although few) 
discrepancies to cause harm.  Exactly how many would be difficult to quantify.  
This makes any potential cost savings due to intervention difficult to calculate.  
It has only been explored in one previous study; Boockvar et al looked at the 
actual ADEs occurring from medication discrepancies and determined that of 
1350 discrepancies, 65 (4.8%) resulted in ADEs.159  A health economic analysis 
was not conducted, but would be beneficial to determine potential cost 
implications. 
The frequency of errors or discrepancies is not necessarily the most important 
measure in patient safety research, rather the frequency of adverse events and 
severity of harm to the patient.  For some events it is important that they never 
occur e.g. ‘never events‘cc.646  Although not listed in the NPSA Never Events 
Framework, it could be expected that those medicines reconciliation related 
ADEs classified as most severe, such as the omission of insulin, should never 
occur.  And, indeed omission of insulin is listed in the NPSA Rapid Response 
Report, (Reducing harm from omitted and delayed medicines in hospital).619  As 
stated earlier the severity of discrepancies identified (Chapter 4) is in keeping 
with those found in previous studies.  Difficulties lie with the subjectivity of 
severity scales and the numerous different scales used within the literature.  
Further studies exploring the rate of discrepancies and errors which go on to 
cause tangible or measurable harm are needed to be able to more accurately 
                                            
cc Never Events are serious, largely preventable, patient safety incidents that should not occur if 
the available preventative measures have been implemented by healthcare providers. (NPSA, 
2011) 
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look at potential cost and cost savings due to intervention (see section 7.8 
further research).   
7.3  Sources Used to Conduct Medicines Reconciliation  
The accuracy of the medication history is reliant on the use and accurate 
interpretation of relevant and up-to-date sources.  HCPs must also recognise 
the potential limitations each source may have and their reliability.   There is a 
plethora of evidence which demonstrates the accuracy of different sources used 
during medication history taking and many that illustrate the importance of using 
more than one source of information. Yet, there is no evidence to suggest that 
any one source is more accurate than another. With this in mind, there is need 
to dispel this myth, concluding that each source adds value to an overall picture.  
Contrary to the NPC guidance,80 it is possible that MAR charts are more 
accurate than suggested as they are a record of what the patient has actually 
been taking.  HCPs within this study felt they presented a truer reflection, 
although no studies have actually looked at their accuracy.  The quantitative 
and qualitative data determined within this study both show that often more than 
one source is not used when taking a medication history, however, the reasons 
for this are unknown.  It is clear from both the current study and published 
evidence that patient involvement is paramount, despite this only 50% of 
patients were used as a source of information during their medication history 
gathering and relevant cues and concerns raised by the patient were 
sometimes ignored.  Patients were not necessarily seen as superfluous, rather 
the HCPs fixated on the process of completing the task and there was 
overreliance on the GP record as a source of information. Furthermore patients 
were not routinely encouraged to bring their medication into hospital, which 
supports previous findings,531 and when they did they were not routinely used 
as a source. Patient involvement is discussed further in section 7.6.1. 
7.4  Patient Safety and Human Factors 
This thesis has been underpinned by patient safety and human factors theory, 
drawing on the previous work of Reason which describes a person and systems 
approach.16  This section will provide a general overview of patient safety and 
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human factors and their role in medicines reconciliation.  Further detail will be 
discussed in subsequent sections.  
There has been international emphasis over the last decade on patient safety.  
With this has come an increased interest in the role human factors plays in 
healthcare and a recognition of their importance.11 Since then, the emphasis on 
understanding human factors and human error in healthcare has grown and is 
becoming more common place.   Over a similar time frame, the drive to 
decrease medication safety incidents has turned focus to improving 
communication about medication at transition points, predominantly admission 
and discharge.276,647-650  Interest in the scale of issues plus interventions to 
improve medicines reconciliation have been sought; more recently being 
embedded into the medicines optimisation agenda in the UK.45  
A human factors informed system should identify and remove system hazards 
from the design. Processes should be designed to diminish the impact of 
intrinsic difficulties which hinder the clinicians’ ability to perform their work and 
deliver safe care. It was acknowledged in Chapter 2 that the study of human 
factors in relation to medicines reconciliation has not previously been well 
explored and that any medicines reconciliation processes in place were 
certainly not designed with human factors in mind.  This could create 
opportunity for error and compromise patient safety.   Several dominant factors 
were seen to potentially contribute to medicines reconciliation-related errors 
and/or discrepancies.  These included: individual factors, team factors, patient 
factors, education and training, IT, communication factors and cultural factors, 
the most significant of which appeared to be communication or lack thereof, 
especially written documentation within and between organisations. 
By using human factors the YCFF and communication models the study has 
provided a fascinating insight into the medicines reconciliation process.  This 
suggests other frameworks of analysis could be used to explore complex 
processes in medicines management.  Carayon et al demonstrated the human 
factors link between system design and patient safety (SEIPS). Their work 
emphasises that a system not designed according to human factors principles 
can create opportunities for errors and hazards.651,652 SEIPS considers system 
in the light of human factors and the Donebedian model; structure, process and 
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outcomes.653  This has been applied to healthcare previously to improve patient 
safety,651,652,654  There are also plans to apply this to medicines reconciliation as 
part of the US based MARQUIS (Medication Reconciliation Quality 
Improvement Study); its aim, to operationalise best practices for inpatient 
medicines reconciliation, test their effect, and understand any barriers and 
facilitators of successful implementation.143 
Despite there not being any previous literature which looks at human factors in 
relation to the medicines reconciliation process, Cohen in his book Medication 
Errors has described potential ‘at risk’ behaviours in medication processes 
which could contribute to error, all of which were discovered in this current study 
and are grounded in a human factors approach (see table 7.1).655 
7.5  Process 
7.5.1 Overview 
Systems, processes and procedures 
Medicines reconciliation forms one small, but extremely important, part of the 
overall healthcare system.  Van Cott stated that healthcare is composed of a 
large set of interacting systems that are connected by intricate networks of 
individuals, teams, procedures, regulations, communication, equipment and 
devices that function with diffused management in a changing and fluid 
environment.656 Medicines reconciliation is an organisation wide process that 
crosses departments, professions and specialties as well as the primary-
secondary care interface.  As demonstrated in the literature review, previous 
studies of medicines reconciliation have studied isolated parts of the process 
rather than the process as a whole. This study has observed the process in its 
entirety and provided a further critical insight into how a range of healthcare 
systems co-exist with medicines reconciliation.  This together with an 
understanding of its relationship to other external systems and people can 
provide a substantive contribution to resolving the issues associated with 
medicines reconciliation.  
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Within the system are a number of defined processes.  A process can be 
defined as: 
‘A sequence of interdependent and linked procedures which, at every 
stage, consume one or more resources (employee time, energy, 
Table 7.1 At risk behaviours in medication processes relating to 
medicines reconciliation (adapted from Cohen p616)655  
Patient information e.g.  not waking the patient for assessments all 
medications  
Drug information e.g. writing incomplete discharge instructions, prescribing, 
dispensing, or administering medications without complete knowledge of the 
medication 
Communication e.g. rushed communication, failure to speak up when there 
is concern, use of error-prone abbreviations (e.g. u instead of units for insulin 
doses), not reading back spoken orders, providing incomplete orders e.g.  
Incomplete details, illegible handwriting  
Environment staffing e.g. failure to supervise, inadequate staff, managing 
multiple priorities 
Patient education e.g.  Prescribing, administration of or dispensing 
medications without educating the patient, disregarding the patients or 
‘caregivers’ concerns about their medications appearance, reactions or 
effects, or other worries, discharging patients without proper education about 
their medications to take home 
Staff education e.g.  Lack of a structured and ongoing staff competency 
programme related to medication use. 
Culture e.g. sacrificing safety for timeliness, failure to report and share error, 
blame culture 
Double check e.g. over-confidence in others work 
Teamwork e.g. reluctance to consult others or ask for help, lack of 
responsiveness to HCP or patient requests 
Technology e.g. failure to fully engage available technology 
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machines, money) to convert inputs (data, material, parts, etc.) into 
outputs. These outputs then serve as inputs for the next stage until a 
known goal or end result is reached.’657  
Previously medicines reconciliation has been described as a system with many 
inter-related proceduresdd that make up one large scale process, which of 
course, crosses the primary secondary care interface (amongst others).  The 
‘output’ described in the definition could be a discharge summary from 
secondary care which is inputted once it reaches the general medical practice. 
Healthcare professionals role in process 
Medicines reconciliation involves different HCPs at different stages within the 
process to produce BPMH. HCP behaviours are a product of the systems and 
processes in which they work. Variation and inconsistencies in approach need 
to be addressed.  This is difficult when there is no ‘gold standard’ approach to 
medication history taking and limited standards for medicines reconciliation. 
There is a need to clearly define roles and responsibilities within the medicines 
reconciliation process.   There is disagreement about who should take the lead 
and responsibility for embedding patient safety principles into medicines 
reconciliation processes within the US.339,340 This is clearer in the UK, as the 
NPSA has suggested pharmacy staff, although further work to identify HCPs’ 
perceptions of the roles they should play in the medicines reconciliation process 
would be beneficial to start to overcome any barriers which exist, for example, 
effective collaboration, teamwork and seamless care.  The WHO suggests that 
healthcare organisations should assign clear roles and responsibilities to HCPs 
for all steps in the medicines reconciliation process to ensure accountability,1 
however, the WHO do not make suggestion as to what these roles and 
responsibilities should be or to whom they should be assigned.  It might be 
pertinent, rather than to assign a specific role to a specific group of HCPs e.g. 
initial clerking medication history to doctors, to provide a list of competencies 
that should be achieved by anyone who is to undertake the role.  This has been 
achieved in other areas of healthcare in Australia658 and the UK.659  This may 
                                            
dd Procedure - A series of steps taken to accomplish an end. 
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take more effort than assigning the appropriate task to a appropriate HCP, 
especially as pharmacists already display many of the relevant competencies 
needed to accurately undertake a medication history (see section 7.4.1 At 
admission - Pharmacy staff).39,49,66,69,71,74,118,122,124,162,208,237,239,277,278,300-321,346-348  
As discussed in Chapter 2 the patient’s journey through hospital includes three 
distinct stages: admission, during stay and discharge.160,289  The following sub-
sections of this chapter will re-visit the process at each of these stages in the 
light of the study findings, plus post-discharge, within primary care, considering 
the role of each individual HCP at each stage. 
7.5.2  At admission 
Doctors 
Following the patient journey, the medicines reconciliation process starts at 
admission to hospital.  Traditionally, within the UK, it is the doctor’s role to clerk 
the patient and take the initial medication history.  Yet, as demonstrated 
throughout the study and supported by existing literature, this leads to a high 
number of errors and discrepancies in the patient’s medication history. 
39,49,66,69,71,74,118,122,124,162,208,237,239,277,278,300-321,346-348  There is a current lack of 
evidence to suggest which interventions would improve doctors’ performance 
during medication history taking. Various defences could be put in place to 
improve the accuracy of medication history at admission, for example, 
increased standardisation of documentation, training and education and 
increased inclusion of the topic in the undergraduate curriculum, which have 
already been shown to work.93,94,96,328,329,338 Training and education also has its 
limitations in comparison to system change.  These are discussed further in 
section 7.6.5.  The identification of appropriate interventions are needed, 
mindful that education and training is not an especially effective means of 
improving patient safety when used alone.660,661   Alternatively, it would be worth 
reviewing whether doctors are the most appropriate people to undertake the 
task and whether pharmacy staff would be better placed given their skill set.  
The observation in Chapter 5 showed that Doctors placed little emphasis on the 
medication during clerking and were more likely to use a systems-based 
approach to eliciting the patients medication history during the medical history 
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taking compared with the pharmacist who would ask questions specifically 
relating to the patients medication using a wider variety of sources.  This is 
similar to previous findings which determined that clerking doctors spend on 
average 45 minutes on the admission interview with approximately 0-5minutes 
on the medication.662  Vashitz in two separate studies looked at the way in 
which doctors cognitively reconcile medication.  They found that clinicans 
commonly arrange clerking information into two groups conditions and 
medicines assigning mental order in terms of systems.  This goes some way to 
explaining the observations seen, although it is unclear whether this is a result 
of the way they have been taught or whether it is inherent.663,664 
Pharmacy staff 
Pharmacy staff acted as a ‘safety net’ identifying various omissions and 
discrepancies in both Chapters 4 and 5. The evidence base also suggests their 
increased accuracy at eliciting medication histories in comparison to 
doctors.39,49,66,69,71,74,118,122,124,162,208,237,239,277,278,300-321,346-348 This increased 
accuracy poses the question whether medication history should be their role.  It 
was also identified by Kwan et al in a systematic review that pharmacists 
contributed the most to interventions which improved medicines 
reconciliation.665  In the current study, pharmacy staff mainly worked ‘office 
hours’, 9.00am to 5.00pm, on weekdays with lack of weekend cover.  It could be 
argued that pharmacy cover should be increased if pharmacists are acting as a 
‘safety net’ to verify medication histories.  This, however, has staffing and cost 
implications raising the question as to whether priority might be accorded to 
specific points in the hospital system, although there may be some justification 
to consider this on admissions wards.  The findings within this study and the 
personal view of the researcher is that pharmacists have many of the 
appropriate skills to undertake tasks associated with medicines management, 
however, where this proves difficult due to time constraints or cost implications 
other professionals involved should be appropriately competency assessed. 
Through observation the quality of medication histories elicited by staff in A&E 
was found to be poor, mainly due to their focus on stabilising the patient rather 
than providing maintenance care.  As previously discussed, for many patients 
the patient journey through hospital starts in A&E therefore it could be argued 
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that it is important to obtain accurate information from the start, moving the 
verification of medication histories by pharmacists into the A&E setting, shown 
to be effective by Mills and McGuffie who took the medication histories and 
prescribed the medication in this setting.66 
The American Society of Hospital Pharmacists (ASHP) argues that pharmacists 
should take a leadership role in improving medicines reconciliation, acting as 
advocates and medicines experts to provide competence based training, inform 
systems and develop evidence based policy and procedure.340 They should 
identify barriers that prevent effective medicines reconciliation and guide 
workflow development, establishing roles and responsibilities.340  Studies have 
shown decreased error where pharmacists have prescribed existing medication 
at admission both in A&E66 and surgical pre-admission clinics.124,321 It would 
also be more efficient as currently the medication history is being taken twice; 
once by the doctor and again by a member of pharmacy staff, (although this 
does act as a ‘safety net’.)  There is also evidence that non-medical prescribing 
by both nurses and pharmacists is clinically appropriate.354 However, the hours 
worked by pharmacy staff currently only allow for a proportion of medication 
histories to be verified. This has the potential to lead to error in those IMCs not 
reviewed, especially as pharmacists are acting as a ‘safety net’ to identify any 
unintended discrepancies.  If pharmacists were to review every IMC and take 
the initial medication history, pharmacist hours would need to be significantly 
increased and the cost-effectiveness of this evaluated (see section 7.8 Further 
Research).   
Other staff 
This study predominantly looked at the role of doctors, pharmacy staff and 
nurses in the secondary care setting, administrative staff, practice pharmacists 
and GPs in primary care, and to a far lesser extent the community pharmacist 
and ambulance staff.  Whilst it is clear that both community pharmacy staff and 
ambulance staff have a role in assuring accurate medicines information at 
admission, further integration is needed at transitions in care, which may mean 
developing studies to determine the added benefit that both groups can provide 
at admission.  Such work should identify the barriers and enablers specific to 
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ambulance staff bringing patient’s own medication into hospital, and examine 
the accuracy and purpose of the medication histories they take. 
7.5.3  During stay 
During the patient’s stay in hospital they come into contact with many HCPs and 
are involved in many systems, processes and procedures.  In terms of 
medicines reconciliation, the main associated processes are the prescribing, 
alteration and transcribing of medication by prescribers (mainly doctors), the 
administration of medication by nurses and the handover of patients.  
Nursing staff 
There is a lack of evidence recognising the role that nursing staff play in 
medicines reconciliation.  Good practice guidance produced by NHS Greater 
Glasgow and Clyde suggests that nurses should maintain an overview of 
whether patients on their ward have had their medicines reconciled at 
admission, prompting relevant HCPs to take action as required; administer 
medication as directed on the admission chart; incorporate medicines 
reconciliation into handover procedures when patients transfer care and at 
discharge and where the prescribers are nurses ensure that prescriptions are 
accurately and legibly recorded.359  Based on the findings in this current  study, 
nurses have a greater role to play as an educator and administrator of 
medicines; identifying omissions and other discrepancies during the 
administration process, ensuring that they pick up on any cues that the IMC 
may be incorrect.  This stresses the importance of their role within the 
medicines reconciliation process.  They are likewise well placed to identify 
errors and discrepancies on the medication chart through routine observation 
and listening to patients, especially if the patient queries medication.  This has 
not been sufficiently acknowledged in previous literature or in practice.    
Within Chapter 5, all handovers were found to be inconsistent, with lack of 
structure as to which information should be conveyed about medication at 
handovers both on the wards and when the patient is transferring care e.g. to 
another ward or intermediate care.  Whilst handover is usually associated with 
nursing staff, it could be further standardised within all professions. 
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Doctors 
Doctors are responsible during the patient stay for altering medication and 
transcribing IMCs.  It is recognised that transcribing, as part of medicines 
reconciliation, carries a substantial risk of errors,52,78,177,363 with a suggested 
overall error rate of 1% in the UK associated with rewriting charts and writing 
discharge prescriptions.52  Transcribing errors may go unnoticed, and then be 
transferred to the next care setting.  Transcribing was rarely seen within this 
current study, nor its impact on accuracy of information about medication.  
Additional work in the area would be useful to determine the accuracy of 
transcribing and the most appropriate HCP to undertake transcribing – although 
the introduction of electronic systems will eliminate the need for transcribing as 
a new IMC will not be required and information on e-prescribing systems will be 
automatically transferred on to the electronic discharge summary.  
During the observation reported in Chapter 5, the majority of changes to 
medication occurred on the consultant ward round.  These were frequently 
unclear and were not communicated (to other HCPs or the patient).  There is 
little in the literature which looks at the alteration of medication within secondary 
or primary care. One US study however highlighted that the family doctor failed 
to communicate critical elements of medication use to the patient.666  There is a 
lack of evidence which looks at how well information about stopping, starting or 
changing medication is communicated either in the notes or verbal to HCPs and 
to patients.  This needs studying in further detail to quantify the issue and to 
work out any potential barriers and facilitators to improving practice. This could 
be done using cognitive processing/think aloud techniques to be able to 
understand the information intended by the sender and the information elicited 
by the receiver of information.667 
7.5.4   At discharge 
Doctors, pharmacists and nurses currently have very different roles at 
discharge.  It is common practice (and supported by the observations here) that 
the doctor writes the discharge summary; the pharmacy staff check the 
accuracy, then they ensure a supply of medication; then nurses (and 
occasionally pharmacists) counsel the patient. There is a lack of evidence on 
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the accuracy and ability of nurses in counselling patients and whether they are 
best placed to provide this role.   As the number of non-medical prescribers 
increases there is the potential for the transcription from the IMC to the 
discharge summary to change; in some organisations this is already conducted 
by a pharmacist.362 Moreover, nurse and pharmacist prescribers have been 
shown, in general, to make clinically appropriate prescribing decisions.354 As 
previously mentioned, the increased introduction of IT could make transcription 
a redundant process as electronic means can facilitate the transfer of 
information from admission through to discharge (see section 7.6.2 Role of 
Information Technology (IT)). 
7.5.5  In primary care 
Chapter 6 presented the results of a small scale observational study to explore 
medicines reconciliation within primary care and to test the use of an 
observation schedule for the processing of discharge information.  The overall 
model used to process information is the same within all practices and mirrors 
the information processing model suggested by Crowe et al.429  There is wide 
variation, however, in the finer detail of the processes used within each GP 
setting, some, but not all, of this appears to be due to the difference in 
demographics of each of the practices, for example, the larger practices may 
have a person allocated to undertake each stage of processing discharge 
information, whereas others may have staff which undertake several roles.  It is 
important that a clinician reviews and interprets the information received in a 
timely way. This was achieved in several of the practices through a ‘rota’ 
system for the GPs.  The GP is the primary record holder, therefore, accuracy is 
paramount as many rely on this as a source of information, especially at 
admission to hospital and with the increased drive to directly access the 
detailed care record and summary care records from the hospital setting.  A 
different model of reconciliation is needed in primary care to reflect the 
differences in process and acknowledge that the patient journey does not stop 
once the patient is discharged.  There is a great need to improve the quality of 
information emerging from secondary care to decrease the number of 
assumptions that are being made in order to make sense of the information 
304 
 
received.  There is also need to improve the quality of data in the primary care 
EHR and to ensure data is contemporary. 
Community pharmacy 
Community pharmacies can provide medication counselling, support and 
reduce discrepancies at discharge.316,416,417 This is dependent on the receipt of 
relevant discharge information for their patients; often they are unaware the 
patient has been in hospital.360,421  The communication observed between 
community pharmacies and both secondary and primary care within this study 
was ad-hoc and tended to be where the patient was using an MDS.  This is 
supported by previous findings, albeit in the same health economy.360  There is 
greater potential for the role of community pharmacists within medicines 
reconciliation at both admission and discharge than is currently 
happening.107,327 Some hospitals in England are encouraging patients to visit 
their community pharmacy for a Medicines Use Review (MUR) post-discharge, 
despite their being little supporting evidence.435   
7.5.6 Closing the loop 
Once the patient reaches primary care this may not be the end of their journey.  
Patients may be readmitted, for example, the renal and elderly patients seen 
within the study.  Errors which have previously occurred may be compounded at 
re-admission with HCPs not questioning what appears to be well-established 
long term medication.  And undeniably, as seen in Chapter 5, the discrepancy 
may be the cause of their readmission. 
7.6  Strategies for Improvement 
The quantitative and qualitative data highlighted variation in ways of working, 
omission and mis-communication of information with poor patient involvement, 
all which had the potential to lead to medication error or discrepancy.  The data 
also showed that these contributory factors could be counteracted through 
improved patient involvement, increased use of IT, standardisation, optimising 
communication, training and education and improving organisational culture.  
These will be discussed in turn below. 
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7.6.1  Patient involvement in medicines reconciliation  
The patient is the constant throughout the whole medicines reconciliation 
process and therefore can add value and information which cannot be gained 
elsewhere, for example, which medications they are currently taking or 
complying with.509,511-513  The results of Chapters 4 and 5 demonstrate that 
patients were not always involved in the consultation about the medication they 
were taking prior to admission (approximately 50% of consultations); their cues 
and concerns frequently ignored. This lack of involvement was identified as a 
contributory factor to medication discrepancy and error.  Conversely, involving 
the patient created a defence.  When they were involved the patients provided 
supplementary information at admission and were able to provide information to 
primary care on any changes to medication regimens at discharge.  They can 
be a useful resource where information needs to be confirmed as seen in 
Chapters 5 and 6. Patients want to be involved in their care and can 
increasingly play a central role in patient safety.502,503  Patients should always 
be engaged even if they are limited in the information which they can provide 
but still should not be relied on as the sole source as there is potential for even 
the most competent of patients to accidently omit medication due to 
forgetfulness or their acute state. 
Davis et al found that patients were keen to participate in safety related 
behaviours especially if encouraged by the doctor, although they were more 
willing to ask general questions about their care, rather than more challenging 
questions.668  Davis et al’s study, however, only questioned English speaking 
patients.  Potentially different findings may have been found in non-English 
speaking patients or for patients who were more vulnerable.  Davis et al 
suggests the use of social cognition models such as the health-belief model and 
the theory of planned behaviour model to define the key predictors of patient 
involvement in safety.  They also suggest observational studies of patient 
involvement to gain an understanding of different factors that affect patient 
involvement such as socio-demographic factors and physical, social and 
environmental factors and the engagement of HCPs.  This would be pertinent 
and relevant to medicines reconciliation.   
306 
 
The WHO policy specifies that patients and their families must be involved in 
the medicines reconciliation process to optimise treatment and improve safety. 
A competent patient is in the best position to be aware of all the medications 
prescribed by multiple caregivers and can also provide information on exactly 
how they use their medicines, information which cannot be obtained from other 
sources.  Involving the patient can reveal a significant amount of extra 
information not provided by other sources.78,121 Within this study, the extent to 
which the patient was involved in medicines reconciliation associated 
consultations depended on the HCP and the patient; specifically their ability to 
communicate; their knowledge about their medication and their confidence to 
speak out.  The HCPs tended to be process focused and be unaware of any 
nuances from the patient which may explicitly or implicitly suggest an 
intervention was needed.  The ability and willingness of the patient to be 
involved in their healthcare varies from patient to patient.  There can be 
difficulties obtaining accurate information from patients about their medication, 
which may be caused by their acute condition, sensory/cognitive impairment, 
lack of support or language barriers.6,76  This affects both their involvement in 
obtaining an accurate medication history and also their ability to participate in 
patient safety.669 Irrespective, the HCP should try to engage with every patient 
and facilitate their involvement, recognising their limitations and 
vulnerabilities.670   
Over the last decade, there has been a national and international drive2,501 to 
empower patients, promote patient involvement and make them central to 
healthcare, ultimately to improve care and patient safety.502,503,671,672  Building a 
safer NHS for patients: Implementing an Organisation with a Memory 
recognised the need for patients to be involved in their care to achieve patient 
safety.27  Initiation of the NPSA, further promoted patient and public 
involvement, introducing numerous campaigns and guidelines.673  Patients can 
be involved in promoting safer healthcare in various ways, for example, being 
vigilant and speaking up to voice any concerns,  encouraging involvement in 
care or identifying adverse drug ADRs;669 acting as an ‘extra barrier’ or ‘safety 
buffer’.674 An appropriate level of engagement is however, important, so as not 
to damage the patient’s relationship with the HCP or erode trust.670,675 
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Several generalised approaches have shown to encourage patient involvement 
in their own safety.  These include inviting the patient to engage,675,676 providing 
appropriate amounts of relevant information677 and being honest and open.669  
More specifically, in terms of medicines reconciliation, widespread engagement 
could be more effectively facilitated through the employment of an interpreter, 
where needed, or returning when the patient or their carer is present, rather 
than what was sometimes observed; an assumption regarding the patient’s 
ability or willingness to participate.  Patients can also be engaged through self-
administration of medication and counselling.  Counselled patients have been 
shown to have been increased knowledge and to display fewer errors than 
uncounselled patients in recalling information about their 
medication82,383,395,424,537 which is imperative if patients are to be used as a 
source of information within the medicines reconciliation process.   They must 
also be encouraged to bring their medication into hospital with them. 
HCPs must recognise it may be the patient’s first visit to hospital and whilst the 
HCP is familiar with the environment the patient may not be.  The patient may 
have varying concerns which differ from those of the HCP or those that the HCP 
assumes of the patient.  Patients may also feel so unwell that interaction with 
the HCP is not of interest.82  Ultimately, HCPs must be further educated on the 
importance and potential value of patient involvement, making patients central 
to communication and process design.  Organisations should also take 
responsibility for making the patient central to healthcare including reference to 
them in all policies and standard operating procedures (SOPs) and indeed 
potentially involving them in the design of services.678 Further work looking at 
the specific role of the patient in the medicines reconciliation process and their 
ability to be involved is needed.  This could potentially be developed through an 
experience-based codesign with the patient.678 
7.6.2  Role of information technology (IT) in medicines reconciliation  
Recent advances in technology provide opportunity to improve the medicines 
reconciliation process and add safeguards to medicines reconciliation 
processes. IT has a significant role to play in the improvement of safety around 
medicines reconciliation processes.  There were several contributory factors 
identified which would be eliminated through the use of appropriate IT.  These 
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include legibility, the completeness of data and transcribing error.  Ideally an 
integrated system in which the medication history is entered (potentially fed in 
from the primary care EHR), then feeds into the electronic prescribing system 
and subsequently the electronic discharge.  This would contribute toward 
seamless care.  Although, where electronic systems transfer the information 
from one stage to the next there is potential for any errors/discrepancies to be 
carried throughout the patient journey if generated or not identified at 
admission. 
Even though there is increasing evidence that the introduction of IT can reduce 
many of the errors and discrepancies from inappropriate medicines 
reconciliation (as well as assist other patient safety issues), widespread use of 
IT-based interventions within hospitals is low and often limited to specific 
areas.385  IT is slowly being embedded into secondary care at varying rates 
through the implementation of e-discharge, EHRs, and e-prescribing.384,385  
Although this can be ostensibly rather frustrating, the current situation provides 
an increased opportunity to improve the medicines reconciliation process.  As 
the use of e-discharge increases so does its potential for being used as an 
accurate source of medication information at re-admission, provided that the 
medication was reconciled on the first admission.  Data completeness is 
important for patient safety475 and data accuracy still relies on the accuracy of 
the primary care EHR and the completeness of discharge summaries.  There is 
still the need for a human to interpret the information.  Once implemented, IT 
can ensure information is uniformly available and can address active and latent 
failures,475 reducing error for example by using forcing functions to ensure fields 
are not left blank.478   
The Health and Social Care Information Centre (HSCIC), formerly Connecting 
for Health (CfH), have published guidance in an attempt to standardise the 
quality of information within medical records and communications when patients 
are admitted to and discharged from hospital.679  They emphasise that 
discharge planning information should be started at the time of admission.  
They describe the information which should be incorporated into electronic 
discharge communication suggesting that information falls into three categories 
mandatory, mandatory with defaults or optional, employing forcing functions for 
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those which are mandatory.  They go on to specify that a list of medications and 
any changes should be mandatory and specific medication recommendations 
mandatory with a default.  Forcing functions are part of human factors 
engineering to force constraints on systems and processes. 
Despite the positives introduced through IT, it should also be acknowledged that 
the introduction of IT systems brings with it other challenges, new ways of 
working and changes to systems and processes and new types of errors.489  
Within this study, variance in the completion of discharge summaries between 
HCPs was still observed.  The electronic discharge improved the amount of 
information provided, however, it did not eliminate the variance in quantity and 
quality between prescribers.  It would appear that there were mixed feelings and 
lack of understanding by some prescribers of the potential added safety of 
electronic discharge versus paper discharge.  Workarounds were employed, for 
example, amending the electronic discharge summary by hand which led to 
inaccuracies in the electronic system. Also, the sharing of logon details and 
passwords between prescribers following lock-out of the system was seen.  
Challenges have previously been seen elsewhere through the introduction of e-
prescribing, leading to even less engagement with the patient due to the 
difficulties of transporting  a computer terminal around the ward.680  In a five 
year analysis of technology-related medication errors 17.1% technology related. 
98.1% of which were socio-technical errors i.e. due to a human interaction with 
technology, rule violation, slips, mistakes and lapses being the highest cause.681 
7.6.3  Standardisation of medicines reconciliation-related processes 
Bates suggested, in 2000, that healthcare, compared with the manufacturing 
industry, had little standardisation.682  Healthcare processes have grown and 
evolved over the years, adapting to circumstances and new knowledge and 
technologies rather than being designed with patient safety in mind.  They are 
often complex, with no one person responsible for the entire system and simple 
mapping of the processes can be a difficult task.  Various studies show that 
when care is divergent, it can impact on clinical outcomes, potentially leading to 
patient harm.25,683-685  Standardisation of tasks can reduce the complexity of 
working, and improve the receipt of correct medication.685 It is being 
increasingly recognised as a way of improving patient safety.686   
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Standardisation, or the routine application of an evidence based protocols are 
effective for reducing human error, and thus harm, in given situations.687  It 
reduces the reliance on memory and allows consistency in data collecting.  It 
also allows staff to work across multiple areas (as seen in Hospital B), resulting 
in increased efficiency and potentially decreased costs.687,688    Standardisation 
of documentation or proformas have been shown to aid the medication history 
taking process within the UK101,442 and Canada,292 providing appropriate boxes 
and prompts to facilitate information gathering by ensuring consistency and 
completeness of information.401   
Standardisation was observed during clerking and medication history 
verification as standardised documentation together with communication 
proformas were used, also electronic discharge.  Standardisation was also 
observed during nursing handover through the use of SBAR, previously shown 
to improve communication.683,684  In primary care communication documentation 
was also used between one general medical practice and community 
pharmacies to notify them of changes to MDS.  A higher use of EHR was seen 
in primary care which also contributed to increased population of data, however, 
like electronic discharge the complete population of fields does not always 
equate to the accurate completion of fields.  
Despite the growing body of evidence and the success of some standardised 
parts of the process there is still room for further standardisation of policy, 
practice and procedure within medicines reconciliation to reduce the wide 
variation in practice within and between organisations.  This could potentially be 
produced nationally through the implementation of policy standards and toolkit 
development to aid implementation.  There are various toolkits which already 
exist which address current issues to varying degrees.  These could be adopted 
and adapted to fit the UK.2,155,156,268  There is also the potential to increases 
standardisation through the implementation of IT e.g. through the use of 
mandatory fields and forcing functions.  However, just because a box is 
completed it does not necessarily mean that the content is of quality. 
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7.6.4  Optimising communication 
Communication is defined as:  
‘the act or an instance of communicating; the imparting or exchange of 
information, ideas, or feelings’57 
Communication failures are an extremely common cause of avoidable harm.689  
The JCAHO in the US has reported that the primary cause of over 70% of 
serious injury or deaths is failure to communicate.689  Whilst it is unclear 
whether incidents have been analysed in a similar way in the UK, improving 
communication features widely in many of the NPSA alerts6,690-693 and research 
illustrating issues with communication about medication at transition points in 
care, within the UK, dates back over 25 years.40-42  This includes delayed 
untimely communication and provision of inaccurate information. 
As previously discussed communication is one of two contributory factors within 
the YCFF (the other being ‘safety culture’), that intersects all other factors (see 
figure 5.1).  However, the YCFF itself does not provide a detailed exposition of 
communication or safety culture because the systematic review on which it is 
based did not generate evidence to underpin this.  This study demonstrates the 
complexities and interdependencies between coordination of care and 
communication about medication, including the fact that communication is both 
verbal and written.  Both verbal and written communication occur throughout the 
medicines reconciliation process including the documentation of the medication 
history, prescribing, the query of discrepancies, instructions to alter medication, 
production of the discharge summary and alteration of the primary care record 
post discharge.  Throughout this study, in Chapters 4, 5 and 6 communication, 
or lack thereof, has been seen as a continuous theme which has led to 
discrepancies and/or error.  This was due to poor communication between 
HCPs or the HCP and the patient (both within and between primary and 
secondary care).   
Simplistic models of communication describe the movement of information 
between a sender and receiver.613  Assumption was often made both in primary 
and secondary care, especially when interpreting documented information e.g. 
in the notes or discharge summary.  This is a direct failure in communication in 
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terms of both the sender and receiver; the sender perhaps not providing 
sufficient information, e.g. in the patient’s medical notes and the receiver failing 
to clarify e.g. ambiguous notes. Some communication models describe 
communication as a cyclical process.614,694-696  Feedback completes the 
communication loop and is described as the most crucial element provided by 
the receiver to the sender.696,697 Feedback ensures the receiver has received 
the message and interpreted the meaning of the message in the desired way. 
Without feedback, the process of communication is not complete. This is more 
easily completed with verbal communication and ‘closing the communication 
loop’ has been shown to improve patient safety.694-696  it is more difficult to 
‘close the loop’ with written information, especially discharge summaries and 
documentation in notes as often the ‘receiver’ is unable to clarify with the  
‘sender’ when needed.     
Effective communication involves a shared understanding and mental model of 
a situation.  Leonard et al describe this as ‘getting everyone in the same movie’, 
which is potentially where efforts should be focused i.e. a shared understanding 
of medicines reconciliation.698  Reasons why this does not always occur can be 
best described using Gerbner’s model of communication.699  He emphasises 
the dynamic nature of communication and factors which affect its reliability.  In 
essence, communication is the relay of an event (E) which has been perceived 
(E1) by a person (M) (see figure 7.1).  A person is unable to perceive the entire 
event and thus selects and filters information to communicate onwards (content) 
using a certain method (form).  The content relayed is then perceived by the 
person receiving the information, again filtering for content in a similar way.  
This could explain some of the mis-interpretation of information by HCPs and 
the failure to pick up on cues from the patient. Also some of the failure to 
provide sufficient content if the HCP assumed they had explained what had 
happened appropriately or that information provided had been received 
effectively.  
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Figure 7.1 Gerbner’s General Model699 
 
The perception and communication can be affected by human factors including 
the attitude and feelings of the person at the time of communicating or receiving 
communication.  This would be difficult to observe and could only be elicited 
through interviews or focus group.  The contribution of human factors to 
communication failure is well recognised.608,689,700   
Using Berlo’s communication model (discussed earlier in Chapter 5), 
communication is multifaceted. All components must be addressed to 
communicate effectively including the ‘source, message, channel and receiver’ 
(see figure 5.2).615,616  This includes effective communication skills of both the 
‘sender’ and ‘receiver’ and a common culture, knowledge and attitude to be able 
to explain and interpret the message.  The message must be structured and 
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have appropriate content and be communicated by the correct means.  Similarly 
Lingard et al suggest communication fails for different reasons which could be 
used to understand some of the communication failures observed within the 
study.609  These include occasion failures; content failures; audience failures 
and purpose failures.  For example, an occasion failure may be the lack of or 
delayed verification of the medication history by pharmacy staff; content failure, 
the failure to include relevant details in the notes e.g. the form or strength of 
medication; audience failures, the failure to communicate to the correct HCP 
e.g. not notifying the district nurse that they need to administer a medication; 
purpose failure, a discrepancy remaining unresolved following a 
communication.   
Applying these communication models to medicines reconciliation, it is 
important that HCPs have a common understanding and knowledge of a) the 
medicines reconciliation process (including definition), b) the ways in which 
communication can fail and c) the information which needs communicating. This 
would ensure that everyone was ‘in the same movie’. This can be achieved, in 
part, through standardisation such as SBAR and use of proformas for 
documentation to prompt the HCP, as discussed previously in section 7.8.1.  
Standardisation is not the only strategy to improve communication.  Training 
and education plus experiential learning may add benefit. This was seen in 
Chapter 5 when the GP registrars completed the discharge summaries more 
fully after seeing things from the ‘other side’ i.e. in primary care.    It could also 
be achieved through the integration of the COT Criteria and Essential 
communication skills for a medication history interview to improve 
communication skills associated with medicines reconciliation into national 
standards and competency assessments within organisations.610,611   
7.6.5 Training and education 
Internationally, successful educational interventions have been recognised to 
improve the accuracy, knowledge and skills of medication history taking 
amongst HCPs, for example, curricula which specifically focus on medicines 
reconciliation at transition in care and medication history taking.93,96,328,329  
Whilst these interventions were successful, there is often a misperception that 
training and education is a must to improve performance and increase safety.   
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Whilst it is important, it has been suggested that training and education are 
generally a weak safety intervention.21  This is demonstrated in a study by 
Peyton et al showed that although educational intervention of doctors and 
nurses increased the accuracy of medicines reconciliation, it only improved from 
14.4% to 18.9%.118 Russ et al provide an overview of when training may or may 
not be appropriate to improve patient safety (see table 7.2).21  Applied to 
medicines reconciliation this means that training should be undertaken initially 
when first introduced to the concept, however, where the HCP continues to 
conduct a task incorrectly a different type of intervention is probably required. 
In Chapter 5, the concept of conscious competence is discussed.  In order to be 
consciously competent, staff must have an awareness of their own 
performance.  Gallwey specifies that to achieve optimum performance the 
conscious, critical self and the performing self must be recognised without 
passing judgement.701  This is difficult to teach and may in part be solved by 
encouraging HCPs to be reflexive.  Stevick suggests that whilst a student’s 
conscious self is developing, the teacher can ‘lend themselves’ as a conscious 
self, serving as a model for how the student’s conscious self may eventually 
act.702  This makes the idea of leaders, role models and champions for 
medicines reconciliation a must within any given organisation.  One previous 
study has explored the role of champions within the medicines reconciliation 
process, demonstrating successful sustained change which led to increased 
compliance with new processes.703  It created engagement and ‘buy-in’ rather 
than feeling that change was being imposed. 
Understanding the conscious and performing self ultimately requires 
experiential learning. Some guidance and instruction is required, however, what 
is more important is the understanding of how to apply the guideline.  This is 
supported by Walton and Elliot who suggest that quality and safety is best 
undertaken in the workplace rather than the lecture theatres.661  Over the last 
few years there has been a shift from didactic teaching to competence based 
education.704,705  The teaching of communication skills are embedded within 
undergraduate programmes, however HCPs must be able to apply these 
principles to different scenarios, including medicines reconciliation.  This could 
be assessed through the consultation frameworks used within Chapter 5. 
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Table 7.2  Overview of when training may or may not be appropriate as 
a human factor approach to patient safety21 
Training is likely an appropriate human 
factors approach to patient safety if… 
Training is likely an inappropriate human 
factors approach to patient safety if… 
A. The goal is for individuals to become familiar 
with new technologies, tools or devices to learn 
about the available options and functions (e.g., 
training a physician when s/he is first introduced 
to an electronic health record; training when first 
learning how to use laparoscopic tools). 
Training should include knowledge about 
strengths and limitations of specific 
technologies. 
A. The goal is for individuals to stop using 
technologies, tools or devices ‘in the wrong 
way’. (This is described as the ‘bad apple’ 
fallacy. 
B. It allows individuals to develop and test new 
techniques or practice evidence-based 
techniques in a safe, low risk environment (e.g., 
simulation of operating room to practice a team 
communication technique that has been 
demonstrated to improve situational 
awareness.) 
B. It is an attempt to change innate human 
characteristics or imperfections (e.g., staff 
meeting to ‘be more vigilant’ unlikely to lead 
to sustainable safety improvements. 
C. It provides a mechanism for individuals to 
gain experience with specialised techniques that 
involve sensorimotor skills (e.g., performing 
surgeries and catheter insertions with 
supervision or in a simulated environment). 
C. It is intended to address a type of error 
that is occurring across multiple people. 
(This indicates the system design does not 
match human characteristics and that 
system changes, not training, are needed.) 
D. It is used to instantiate knowledge in realistic 
scenarios, such as to practice or test 
procedures for emergency situations (e.g., rapid 
response). 
D. Individuals have been previously trained 
about the safety issue(s) and the problem 
persists. (Additional training is unlikely to be 
effective. The phenomenon above indicates 
there is an issue with other system 
components.) 
E. Other system components are considered 
first, redesigned, and addressed using human 
factors expertise and principles and no other 
system changes can possibly be made. 
E. Training is the only safety intervention or 
the primary intervention used, especially 
when other system components have not 
been carefully considered and modified first. 
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Walton and Elliot suggest a shift in medical education to that which trains HCPs 
on the complexity and interdependence of systems (systems theory) so that 
they have a better chance of making sense of their workplace and the potential 
reasons why things go wrong thus preventing error. By understanding the 
nature of errors and application of quality improvement error can be reduced.  In 
2005, the Australian Council for Safety and Quality in Health Care published the 
National Patient Safety Education Framework (NPSEF).706  It identifies 
competencies which HCPs need to deliver safe healthcare and contains 7 
domains including communication, the management of ADEs and near misses, 
working safely and continual learning; all of which are applicable to medicines 
reconciliation.   
In summary, there needs to be a balance between the level of knowledge and 
skills gained as an undergraduate and those learned in practice in order to allow 
the HCP to be reflexive and apply patient safety, communication and medicines 
reconciliation principles in their practice.  Competence and educational 
frameworks for HCP in both patient and medication safety supported by 
regulatory and professional bodies, similar to the NPSEF in Australia, could 
assist the standardisation of knowledge and skills throughout undergraduate 
curriculum.  These could be developed based on existing literature, together 
with the findings from this study to try to improve the standard of communication 
at transitions and the reconciliation of medicines (see also section 7.8 Further 
Research). 
7.6.6  Improving organisational safety culture  
Safety culture is one aspect of the wider culture of an organisation.  
‘The safety culture of an organisation is the product of individual and 
group values, attitudes, perceptions, competencies, and patterns of 
behaviour that determine the commitment to, and the style and 
proficiency of, an organisation’s health and safety management’ (HSC, 
1993)707.  
‘Organisations with a positive safety culture are characterised by 
communications founded on mutual trust, by shared perceptions of the 
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importance of safety and by confidence in the efficacy of preventive 
measures’ (HSC, 1993)707 
Medicines reconciliation is a complex area of high risk, which although not 
always demonstrated, could lead to serious consequences.  Recognising this, it 
is important that organisations develop a culture of safety such that the 
processes and workforce are focused on a clear goal.11  This was only seen in 
one of the secondary care organisations studied.  To err is Human and Building 
a safer NHS for patients were clear from the outset that for healthcare 
organisations to improve safety they must provide clear leadership, make safety 
and risk everyone’s concern whilst recognising human limits and ability.11,27  
This includes designing processes with safety in mind, avoiding reliance on 
memory, using forcing functions where appropriate, simplifying and 
standardising where possible, promoting effective team functioning, including 
the patient in design of care processes, improving access to information and 
creating a learning environment where everyone learns form error.  This was 
seen in Hospital D, and to some extent in Hospitals B and C, but not in A.  Lack 
of awareness by HCP of the extent to which errors occur and the potential 
causes are a barrier to improving patient safety.  One example, seen within this 
study, was the difference in attitude between doctors who have spent time in 
primary care and seen discrepancies from the ‘other side’, the primary care 
perspective. They were found to complete the discharge summaries more 
thoroughly.  
Culture shapes the clinician and staff perceptions about what is normal 
behaviour in a particular work area. It also influences a person’s motivation to 
engage in safety behaviours.632   There is emerging evidence to support the 
effectiveness of interventions to improve safety culture.632  Westrum suggests 
that leadership shapes culture, which in turn encourages information flow and 
that an open, generative culture leads to the increased uptake of innovation.708  
It is therefore imperative that organisations as well as encouraging a culture of 
safety appoint leaders to drive improvement in medicines reconciliation and 
communication at transitions.   Strategies to improve patient safety culture work 
best when several interventions are combined that focus on leadership, team 
work, and behaviour change.  The most common types of interventions include: 
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team training, team communication tools, executive walk rounds and 
interdisciplinary rounding.  Weaver suggests the organisation should consider 
incorporating these elements in order to improve safety culture.632   Tools  exist 
which allow organisations to assess their safety culture.709,710   
Recently, an interest in HROs has been explored.  High reliability organisations 
(HROs) are:  
‘Organisations that work in situations that have the potential for large-
scale risk and harm, but which manage to balance effectiveness, 
efficiency and safety.  They also minimise errors through teamwork, 
awareness of potential risk and constant improvement.’711 
A small number of studies have considered HROs in healthcare, whilst there is 
little empirical evidence exploring the links between HROs and safety culture, it 
is thought that HROs have a positive safety culture.711  The AHRQ in the US 
has issued guidance for hospital leaders on becoming a HRO which 
recommends strong leadership, ownership, appropriate policies and procedures 
a safety culture and just culture, similar attributes to those suggested to 
promote a culture of patient safety.712  These principles in turn should be 
applied to medicines reconciliation processes to improve safety and outcomes. 
7.7  Recommendations for Practice, Policy and Theory 
The findings within this study have a series of implications for practice, policy 
and theory.  The following recommendations are suggested based on these 
findings, supported through existing literature. First and foremost, a common 
definition of medicines reconciliation must be accepted nationally to ensure a 
shared understanding across organisations and between HCPs. 
Each organisation within this study and within the UK appear to be at varying 
stages in  improving medicines reconciliation.  Ideally, improvement should also 
incorporate cross-organisational benchmarking.  However, this is likely to prove 
difficult due to the lack of replicable quality indicators for medicines 
reconciliation; the lack of 'Gold-standard' methods for eliciting a medication 
history and transferring information across the interface; and the processing of 
this information within primary care.  This lack of standardisation has the 
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potential to lead to error.  Some national organisations have attempted to 
progress standardisation through the publication of various documents e.g. RPS 
which address aspects of medication safety at transitions.276,648,650,713   These, 
however, have predominantly used consensus of expert opinion rather than 
drawing on the extensive evidence base and or employing a theory-based 
approach.  Much of the previous focus has been targeted at secondary care.  
Whilst this still remains important, this study has shown that an increased focus 
in primary care is also required to improve standard operating procedures and 
the way in which discharge summaries are processed. 
This study has demonstrated that accurate medicines reconciliation requires a 
combination of appropriate questioning, together with effective, patient-centred 
communication skills plus correct interpretation of the information 
gathered.  Considering this, together with the contributory factors and defences 
identified, a framework of standards for medicines reconciliation should be 
developed using the evidence-informed observation schedules as a template 
and integrating the consultation frameworks used for analysis of 
communication.  The next stage would be to evaluate this overarching 
medicines reconciliation framework using a multidisciplinary group from primary 
and secondary care organisations potentially employing either a Delphi 
approach or focus groups.  Ultimately testing these in practice and determining 
their applicability to other specialities and settings, for example, surgical wards, 
hospices and psychiatry.  Fernandes et al suggest an evidence based bronze to 
platinum ranking which looks at the varying intensity of medicines reconciliation 
activities conducted and could be used to ascertain different levels of attainment 
in  implementing good practice, ultimately providing a way of ranking 
improvement within an organisation (see table 7.3).289  
The NHS medication safety thermometer is seeking to improve this through 
collating data nationally on safety measures including medicines reconciliation 
to allow organisations to determine their position.714  The NHS safety 
thermometer, nevertheless, is only quantitative, and does not look at the quality 
aspects of the process (i.e. just because an organisation reconciles medication 
for a high number of patients does not mean that they are accurate or that the 
best possible process is being used).714  The NHS Safety Thermometer is 
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currently under review as it has been criticised for measuring point prevalence 
rather than trends over time (Gerry Armitage. Professor, Health Services 
Research, University of Bradford. Personal Communication. 24th February 
2014)  The suggested framework would provide a way of measuring the quality 
aspects of the process. 
Organisations must also clearly define the roles and responsibilities of their 
staff, determining the most appropriate skill mix for their organisation, whilst still 
recognising the limitations of the individual professions.  Most significantly, the 
feasibility of pharmacy staff undertaking the initial medication history in terms of 
both accuracy and cost effectiveness should be fully evaluated given the wide 
body of literature and findings within this study.  The ability of nursing staff to 
counsel effectively at discharge should also be considered.  The nursing 
profession must also recognise the role they play within medicines reconciliation 
and the importance of information provided by patients during administration 
rounds.  Community pharmacist could also have a greater role at both 
admission, providing information and at discharge, ensuring patients 
understand their medication.360,439 
This thesis developed two evidence-informed observational schedules which 
were tested in practice then used as a framework to analyse the qualitative 
observations.  Communication models including consultation models were also 
explored and successfully used to analyse patient-HCP interaction.  Similarly, 
the YCFF was used as an analytical framework to categorise both the 
contributory factors and defences that affect the medicines reconciliation 
process.  There is the opportunity that it could be applied to other observational 
work within patient safety to gain a deeper understanding of factors which could 
lead to error or patient harm, provided it is allied with other quantitative  and 
qualitative methods that triangulate findings e.g. focus groups, questionnaires, 
interviews.  
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Table 7.3   Medicines reconciliation in varying levels of intensity as seen 
in published studies 289 
Level Key components Published 
Examples 
Bronze BPMH with admission reconciliation 50,124 
Silver Bronze level + reconciliation at discharge 
by prescriber only ± electronically 
generated discharge prescription 
183,463 
Gold Silver level + discharge reconciliation is 
interprofessional e.g. prescribing 
physician and pharmacist collaboration + 
electronically generated discharge 
prescription 
71,463 
Platinum Gold level + attention to broader 
medication management issues e.g. 
appropriateness of agents, safety and 
effectiveness assessment + medication 
counselling prior to discharge (including 
discussion of medication changes) + 
provision of patient friendly reconciled 
medication schedules at discharge 
71,100,105,122 
Diamond Platinum level + additional elements such 
as post discharge follow up phone call by 
HCP 
Communication of medication changes 
with rationale directly to community 
pharmacy and primary care physician 
123,312,403,405 
7.8 Further Research 
The findings within this study have identified further areas associated with 
medication error at transitions which should be prioritised for research.  These 
have been outlined throughout the thesis with the key suggestions summarised 
in this section.   
Studies exploring the rate of discrepancies and errors which go on to cause 
tangible or measurable harm are needed to be able to more accurately look at 
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potential cost and cost savings due to intervention.  These are difficult to design 
as it would be unethical to identify discrepancies in IMCs prospectively and not 
intervene to determine whether or not they would go on to harm.  For this 
reason it must be done retrospectively, perhaps identifying the number of harm 
events that occur within a given timeframe, possibly identified through incident 
reporting or potentially prospective data collection, followed by the retrospective 
analysis of the number of discrepancies which occurred over the same 
timeframe.   Further studies should also consider the identification of measures 
of severity which recognise that not all discrepancies will result in patient harm. 
The accuracy of pharmacists taking the initial medication history and prescribing 
at admission, in comparison to doctors in the UK, should be explored through 
redesign of medication clerking processes to involve pharmacists using quality 
improvement techniques.  This should be followed by an evaluation post 
implementation using a controlled before and after design.  Alternatively a 
randomised control trial could be used to determine whether the frequency and 
severity of discrepancies decrease when pharmacists take the initial medication 
history.  
Frameworks of standards for the medicines reconciliation process, plus 
competence and educational frameworks should be developed and tested.  This 
could be conducted using the literature review, findings from this study, and the 
evidence-informed observation schedules as a template, integrating the 
consultation frameworks used for analysis of communication.  The development 
of competence and educational frameworks for HCP based on existing literature 
and findings from this study in both patient and medication safety supported by 
regulatory and professional bodies, similar to the NPSEF in Australia, could 
assist the standardisation of knowledge and skills throughout undergraduate 
curriculum.  A multidisciplinary group from primary and secondary care 
organisations potentially employing either a Delphi approach or focus groups 
could be used to develop these, before testing these in practice.  Their 
applicability to other specialities and settings, for example, surgical wards, 
hospices and psychiatry could also be tested to try to improve the standard of 
communication at transitions and the reconciliation of medicines. 
324 
 
7.9  Strengths and Limitations of the Overall Study 
The strengths and limitations of this study have been discussed in detail in 
previous chapters, consequently this section will summarise those judged to be 
the most notable, and those which have the broadest relevance to the entire 
study.  The overall study design uses a pragmatic mixed methods approach 
which allows triangulation of quantitative with qualitative data.  It has also 
allowed the quantitative findings to be contextualised through observation of 
primary and secondary care.  At the time of writing, this approach does not 
appear to be evident in any previous medicines reconciliation studies.   
An extensive literature review was conducted which informed the development 
of evidence informed observation schedules that were subsequently tested in 
practice.  Epidemiological work demonstrated that the scale of the problems 
identified within the literature review existed within the research sites and 
consequently justified further exploration of the problem and undeniably the use 
of observation.  The observation went on to identify contributory factors and 
defences from which specific interventions could be developed, or the process 
redesigned. 
Despite these strengths, the study is only conducted in one health economy, 
nevertheless, the multi-centre design and purposive sampling allowed sites to 
be chosen to maximise generalisability and, in qualitative terms, transferability.  
Although some multi-centre studies have been published before in abstracts in 
the UK, none have previously been completed in the same depth.  A key 
strength of the research design is the focus on care transitions, although the 
study only looks at the interface between hospital and general medical practice 
rather than other interfaces such as care homes and community pharmacy.  
This work also included medical, elderly and renal patients.  Whilst this is 
limited, and not a fully representative patient population, there is a significant 
body of evidence which demonstrates that similar reconciliation errors and 
discrepancies occur in areas such errors paediatrics, surgery and psychiatry.   
The gap in evidence concerning the nature of contributory factors in these 
specialties, however, remains.  Further work looking at a broader applicability of 
the findings would be of benefit.  There may be other potential challenges with 
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medicines reconciliation in these specialties, for example surgical patients may 
be away from their bedside in theatre, paediatric patients may rely more heavily 
on a carer to provide information and mental health processes differ from acute 
hospitals in the way they conduct ward rounds. 
The researcher’s role as a pharmacist is a strength as it facilitated access to 
research sites and allowed the researchers professional knowledge to be 
applied to the study design and data analysis, however, it could potentially also 
lead to bias.  This was minimised through reflexivity by the researcher.  It is 
unclear the advantage of the researchers employment in the NHS or as a 
pharmacist.  Whilst the employment of the researcher within one of the NHS 
hospitals being studied may have made the researcher appear more bona fide 
to the participants, it may also have created bias within observation.  Insider 
knowledge can cause blindness and lack of objectivity.   
Despite the limitations above, the principal strength of this study is that it is the 
first multi-centre, mixed-methods study to review the entire process of 
medicines reconciliation across primary and secondary care within the UK and 
internationally. 
7.9  Conclusion 
Research illustrating issues with communication about medication at transition 
points in care dates back over 25 years within the UK, with medication, 
communication and care coordination continuing to be a problem.  Previously 
studies of medicines reconciliation have looked at the scale of error and 
discrepancy and suggested interventions to improve inaccuracy at care 
transitions, without exploring the reasons why such phenomena occur.  This 
mixed methods study has appraised routine medicines reconciliation practice 
across in four health economies in West Yorkshire, examining the entire 
process from hospital admission through to discharge and into primary care.  
Following a large scale literature review, the roles of different HCPs involved in 
the process were examined, alongside that of the patient and their interaction 
with the healthcare team. The various systems that support reconciliation have 
also been appraised including IT; the analysis was enhanced by a human 
factors perspective, so as to determine the safety of the process.   
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Firstly, the study determined the type and severity of discrepancies occurring at 
admission to hospital so as to demonstrate that medicines reconciliation 
discrepancies were a problem in the research sites studied and to justify further 
exploration of the problem. This was followed by a qualitative observational 
study of current medicines reconciliation practice in both primary and secondary 
care.  Two evidence-informed, observational schedules were developed, tested, 
and used as a framework for data collection and analysis.   The YCFF was also 
applied to identify potential factors which contribute to medicines reconciliation 
error/discrepancy, and also to identify and categorise potential defences which 
could lead to the reduction of such errors or discrepancies.608 Finally 
consultation models were used to examine HCP-patient interaction. 
Both quantitative and qualitative findings have shown wide variation in practice 
both within and between organisations, some of which was detrimental to the 
accuracy of medicines reconciliation. The quantitative findings demonstrated 
higher rates of unintended medication discrepancies per patient than in 
previous studies; however, the majority were omissions, consistent with other 
research.  And, although the literature and results in Chapter 4 strongly suggest 
that the majority of discrepancies related to medicines reconciliation do not 
relate to patient harm the study has demonstrated that a small but clinically 
significant majority were judged to cause harm. The observation placed the 
quantitative findings in context, inadequate communication, specific individual 
factors such as variation in approach and assumptions made about patients, 
and patient factors such as lack of capacity or understanding of English were 
commonplace. The quantitative findings also showed that the patient and 
patient’s own medication were used in less than half of all medicines 
reconciliations with much time being spent waiting for information from general 
practice.   This was supported by the qualitative findings which determined that 
patients were not routinely involved in discussions about their medication, 
despite their capacity to do so, and were also unlikely to be given medicines 
information during admission, including changes to their prescription.  Areas of 
good practice which acted as defence against errors and/or discrepancies were 
identified.  These were mainly attributable to individuals and teams gained from 
their experience e.g.  looking for certain ‘red flags’ within information sources 
rather than the organisations themselves. However, some organisations had 
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standardised the process e.g. documentation and implemented electronic 
discharge systems. The better use of IT would potentially reduce some of the 
potential risks, mindful that it could also introduce new types of error as novel 
ways of working are established.  
These findings suggest potential reasons why there is such a high rate of error 
associated with medicines reconciliation.  This work can also inform the design 
of interventions which target the cause of mis-communication about medication 
at interfaces in care. There is an increased need for consistency and greater 
standardisation of medicines reconciliation-related policy, procedures and 
documentation.  This could be achieved through adoption of established good 
practice, better utilisation of IT and improvement of safety culture.  Also, the 
development of a framework of standards which could be used as an 
assessment tool for organisations to assess their practice and benchmark their 
service quality.  A review of skill mix is also needed to determine the most 
suitable staff to undertake relevant tasks associated with medicines 
reconciliation.  
This study looked specifically at medical and renal patients; the generalisability 
and transferability of these findings to other specialties is unclear.  Although the 
interface between secondary care and general practice, was studies. Other 
interfaces such as secondary care and intermediate care or care homes were 
excluded.  
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